the next EVRA patch should be apply on the usual “ Change Day ” .
figure 3 :
when reconstitute 250 microgram / ml ( 8 mio IU / ml ) Interferon beta-1b .
frequency per dose be define a follow :
DISPOSAL
adverse Reactions
Me
Electrophysiological study demonstrate that olanzapine selectively reduce the firing of mesolimbic ( A10 ) dopaminergic neuron , while have little effect on the striatal ( A9 ) pathways involve in motor function .
11 .
the needle cover of the pre-filled syringe contains dry natural rubber ( a derivative of latex ) , which may cause allergic reaction . lp
severe gastro-enteritis define a a score ≥ 11 on the Vesikari scale ( § ) ATP cohort for efficacy * Statistically significant ( p & lt ; 0.05 )
product invent name
therefore , KOGENATE Bayer should be use during pregnancy and lactation only if clearly indicate .
general CLASSIFICATION FOR SUPPLY
5 LT-08409 Vilnius Lithuania
read all of this leaflet carefully before you start take this medicine , even if this be a repeat prescription .
to help reduce these symptom your doctor may advise you to take a fever-reducing painkiller before a dose of Rebif and then for 24 hour after each injection .
transdermal use .
2 .
check with
Special STORAGE CONDITIONS ed
list OF EXCIPIENTS
443 Ísland Vistor hf .
if you be use Neupro for Parkinson ’ s disease the following side effect may occur :
15 mg / kg / day a 2 divided dos ( n = 17 )
4 .
Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom
4 Member State EU / EEA
renal and Urinary Disorders
14 tablet 28 tablet 56 tablet 56 x 1 tablet 98 tablet
buprenorphine be metabolise by 14-N-dealkylation and glucuroconjugation of the parent molecule and the dealkylated metabolite .
change the site with each injection may help to prevent such skin change .
check with your child ’ s doctor .
sign and symptom Very common symptom in overdose ( & gt ; 10 % incidence ) include tachycardia , agitation / aggressiveness , dysarthria , various extrapyramidal symptom , and reduce level of consciousness range from sedation to coma .
7 .
20 The result of the 48 week analysis of the South African study BI 1100.1368 confirm that the 4 / 7 mg / kg and 150 mg / m2 nevirapine dose group be well tolerate and effective in treat antiretroviral naïve paediatric patient .
ori Diagram T
1,200 / 100 b.i.d .
do not take Carbaglu :
14 .
general
gastrointestinal disorder
PHARMACEUTICAL FORM
content BY WEIGHT , BY VOLUME OR BY UNIT
this infusion solution must be use within 24 hour if store at ≤ 25 ° C ( ≤ 77 ° F ) or within 48 hour if store refrigerate at 2 to 8 ° C ( 36 to 46 ° F ) .
3 .
in these patient consideration should be give to use a different type of dialysis membrane or different class of antihypertensive agent .
why have Pritor be approve ?
DEFINING CLINICAL SIGNS None Definite pink to red coloration Increased redness , possible oedema Very red , with oedema , with or without vesiculation Deep red , swell and oedema with or without sign of bulla formation and necrosis
Boehringer Ingelheim Comm . V .
2 .
the incidence of clinically significant decrease in haemoglobin ( & gt ; 2 g / dL ) , confirm by repeat testing , be significantly lower in patient on celecoxib compare to the NSAID group , relative risk 0.29 , 95 % CI 0.17- 0.48 .
control clinical trial include approximately 2100 patient of Hoehn and Yahr stage I – IV .
treatment of duodenal ulcer : one 30 mg capsule every day for 2 week
20 % to 61 % , p & lt ; 0.001 ) .
5.1 Pharmacodynamic property
general CLASSIFICATION FOR SUPPLY
in the outer package and discard or whenever possible hand in to your pharmacist .
3 .
combination antiretroviral therapy have be associate with redistribution of body fat ( lipodystrophy ) in HIV patient include the loss of peripheral and facial subcutaneous fat , increase intra-abdominal and visceral fat , breast hypertrophy and dorsocervical fat accumulation ( buffalo hump ) .
CSF and Plasma Pharmacokinetics of Ziconotide & # 91 ; mean ± SD ( median ) & # 93 ;
not all pack size may be market .
absorption : peak efavirenz plasma concentration of 1.6 - 9.1 μ M be attain by 5 hour follow single oral dos of 100 mg to 1,600 mg administer to uninfected volunteer .
5 .
8 .
Polska Ul .
general CLASSIFICATION FOR SUPPLY
20 mg
be sure to discuss this with your doctor .
haemoglobin decrease
patient should brush their teeth thoroughly twice daily and have regular dental examination .
effective contraceptive measure must be take by woman of child-bearing potential .
Wyeth Europa Ltd .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
in case of severe or recurrent headache , visual problem , nausea and / or vomiting , a fundoscopy for papilloedema be recommend .
time , hour
312
headache Dizziness , somnolence , paraesthesia , syncope
name OF THE MARKETING AUTHORISATION HOLDER
Citrulline or arginine supplementation be require for patient diagnose with neonatal-onset form of carbamyl phosphate synthetase or ornithine transcarbamylase deficiency at a dose of 0.17 g / kg / day or 3.8 g / m2 / day .
method AND ROUTE ( S ) OF ADMINISTRATION
skin infection ( e.g . folliculitis ) .
close clinical monitoring be require when deferasirox be combine with these substance .
discus with your doctor whether you can drive or use machine at all , if you have a lot of hypo or if you find it hard to recognise hypo .
follow an infusion of Paxene , the patient ’ performance at skilled task ( drive , operate machinery , etc . ) may be impaired due to the alcohol content of Paxene ( see 4.4 and 6.1 ) .
- with a long history of diabetes ,
Rebetol
there be limited information available with regard to overdose in human .
severe hypoglycaemia may lead to unconsciousness and / or convulsion and may result in temporary or permanent impairment of brain function or even death .
hypotension , orthostatic blood pressure decrease , syncope , flush
5 .
in a study in 722 randomised patient not adequately responsive to hydrochlorothiazide 25 mg treatment , the combination of aliskiren / hydrochlorothiazide 300 mg / 25 mg produce systolic / diastolic blood pressure reduction of 16.78 / 10.7 mmHg , which be significantly greater than hydrochlorothiazide 25 mg monotherapy .
+ p & lt ; 0.0001 EFFENTORA versus placebo , in favor of EFFENTORA , by an analysis of variance PID = pain intensity difference ; SEM = standard error of the mean
name OF THE VETERINARY MEDICINAL PRODUCT
14 PACKAGE LEAFLET
in the elderly , progressive deterioration of renal function may lead to a steady decrease in insulin requirement .
Nederland Novartis Pharma B. V .
post Marketing adverse event have be spontaneously report for Silgard and be not list above .
careful control of your diabetes , and prevention of hypoglycaemia , be important , also for the health of your baby .
( C ) Turn dose knob clockwise until a “ 2 ” appear in the dose window .
guidance be give separately for adult and paediatric patient .
you should not throw away any medicine through wastewater or household waste .
for any information about this medicine , please contact the local representative of the Marketing Authorisation Holder .
if you be not able to swallow or if you be unconscious , you will require an injection of glucose or glucagon ( a medicine which increase blood sugar ) .
manic episode in Bipolar I Disorder - in a 12-week controlled trial , the incidence of EPS be 23.5 % for aripiprazole-treated patient and 53.3 % for haloperidol-treated patient .
E .
CHMP / 1268 / 04
insulin overdose may lead to severe and sometimes long-term and life-threatening hypoglycaemia .
each soluble tablet contain 100 mg of 13C-urea
not all pack size may be market .
4 .
in conclusion , the CHMP considers Implanon to be an effective method of contraception with no apparent safety concern and that the benefit-risk balance of Implanon be positive .
Humira 40 mg solution for injection in pre-filled syringe be supply a a sterile solution of 40 mg adalimumab dissolve in 0.8 ml solution .
adverse reaction in clinical trial in HIV Patients Blood and lymphatic system disorder
1 .
also tell your doctor if you have have a kidney transplant or if you have be tell that you have a narrowing of your kidney artery .
instruction ON USE
France :
method OF ADMINISTRATION a
therefore you should immediately stop take PROTELOS and see your doctor if you experience symptom of angioedema or hypersensitivity syndrome .
the amount of urine you produce ) .
guidance on the pharmacodynamic section of the summary of product characteristic for antibacterial medicinal product Points to consider on Biostatistical / methodological issue arise from CPMP discussion on licensing application :
12 / 12 / 2008
a ) 13.2.1996 b ) 8.7.1996 c ) OJ L 170 , 9.7.1996
administration of activated charcoal to healthy volunteer immediately or up to two hour after ingestion of amlodipine have be show to significantly decrease amlodipine absorption .
you must tell your doctor if you think that you be ( or might become ) pregnant .
what Helixate NexGen 500 IU IS AND WHAT IT IS USED FOR
Mixtard 30 InnoLet 100 IU / ml
high blood pressure , if not treat , can damage blood vessel in several organ , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
example of symptom that tell you that your blood sugar level be fall too much or too fast : sweating , clammy skin , anxiety , fast heart beat , high blood pressure , palpitation and irregular heartbeat .
the Committee for Medicinal Products for Human Use ( CHMP ) decide that Pylobactell ’ s benefit be greater than it risk for the in vivo diagnosis of gastroduodenal H. pylorus infection .
inspect for particle a before , and do not use if the solution be not clear .
6 .
if such medicinal product be to be administer with food , patient should be advise to , if possible , take them with a meal when BYETTA be not administer .
therefore , patient should consult their physician a to whether drive or use of machine be permit .
25 Yondelis be supply in a Type I colourless glass vial with a bromobutyl rubber stopper cover with an aluminium flip-off seal .
4.5 Interaction with other medicinal product and other form of interaction
renal and urinary disorder :
4 .
a a general recommendation , caution should be exercise when treat the elderly ( see section 4.2 and 4.4 ) .
3 ) • European Parliament and Council Regulation ( EC ) No 141 / 2000 of 16 December 1999 on orphan medicinal product ( OJ L 18 , 22.1.2000 , p .
Musculoskeletal , connective tissue and bone disorder
co-administration of multiple dos of sitagliptin ( 50 mg twice daily ) and metformin ( 1,000 mg twice daily ) do not meaningfully alter the pharmacokinetics of either sitagliptin or metformin in patient with type 2 diabetes .
6.6 Special precaution for disposal and other handling
3 Adult patient on peritoneal dialysis The treatment be divide into two stage :
this can be discuss with your doctor .
100
BATCH
keep out of the reach and sight of child .
an analysis of safety data in patient ≥ 60 year of age treat with Xeloda monotherapy and an analysis of patient treat with Xeloda plus docetaxel combination therapy show an increase in the incidence of treatment-related grade 3 and 4 adverse reaction and treatment-related serious adverse
ho Hold the new IRU so the top be face you .
Czech Republic
it be recommend that
gastrointestinal disorder :
3 year
7 Renal and urinary disorder adverse event :
blister of 7 tablet
clinical study have demonstrate that adult patient receive r-HuEPO one , two or three time weekly may be convert to once weekly or once every other week Nespo .
lower the amount of angiotensin II allow the blood vessel to relax ; this lower blood pressure .
the dose may be increase by approximately 25 % of the previous dose if the rate of rise in haemoglobin be le than 1.0 g / dl ( 0.621 mmol / l ) over a month .
NovoRapid InnoLet 100 U / ml Solution for injection in a pre-filled pen Insulin aspart
BATCH NUMBER
EU / 1 / 07 / 419 / 003
nervous system disorder
3 .
B .
the blood-pressure-lowering effect be sustain during long-term treatment , and be independent of age , gender , body mass index and ethnicity .
p-value
DATE of first authorisation :
none .
EU / 1 / 07 / 415 / 047 EU / 1 / 07 / 415 / 048 EU / 1 / 07 / 415 / 049 EU / 1 / 07 / 415 / 050 EU / 1 / 07 / 415 / 051
rubber membrane
not know :
in the study of patient with advanced phase CML or Ph + ALL , the response in term of blood count be also similar with once- and twice-daily Sprycel .
co-administration of EMEND with warfarin result in decreased prothrombin time , report a International Normalised Ratio ( INR ) .
1 vial contains 50,000 IU epoetin beta .
60 day from the confirmation of Bacillus anthracis exposure
14 - Dispose of the vial and the remain unused portion of the solution into the disposal unit .
statement OF ACTIVE SUBSTANCE ( S )
hypersensitivity to the active substance or to any of the excipients Uncontrolled hypertension .
in 2002 a number of new activity in relation with orphan medicine be initiate or develop .
if you have vision problem , faint or experience confusion or hallucination while take Ketek , do not drive , operate heavy machinery , or engage in dangerous activity .
1 .
fertility , prenatal development and postnatal development be unaffected in rat .
it may harm them , even if their symptom be the same a yours .
the container must not be refill .
Merck Sharp & amp ; Dohme B. V .
you may need treatment for them , or your doctor may decide to change your dose of Nexavar , or stop treatment altogether .
9 .
11 .
during 1997 a total of 62 inspection be request by the CPMP and CVMP in connection with the assessment of 68 application .
HVL ( & gt ; 600,000 IU / ml )
Eesti Österreich Merck Sharp & amp ; Dohme OÜ Tel . : + 372 6139 750 msdeesti @ merck.com
in adult patient receive interferon in combination with ribavirin , the achieve sustained response rate be 47 % .
the solution should be administer slowly , at a rate a determine by the patient ’ s comfort level , not to exceed 10 ml per minute .
capsule
surgery patient in autologous predonation programme
España Km .
manufacturer ( S ) OF THE BIOLOGICAL ACTIVE SUBSTANCE ( S ) AND MANUFACTURING AUTHORISATION HOLDER ( S ) RESPONSIBLE FOR BATCH RELEASE
pancreatitis
2 .
no data be available to make a dose recommendation .
pharmacokinetics in special patient group
efavirenz regimen
4 .
46-56
certain medicine may interfere with the effect of Glivec when take together .
the carcinogenic potential of darbepoetin alfa have not be evaluate in long-term animal study .
Roche Registration Ltd .
dopamine agonist and antagonist act on the postsynaptic dopamine receptor be not expect to interfere with DaTSCAN image and can therefore be continue if desire .
treated animal should be keep warm and at a constant temperature , both during the procedure and recovery .
method OF ADMINISTRATION
Corporation Tel : + 359 2 970 43 21
Amenorrhoea , impotence , breast pain , menorrhagia , menstrual disorder , ovarian disorder , vaginal disorder , sexual dysfunction ( not specify ) , prostatitis
NeoRecormon Multidose 50,000 IU Lyophilisate and solvent for solution for injection ( 5000 IU / ml ) Epoetin beta
tacrolimus be not anticipate to impact exposure of efavirenz .
15 .
this article cover revenue from programme carry out jointly with other regulatory agency ( inside and outside the EU ) , pharmaceutical company or other body authorise by the EMEA & apos ; s Management Board .
Eisai Ltd . , Mosquito Way , Hatfield , Herts , AL10 9SN , UK
the in vivo bioequivalence study show an equivalent but statistically significant superiority for the test product for Cmax and a shorter Tmax , indicate that the test product have a slightly higher peripheral deposition .
press the injection button completely in to discard the insulin .
N. V .
2 .
20000 IU
S R.O .
the WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN ”
package LEAFLET
generalise hypersensitivity reaction include erythema , urticaria , rash and pruritus have be observe uncommonly ( approximately 0.1 % of all patient treat with Fertavid ) .
powder and solvent for suspension for injection
therapy ( N = 453 ) Sitagliptin 100 mg once daily
1 .
infusion rate for 75 kg patient ml / h Concentrations of rFVIII solution 100 IU / ml 200 IU / ml 400 IU / ml
Tel : + 356 25600 500
Special WARNING ( S ) , IF NECESSARY
- antipsychotic ( medicine use to treat psychosis )
& # 91 ; 95 % CI :
see also section 4.4 .
manufacturer ( S ) OF THE BIOLOGICAL ACTIVE SUBSTANCE ( S ) AND MANUFACTURING AUTHORISATION HOLDER ( S ) RESPONSIBLE FOR BATCH RELEASE
elimination The terminal half-life be determine by the rate of absorption from the subcutaneous tissue .
TAC-treated patient subset accord to prospectively defined major prognostic factor be analyze :
discus with your doctor whether you can drive or use machine at all , if you have a lot of hypo or if you find it hard to recognise hypo .
QUALITATIVE AND QUANTITATIVE COMPOSITION
118 ( 56.5 % )
Special population ro
no significant difference be see in the STEMI population .
the possibility that the patient be take other medication that interact with methotrexate ( eg , medication which may interfere with methotrexate elimination or binding to serum albumin ) should always be consider when laboratory abnormality or clinical toxicity be observe .
ear and labyrinth disorder Sudden deafness2 System Organ Class :
be familiar with your warning symptom .
50 microgram
medicinal product subject to medical prescription .
at mid-cycle , high level of LH trigger corpus luteum formation and ovulation .
not know :
pregnancy
in Study III the efficacy and safety of abatacept be assess in patient with an inadequate response to a TNF blocking agent , with the TNF blocking agent discontinue prior to randomization ; other DMARDs be permit .
Diovan 40 mg
rare : severe hypersensitivity / allergic reaction , which may include swell of the face and / or lip , difficulty in breathing , and / or shock ( cardiovascular collapse )
in placebo control trial temporary iron deficiency be more pronounced in patient treat with NeoRecormon than in control ( see section 4.4 ) .
5b 5b 6c 7d
use of EU special contribution for orphan medicine 2001
use any eye ointment or eye gel last .
opaque PVC / Aclar blister with push-through aluminium lidding in pack size of 14 , 28 , 56 , 84 , 98 , 168 , 196 modified-release tablet , multi-packs contain 196 ( 2 pack of 98 ) modified-release tablet and 49 x 1 modified-release tablet in perforated unit dose blister .
MARKETING Authorisation Holder and Manufacturer
keep out of the reach and sight of child .
the distribution and elimination kinetics have generally be describe by a bi-exponential decay function , with a terminal half-life of 6-15 h .
Malta Chiesi Farmaceutici S. p . a Tel : + 39 0521 2791
- Benign intracranial hypertension ( high pressure within the brain ) have be report during
hypertensive crisis Hypertension
content BY WEIGHT , BY VOLUME OR BY UNIT
metabolism and nutrition disorder
1 .
Table 1
- if the solution be cloudy or there be particle in it .
weight increase *
if your blood sugar be too high ( hyperglycaemia ) , you may not have inject enough insulin .
all patient , irrespective of genotype , who have demonstrate serum HCV-RNA below the limit of detection at Week 12 should receive 48 week of therapy .
Gastro-resistant capsule , hard
EXP { month / year } Once broach , use within 8 hour
16 .
9 .
in a clinical trial with 172 patient receive basiliximab , the incidence of human antimurine antibody ( HAMA ) in renal transplantation patient treat with basiliximab be 2 / 138 in patient not expose to muromonab-CD3 and 4 / 34 in patient who receive muromonab-CD3 concomitantly .
5.1 Pharmacodynamic property
this medicinal product be authorise in the Member States of the EEA under the following name :
comparison show that the pharmacokinetics of darbepoetin alfa be similar for paediatric and adult patient with CRF .
Epistaxis Throat tightness
contains lactose and wheat starch .
the observed undesirable effect be generally of a mild severity .
4 .
Insuman Comb 15 100 IU / ml suspension for injection in a cartridge
12 .
in addition , an updated RMP should be submit
- Restlessness
infection and infestation
if renal failure occur , treatment should be discontinue .
this be describe in section 2 of this leaflet under “ Take special care with Kivexa ” .
Additionally , patient treat with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of develop anaemia ( low number of red blood cell ) .
Special STORAGE CONDITIONS
Special STORAGE CONDITIONS
medicine that may cause your blood sugar level to rise ( hyperglycaemia ) include :
in 61 of these 117 patient FIP1L1-PDGFRα fusion kinase be identify .
27 % ( 8 cycle ) NA N = 63 pt ( median 7 cycle ) or total median 14 cycle ( range 7-32 )
Strada Statale 156 Km 50 04010 Borgo San Michele ( Lt ) Italy
usually , the first symptom of hyperglycaemia set in gradually , over a period of hour or day .
treatment of influenza infection Oseltamivir be effective only against illness cause by influenza virus .
both the Metavir score and Ishak grade decrease among subject treat with ViraferonPeg in combination with ribavirin .
more extensive haemarthrosis , muscle bleed or haematoma
not know :
package size :
name OF THE MEDICINAL PRODUCT
it may harm them , even if their symptom be the same a yours . − If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
method OF ADMINISTRATION
patient should be tell that it might take longer than usual to stop bleeding when they take clopidogrel ( alone or in combination with ASA ) , and that they should report any unusual bleeding ( site or duration ) to their physician .
Č eská republika sanofi-aventis , s. r. o .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
Hepatobiliary disorder
your insulin dosage may need to be change during pregnancy and after give birth .
- have a tendency to hypoglycaemia ,
study in healthy volunteer show that cetirizine , at dos of 5 and 10 mg strongly inhibit the wheal and flare reaction induce by very high concentration of histamine into the skin , but the correlation with efficacy be not establish .
woman undergo superovulation prior to assist reproductive technique such a in vitro fertilisation ( IVF ) :
Invented name Zerene
6 .
if you take more Keppra than you should :
ask your doctor or pharmacist for advice before take any medicine .
92 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
2 .
some undesirable effect have be report since the marketing of CoAprovel but the frequency for them to occur be not know .
the exposure after an oral dose may be increase by food .
BATCH NUMBER
overall experience with IVF indicate that in general the treatment success rate remain stable during the first four attempt and gradually decline thereafter . • Anovulation A sequential treatment scheme be recommend start with daily administration of 50 IU Fertavid .
6 .
48 6.3 Shelf life
blister FOIL
how to store REYATAZ 6 .
the patient should then gently level the powder in the spoon by scrap the extra powder back into the bottle use a flat edge of a knife or spatula .
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
BYETTA should come from needle tip .
do not pass it on to
the physician must therefore take possible interaction into account and should always ask his patient about any medicinal product they take .
they include : increased urination ; feel thirsty ; lose your appetite ; feel sick ( nausea or vomiting ) ; feel drowsy or tire ; flush , dry skin ; dry mouth and a fruity ( acetone ) smell of the breath .
4 .
dialysis patient convert from once weekly to once every other week dose with Aranesp should initially receive a dose equivalent to twice the previous once weekly dose .
sodium phosphate monobasic Sodium phosphate dibasic Sodium chloride Polysorbate 80 Water for injection
Elisabethhof 19 2353 EW Leiderdorp Netherlands
th EU / 1 / 99 / 128 / 002
{ MM-YYYY } Do not use after 2 month of first open the bottle
you can take Micardis with or without food .
if after a dose reduction , haemoglobin continue
5 .
know hypersensitivity to the active substance or to any of the excipients ( see section 6.1 ) , or other humanised monoclonal antibody .
Pancytopenia , Bone marrow depression , Anaphylactic shock , Psychotic reaction , Migraine , Olfactory nerve disorder , Hearing impair , Vasculitis , Pancreatitis , Liver necrosis , Petechiae , Tendon rupture
sanofi Pasteur MSD , Tel : + 46.8.564.888.60 United Kingdom :
elderly
control clinical trial have not show significant benefit attributable to the administration of M
endocrine disorder
lactation ( see section 4.3 ) :
6 .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
human data demonstrate that , after systemic administration , tacrolimus be excrete into breast milk .
do not take & # 91 ; Neurontin and associate name & # 93 ; − if you be allergic ( hypersensitive ) to gabapentin or any of the other ingredient of & # 91 ; Neurontin and associate name & # 93 ; .
each sachet contain 250 mg of stiripentol . • The other ingredient in this medicine be povidone K29 / 32 , sodium starch glycolate type A , glucose liquid ( spray dry ) , erythrosine ( E127 ) , titanium dioxide ( E171 ) , aspartame ( E951 ) , tutti frutti flavour ( contain sorbitol ) , carmellose sodium , hydroxyethylcellulose .
- if you have serious heart disease or have have a recent heart attack .
4 .
June 2008
correction for anaemia may lead to increase appetite , and potassium and protein intake .
EU / 1 / 01 / 185 / 069 1 Pack Blister EU / 1 / 01 / 185 / 070 4 Pack Blister EU / 1 / 01 / 185 / 071 1 Pack Unblistered
Magyarország Alcon Hungária Gyógyszerkereskedelmi Kft . + 36-1-463-9080
the label on the pen should be check to make sure it contain the correct insulin .
Tel : + 420 271 730 661
driving and use machine
label TEXT
gastrointestinal disorder Very rare ( & lt ; 1 / 10,000 )
the MAH confirm the intention , in a letter of commitment , to submit across EU a paediatric liquid formulation in order to provide a dosage form more suitable for use in child .
6.5 Nature and content of container
8 .
27
• Anticoagulant drug ( e. g. warfarin ) .
lot
4.4 Special warning and precaution for use
1
you should also tell your doctor : if you be on a low-salt diet if you have sign such a abnormal thirst , dry mouth , general weakness , drowsiness , muscle pain or cramp , nausea , vomit , or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide ( contain in Irbesartan Hydrochlorothiazide Winthrop ) if you be to undergo any surgery or receive anaesthetic
28 % Nevirapine :
Hold one Tamilfu 75 mg capsule over a small bowl , carefully pull the capsule open and pour the powder into the bowl .
symptom suggestive of neuroleptic malignant syndrome have be report with abrupt withdrawal of dopaminergic therapy ( see section 4.2 )
do not freeze .
1 , 5 , 7 , 10 , 14 , 15 , 20 , 21 , 30 , 50 , 60 , 90 , 100 , 250
when dose orally , blood trough level should be draw approximately 12 hour post-dosing , just prior to the next dose .
42 pipette
for subcutaneous use .
haemoglobin decrease
PHARMACEUTICAL FORM AND CONTENTS
if no alternative treatment be available , the dose interval must be adjust and renal function should be closely monitored ( see section 4.2 and 5.2 ) .
treatment with NeoRecormon be divide into two stage .
this be compare with a rise of 4.07 point in the patient take placebo from a start value of 24.54 .
110.7 ) .
4 .
very rarely :
10 .
they may differ from the general information contain in this leaflet .
Norway
larger decrease in plasma concentration of paliperidone could occur with higher dos of carbamazepine .
Kaletra contain polyoxyl 40 hydrogenated castor oil .
8 .
BATCH :
PHARMACEUTICAL PARTICULARS
a dose- dependent increase in placental weight be find in the rabbit and rat which may indicate effect on placental function .
prolong or severe hypoglycaemic episode may be life-threatening .
Pharmacotherapeutic group :
4.4 Special warning and precaution for use
if in doubt , talk to your doctor .
aripiprazole should be use with caution in patient with known cardiovascular disease ( history of myocardial infarction or ischaemic heart disease , heart failure , or conduction abnormality ) , cerebrovascular disease , condition which would predispose patient to hypotension ( dehydration , hypovolemia , and treatment with antihypertensive medication ) or hypertension , include accelerate or malignant .
list OF EXCIPIENTS
oral use
thiazide diuretic-associated azotemia may occur in patient with impaired renal function .
vascular disorder Venous thromboembolic event have rarely be report .
an allergic reaction may be recognise a a rash , itching , a swollen face , swollen lip or shortness of breath .
SIFROL have be associate with sleepiness and episode of suddenly fall asleep , particularly in patient with Parkinson ’ s disease .
TSS Erosions
6-10-14
Uncommon Not know Musculoskeletal and connective tissue disorder
Danmark Merck Sharp & amp ; Dohme , Tlf : + 45 43 28 77 66 dkmail @ merck . com
solution for Injection in prefilled
Kaplan-Meier curve for overall survival ( intent-to-treat population )
1 5
the date the product be remove from the refrigerator and set at room temperature ( not exceed 25oC ) and the date the bottle should be withdraw should be note on the outer carton .
keep out of the reach and sight of child .
oral hypoglycaemic agent ( OHAs ) , octreotide , monoamine oxidase inhibitor ( MAOIs ) , non-selective beta-adrenergic blocking agent , angiotensin convert enzyme ( ACE ) inhibitor , salicylate , alcohol , anabolic steroid and sulphonamides .
continuous rotation of the injection site within a give area may help to reduce or prevent these reaction .
1 .
renal or hepatic impairment may reduce insulin requirement .
România GlaxoSmithKline ( GSK ) S.R.L .
tablet .
patient treat with Peg Intron and ribavirin combination therapy and zidovudine be at increased risk of develop anaemia and therefore the concomitant use of this combination with zidovudine be not recommended ( see section 4.5 ) .
if the haemoglobin be rise by more than 2 g / dl ( 1.25 mmol / l ) per month , or if the sustained haemoglobin exceed 12 g / dl ( 7.5 mmol / l ) reduce the epoetin alfa dose by 25 % .
- Addition of a statement that decision to prescribe a selective COX-2 inhibitor should be base on
any unused product or waste material should be dispose of in accordance with local requirement .
this SPC be the one that be annex to the Commission Decision on this Article 31 referral for nimesulide contain medicinal product .
the recommend dose of Riprazo be 150 mg once daily .
transfer a patient to a new type or brand of insulin should be do under strict medical supervision .
the median overall survival have not be reach for any of the four treatment group .
Czech Republic
hepatitis / increase liver enzyme Cases of liver injury , include severe elevation of liver enzyme ( & gt ; 10 time upper limit of normal ) , hepatitis and jaundice have be report with duloxetine ( see section 4.8 ) .
9896
pre-filled SYRINGE
CVMP / 431317 / 06 1 / 1 © EMEA 2006
if require , a second administration of meloxicam can be give after 24 hour .
3 Benzalkonium chloride , which be commonly use a a preservative in ophthalmic product , have be report to cause punctate keratopathy and / or toxic ulcerative keratopathy .
if you stop use CEPROTIN
MARKETING Authorisation Holder Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom
4.2 Posology and method of administration
España Actelion Pharmaceuticals España S.L .
due to delayed elimination of lansoprazole in the elderly it may be necessary to administer the treatment in dos of 15-30 mg adjust to individual requirement .
Pharmacotherapeutic group :
the result of the additional study support the use of Parareg for hypercalcaemia in patient with primary hyperparathyroidism .
adult ( include the elderly ≥ 65 year of age )
not applicable
in case of doubt , always contact your doctor or pharmacist .
for a full list of excipients , see section 6.1 .
these change be intend to facilitate the efficient handling of task , while maintain support to the Committee for Proprietary Medicinal Products ( CPMP ) , it work party and to the Committee for Orphan Medicinal Products ( COMP ) .
- Tamiflu belongs to a group of medicine name “ neuraminidase inhibitor ” .
- an animal insulin ( especially a bovine insulin ) to human insulin ,
flushed face • fruity smell on the
the outcome of the NeoSpect scan be compare to the actual diagnosis , base on the histology of the 7 Westferry Circus , Canary Wharf , London E14 4HB , UK Tel .
Cleared from
benefit / Risk consideration Based on the documentation submit by the MAH and the scientific discussion within the Committee , the CPMP consider that the benefit / risk ratio of Calcichew-D3 mite be favourable for use relating to prevention and treatment of vitamin D and calcium deficiency , for use a vitamin D and Calcium supplement a an adjunct to specific osteoporosis treatment of patient who be at risk of vitamin D and calcium deficiency .
2 750 000 366 000 231 000 1 840 000
how to store TAXOTERE 6 .
25 ( 30 ) 29 ( 35 ) 29 ( 35 )
it explain how the Committee for Medicinal Products for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
it be important to realise that systemic leakage can be dangerous because BEROMUN can have undesirable side-effects on the main organ of the body .
IV treatment should be follow by oral route a soon a possible .
no clinically significant reduction in glimepiride AUC and Cmax be observe after repeat dos of rosiglitazone for eight day in healthy adult subject .
insulin absorption and hence the blood glucose lower effect of a dose may vary from one injection area to another ( e. g. the abdominal wall compare with the thigh ) .
mean overall survival
the prostate gland be just underneath the bladder in men .
application period of medicated feed a the sole daily ration
LABELLING AND PACKAGE LEAFLET
- what you should do in emergency situation when you feel unwell or become ill .
0.27 ( 27 )
- nausea ( feel sick ) and / or vomit ( be sick )
store in the original package in order to protect from moisture .
3 .
for the eligible histology population , the efficacy result be similar .
the in vitro study suggest that CYP3A4 and CYP2B6 be the major isozymes responsible for efavirenz metabolism and that it inhibit P450 isozymes 2C9 , 2C19 , and 3A4 .
patient with renal impairment For patient with mild renal impairment ( creatinine clearance ≥ 50 to & lt ; 80 ml / min ) , the recommended initial dose be 3 mg once daily .
metabolism Nepafenac undergo relatively rapid bioactivation to amfenac via intraocular hydrolases .
PegIntron be likely to also cause this effect .
- you have almost normal or , at least , greatly improve blood sugar level ,
99 Latvija sanofi-aventis Latvia SIA Tel : + 371 67 33 24 51
in rabbit , vaginal bleeding and abortion possibly associate to prolong haemostasis , but no foetal abnormality be note .
Biochemistry :
10 .
4 Cardiac conduction abnormality and arrhythmia
– The other ingredient be zinc chloride , glycerol , metacresol , phenol , disodium phosphate dihydrate , sodium hydroxide , hydrochloric acid , protamine sulphate and water for injection .
the replacement interferon beta-1a act in the same way a naturally produce interferon beta .
10 mg
Phototoxicity can occur in cloudy weather or even in the absence of direct exposure to the sun .
pharmacological PROPERTIES
16 .
not applicable .
Merck Sharp & amp ; Dohme Romania S. R. L .
since these neurotransmitter be also involve in reduce the sensation of pain , block their re-uptake into nerve cell may also improve the symptom of neuropathic pain .
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
there be no data on maintenance of effect and limited data on long term safety ( see section 4.4 and 4.8 ) .
the CHMP be of the opinion that base on the totality of the data submit , include the data from the pulmonary deposition study ( Study 2007-76-DOS-6 ) , a similar particle size distribution between the test and the reference product could be demonstrate .
patient receive rifabutin with APTIVUS / ritonavir should be closely monitor for emergence of adverse event associate with rifabutin therapy .
however , norfloxacin and metronidazole combine reduce the MPA exposure by approximately 30 % follow a single dose of CellCept .
do not store above 25 ° C .
other day or 3 time
after a single dose of 100mg nimesulide a peak plasma level of 3-4 mg / l be reach in adult after 2-3 hour .
how do Axura work ?
- -
very rarely :
1 pre-filled syringe ( non- blister )
RISPERDAL and associate name ( see Annex I ) 0.5 mg orodispersible tablet RISPERDAL and associate name ( see Annex I ) 1 mg orodispersible tablet RISPERDAL and associate name ( see Annex I ) 2 mg orodispersible tablet RISPERDAL and associate name ( see Annex I ) 3 mg orodispersible tablet RISPERDAL and associate name ( see Annex I ) 4 mg orodispersible tablet
keep out of the reach and sight of child .
there be two type of syrinx : • syringe with a yellow plunger and an automatic safety system • syringe with yellow plunger and a manual safety system .
use in child and adolescent There be limited experience with the administration of Rapamune in child and adolescent .
patient with a recent history of pulmonary infiltrates or pneumonia may be at higher risk .
colitis ( inflammation of the colon ) , hepatitis and skin , hair , beard and nail discoloration .
Citywest Tritace 1.25mg tablet Business Campus , Dublin 24 , Tritace 2.5mg tablet Ireland Tritace 5mg tablet Tritace 10mg tablet
1 ml ( one vial ) contain 50
list OF THE NAMES , PHARMACEUTICAL FORMS , STRENGTHS , ROUTES OF ADMINISTRATION , MARKETING AUTHORISATION HOLDERS , PACKAGING AND PACKAGE SIZES OF THE MEDICINAL PRODUCT IN THE MEMBER STATES
6 .
Jeseniova 30 CZ 130 00 Praha 3 Tel : + 420 221 421 611
oral
monitoring of blood glucose be necessary during insulin infusion .
very common
26 Elderly ( see section 4.4 Fluid retention and cardiac failure ) No dose adjustment be require in the elderly .
Astellas Pharma GmbH , Neumarkter Str .
4.7 Effects on ability to drive and use machine
how to take Zyrtec 4 .
BATCH
appropriate therapy such a blood transfusion may be give to patient when indicate .
after cleaning , do not touch the rubber stopper with your hand or allow it to touch any surface .
DepoCyte
a per the CHMP Guideline on Risk Management Systems for medicinal product for human use , the updated RMP should be submit at the same time a the next Periodic Safety Update Report ( PSUR ) .
when ritonavir be co-administered an increase in clarithromycin concentration may occur .
1 .
if you take more Epivir than you should Accidentally take too much Epivir be unlikely to cause any serious problem .
10 to 14 day
2 .
Slovenská republika Merck Sharp & amp ; Dohme IDEA , Inc .
23 PACKAGE LEAFLET :
PHARMACEUTICAL PARTICULARS
valsartan work by block the effect of angiotensin II .
33 EMEA General Report 2000
what Kepivance look like and content of the pack
among patient from study WV16240 , who receive Pegasys monotherapy and enter the long-term follow-up study , the rate of sustain HBeAg seroconversion 12 month after the end of therapy be 48 % ( 73 / 153 ) .
dizziness
withdrawal PERIOD
due to it increased carbohydrate content darbepoetin alfa have a longer terminal half-life than r-HuEPO and consequently a greater
respiratory system ( no effect be find to be common ) ; uncommon : shortness of breath , cough ; rare : shallow breathing .
9 .
- Keep this leaflet .
Č eská republika MEDA Pharma s. r. o .
Special STORAGE CONDITIONS
България BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT .
insulin requirement may be alter during illness or emotional disturbance .
Organon , Kloosterstraat 6 , P. O .
25 mg / 2 ml
do not store above 30 ° C .
respiratory , thoracic and mediastinal disorder
blister ( PVC / PE / PVDC / alu )
Norway
monitoring of cardiac and vital sign be recommend , along with appropriate symptomatic and supportive measure .
Alcoholic drink can make erection difficulty worse .
infection and infestation
interaction study with cimetidine ( non-specific cytochrome P450 inhibitor ) and rifampicin ( non-specific cytochrome P450 inducer ) , indicate that in vivo CYP enzyme be involve in the metabolism of leflunomide only to a small extent .
in clinical trial conduct in a broad range of indication and at a wide range of dos ( from 6 MIU / m2 / week in hairy cell leukaemia up to 100 MIU / m2 / week in melanoma ) , the most commonly report undesirable effect be fever , fatigue , headache and myalgia .
in the indication “ increase the yield of autologous blood ” : myocardial infarction or stroke in the month precede treatment , unstable angina pectoris , increase risk of deep venous thrombosis such a history of venous thromboembolic disease .
please tell your doctor or pharmacist .
read the package leaflet before use .
atorvastatin lower plasma cholesterol and lipoprotein serum concentration by inhibit HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increase the number of hepatic LDL receptor on the cell surface for enhanced uptake and catabolism of LDL .
if you accidentally take too many tablet , contact your doctor immediately .
6.6 Special precaution for disposal and other handling
Polska Roche Polska Sp.z o.o .
Erbitux be contraindicate in patient with know severe ( grade 3 or 4 ) hypersensitivity reaction to cetuximab .
transdermal use
not applicable .
a .
there be no adequate and well-controlled study in pregnant woman .
fatigue Asthenia Pyrexia
30 mg
indication ( S )
th Sodium phosphate monobasic Sodium phosphate dibasic
2 .
these reaction be usually transitory and normally they disappear during continued treatment .
if any of these symptom occur , stop the injection immediately and contact your doctor .
the table below report adverse reaction by MedDRA system organ class ( MedDRA SOCs ) .
do not store above 25oC .
lot :
the maximal daily dose be usually not higher than 225 IU FSH .
pre-filled syringe ( glass ) with an automatic safety system
list OF THE NAMES , PHARMACEUTICAL FORMS , STRENGTHS , ROUTES OF ADMINISTRATION , MARKETING AUTHORISATION HOLDERS , PACKAGING AND PACKAGE SIZES OF THE MEDICINAL PRODUCT IN THE MEMBER STATES
4.5 Interaction with other medicinal product and other form of interaction
oral use
Vianex S. A Tatoiou Street 18 Km Athens-Lamia National Road 14671 Nea Erythrea Athens Greece
uth stomach or abdominal pain , diarrhoea , nausea ( feel sick ) , viral infection , depression , emotional lability , insomnia , anxiety , sore throat and painful swallowing , fatigue , chill / rigor , fever , flu-like reaction , feeling of general discomfort , headache , weight loss , vomit , irritability , weakness , mood swing , cough
last Observation Carried Forward
pregnancy and breast-feeding Ask your doctor for advice before take any medicine .
food effect When give post-prandially , the extent of nateglinide absorption ( AUC ) remain unaffected .
all of these additive factor of anaemia should also be carefully consider when decide to increase the dose of erythropoietin in cancer patient .
sarcoma be associate with the long-term presence of the heterotopic bone .
European PUBLIC ASSESSMENT REPORT ( EPAR )
all treatment arm have 24 week treatment-free follow-up .
medicine should not be dispose of via wastewater or household waste .
other INFORMATION
each vial provide 120 microgram / 0.5 ml of peginterferon alfa-2b when reconstitute a recommend .
4.5 Interaction with other medicinal product and other form of interaction
EXP { month / year } Once open use within 10 day .
Fluoxetine ( a CYP2D6 inhibitor ) , single dos of antacid ( aluminium , magnesium ) or cimetidine have not be find to significantly affect the pharmacokinetics of olanzapine .
water for injection .
impaired renal and / or hepatic function
infusion reaction decrease to 2 % follow the second infusion in both rituximab and placebo group .
the pharmacokinetics of cinacalcet have not be study in patient & lt ; 18 year of age .
John & apos ; s Wort ) may be expect to have similar effect and similar dose increase should therefore be apply .
Germany
2 .
stomach pain , fast and deep breathing , sleepiness or even loss of consciousness may be sign of a serious condition ( ketoacidosis ) result from lack of insulin .
on the basis of these data the two formulation be consider to exhibit an equivalent therapeutic ratio and to be clinically interchangeable ” .
any unused medicinal product should be discard or return to the pharmacy .
the pen should be turn gently to avoid foaming in the cartridge .
5 pre-filled syrinx of solvent .
there be no adequate data from the use of ibandronic acid in pregnant woman .
Pyrexia , mucosal inflammation , fatigue Common :
Insuman Comb 50 be a fluid ( suspension ) for injection under the skin .
- patient with myocardial infarction within the last 90 day ,
medicinal product by
therefore the test shall be use after at least four week without systemic antibacterial therapy and two week after last dose of acid antisecretory agent .
on Day 3 , those randomize to receive Suboxone be switch to the combination tablet .
Česká republika Teva Pharmaceuticals CR , s.r.o Telephone : + ( 420 ) 606 763 892 Danmark Teva Sweden AB Telephone :
in an additional 1-year study of sitagliptin 100 mg once daily in combination with metformin , the incidence of adverse reaction consider a drug-related in patient treat with sitagliptin / metformin compare to sulphonylurea / metformin be 14.5 % and 30.3 % , respectively .
6.6 Special precaution for the disposal of unused veterinary medicinal product or waste material derive from the use of such product
this mean that IntronA be inject with a short needle into the fatty tissue just under the skin .
- one human insulin preparation to another ,
7 patch
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
common ( & gt ; 1 / 100 , & lt ; 1 / 10 )
361 5 .
a lower start dose ( 5 mg ) should be consider for such patient .
BATCH NUMBER
Ísland Vistor hf .
1 .
to be eligible patient have to have have one or more of the following : myocardial infarction , stroke , percutaneous cardiac intervention or coronary artery bypass graft , acute coronary syndrome , coronary artery disease , or peripheral arterial obstructive disease .
they must not give you any food or drink a it could choke you . ► If severe hypoglycaemia be not treat , it can cause brain damage ( temporary or permanent ) and even death ► If you have a hypo that make you pass out , or a lot of hypo , talk to your doctor .
40 µg
gastrointestinal disorder :
female mouse receive duloxetine for 2 year have an increase incidence of hepatocellular adenoma and carcinoma at the high dose only ( 144 mg / kg / day ) , but these be consider to be secondary to 59 hepatic microsomal enzyme induction .
MARKETING AUTHORISATION NUMBER ( S )
Write down the date you open it in the space on each bottle label and box .
in addition , injection site disorder , fever , anorexia , vomit , and emotional lability occur more frequently in child and na
1.3 6.7 0.3 0.4 0.04 0.2 1.5
5 % 4 %
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED
these be harmless , but if the air bubble be too big , it may make the dose of your injection le accurate .
the side effect in this section be give with an estimation of the frequency with which they may occur .
Telithromycin be widely distribute throughout the body .
5.2 Pharmacokinetic property
if you notice any serious effect or other effect not mention in this leaflet , please inform your veterinary surgeon .
hallucination , confusion Increased libido
insulin suspension should not be add to infusion fluid .
human erythropoietin be an endogenous glycoprotein hormone that be the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cell in the bone marrow .
list OF EXCIPIENTS
EU - Number
capsule , hard
ustekinumab prevents IL-12 and IL-23 contribution to immune cell activation , such a intracellular signaling and cytokine secretion .
Keet the Penfill in the original package .
physician consider treatment in these patient should carefully weigh the risk versus the benefit of re-treatment .
17 wise addition of the water for injection down the inside of the vial and not directly onto the lyophilized cake .
single dose pharmacology study in cynomolgus monkey have show no effect other than the anticipated dose-dependent paralysis of injected muscle , together with some diffusion of toxin at high dos produce similar effect in neighbour non-injected muscle .
Ísland Eli Lilly Danmark A / S , Útibú á Íslandi Tel : + 354 520 34 00
Holsten Pharma GmbH Im Bürgerstock 7 79241 Ihringen Germany
-
EU / 1 / 97 / 050 / 005
13.06.2008
oral use
BATCH NUMBER
& gt ; 169
if you develop sign or symptom of kidney stone ( pain in your side , blood in your urine , pain when you urinate ) , please inform your doctor immediately .
concentration of bepridil , systemic lidocaine or quinidine may be increase when co-administered with Invirase / ritonavir .
tap the vial firmly and repeatedly on a hard surface , protect to cushion impact , until no powder be visible .
each capsule contain rivastigmine hydrogen tartrate correspond to rivastigmine 3.0 mg .
Uncommon :
15 10
5.3 Preclinical safety data
100 mg
do try to take the tablet at around the same time every day . c .
1 .
both study enrol adult patient ( ≥ 18 year ) who have a history of receive Botulinum Toxin Type A .
dos of 500 , 750 , 1,000 , and 1,250 mg / m2 ( total dose per cycle over 5 day ) have be evaluate clinically in patient .
abdominal palpation should be sufficient to detect abnormal increase in splenic volume .
10 cartridge
follow by 600 mg / m2 IV 22 hr
the odds ratio ( 95 % exact confidence interval ) be 2.96 ( 1.34 , 7.50 ) .
non-small cell lung cancer ( Tarceva administer a single agent in study BR.21 ) :
5 .
content BY WEIGHT , BY VOLUME OR BY UNIT
MARKETING AUTHORISATION NUMBER ( S )
C .
PegIntron alone be not study in HCV / HIV co-infected patient .
Tel : + 351 22 986 6100
6.4 Special precaution for storage
lot
5 .
14 .
mean change from
Adeno-carcinoma
the median lethal dos be approximately 210 mg / kg ( mouse ) and 175 mg / kg ( rat ) .
read all of this leaflet carefully before you start use this medicine .
most reported adverse event be not unexpected , mainly gastro-intestinal disorder or cutaneous disorder .
all the result show a clear improvement of Doxyprex treat pig , with no relapse and no death , compare to a negative control .
in view of it pharmacodynamic effect , rivastigmine should not be give concomitantly with other cholinomimetic substance and might interfere with the activity of anticholinergic medicinal product .
carton
720 ELISA Units 20 microgram
patient who be take other medicinal product which may cause orthostatic hypotension .
Developmental toxicity study perform in rat and rabbit have reveal no evidence of harm to the foetus or neonatal rat due to etanercept .
injection
after single intravenous dos range from 0.25 to 10 mg / kg , concentration be dose proportional .
when the injection button be pull out , the loaded dose be indicate by the last mark ( flat arrow ) on the red dosage control dial that be come out and appear visible ( the example in the Figure show the injection button pull out and a loaded dose of 150 IU ) .
paediatric Patients The safety and efficacy of CANCIDAS be evaluate in paediatric patient 3 month to 17 year of age in two prospective , multicenter clinical trial .
4.10 Overdose ( symptom , emergency procedure , antidote ) , if necessary
4 4.7 Effects on ability to drive and use machine
in patient with inhibitor titre above 10 BU or with high anamnestic response , the use of ( activate ) prothrombin complex concentrate ( PCC ) or recombinant activate factor VII ( rFVIIa ) preparation have to be consider .
store in the original package .
a with all insulin preparation , Insulin Human Winthrop Comb 25 must not be mixed with solution contain reduce agent such a thioles and sulphites .
Special STORAGE CONDITIONS
N03AF03 .
• high blood pressure which be be control with medicine prescribe by your doctor ;
Italia Chiesi Farmaceutici S. p . a Tel : + 39 0521 2791
3 year .
insulin Human Winthrop Rapid can be use during breastfeeding .
sachet 50
DATE OF REVISION OF THE TEXT
23.5 19.4
nervous system disorder
lopinavir and ritonavir level may increase on stop St John ’ s wort .
Nederland GlaxoSmithKline BV Tel : + 31 ( 0 ) 30 69 38 100 nlinfo @ gsk.com
3 .
medicine should not be dispose via wastewater or household waste .
dose level have no consistent effect on the volume of distribution in any of the study .
7 .
in clinical study , minimal
Luxembourg / Luxemburg sanofi-aventis Belgium Tél / Tel : + 32 ( 0 ) 2 710 54 00 ( Belgique / Belgien )
MARKETING Authorisation Holder Novartis Europharm Limited Wimblehurst Road Horsham West Sussex , RH12 5AB United Kingdom
follitropin alfa
each patch release 6 mg of rotigotine per 24 hour .
Uncommon vision blur Ear and labyrinth disorder :
before you take Irbesartan Krka 3 .
- Pack of 10 vial of powder for solution for injection or infusion , 10 ampoule of water for
• Keep out of the reach and sight of child • Do not freeze • Arixtra do not need to be keep in the fridge .
inject Humalog a your physician or nurse have teach you .
it be therefore recommended that the diabetic patient carry some sugar lump , sweet , biscuit or sugary fruit juice . • Severe hypoglycaemic episode , where the patient have become unconscious , can be treat by glucagon ( 0.5 to 1 mg ) give intramuscularly or subcutaneously by a person who have receive appropriate instruction , or by glucose give intravenously by a medical professional .
- Ethanol
small difference in the carbohydrate chain structure be know to exist .
increase digoxin level observe in patient receive ritonavir may lessen over time a induction develop ( see section 4.4 ) .
darunavir / ritonavir 400 / 100 mg BID
concentration of these antiarrhythmic may be increase when co-administered with REYATAZ / ritonavir .
109 An increase incidence of thrombotic vascular event ( see section 4.4 and section 4.8 - General ) have be observe in patient receive erythropoietic agent .
do not use in male breeding dog .
correspond data base on whole blood average 47.6 l .
do tell your doctor that you miss a dose .
d .
- AV-block of 3rd degree
• OTHER CONDITIONS
a with any ocular medication , if transient blur vision occurs at instillation , the patient should wait until the vision clear before drive or use machinery .
ratio for overall survival range between 1.25 and 2.47 in favour of control .
a minor infection such a a cold should not be a problem , but talk to your doctor first . • if your child have diarrhoea or be vomit .
MARKETING AUTHORISATION NUMBER
per day 0.025 - 0.035 0.035 0.045 - 0.050 0.045 - 0.050
if necessary , your doctor may advise you to take vitamin supplement .
it explain how the Committee for Medicinal Products for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
85 If you forget to take Arixtra • Take the dose a soon a you remember .
in clinical trial , worsen of Parkinsonian symptomatology and hallucination be report very commonly and more frequently than with placebo ( see section 4.8 ) , and olanzapine be not more effective than placebo in the treatment of psychotic symptom .
measles , mumps , and rubella vaccine ( live ) .
otherwise , the liquid may leak out which can cause inaccurate dosing .
renal failure , renal insufficiency
Mycophenolic acid ( UDP-glucuronyl transferase substrate ) :
BATCH NUMBER
very common side effect
general CLASSIFICATION FOR SUPPLY lp
treatment of ear mite ( Otodectes cynotis ) .
EU / 1 / 99 / 103 / 002
( see section 4.5 and 5.2 . )
Retrieved Drop Outs
3.12 - 3.24 mg cetrorelix acetate equivalent to 3 mg cetrorelix .
Silgard be an adjuvanted non-infectious recombinant quadrivalent vaccine prepare from the highly purified virus-like particle ( VLPs ) of the major capsid L1 protein of HPV type 6 , 11 , 16 and 18 .
keep out of the reach and sight of child .
( aluminium hydroxide / magnesium hydroxide ) have no clinically relevant effect on the pharmacokinetics of lumiracoxib .
any sign of inflammation or infection .
if your allergic rhinitis be intermittent ( presence of symptom for le than 4 day per week or for le than 4 week ) , your physician will recommend you a treatment schedule that will depend on the evaluation of the history of your disease .
Executive support
oral antidiabetic medicinal product , monoamine oxidase ( MAO ) inhibitor , beta-blockers , angiotensin convert enzyme ( ACE ) inhibitor , salicylate , anabolic steroid and glucocorticoid ( except topical administration ) , oral contraceptive , thiazide , thyroid hormone , sympathomimetics , danazol , octreotide and sulphonamides .
- you have hyperglycaemia ( high blood sugar level ) ,
after administration of epoetin alfa , the number of erythrocyte , the Hb value and reticulocyte count increase a well a the 59Fe-incorporation rate .
statement OF ACTIVE SUBSTANCE ( S )
ho One pre-filled syringe ( 0.6 ml ) contain 7.5 mg fondaparinux sodium .
suspension for injection in a pre-filled pen .
VIRACEPT should not be mixed with orange juice , apple juice , apple sauce or other liquid or food that be acidic due to taste .
the aPTT be prolong in all haemophiliac .
how to store Insuman Comb 25 6 .
a total of 345 interferon alpha relapse patient be treat in two clinical trial with t
ViraferonPeg ViraferonPeg pharmacodynamics be assess in a rise single-dose trial in healthy subject by examine change in oral temperature , concentration of effector protein such a serum neopterin and 2 ’ 5 ’ -oligoadenylate synthetase ( 2 ’ 5 ’ -OAS ) , a well a white cell and neutrophil count .
use of injection site should be rotate so that the same site be not use more than approximately once a month .
your doctor will decide on the dose of Fertavid to be give .
15 January 2001 Date of last renewal :
Hepatobiliary disorder :
46.0 ( 63 / 137 ) 35.0 , 57.0
however , elevate creatine phosphokinase and rhabdomyolysis , not necessarily in association with NMS , have also be report .
Astellas Pharma S. p . A. ic
85 body , shortness of breath , wheeze , reduction in blood pressure , fast pulse , or sweating .
capsule , hard
do not stop take your medicine unless you have discuss this with your doctor first .
cancer patient receive chemotherapy in
name OF THE VETERINARY MEDICINAL PRODUCT
European Medicines Agency
read the package leaflet before use .
in combination therapy with ribavirin , take notice of the respective informing text of ribavirin contain medicinal product .
1ère Avenue - 2065 m 06516 CARROS France
other SPECIAL WARNING ( S ) , IF NECESSARY
a a routine precaution , if you be over 65 year your blood pressure may be monitor by your doctor .
haemophiliac patient : there have be report of increase spontaneous bleeding in haemophiliac patient receive antiretroviral protease inhibitor ( see section 4.4 ) .
HBeAg seroconversion be increase in patient with elevated ALT level ; 77 % ( 20 / 26 ) of patient with pre-treatment ALT & gt ; 2 x ULN seroconverted .
Cmin
1 , TRIQ IX-XORROX B ’ KARA BKR 1633 MALTA Tel : + 356 21447184 admin @ ejbusuttil . com
Aplastic anaemia
study on reproduction be not perform in animal .
then take your next dose a you would have on your originally schedule day , have you not forget a dose .
3 .
adolescent with existence of or history of severe psychiatric condition be contraindicate ( see “ Do not use Viraferon ” )
EU / 1 / 97 / 030 / 062
insulin and analogue for injection , intermediate-acting combine with fast-acting , insulin ( human ) .
pregnancy and breast-feeding
Unfractionated heparin be administer intravenously or subcutaneously at the physician ’ s discretion , most commonly a an intravenous bolus of 5,000 U follow by a continuous infusion of 1,000 U / h .
vaccination may result in moderate swelling of the breast tissue which will resolve within 30 day .
PHARMACEUTICAL Form
Belgium :
PHARMACEUTICAL FORM AND CONTENTS
do not store the solution without your doctor ’ s advice .
10 .
 Cardiac disorder :
2 .
expiry DATE
nervousness
- determine how much Insulin Human Winthrop Basal per day you will need ,
during an initial open-label phase , patient be titrate to an effective dose of Effentora .
one patient experience involuntary muscle contraction .
renal impairment
4.8 Undesirable effect
4.4 Special warning and precaution for use
EU / 1 / 99 / 126 / 002
CONDITIONS OF THE MARKETING AUTHORISATION
there be fewer breakthrough Aspergillus infection in patient receive posaconazole prophylaxis when compare to control patient .
general CLASSIFICATION FOR SUPPLY
MARKETING AUTHORISATION NUMBER ( S )
Тел . : + 359 2 489 98 28
in patient with baseline haemoglobin ≤ 10 g / dl ( n = 899 ) , the hazard ratio point estimate for survival be 0.98 ( 95 % CI 0.68 to 1.40 ) .
- you do not eat enough , or eat food contain le carbohydrate than normal ( sugar and substance
20.57 %
4 .
15 .
conjugate to tetanus toxoid a carrier protein Neisseria meningitidis serogroup C ( strain C11 ) polysaccharide conjugate to tetanus toxoid a carrier protein
target SPECIES
wait one week and if the symptom improve redose at 100 % dose
5.2 Pharmacokinetic property
lipase increase Haemoglobin decrease
10 mL twice daily
also go for regular health check , include mammography .
other factor that will increase the risk of heart disease include high blood pressure , diabetes , increase weight , lack of exercise , smoking , or a family history of heart disease .
- In your brain
this leaflet be a general guide .
each sachet contain 250 mg of stiripentol
attach the needle by twist in a clockwise direction until the needle fit securely on the syringe .
the European Commission grant a marketing authorisation valid throughout the European Union for Ventavis to Bayer Schering Pharma AG on 16 September 2003 .
lot :
( 400 / 100 mg twice daily / 600 mg once daily )
5 x 3 ml Liprolog Mix50 cartridges for a 3 ml pen 2 x ( 5 x 3 ml ) Liprolog Mix50 cartridges for a 3 ml pen
at least 10 case with acute autoimmune haemolytic anaemia be know .
immunisation of progeny from vaccinated bird should therefore be delay until such antibody have decline .
efficacy result for study 006
pharmacological PROPERTIES
there have be case of cytolytic and cholestatic hepatitis and hepatic failure ; in some of them outcome be fatal , include one patient on high dose paracetamol .
Lilly
& gt ; 80 50-79 30-49 & lt ; 30 -
the most commonly report potentially life-threatening or fatal adverse event include mucositis , diarrhoea , neutropaenia , renal impairment , and electrolyte disturbance .
0.25 mg
pregnancy and Breast-feeding :
package SIZE
keep out of the reach and sight of child .
au Rare ( ≥ 1 / 10,000 to & lt ; 1 / 1,000 ) pulmonary adverse effect , in particular interstitial pneumonia , have be report after G-CSF administration .
Uncommon :
10 .
Zenapax be indicate for the prophylaxis of acute organ rejection in de novo allogenic renal transplantation and be to be use concomitantly with an immunosuppressive regimen , include t
C )
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
bottle presentation Do not store above 30 ° C .
a causal relationship have be suggest , although the mechanism of action have not be elucidate .
efficacy result be summarise in Table 3 .
9
capsule , hard
care must be take to ensure the sterility of the prepared solution since Replagal do not contain any preservative or bacteriostatic agent ; aseptic technique must be observe .
12 .
4.1 Therapeutic indication
48 week
in clinical study , minimal accumulation be observe with either route of administration .
Malta V. J .
since 2002 more than 44,000,000 generic tablet of this formulation have be supply to the market and that thousand of subject have be switch from the originator product to the generic product .
if your doctor be not available , you must urgently seek alternative medical advice ( e. g. the emergency unit of the nearest hospital ) .
store in a refrigerator ( 2 ° C - 8 ° C ) .
data from laboratory study with different bacteria show that cefovecin be effective against the bacteria specify in the product information ( SPC and package leaflet ) .
medicinal product subject to medical prescription
it act by inhibit protein synthesis in the bacteria cell .
Ireland GlaxoSmithKline ( Ireland ) Limited Tel : + 353 ( 0 ) 1 4955000
child and adolescent :
instruction ON USE
• rash over the whole body •
treatment with NeoRecormon should be temporarily discontinue if haemoglobin level exceed 13 g / dl ( 8.1 mmol / l ) .
clear yellow to brown solution .
medicine use to treat fungal infection ( antifungal ) :
Telephone : + ( 421 ) 2 5726 7974 Suomi / Finland Teva Sweden AB Telephone :
what benefit have IVEMEND show during the study ?
- If you be not eat enough your blood sugar level may become too low ( hypoglycaemia ) .
no special requirement .
name OF THE MEDICINAL PRODUCT
general CLASSIFICATION FOR SUPPLY
g
summary OF PRODUCT CHARACTERISTICS
Micardis be not recommend for use in child below 18 year due to a lack of data on safety and efficacy .
how to use Insulin Human Winthrop Comb 15 4 .
one 3 ml unit-dose vial ( glass Type I ) of lyophilisate seal with a halogenobutyl rubber stopper and an aluminium cap , supply with a vial ( glass Type I ) of 0.5 ml sterile solvent .
erythropoietin receptor may be express on the surface of a variety of tumour cell .
like the natural hormone erythropoietin , MIRCERA increase the number of red blood cell and haemoglobin level in your blood .
at the usual metformin dos and dose schedule , steady state plasma concentration be reach within 24-48 h and be generally le than 1 µg / ml .
63
Bayer-Logo
week 3
APIDRA
13 .
name OF THE MEDICINAL PRODUCT
attach a butterfly needle to the syringe . and inject the reconstituted solution into a vein .
oral use
ADARTREL
pharmacokinetic interaction study in postmenopausal woman have demonstrate the absence of any interaction potential with tamoxifen or hormone replacement therapy ( oestrogen ) .
DATE of first authorisation :
film-coated tablet
tell your doctor if you be breast-feeding or intend to breast-feed .
EU / 1 / 96 / 007 / 016 EU / 1 / 96 / 007 / 027
EU / 2 / 08 / 088 / 001
17 October 2003 Date of last renewal :
significant cardiovascular disease , e. g. congestive heart failure ( New York Heart Association Class II , III or IV ) , severe angina pectoris , cardiac arrhythmia , myocardial infarction within a 3 month period prior to treatment , venous thrombosis , occlusive peripheral arterial disease , recent pulmonary embolism .
blur vision , conjunctivitis , eye pain , abnormal vision , lacrimal gland disorder
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
medicinal product subject to medical prescription .
infection and infestation Common :
you may need to read it again .
EU / 1 / 96 / 007 / 015 EU / 1 / 96 / 007 / 026
17 1 .
dosage in renal impairment
Panretin be usually apply for up to 12 week at first , and treatment continue after this period only on lesion which have respond to treatment .
( read the package leaflet of Telzir oral suspension for guidance on whether to take it with or without food . )
- you be do le exercise than usual , you be under stress ( emotional distress , excitement ) , or you
do not keep the pre-filled pen that you be use in the fridge .
other anti-epileptic medicinal product The pharmacokinetic interaction between rufinamide and other anti-epileptic drug have be evaluate in patient with epilepsy use population pharmacokinetic modelling .
the safety of the veterinary medicinal product have not be establish during lactation .
7 .
serum electrolyte and creatinine should be monitor frequently .
1 .
common :
do not use any Dafiro pack that be damage or show sign of tamper .
the combination of amlodipine and valsartan produce dose-related additive reduction in blood pressure across it therapeutic dose range .
there be no evidence of clinically relevant medicine accumulation follow once daily dosing of desloratadine ( 5 mg to 20 mg ) for 14 day .
package size
what EXJADE be EXJADE contain an active substance call deferasirox .
avoid contact by pregnant woman .
the addition of valsartan 160 mg produce an additional reduction in systolic / diastolic blood pressure of 2.9 / 2.1 mmHg compare to patient who remain on amlodipine 10 mg only .
do not massage the injection site .
base on the review of the data and the Company ’ s response to the CHMP list of question , at the time the withdrawal , the CHMP have concern and be of the provisional opinion that Orathecin could not be approve for treatment of patient with advanced or metastatic pancretic cancer .
the best site for injection be tissue with a layer of fat between skin and muscle : thigh , outer surface of the upper arm ( you may need the assistance of another person to use this site ) , abdomen ( except the navel or waistline ) .
for the purpose of ambulatory use , Aranesp may be remove from storage once for a maximum single period of seven day at room temperature ( up to 25 ° C ) .
United Kingdom sanofi-aventis Tel : + 44 ( 0 ) 1483 505 515
121 9 .
take special care with Irbesartan Krka
total plasma clearance of fentanyl be about 0.5 l / h / kg .
310 Pregnancy and breast -feeding Ask your doctor or pharmacist for advice before take any medicine .
Invented name Optisulin Optisulin Optisulin Optisulin Optisulin
au The following substance may reduce insulin requirement :
it must have an evenly milky white appearance .
24 / 33
adverse REACTIONS
treatment of patient with hairy cell leukaemia .
both have an absolute bioavailability of approximately 77 % .
if on repeated measurement IGF-I level exceed + 2 SD compare to reference for age and pubertal status , the IGF-I / IGFBP-3 ratio could be take into account to consider dose adjustment .
hepatic impairment Caution should be exercise when administer Exforge to patient with hepatic impairment or biliary obstructive disorder ( see section 4.4 ) .
6.4 Special precaution for storage
Κύπρος Οδός Αγίου Νικολάου , 8 CY-1055 Λευκωσία Τηλ : + 357-22 757188
patient have take pioglitazone at higher than the recommended highest dose of 45 mg daily .
among patient who be not in response at week 4 , 43 % of Trudexa maintenance patient respond by week 12 compare to 30 % of placebo maintenance patient .
- Valproate
oral drop , solution
any unused vaccine or waste material should be dispose of in accordance with local requirement .
the cytotoxicity of MTIC be think to be due primarily to alkylation at the O6 position of guanine with additional alkylation also occur at the N7 position .
haemodialysis and adult patient on peritoneal dialysis ( See section 4.4 ) .
6 4 2
PHARMACEUTICAL FORM AND CONTENTS
5 .
film coat tablet
further information
6 tablet SIFROL 0.088 mg Total
13 A .
Special STORAGE CONDITIONS
the cumulative renal excretion of total orlistat-related material be & lt ; 2 % of the give dose .
PHARMACEUTICAL PARTICULARS
hypokalaemia , lipid increase , appetite disorder ( include anorexia ) , hyperuricaemia
3 ml
13 .
which an estimate & gt ; 70 million patient be treat with celecoxib ( various dos , duration , and
99.4
usually , Humira be use with methotrexate .
however , the potential influence of hepatic insufficiency on Oprymea pharmacokinetics have not be investigate .
infliximab Experienced Patients Placebo Humira N = 166 160 / 80 mg N = 159
capsule , hard
PHARMACEUTICAL PARTICULARS
active substance :
recommendation concern
the individual patient dose = 75 kg x 1 µg = 75 µg The corresponding amount of Nplate solution to inject = 75 µg x 1 ml = 0.15 ml 500 µg
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
50 , 60 , 100 , 120 , 150 ml
because the number of patient with adrenal cortical carcinoma be low , the disease be consider ‘ rare ’ , and Lysodren be designate an ‘ orphan medicine ’ ( a medicine use in rare disease ) on 12 June 2002 .
6.4 Special precaution for storage
13 .
a .
Merck Sharp & amp ; Dohme B. V .
swallow Tasmar with water .
EGFR have be implicate in the control of prenatal development and may be essential for normal organogenesis , proliferation , and differentiation in the developing embryo .
solution for infusion
Invasive fungal infection account for more than half of the fatality amongst patient who develop opportunistic infection .
1 pre-filled syringe + 1 injection needle
in normal donor , pulmonary adverse event ( haemoptysis , pulmonary haemorrhage , pulmonary infiltrates , dyspnoea and hypoxia ) have be report very rarely in post marketing experience .
upon initiation of treatment in patient with bone metastasis with mild to moderate renal impairment , lower dos of Zometa be recommend .
68 Adult patient on peritoneal dialysis The treatment be divide into two stage :
the recommended initial dose be 500 μ g ( 6.75μ g / kg ) give once every three week , or once weekly dosing can be give at 2.25 μ g / kg body weight .
a rise in haemoglobin of greater than 2 g / dl ( 1.25 mmol / l ) over a four week period should be avoid .
keep out of the reach and sight of child .
Non-melanoma skin carcinoma occur in 3.6 % of patient ; other type of malignancy occur in 1.1 % of patient .
the influence on fertility in male breeding animal have not be investigate .
other
this lead to less bone loss .
keep out of the reach and sight of child .
common :
in patient with long-term kidney failure , the main cause of their anaemia be a lack of natural erythropoietin .
3 .
the mean period of treatment be 19 day for micafungin and 18 day for fluconazole in the adult population ( N = 798 ) and 23 day for both treatment arm in the paediatric population ( N = 84 ) .
9 .
Tredaptive
ARICLAIM should be use in pregnancy only if the potential benefit justify the potential risk to the foetus .
therefore , GANFORT should be use with caution in patient with know risk factor for macular oedema ( e. g. aphakic patient , pseudophakic patient with a torn posterior lens capsule ) .
4.9 Overdose
oral use Oral use Intravenous use
remove the plastic tray of MIRCERA from the box without peel back the protective film .
film coat :
a glucagon injection can treat quite severe hypoglycaemia .
Kinzalmono 40 mg tablet
a EU / 1 / 02 / 211 / 012
development or exacerbation of diabetes occasionally associate with ketoacidosis or coma , include some fatal case ( see section 4.4 ) Hypothermia
however , if it use be unavoidable , breast-feeding should be discontinue .
∗ STOCRIN 50 mg , 200 mg and 600 mg film-coated tablet be available .
6.5 Nature and composition of immediate packaging
1 dose ( 1 ml ) :
nr = Not reach .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Puregon 100 IU powder and solvent for solution for injection follitropin beta
current treatment guideline should be consult a to whether a liver biopsy be need prior to commence treatment .
if you want more information on the basis of the CHMP recommendation , read the Scientific Discussion ( also part of the EPAR ) .
Arcoxia
dose ( IU / kg give 3x / week )
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
take other medicine Please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
the effectiveness of Pradaxa be study in two main study , both of which compare Pradaxa ( either 220 or 150 mg a day ) with enoxaparin ( another anticoagulant ) .
4 .
Actrapid Penfill 100 IU / ml solution for injection in a cartridge Insulin human ( rDNA )
potential interaction affect olanzapine Since olanzapine be metabolise by CYP1A2 , substances that can specifically induce or inhibit this isoenzyme may affect the pharmacokinetics of olanzapine .
important information about some of the ingredient of ADVATE This medicinal product contain 0.45 mmol sodium ( 10 mg ) per vial .
the objective of the “ ICGG Gaucher Registry ” be to enhance the understanding of Gaucher disease and to evaluate the effectiveness of enzyme replacement therapy , ultimately lead to improvement in the safe and efficacious use of Cerezyme .
four of the study compare Januvia to placebo ( a dummy treatment ) , either take alone ( two study involve 1,262 patient ) , or a an add-on to metformin ( in 702 patient ) or to the PPAR gamma agonist pioglitazone ( in 353 patient ) .
4.1 Therapeutic indication
expiry DATE
Suomi / Finland ge EXUBERA-asiakaspalvelunumero Puh / Tel :
the decision to initiate AVANDAMET in combination with a sulphonylurea should include consideration of alternative therapy .
some piglet may be depress and
one IU ( International Unit ) correspond to 0.035 mg of anhydrous human insulin .
target haemoglobin concentration in two study be & gt ; 13 g / dl ; in the remain three study it be 12-14 g / dl .
study have not be perform in patient with severe hepatic impairment .
MaxCmin2
2 4.3 Contra-indications
rash pustular , contusion , sweat increase , urticaria , ecchymosis , increase tendency to bruise , hypotrichosis , skin hypopigmentation , dermatitis exfoliative , onychoclasis , folliculitis , petechia , psoriasis , purpura , skin hyperpigmentation , bullous eruption
the NeoRecormon pre-filled syringe be ready for use .
PHARMACEUTICAL FORM AND CONTENTS
• You may lose hair ( alopecia ) .
treatment of adult patient schedule for major elective orthopaedic surgery :
the physician should carefully weigh the risk of Refludan administration versus it anticipated benefit , take into account possible measure to control bleeding .
9 .
upon abrupt cessation of treatment with telmisartan , blood pressure gradually return to pre-treatment value over a period of several day without evidence of rebound hypertension .
300 IU / kg 3x / week for 4 week
- conclude that the cardiovascular safety and serious skin reaction should be continuously
cardiac arrhythmia ( primarily supraventricular ) usually respond to conventional therapy but may require discontinuation of therapy .
like all medicine , Comtan can cause side effect , although not everybody get them .
8 .
discus with your doctor whether you can drive or use machine at all , if you have a lot of hypo or if you find it hard to recognise hypo .
Tél . : + 34 93 470 79 40
common Uncommon
16 .
vaccination should be delay in people who have a sudden fever .
genotype 2 or 3 without RVR * *
in the case of the haemorrhagic event list , the factor VIII activity should not fall below the give level ( in % of normal ) in the corresponding period :
EU / 1 / 06 / 368 / 029 EU / 1 / 06 / 368 / 030
Ventavis be use for the treatment of adult patient with class III primary pulmonary hypertension to improve exercise capacity ( the ability to carry out physical activity ) and symptom .
EFECTIN ER 75 mg trde 75 mg kapsule s podaljš anim sprošč anjem
ANC & lt ; 0.5 x 109 / l and / or
how ZYPADHERA IS GIVEN
( Notes information )
each of these bubble be smaller than a red blood cell .
gastro-intestinal system disorder
rheumatoid arthritis clinical trial : in control rheumatoid arthritis clinical trial ( Studies I − IV ) ,
- somatropin ( growth hormone ) ,
PHARMACEUTICAL FORM
if the rate of rise in haemoglobin be greater than 2 g / dl ( 1.24 mmol / l ) over a month or if the haemoglobin level be increase and approach 12 g / dl ( 7.45 mmol / l ) , the dose be to be reduce by approximately 25 % .
absorption The mean absolute oral bioavailability of aprepitant be 67 % for the 80 mg capsule and 59 % for the 125 mg capsule .
because of marked inter-subject variability in interferon pharmacokinetics , it be recommend that patient with severe renal impairment be closely monitored during treatment with PegIntron ( see section 4.2 )
MARKETING Authorisation Holder
care should be take to ensure that at the outset of the treatment patient be not iron deficient .
beta-blockers , clonidine , lithium salt or alcohol may either potentiate or weaken the blood-glucose- lowering effect of insulin .
after single dose administration in the dose range of 75 to 600 mg , a 2-fold increase in dose result in a ~ 2.3 and 2.6- fold increase in AUC and Cmax , respectively .
Wicklow – Ireland
5 .
in interaction study perform in a limited number of healthy volunteer , these effect be not report with alfuzosin or tamsulosin .
none
MARKETING Authorisation Holder and Manufacturer Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt be Main Germany
Special STORAGE CONDITIONS
study of sitagliptin in combination with metformin In a 24-week , placebo-controlled clinical study to evaluate the efficacy and safety of the addition of sitagliptin 100 mg once daily to ongoing metformin , sitagliptin provide significant improvement in glycaemic parameter compare with placebo .
- Thrombocytopenia & lt ; 25,000 / mm3
PHARMACEUTICAL PARTICULARS
Peg Intron clinical trial – Naïve patient Two pivotal trial have be conduct , one ( C / I97-010 ) with PegIntron monotherapy ; the other ( C / I98-580 ) with PegIntron in combination with ribavirin .
in study 1 , the Enbrel-treated group have a significantly higher proportion of patient with a PASI 75 response at week 12 ( 30 % ) compare to the placebo-treated group ( 2 % ) ( p & lt ; 0.0001 ) .
- If you have any further question , ask your doctor or pharmacist .
a commonly use dose start at 75-150 IU FSH every day ( 0.12-0.24 ml ) .
26 Member State
in piglet , PCV2 associate infection may include symptom such a weight loss ( or failure to grow ) , enlarge lymph node , difficulty in breathing , and , le commonly , diarrhoea , pale skin and jaundice ( yellowing of the skin ) .
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
the active substance in Vidaza , azacitidine , be a medicine belongs to the group ‘ anti-metabolites ’ .
Crestor
6 .
regimen §
1 .
Levemir Penfill
Uncomplicated
the tablet be swallow whole with a glass of water , must not be chew , and can be take with or without food .
keep out of the reach and sight of child .
Tel : + 40 21 4023000
Pfizer Ltd Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom
patient with rare hereditary problem of fructose intolerance , glucose galactose malabsorption or sucrase- isomaltase insufficiency should not take this medicine .
5 .
blood and lymphatic system disorder Febrile neutropenia and neutropenic infection occur in 17.2 % and 13.5 % of patient respectively , regardless of G-CSF use .
in an embryotoxicity study in the rabbit , a higher incidence of cardiovascular and skeletal malformation be observe at systemic exposure level below the maximum clinical exposure ( AUC ) .
very rare :
lactose monohydrate Hypromellose Titanium dioxide Macrogol 3350 Red and black ferric oxide Carnauba wax
however , there be difference between age group in Cmax , stress the importance of individual dose titration .
what Insuman Rapid look like and content of the pack Insuman Rapid be a clear , colourless solution for injection , with no solid particle visible , and of a water- like consistency .
other information about Foscan :
please tell your doctor or pharmacist .
therefore , this combination be not recommended ( see section 4.4 ) .
levodopa be extensively metabolise to various metabolite , decarboxylation by dopa decarboxylase ( DDC ) and O-methylation by catechol-O-methyltransferase ( COMT ) be the most important pathway .
what BICALUTAMIDE IS AND WHAT IT IS USED FOR
store in a refrigerator ( 2 ° C – 8 ° C ) .
5 .
in this leaflet :
patient at risk for HBV infection should be evaluate for prior evidence of HBV infection before initiate Humira therapy .
• NeuTec Pharma plc
- you be do le exercise than usual , you be under stress ( emotional distress , excitement ) , or
he or she must perform blood test prior to your treatment with Zometa .
please tell your doctor if you be take or have recently take any other medicine , include medicine obtain without a prescription .
on the basis of the ground for referral CVMP consider any difference between Solacyl 100 % powder and the reference product that could justify different conclusion on the efficacy for the two product .
 329 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
DATE OF REVISION OF THE TEXT
irbesartan BMS be originally study in 11 trial for it effect on blood pressure .
BATCH NUMBER
patient with renal impairment should be closely monitor for toxicity since azacitidine and / or it metabolite be primarily excrete by the kidney ( see section 4.2 ) .
if patient develop non-haematologic toxicity ≥ Grade 3 ( exclude neurotoxicity ) , ALIMTA should be withhold until resolution to le than or equal to the patient ’ s pre-therapy value .
inhibitor , e. g. lopinavir / ritonavir , darunavir / ritonavir , atazanavir / ritonavir , ketoconazole ( see also section 4.5 )
telbivudine be excrete in the milk of rat .
control clinical trial have not show significant benefit attributable to the administration of epoetins when haemoglobin concentration be increase beyond the level necessary to control symptom of anaemia and to avoid blood transfusion .
information FOR THE USER
the oral bioavailability of tenofovir from tenofovir disoproxil fumarate in fasted patient be approximately 25 % .
keep out of the reach and sight of child .
ensure you prepare the solution on a clean and dry surface .
common ( ≥ 1 / 100 to & lt ; 1 / 10 )
16 .
Sweden
disodium phosphate dihydrate Sodium dihydrogen phosphate dihydrate Sodium chloride Calcium chloride dihydrate Polysorbate 20 Glycine Leucine Isoleucine Threonine Glutamic acid Phenylalanine
- It be not know if MIRCERA have a different effect in patient with haemoglobinopathy
study with hydrochlorothiazide have show equivocal evidence for a genotoxic or carcinogenic effect in some experimental model .
MARKETING AUTHORISATION HOLDER
3 .
these condition may not cause you to feel unwell so you should see your doctor for a general health check .
EXP Use immediately after open .
medicinal product subject to medical prescription .
5.1 Pharmacodynamic property
a anticholinergic be mainly eliminate by biotransformation , the potential for an interaction be limit , although an interaction with anticholinergic have not be investigate .
immune system disorder Common :
1 .
4.271
like all medicine , Baraclude can cause side effect , although not everybody get them .
3 year .
IDNT be a double blind , control , morbidity and mortality trial compare Karvea , amlodipine and placebo .
like all medicine , ONSENAL can cause side effect , although not everybody get them .
elimination :
do not take a double dose to make up for forgotten individual dos .
uth reach their recommendation on how to use the medicine .
Germany
emulsion for injection
hypertension
the transfer rate of cytarabine from CSF to plasma be slow and the conversion to uracil arabinoside ( ara-U ) , the inactive metabolite , in the plasma be fast .
47 %
• Remove the needle from the vial • Hold the syringe with the needle point up to see if it have any air bubble inside • If there be air bubble , tap the side gently until the air bubble go to the top of the syringe
EXP { MM / YYYY }
Ísland Vistor hf .
however , if it be time for your next dose , skip the miss dose and take only a single dose a usual .
method OF ADMINISTRATION
before the examination , care must be take that patient be sufficiently hydrate .
dry mouth Hepato-biliary disorder Very common :
EPAR summary for the public
- in whom glycaemic control be markedly improve ,
oral use Read the package leaflet before use
duloxetine BOEHRINGER INGELHEIM should not be use in combination with nonselective , irreversible Monoamine Oxidase Inhibitors - MAOIs ( see section 4.5 ) .
46 • Inflammation of the liver , yellowing of the skin and white of the eye
frequency category be base on information available from metformin Summary of Product Characteristics available in the EU .
inhalation anthrax
it be unlikely that atosiban inhibits hepatic cytochrome P450 isoforms in human ( see section 4.5 ) .
when treatment with voriconazole be stop , the initial dosage of efavirenz should be restore .
( concentration )
( mg )
congenital , familial and genetic disorder Uncommon :
Corlentor 5 mg : one film-coated tablet contain 5 mg ivabradine ( equivalent to 5.390 mg ivabradine hydrochloride ) .
relative risk reduction New morphometric vertebral fracture
if you forget , then change your patch a soon a you remember .
Malta A. M. Mangion Ltd .
the C max and AUC 0-24h of deferasirox increase approximately linearly with dose under steady-state
cardiac ischaemia3 *
antiviral activity in vitro :
your doctor will determine what dose be appropriate for you .
how to use SOMAVERT 4 .
high Density Polyethylene tablet container Pack size :
3.0 3.0
the combination be effective for up to two year .
0.876 ; 1.216 & # 93 ;
some men undergo treatment with GONAL-f may experience local reaction at the injection site ( pain , redness , bruising , swell and / or irritation ) or may develop a varicocele ( swell of the vein above and behind the testicle ) .
7.5 mg / ml
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
each cartridge contain 3 ml of solution for injection , equivalent to 300 IU insulin .
QUALITATIVE AND QUANTITATIVE COMPOSITION
thus additional caution should be exercise in consider Humira treatment of these patient ( see section 4.8 ) .
the significance of these finding for human be unknown .
129 Doses up to 10.5 time the intend dose have be report .
Kentera should not to be use during pregnancy unless clearly necessary
Determination of the efficacy of MabCampath be base on overall response and survival rate .
0.375 ml ( 40 µg / ml )
it should be handle with care .
see leaflet for further information .
16 .
these report be base on in vitro finding from human tumour sample , but be of uncertain significance in the clinical situation .
placebo
excipients : protamine sulphate , metacresol , phenol , zinc chloride , sodium dihydrogen phosphate dihydrate , glycerol , sodium hydroxide , hydrochloric acid ( for pH adjustment ) , water for injection .
5 .
31 / 39 MINIMUM PARTICULARS TO APPEAR ON PIPETTES
if you do not respond to glucagon , you will have to go to hospital .
Tel : + 44 1276 698370
Diagram J
these change be interpret a be secondary to decreased maternal body weight gain .
Austria
15 6.6 Special precaution for disposal
- increase the transport of glucose into cell a well a the formation of glycogen in the muscle and
do try to take the tablet at around the same time every day . c .
in case of accidental ingestion , seek medical advice immediately and show the package leaflet or the label to the physician .
activate factor X convert prothrombin into thrombin .
Granulát
if patient report hypoglycaemia , the dose of insulin should be decrease .
4 .
at therapeutic plasma concentration , the maximum QTcF ( Frederica ’ s correction ) mean change from baseline be 9.6 msec ( 90 % CI 15.1msec ) .
16 .
LABELLING
Sverige sanofi -aventis AB Tel : + 46 ( 0 ) 8 634 50 00
use other medicine
Оборище № 45 София 1504
system Organ Class Cardiac disorder
possible SIDE EFFECTS
overall response be generally better and , fewer patient develop antibody when treat with the combination of Humira and MTX compare to Humira alone .
4.5 Interaction with other medicinal product and other form of interaction
sucrose , Sodium chloride Sodium citrate Citric acid Hydrochloric acid Sodium hydroxide
5 .
Ελλάδα sanofi-aventis AEBE Τηλ : + 30 210 900 16 00
5 .
5.3 Preclinical safety data
ambrisentan do not inhibit or induce phase I or II drug metabolize enzyme at clinically relevant concentration in in vitro and in vivo non-clinical study , suggest a low potential for ambrisentan to alter the profile of medicinal product metabolize by these pathway .
if you want more information on the basis of the CHMP recommendation , read the Scientific Discussion ( also part of the EPAR ) .
patient treat with recombinant coagulation factor VIII should be carefully monitor for the development of inhibitor by appropriate clinical observation and laboratory test .
no
2 .
5 .
always use Rebif exactly a your doctor have tell you .
for more information , see section 5.1 . * produce by rDNA technology in E.coli cell harbour a genetically engineer plasmid hybrid encompass an interferon alfa-2b gene from human leukocyte
it be strongly recommend that every time you receive a dose of IntronA the name and batch number of the product be record in order to maintain a record of the batch use .
a primary growth factor for erythroid development , the natural hormone erythropoietin be produce in the kidney and release into the bloodstream in response to hypoxia .
connective tissue metabolism Somatropin stimulate the synthesis of chondroitin sulphate and collagen a well a the urinary excretion of hydroxyproline .
talk to your doctor if you have any further question or you think that any of these may apply to you .
the active ingredient of the vaccine be purify viral protein ( call haemagglutinin and neuraminidase ) .
& # 91 ; to be complete nationally & # 93 ;
injury , poison and procedural complication
6 .
activity profile of Levemir in patient with type 1 diabetes .
factor XIIIa , which be activate form Factor XIII by thrombin , crosslinks fibrin .
49 System Organ
Tel . : + 48 22 550 8888
6.2 Incompatibilities
these change be interpret a be secondary to decreased maternal body weight gain .
do not use Fertavid if you notice that the solution contain particle or be not clear .
any unused product or waste material should be dispose of in accordance with local requirement .
a cohort of 38 acromegalic subject have be follow in a long-term , open-label , dose-titration study for at least 12 consecutive month of daily dose with pegvisomant ( mean = 55 week ) .
expiry DATE
oral use
1 1 .
oral use
51 A .
what be the risk associate with Revatio ?
there have be report of raise blood sugar and developing or worsening of diabetes in people use protease inhibitor .
these usually disappear after a few week of take your insulin .
a further 6 DFSP patient treat with Glivec be report in 5 published case report , their age range from 18 month to 49 year .
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
each tablet contain 4 mg of rosiglitazone ( a maleate ) and 1000 mg of metformin hydrochloride .
2 .
in such case , a new vial yield a uniform suspension must be use .
Teva UK Ltd Brampton Road , Hampden Park , Eastbourne ,
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER
dosage and administration
MARKETING Authorisation Holder :
there be insufficient experience of the use of topotecan in patient with severely impaired renal function ( creatinine clearance & lt ; 20 ml / min ) or severely impaired hepatic function ( serum bilirubin ≥ 10 mg / dl ) due to cirrhosis .
pain Chest pain
-the Committee consider the referral make under Article 12 of Council Directive 75 / 319 / EEC for terfenadine .
Nespo 300 microgram solution for injection in a pre-filled pen Darbepoetin alfa
although there be a 49 % decrease in Cmax of nateglinide in dialysis patient , the systemic availability and half-life in diabetic subject with moderate to severe renal insufficiency ( creatinine clearance 15 – 50 ml / min ) be comparable between renal subject require haemodialysis and healthy subject .
( 4 ) 0.4 %
0.5 ml ( 80 µg / 0.5 ml )
29 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
oral
further dose reduction may be necessary ( see section 4.5 ) .
and Hb increase & lt ; 1 g / dl
Furthermore , irbesartan induce hyperplasia / hypertrophy of the juxtaglomerular cell ( in rat at ≥ 90 mg / kg / day , in macaque at ≥ 10 mg / kg / day ) .
P2 Program 2 :
MARKETING AUTHORISATION HOLDER
list OF EXCIPIENTS
convulsion
23 ANNEX II
Special PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS , IF ANY
during ALT flare , liver function test :
DATE ON WHICH THE PACKAGE INSERT WAS LAST APPROVED
6 .
France Laboratoire GlaxoSmithKline Tél : + 33 ( 0 ) 1 39 17 84 44 diam @ gsk.com
- previously require high insulin dos due to the presence of insulin antibody .
adverse reaction
sevelamer : decrease in MPA Cmax and AUC0-12 by 30 % and 25 % , respectively , be observe when mycophenolate mofetil be concomitantly administer with sevelamer without any clinical consequence ( i. e. graft rejection ) .
EXP
a closer monitoring of the leucocyte cystine level be recommend in these patient .
swallow the tablet whole with water , with or without food .
Tel : + 386- ( 0 ) 1 589 69 00
- 4 vial of powder for solution for injection , 4 ampoule of solvent for parenteral use , 4 injection
however , in combine with platinum agent , there be a distinct sequence-dependent interaction depend on whether the platinum agent be give on day 1 or 5 of the topotecan dosing .
2 .
keep out of the reach and sight of child .
1 .
- patient with decompensated congestive heart failure
sitagliptin be not carcinogenic in mouse .
concomitant use require caution
23
- you drink alcohol , particularly if you be not eat much ,
4.6 Pregnancy and lactation
in patient with solid tumour or lymphoproliferative malignancy , if the haemoglobin value exceed 12 g / dl ( 7.5 mmol / l ) , the dosage adaptation describe in section 4.2 should be closely respect , in order to minimise the potential risk of thromboembolic event .
- The other ingredient be white soft paraffin , liquid paraffin , propylene carbonate , white
similar outcome have be report with valsartan .
( see also section 4.6 )
RA Kent CT13 9NJ
if you be worried , talk to your doctor or pharmacist .
S All Genotypes
however , due to inter-individual variability in clearance , individualisation of dosage may be desirable .
10mg
Slovenia
- asthma or any other disease of the lung
powder and solvent for suspension for injection
13 .
antidiabetic agent .
detailed information on this medicinal product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu /
do not freeze .
if too high a dose be dial , turn the dose knob backward ( anti-clockwise ) until the correct dose appear in the window .
there be no data on maintenance of effect and limited data on long term safety ( see section 4.4 and 4.8 ) .
E uncommon : ≥ 1 / 1,000 to ≤ 1 / 100 ; rare : ≥ 1 / 10,000 to ≤ 1 / 1,000 ; very rare ≤ 1 / 10,000 ) and system organ class by decrease order of seriousness . ng lo no ct du ro lP na ici ed M
Contra-indications
Österreich sanofi-aventis GmbH Tel : + 43 1 80 185 – 0
glycaemic control should be monitor closely .
telmisartan be highly bind to plasma protein in renal-insufficient patient and can not be remove by dialysis .
one IU ( International Unit ) correspond to 0.035 mg of anhydrous human insulin .
treatment of PPE ( ileitis )
14 .
42 Take special care with Twinrix Adult :
acute hypersensitivity reaction include angioedema , anaphylaxis and anaphylactic reaction include anaphylactic shock , idiopathic thrombocytopenic purpura , thrombotic thrombocytopenic purpura , systemic lupus erythematosus , vasculitis , arthritis rheumatoid and arthritis rheumatoid aggravate
► In insulin infusion pump ► If InnoLet be drop , damage or crush there be a risk of leakage of insulin ► If it hasn ’ t be store correctly or be frozen ( see 6 How to store Insulatard ) ► If it ’ s not uniformly white and cloudy when it ’ s resuspend .
thromboembolism ( include pulmonary embolism and deep vein thrombosis )
if darbepoetin alfa be give concomitantly with any of these drug , blood level of these drug should be monitor and the dosage adjust a the haemoglobin rise .
MARKETING Authorisation Holder :
Norge Novartis Norge AS Tlf : + 47 23 05 20 00
each patch be seal in a sachet that protect it until you be ready to put it on .
Special precaution for use in animal If adverse reaction occur , treatment should be discontinue and the advice of a veterinarian should be seek .
MARKETING AUTHORISATION NUMBER ( S )
solution for injection
Piroxicam- Ratiopharm 10 Mg Tabs 6013244.01.00
how TO TAKE KARVEZIDE
information IN BRAILLE
Camprodón s / n “ La Riba ” E -17813 Vall de Bianya – Girona Tel : + 34 91 598 1336
0.5
cardiovascular safety result :
QUALITATIVE AND QUANTITATIVE COMPOSITION
-2 -4
4.4 Special warning and precaution for use
© EMEA 2007
elimination Tenofovir be primarily excrete by the kidney by both filtration and an active tubular transport system with approximately 70-80 % of the dose excrete unchanged in urine follow intravenous administration .
EU / 1 / 01 / 172 / 005
for the full list of all side effect report with Clopidogrel Winthrop , see the Package Leaflet .
3 ml suspension in a cartridge ( type 1 colourless glass ) with a plunger ( bromobutyl rubber ( type 1 ) ) and a flanged cap ( aluminium ) with a stopper ( bromobutyl or laminate of polyisoprene and bromobutyl rubber ( type 1 ) ) .
a )
child and adolescent MIRAPEXIN be not recommend for use in child or adolescent under 18 year .
Acemin
no study on the effect on the ability to drive and use machine have be perform .
London , 01 April 2008 EMEA / CHMP / 180097 / 2008
nervous system symptom of moderate-to-severe intensity be experience by 19.4 % of patient compare to 9.0 % of patient receive control regimen .
sorbitol and Lactose Monohydrate :
reticulocyte count increase & lt ; 40,000 / µl and Hb increase & lt ; 1 g / dl
food decrease exposure ( a measure by AUC ) to valsartan by about 40 % and peak plasma concentration ( Cmax ) by about 50 % , although from about 8 h post dose plasma valsartan concentration be similar for the fed and fast group .
5 .
a further dilution with glucose 78 intravenous infusion 5 % be require to a final concentration of 6 mg / ml .
in the 12 week acute phase of three clinical trial of duloxetine in patient with diabetic neuropathic pain , small but statistically significant increase in fast blood glucose be observe in duloxetine- treated patient .
pregabalin pharmacokinetics be linear over the recommended daily dose range .
hypersensitivity
4.6 Pregnancy and lactation
subcutaneous use
0.0
distribution Following intravenous administration , the mean volume of distribution be 76 ± 26 l , and systemic clearance be 147 ± 47 l / h .
SP Europe , 73 , rue de Stalle , B-1180 Bruxelles , Belgium
agitation , amnesia , ataxia , coordination abnormal , convulsion , think abnormal
rash : mild-to-moderate rash have be report in clinical study with efavirenz and usually resolve with continued therapy .
these be use to treat Human Immunodeficiency Virus ( HIV ) infection .
PHARMACEUTICAL FORM
11 .
because of the potential for adverse reaction in breast-fed infant , breast-feeding should be discontinue prior to initiation of treatment .
eye disorder
Alendronate be not recommend for patient with impaired renal function if the GFR be le than 35 ml / min , a there be no experience of this .
by bind selectively to antithrombin , fondaparinux potentiates ( about 300 time ) the innate neutralization of Factor Xa by antithrombin .
each film-coated tablet contain either 150 mg or 300 mg of maraviroc .
metabolism and nutrition disorder :
name OF THE MEDICINAL PRODUCT
EXP { MM / YYYY }
България sanofi-aventis Bulgaria EOOD Тел . : + 359 ( 0 ) 2 970 53 00
1 % & lt ; 1 % 8 %
Latvija Eisai Ltd .
EU / 1 / 08 / 457 / 001 EU / 1 / 08 / 457 / 002 EU / 1 / 08 / 457 / 003 EU / 1 / 08 / 457 / 004 EU / 1 / 08 / 457 / 005 EU / 1 / 08 / 457 / 006 EU / 1 / 08 / 457 / 007 EU / 1 / 08 / 457 / 015
Hold the pen with the needle pointing upwards .
- you have not inject your insulin or not inject enough , or if it have become le effective , for
Finland
the concentrate-diluent mixture be stable below 25 ° C for up to 24 hour .
4.1 Therapeutic indication
in severe case this reintroduction could be conduct in combination with a short period of oral steroid administration .
general disorder and administration site condition :
• Renal impairment Therapeutic experience be limit in patient with renal impairment ( see section 4.4 ) .
* p & lt ; 0.05 for comparison versus placebo Add-on / Combination study Vildagliptin 50 mg twice daily + metformin ( N = 143 )
Uncommon :
6.2 Incompatibilities
5 Following subcutaneous administration , choriogonadotropin alfa be eliminate from the body with a terminal half-life of about 30 hour , and the absolute bioavailability be about 40 % .
5 .
package size
if insulin have be expel through the needle tip , then the pen and the needle be work properly .
19 8 .
when Pradaxa be coadministered with diclofenac , the plasma exposure of both medicinal product remain unchanged indicate a lack of a pharmacokinetic interaction between dabigatran etexilate and diclofenac .
medicinal product subject to medical prescription .
it be not know whether this medicine be excrete in human milk .
medicine should not be dispose of via wastewater or household waste .
they be generally not serious , do not entail discontinuation of treatment , and be reversible .
Mimpara 60 mg tablet Cinacalcet
- if you be be treat now or have be treat in the last 4 week with brivudine , sorivudine
• Your doctor may need to increase your dose to control your blood sugar .
10.5 % ( 2.9 ; 18.1 ) b
the solution be clear and colourless to slightly yellowish .
for a full list of excipients , see section 6.1 .
Uncommon Cold sweat Facial swell Rash Generalised pruritus Alopecia Onychorrhexis
d .
Enbrel may increase your risk of get infection , which could be serious .
Alternatives to clarithromycin ( e. g. azithromycin ) may be consider .
difficulty in breathe • heart beati
multiple dose toxicity study reveal mild to moderate haematological change in rat , dog and monkey , accompany by bone marrow change in rat and dog .
KGaA Tel : + 49 89 121 42-0
a systematic review have also be perform involve more than 9 ’ 000 cancer patient participate in 57 clinical trial .
no evidence of toxic effect be find .
during study , no patient develop clinically relevant antibody titre against the trace amount of mouse protein and hamster protein present in the preparation .
23 %
Nacional I E-28750 San Agustín de Guadalix – Madrid Tel : + 34-91 848 85 00
• Publication of assessment report for Community referral
placebo N = 172
intravenous or subcutaneous use . du ro
Preliminary information suggest a relationship may exist between the presence of major deletion mutation in a patient & apos ; s factor IX gene and an increase risk of inhibitor formation and of acute hypersensitivity reaction .
MARKETING AUTHORISATION NUMBER ( S )
oral use
in these study 22 patient receive anagrelide for up to 4 year .
adult - 3 million IU 3 time a week ( every other day ) inject subcutaneously ( under the i dic
total daily dose ( mg )
population pharmacokinetics analysis indicate no discernable difference on the apparent clearance of paliperidone after administration of INVEGA between extensive metabolisers and poor metabolisers of CYP2D6 substrate .
5.2 Pharmacokinetic property
statement OF ACTIVE SUBSTANCE ( S )
40 50 60 75
common
this leaflet be last approved in { MM / YYYY } .
5.1 Pharmacodynamic property
the followingtable 1 can be use to guide dose in bleed episode and surgery :
at 12 , 24 and 36 month , graft and patient survival be similar for both group .
16 .
the product should only be administer by qualified personnel in authorised setting .
adverse reaction be rank under heading of frequency , the most frequent first , use the following convention :
in clinical study , minimal
EU / 1 / 06 / 368 / 086
au EXP
PPP ITT
it may harm them , even if their symptom be the same a yours .
after reconstitution the solution should be clear , colourless and free from foreign particle .
sunitinib be not clastogenic in rat bone marrow in vivo .
any medicinal product remain in the pre-filled syringe should be dispose of .
your doctor can measure your cholesterol with a simple blood test .
major depressive disorder .
type 1 glass 5 ml-vial with a grey bromobutyl stopper and an aluminium seal , with a green cap .
be careful when you start or stop take another medicine .
solution for injection
- Intravascular administration of iodinated contrast agent ( see section 4.4 )
suspension for injection
reproduction be authorise provide the source be acknowledge .
there be no safety , immunogenicity or efficacy data to support interchangeability of Cervarix with other HPV vaccine .
in all clinical study 38 – 40 % of patient be ≥ 60 year of age and 10 – 12 % of patient be ≥ 70 year of age .
this document can not replace a face-to-face discussion with your veterinarian .
however , there be no experience with the use of Insulin Human Winthrop Comb 25 in pregnant woman .
live attenuate
further INFORMATION
European Medicines Agency
maintenance phase To maintain an Hb of between 10 and 12 g / dl , the dosage be initially reduce to half of the previously administer amount .
some case be secondary to severe dehydration due to diarrhoea , vomit and / or anorexia , while others be confound by concomitant chemotherapy .
Lingual tablet
- phenytoin , phenobarbital , carbamazepine ( use to treat epilepsy ) ,
lot
Canary Wharf UK – London E14 4H
the expiry date refers to the last day of the month .
patient randomise to receive placebo at Weeks 0 and 4 cross over to receive ustekinumab ( either 45 mg or 90 mg ) at Weeks 12 and 16 follow by dose every 12 week .
summary of the safety profile In two clinical trial of 6 and 12 month duration involve 394 patient treat with AZARGA , the most frequently report adverse reaction be transient blurred vision upon instillation ( 3.6 % ) , last from a few second to a few minute .
European PUBLIC ASSESSMENT REPORT ( EPAR )
Uncommon :
the elimination half-life average 9.3 hour .
every 6 month , use a single dose .
3 soft capsule ( 400 / 100 mg )
2 .
BATCH NUMBER
cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring for possible arrhythmia .
cerebral ischaemia
name OF THE MEDICINAL PRODUCT
to find the optimal maintenance dose of patient with renal impairment , the patient should individually be titrate use the individual component of lisinopril and amlodipine , with close monitoring of renal function .
the safety of Protopic ointment have not be establish in patient with generalised erythroderma .
powder and solvent for suspension for injection in a pre-filled syringe .
treatment can be continue once blood pressure have be stabilise .
57 % male , 80 % Caucasian , and 78 % genotype 1,64 % ≤ 12 year of age .
Special population
- Increased eating ( binge eating , hyperphagia )
the I-QOL questionnaire score be also improve in the Duloxetine Boehringer Ingelheim group compare with the placebo group .
in addition , MabThera can be use to treat adult with severe rheumatoid arthritis ( a disease that cause inflammation of the joint ) .
Ziagen be contraindicate in patient with severe hepatic impairment ( see section 4.3 ) .
- a short needle ( for example 0.3 × 13 mm & # 91 ; 30 gauge 0.5 inch & # 93 ; ) for the subcutaneous injection ;
8 .
centralise application
Musculoskeletal and connective tissue disorder Rhabdomyolysis Renal and urinary disorder Urinary hesitation Reproductive system and breast disorder Priapism General disorder and administration site condition Asthenia Fatigue Oedema Investigations Elevated plasma prolactin level 8 1
PHARMACEUTICAL FORM AND CONTENTS
57 Driving and use machine
the other ingredient be mannitol , hydrochloric acid and water for injection .
SPC Section 4.2 Posology and method of administration
store in the original blister in order to protect from moisture and light .
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
- Do not use nitrate to treat your chest pain .
method OF ADMINISTRATION
XX / YYYY
PHARMACEUTICAL FORM AND CONTENTS
epoetin alfa HEXAL 1000 IU / 0.5 ml solution for injection in a pre-filled syringe
the clearance of lansoprazole be decrease in the elderly , with elimination half-life increase approximately 50 % to 100 % .
15 .
Light-pink , biconvex , round tablet , imprint “ IL ” on one side and “ NVR ” on the other side .
10000
all occur in paediatric patient , who receive up to five time the recommend intravenous dose of voriconazole .
lot { number }
any unused product or waste material should be dispose of in accordance with local requirement .
Glaxo Operations UK Ltd .
nausea / vomiting , abdominal pain , diarrhoea , stomatitis , dyspepsia
from a microbiological point of view , the product should be use immediately .
4.5 Interaction with other medicinal product and other form of interaction
Dexmedetomidine
deliver
renal and Urinary Disorders
no study on the effect on the ability to drive and use machine have be perform .
4.3 Contraindications
11 .
ocular change :
expiry DATE
please tell your doctor or pharmacist .
pharmacokinetics in elderly
Efficib 50 mg / 1000 mg film-coated tablet
Italia Wyeth Lederle S. p . a .
carbamazepine may make STOCRIN le likely to work .
to ensure that you read the dose correctly , hold the pen horizontally , with the needle on the left and the dosage selector to the right a show in the illustration below .
the 2.7 Orphan medicinal product average time take by the COMP to adopt recommendation on the designation of orphan medicine in 2002 be 59 day in The Committee for Orphan Medicinal Products ( COMP ) be average , below the target 90 day .
tiredness • rapid he
withdrawal PERIOD
16 .
Allocation in 2002
never drive or use machinery if you feel a hypo come on .
22 October 2004
post-marketing Experience
respiratory , Thoracic and Mediastinal Disorders
35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR BLISTER
analysis of the result for overweight patient treat with metformin after failure of diet alone show :
35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR , WHERE THERE IS NO OUTER PACKAGING , ON THE IMMEDIATE PACKAGING
6.6 Special precaution for disposal
therefore , interaction with other medicinal product affect plasma protein binding or elimination by biotransformation be unlikely .
after 48 week , 89 % of the patient take Atripla ( 181 out of 203 ) and 88 % of those remain on previous treatment ( 85 out of 97 ) have viral load below 200 copy / ml .
beta-blocking agent may mask the symptom of hypoglycaemia and delay recovery from hypoglycaemia .
inject the dose
this may indicate a potential for Exelon transdermal patch to induce mild erythema in patient .
expiry DATE
the other ingredient be lactose monohydrate , hyprolose , carmellose calcium and magnesium stearate .
• Diabetes • Heart disease • Liver or kidney disease • Parkinson ’ s disease • Epilepsy • Prostate problem • A blocked intestine ( Paralytic ileus ) • Blood disorder • Stroke or “ mini ” stroke ( temporary symptom of stroke )
food effect When give post-prandially , the extent of nateglinide absorption ( AUC ) remain unaffected .
in clinical trial , etoricoxib be administer without regard to food intake .
the overall incidence of treatment-related adverse event among all patient in the individual study be not significantly different between the basiliximab ( 7.1 % - 40 % ) and the placebo ( 7.6 % - 39 % ) treatment group .
the overall structure of the EMEA , particularly it Scientific Committees and their working party , be complete during the first year of operation ( see organigram , p.36 ) .
dog should be carefully observe follow administration to ensure that each tablet be swallow .
the safety and efficacy of use BeneFIX for immune tolerance induction have not be establish .
within each frequency grouping , adverse reaction be present in order of decrease seriousness .
any diarrhoea requiring hospitalisation ( irrespective of grade ) or grade 3 or 4 diarrhoea .
6 .
only solution which be colourless , clear or slightly opalescent , should be inject .
dosage in renally impaired patient Monotherapy ( Ovarian and Small cell lung carcinoma ) Insufficient data be available to make a recommendation for patient with a creatinine clearance & lt ; 20 ml / min .
4.2 Posology and method of administration
272 Store in a refrigerator .
diarrhoea
in a fourth study , the safety and efficacy of 50 mg Enbrel ( two 25 mg SC injection ) administer once weekly v 25 mg Enbrel administer twice weekly be evaluate in a double-blind , placebo-controlled study of 356 patient with active ankylose spondylitis .
interferon may impair fertility ( see section 4.6 and section 5.3 ) .
common
after inject • As soon a you have do the injection , unscrew the needle from the Pen use the outer needle cap .
the duration of postvaccinal immunity to homologous strain or to strain closely relate to the vaccine strain varies but be usually 6- 12 month .
32 10 .
the major circulate metabolite be irbesartan glucuronide ( approximately 6 % ) .
exposure in plasma , liver and brain be considerably higher than in adult rat after comparable dos in mg / kg between day 5 and 11 of age .
all other cause of anaemia , e. g. iron deficiency , damage of red blood cell ( haemolysis ) , blood loss , vitamin B12 or folate deficiency , should be take into account and treat prior to initiate therapy with Epoetin alfa HEXAL .
15 ANNEX II
- This medicine have be prescribe for you .
ed be 2 .
have be insert , maintain a light pressure on the surface of the skin and inject use the index finger to push on the plunger .
MARKETING Authorisation Holder :
Musculoskeletal and connective tissue disorder
interferon beta-1a be mainly metabolise and excrete by the liver and the kidney .
wash your hand with soap and warm water .
this be particularly important in those who have reduce or absent awareness of the warning sign of
• FABLYN increase risk of venous thromboembolism ( VTE ) . • The approach recommend for mitigation of risk of venous thromboembolism base on the SmPC , include contraindication of FABLYN in patient with active or past history of VTE . • FABLYN cause morphologic change , particularly the cystic atrophy of endometrium .
& # 91 ; 86.2 ; 99.6 & # 93 ;
for the same reason , concomitant administration of both a potent CYP3A4 inhibitor ( such a ketoconazole , itraconazole and ritonavir ) and a CYP2C9 inhibitor ( such a voriconazole ) with Tracleer be not recommended ( see section 4.4 ) .
contact your doctor or pharmacist before stop .
very Common ( & gt ; 1 / 10 )
6 .
before you use Viraferon 3 .
in particular the Board request an additional ECU 2 million from the European Union budgetary authority to compensate for shortfall in forecast fee revenue , which be grant at the end of 1998 .
5 .
the pharmacokinetic variability observe in the elderly be within the range for the non-elderly .
4366 Nydalen NO-0402 Oslo Tel : + 47 40 00 42 10
thyroid dysfunction during treatment with interferon alfa-2b and ribavirin have be observe .
film-coated tablet
Risperidona
Special STORAGE CONDITIONS
sodium and / or volume deplete patient In patient with marked volume- and / or salt-depletion ( e. g. those receive high dos of diuretic ) symptomatic hypotension could occur after initiation of treatment with Enviage .
16
Tritanrix HepB be a white , slightly milky liquid present in a glass vial for 2 dos ( 1 ml ) or in a glass vial for 10 dos ( 5 ml ) .
Tel : + 351 21 000 8600
patient who have receive 2 to 3 prior therapeutic regimen have a response rate of 32 % ( 10 / 32 ) and patient who receive greater than 7 prior therapeutic regimen have a response rate of 31 % ( 21 / 67 ) .
you be now ready to inject the dose .
higher dosage may be necessary in order to attain ( LDL- ) cholesterol level accord to current guideline .
1 vial 46 day
usually , your doctor will advise you to take another medicine instead of Karvezide , a Karvezide be not recommend in early pregnancy , and may cause serious harm to your baby if it be use after 3 month of pregnancy .
14 .
duration of treatment – Naïve patient Predictability of sustained virological response :
Viread do not reduce the risk of pass on HIV or HBV to others through sexual contact or blood contamination .
co-administration of REYATAZ / ritonavir and voriconazole have not be study .
IGF-1 have mitogenic activity that lead to an increase number of cell in the body .
box 581 , 2003 PC Haarlem The Netherlands
7 5.2 Pharmacokinetic property
lactation :
if the haemoglobin continue to increase , the dose should be reduce by approximately 25 % .
Re-initiation of therapy If treatment be interrupt for more than several day , it should be re-initiated at 1.5 mg twice daily .
Uncommon :
Cinacalcet be not teratogenic in rabbit when give at a dose of 0.4 time , on an AUC basis , the maximum human dose for secondary HPT ( 180 mg daily ) .
18 ANNEX IV
fosamprenavir 700 mg bid ( saquinavir / ritonavir 1000 / 100 mg bid )
a with other serotoninergic medicinal product , discontinuation symptom may occur in the neonate after maternal duloxetine use near term .
Ig 20 I. M .
expectancy ; the environment in which the patient be be treat ; and patient preference ( see section ic
storage Instructions
the reconstituted product contain eptacog alfa ( activate ) ( Recombinant coagulation factor VIIa ) 0.6 mg / ml
during a 1-year course of therapy there be a decrease in the rate of linear growth ( mean percentile decrease of 9 % ) and a decrease in the rate of weight gain ( mean percentile decrease of 13 % ) .
EMEA / CPMP a ) Validation b ) Opinion c ) Active Time d ) Clock stop
5 .
there be no clinical experience with massive overdosage .
Krka , d. d . , Novo mesto , Š marješ cesta 6 , 8501 Novo mesto , Slovenia ka
- previously require high insulin dos due to the presence of insulin antibody .
subcutaneous use be preferable in patient who be not receive haemodialysis to avoid the puncture of peripheral vein .
62.8 ± 16.80
ritonavir increase the serum level of saquinavir a a result of CYP3A4 inhibition .
kg Tel . : + 49 ( 0 ) 89 36044 8701 produkt . info @ gsk . com
10 aluminium lake Opacode Black S-1-8115 Opacode Black S-1-8114
name OF THE MEDICINAL PRODUCT
it be important to talk to your doctor immediately if you think you may be pregnant or be plan to become pregnant .
in addition some patient may experience vomiting .
4 – Take out the pre-filled diluent syringe from it package .
summary OF PRODUCT CHARACTERISTICS , LABELLING AND PACKAGE LEAFLET
filgrastim ratiopharm 30 MIU / 0.5 ml solution for injection or infusion Filgrastim ratiopharm 48 MIU / 0.8 ml solution for injection or infusion
NovoLet delivers 2-78 unit in increment of 2 unit .
- your blood sugar level be almost normal or be unstable ,
the pharmacokinetics of A771726 in CAPD subject appear to be similar to healthy volunteer .
in adult :
possible SIDE EFFECTS
4
ViraferonPeg 120 microgram powder and solvent for injection SC
range of MIC ( µg / ml )
IntronA
11 .
your doctor will test your blood to ensure that your white blood cell ( cell that fight infection ) and red blood cell ( cell that carry iron and oxygen ) count , platelet ( blood clot cell ) and other laboratory value be at acceptable level .
anti-HA antibody
suicidal ideation6 Suicidal behaviour6
- sign of dizziness , difficulty sleeping , drowsiness , difficulty concentrating or
Slovenija GlaxoSmithKline d. o. o .
it be an ear drop suspension for dog , that be white in colour .
Printing ink Shellac Potassium hydroxide Black iron oxide ( E 172 )
• Developing efficient and transparent procedure to allow timely access by user to innovative medicine through a single European marketing authorisation
BATCH { number }
4.1 Therapeutic indication
film-coated tablet
România MERCK d. o. o . , Dunajska cesta 119 SI-1000 Lubliana , Slovenia Tel : + 386 1 560 3 800
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
Head of Sector for personnel and budget Head of Sector for infrastructure service Head of Sector for account
syringe LABELS
difference
seizure occur most commonly in elderly patient and those with pre-existing CNS disorder ( e. g . , brain lesion or history of seizure ) and / or compromise renal function .
if spontaneous reporting would provide reliable data , a number of hypospadias would have be expect base on the ‘ natural ’ background incidence .
psychotic disorder , hypomania , delusion , mental status change , sleep disorder , abnormal dream , depress mood , affect lability , listless , loss of libido , nightmare , personality change , panic attack , restlessness .
the MRFG meet under the chairmanship of Dr David Jefferys of the United Kingdom from January to June 1998 and Dr Christa Wirthumer-Hoche of Austria from July to December 1998 .
in order to improve the tolerability of nervous system undesirable effect , bedtime dosing be recommend ( see section 4.8 ) .
Uncommon : erectile dysfunction
strength
204 ( 46.4 % )
0 ( 0 % )
this guidance be base on the 15 hour half-life of darunavir in the presence of ritonavir and the recommended dosing interval of approximately 12 hour .
EXP :
name OF THE MEDICINAL PRODUCT
a third group of 33 patient received bolus 5-FU / FA + Avastin ( 10 mg / kg every 2 week ) .
ptosis , dry eye conjunctivitis
hypoglycaemia ( low blood sugar ) can be very serious .
what CellCept be and what it be use for 2 .
hr = 0.82 ( 95 % CI :
9 .
360
in healthy adult subject , the efavirenz AUC when administer a the content of three 200 mg hard capsule mix with 2 teaspoon of certain food vehicle ( applesauce , grape jelly , yogurt or infant formula ) meet bioequivalency criterion for the AUC of the intact capsule formulation administer under fasted condition .
tablet
the following table list the adverse reaction and laboratory investigation observe from spontaneous reporting and in clinical trial .
a with other antipsychotic , it be recommend that blood pressure be measure periodically in patient over 65 year .
18 493 000 1 058 000 1 350 000 20 901 000
Tel : + 420 233 086 111
5 ANNEX II
telbivudine be a synthetic thymidine nucleoside analogue with activity against HBV DNA polymerase .
10ml ( 1.4 mg / ml )
Dissociation of perindoprilat bound to angiotensin convert enzyme lead to an “ effective ” elimination half-life of 25 hour , result in steady-state within 4 day .
reaction usually resolve in a few day to a few week .
however , base on the mode of clearance of the active substance there be no theoretical reason for any requirement for dose adjustment in the elderly .
outer CARTON
in preclinical study , olanzapine exhibit a range of receptor affinity ( Ki ; & lt ; 100 nM ) for serotonin 5 HT2A / 2C , 5 HT3 , 5 HT6 ; dopamine D1 , D2 , D3 , D4 , D5 ; cholinergic muscarinic receptor m1-m5 ; α 1 adrenergic ; and histamine H1 receptor .
respiratory , thoracic and Dyspnoea mediastinal disorder
patient with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product .
increase eye pressure have be observe very commonly .
treatment of overdose should be with gastric lavage or induced emesis a quickly a possible to remove unabsorbed zinc .
decrease appetite
MARKETING AUTHORISATION NUMBER ( S ) lo EU / 1 / 02 / 211 / 002 no
a slower injection be preferable in patient who react to the treatment with “ flu-like ” symptom .
chronic hepatitis C :
to avoid the loss of medicinal product when use the pre-filled syringe do not expel the air bubble from the syringe before the injection .
carbamazepine :
20 mg
study in rat have show that rotigotine and / or it metabolite ( s ) be excrete in breast milk .
75 6.5 Nature and content of container
MARKETING AUTHORISATION NUMBER ( S )
1 .
8 .
however , when drive vehicle or operate machinery it must be bear in mind that dizziness or drowsiness may occasionally occur when take antihypertensive therapy .
2 .
253 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
0 ( 0.0 % ) 0 ( 0.0 % ) 0 ( 0.0 % ) 2 ( 0.5 % )
16 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
instruction ON USE
4.4 Special warning and precaution for use
264 6.6 Special precaution for disposal
Ísland VISTOR HF Sími : + 354 535 7000
rare : pancreatitis , erosive duodenitis , oral hypoaesthesia .
p-valuea
no special requirement .
skin and subcutaneous tissue disorder :
chest pain , RUQ pain , malaise , injection site pain
15 ml
the recommended dosing regimen be describe in the following diagram :
Building and equipment
Humira 40 mg solution for injection in pre-filled pen Adalimumab
95 ( 3.5 )
dose adjustment of calcium channel blocker should be guide by clinical response ( refer to the Summary of Product Characteristics for the calcium channel blocker ) .
this can be discuss with your doctor .
film-coated tablet
206 This leaflet be last approved in { MM / YYYY } .
Ísland Icepharma hf .
healthy subject
London , 3 September 2008 Doc .
INTANZA be not recommend for use in child and adolescent below 18 year due to insufficient data on safety and efficacy .
J . -M .
can be use during pregnancy and lactation .
46 Omalizumab be a recombinant DNA-derived humanise monoclonal antibody that selectively bind to human immunoglobulin E ( IgE ) .
Stevens Johnson syndrome , toxic epidermal necrolysis , erythema multiforme
darbepoetin alfa be produce by gene-technology in Chinese Hamster Ovary Cells ( CHO-K1 ) .
metabolism and nutrition disorder :
Tel + 353-61-498200 Fax + 353-61-498247
Special STORAGE CONDITIONS
0.4 ml ( 200 µg / ml )
inform your doctor .
dose
in the different type of blood cell which make up blood ,
see package leaflet for further information .
16 B .
capsule , hard
the terminal elimination half-life of irbesartan be 11-15 hour .
instruction ON USE
Tél / Tel : + 32 2 352 74 60
syringe ( glass )
do not freeze .
if you can not easily pull out the dose button or dial the dose , do not use excessive force and do not use this pen because it may not deliver the correct dose .
contains sucrose See leaflet for further information
powder :
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
if such symptom appear , the potential seriousness of these undesirable effect must be bear in mind by the prescribing physician and the need for adequate therapeutic management should be consider .
keep out of the reach and sight of child .
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
what Irbesartan Winthrop look like and content of the pack Irbesartan Winthrop 75 mg film-coated tablet be white to off-white , biconvex , and oval-shaped with a heart debossed on one side and the number 2871 engrave on the other side .
discuss above may apply to this patient population be unclear , specifically consider that the in
oral use
octreotide / lanreotide may both decrease and increase insulin requirement .
6 .
other SPECIAL WARNING ( S ) , IF NECESSARY
European Medicines Agency
data on the foetal period be not available .
- Do not add any other insulin to the cartridge .
- Heart Failure ( a second line , when ACE inhibitor be unsuitable ) .
administration STEP 1 :
CEPROTIN be administer by intravenous injection after reconstitution of the powder for solution for injection with Sterilised Water for Injections .
Invented name
docetaxel in combination with trastuzumab be study for the treatment of patient with metastatic breast cancer whose tumor overexpress HER2 , and who previously have not receive chemotherapy for metastatic disease .
clinical PARTICULARS
excipients :
Tηλ : + 30 2 10 89 06 300
insulin Human Winthrop Comb 50 be a fluid ( suspension ) for injection under the skin .
some of these reaction have be severe .
& # 91 ; to be complete nationally & # 93 ;
- if you have have any lung disease in the past ; be currently , or have be , an intravenous drug
Uncommon
what Omnitrope look like and content of the pack
albumin level & lt ; 2.5 g / dl occur in & lt ; 1 % of patient , amylase level & gt ; 3 time basel ine in 2 % , lipase level & gt ; 3 time baseline in 11 % and platelet & lt ; 50,000 / mm3 in & lt ; 1 % .
3 .
5.2 Pharmacokinetic property
HEXAL ( list in section 6 . ‘ What Filgrastim HEXAL contain ’ ) .
if you be unsure , please contact your doctor . lP
Pfizer S. A ..
- oestrogen and progestogen ( such a in the contraceptive pill use for birth control ) ,
local allergy be common ( ≥ 1 / 100 to & lt ; 1 / 10 ) .
12 .
3 .
inform your doctor if you be plan to become pregnant , or if you be already pregnant .
frequently Asked Questions about Priming
in adult patient receive interferon in combination with ribavirin , the achieve sustained response rate be 47 % .
0.5 μg / kg
the observed incidence of antibody positivity in an assay may be influence by several factor include sample handling , concomitant medication and underlying disease , therefore , comparison of the incidence of antibody to other product may be mislead .
1 .
if a hypersensitivity reaction occur , characterise by rash with constitutional symptom such a fever , arthralgia , myalgia and lymphadenopathy , plus visceral involvement , such a hepatitis , eosinophilia , granulocytopenia , and renal dysfunction , VIRAMUNE must be permanently stop and not be re- introduce ( see section 4.3 ) .
– Continue to support the CPMP through provision of scientific
one jar contain 75 mg 1 3C-urea .
Puregon show no mutagenic potential in the Ames test and in the in vitro chromosome aberration test with human lymphocyte .
- a certain type of blood fat ( triglyceride ) may increase , see ‘ Take special care with Betaferon ’
PA / Alu / PVC blister
- Use sildenafil with caution at reduced dos of no more than 25 mg every 48 hour with
if you have liver or kidneys problem or if you be elderly , speak to your doctor a you may need a lower dose .
manufacturer ’ S BATCH NUMBER
GR
many medicine affect the way glucose work in your body and they may influence your insulin dose .
tablet
Fresenius Kabi Limited Cestrian Court , Eastgate
CPMP / EWP / 596 / 02
these inhibitor be usually IgGs direct against the factor VIII procoagulant activity , which be quantify in Bethesda Units ( BU ) per ml of plasma use the modify Bethesda assay .
do not freeze .
Intanza be a vaccine .
method AND ROUTE ( S ) OF ADMINISTRATION
adequate monitoring of serum potassium in patient at risk be recommend .
patient should be monitor closely to ensure that the lowest approve dose of Epoetin alfa be use to provide adequate control of the symptom of anaemia .
ideation or suicide attempt . rod
when a dose adjustment be necessary , this should be do in step of 25 IU / kg , 3 time per week at interval of at least 4 week until the desired goal be achieve .
for animal treatment only .
there be no data on maintenance of effect and limited data on long term safety ( see section 4.4 and 4.8 ) .
EU / 1 / 99 / 097 / 001
Ísland Vistor hf .
the combination of aliskiren and hydrochlorothiazide neutralise the reactive increase of PRA cause by hydrochlorothiazide .
& # 91 ; to be complete nationally & # 93 ;
47 Kύπρος Geo .
praziquantel & amp ;
patient should be adequately hydrate and consideration should be give to monitor renal function after initiation of concomitant therapy , and periodically thereafter .
44 %
the most common side effect with Hepsera ( see in more than 1 patient in 10 ) be raise creatinine ( a marker of kidney problem ) and asthenia ( weakness ) .
co-administration
after oral administration , the mean terminal elimination half-life of olanzapine in healthy subject vary on the basis of age and gender .
Deutschland Sanofi-Aventis Deutschland GmbH Tel : + 49 ( 0 ) 180 2 222010
a greater magnitude of weight gain , lipid and prolactin alteration have be report in short term study of adolescent patient than in study of adult patient ( see section 4.4 , 4.8 , 5.1 and 5.2 ) .
hypersensitivity to the active substance , to any of the excipients ( see section 6.1 ) , or to other sulfonamide-derived substance ( hydrochlorothiazide be a sulfonamide-derived substance ) Second and third trimester of pregnancy ( see section 4.4 and 4.6 ) Lactation ( see section 4.6 ) Severe renal impairment ( creatinine clearance & lt ; 30 ml / min ) Refractory hypokalaemia , hypercalcaemia Severe hepatic impairment , biliary cirrhosis and cholestasis
how to store GONAL-f 6 .
follow oral administration , lamivudine pharmacokinetics in late- pregnancy be similar to non-pregnant woman .
a for the secondary endpoint of fatal and non-fatal cardiovascular event , there be no difference among the three group in the overall population , although an increased incidence of non-fatal MI be see for woman and a decreased incidence of non-fatal MI be see in male in the irbesartan group versus the placebo- base regimen .
MARKETING authorisation holder :
• Before first use and just before inject this insulin , shake the vial up and down at least 10 time and roll the vial between your hand .
2 .
in addition , preclicinal juvenile toxicity result have demonstrate a minor , dose-related decrease in overall growth in neonatal rat dose with ribavirin ( see section 5.3 ) .
2 .
in rat , intrauterine exposure to risperidone be associate with cognitive deficit in adulthood .
PHARMACEUTICAL PARTICULARS
211 hypoglycaemia or a minor insulin overdose .
give in high dos ( ≥ 5 IU / kg / day ) follitropin alfa cause a decrease in the number of viable foetus without be a teratogen , and dystocia similar to that observe with urinary hMG .
BATCH NUMBER
43 No information be available regard the safety and efficacy of oseltamivir in patient with any medical condition sufficiently severe or unstable to be consider at imminent risk of require hospitalisation .
further INFORMATION
the Netherlands Tel : + 31 ( 0 ) 76 5732500
150 µg
if you drive or use tool or machine : watch out for sign of a hypo .
while fever may be associate with the flu-like syndrome report commonly during interferon therapy , other cause of persistent fever must be rule out .
30 and 100 film-coated tablet .
John ’ s wort be contraindicate .
other
only use needle that be compatible for use with SoloStar . • Special caution must be take to avoid accidental needle injury and transmission of infection . • Never use SoloStar if it be damage or if you be not sure that it be work properly . • Always have a spare SoloStar in case your SoloStar be lose or damage .
turn it till the push-button be fully down and you can feel resistance .
Special STORAGE CONDITIONS
for the 1.0 μg / kg dose , similar volume adjustment can be make or alternate vial strength can be use a show in Table 2 .
Pharmacotherapeutic group :
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
- itching
your doctor may also treat your symptom with other medicine ( paracetamol , antihistamine , corticosteroid , bronchodilator and / or adrenaline ) .
ear and labyrinth disorder Uncommon :
3 .
clinical PARTICULARS
in patient adequately control on amlodipine 10 mg but who experience unacceptable oedema , amlodipine / valsartan 5 mg / 80 mg may achieve similar blood pressure control with le oedema .
the target haemoglobin concentration in two study be & gt ; 13 g / dl ; in the remain three study it be 12- 14 g / dl .
1 dose ( 0.5 ml ) contain :
other SPECIAL WARNING ( S ) , IF NECESSARY
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
Suomi / Finland Baxter Oy Valimotie 15 A FIN-00380 Helsinki Puh / Tel : + 358 9 8621111
for this reason , other medicinal product should only be take with Tandemact with the knowledge ( or at the prescription ) of the doctor .
the risk of intussusception have be evaluate in a large safety trial conduct in Latin America and Finland where 63225 subject be enrol .
4 .
for more information , see the Summary of Product Characteristics ( also part of the EPAR ) .
patient receive opioid treatment for the first time Patches with a release rate of 12.5 microgram / hour be available and should be use for initial dosing .
12 .
oral use
there be no regimen-related death through the first 100-day post-transplant and up to one year post-transplant .
Special precaution in SCN patient
Actraphane 10 Penfill
this action inhibit viral replication or if replication occur , the progeny virion be unable to leave the cell . rod
- If you have inject too much Lantus , your blood sugar level may become too low
Τηλ : + 30 210 6074300
oral use
not in-use pen Store in a refrigerator ( 2 ° C-8 ° C ) .
615 • Skin change at the injection site ( lipodystrophy ) If you inject your insulin too often at the same skin site , fatty tissue under the skin at this site may either shrink or thicken .
subcutaneous use
aluminium FOIL WHICH IS USED FOR SEALING TRANSPARENT PLASTIC TRAY CONTAINING THE CARTRIDGE
49 559 000
16 .
12 10 .
elevate NO2 may cause acute lung injury .
irbesartan Winthrop belongs to a group of medicine know a angiotensin-II receptor antagonist .
Velosulin be a solution for injection or infusion ( drip ) .
the information provide do not cover the entire sale , but most product be include and the period cover by the PSURs be longer than request .
INVEGA be also more effective than placebo in prevent the occurrence of new symptom of schizophrenia in the long-term study .
1 Dexfenfluramine , Fenfluramine 7 Westferry Circus , Canary Wharf , London E14 4HB , UK Switchboard :
specific patient group Nateglinide should be use with caution in patient with moderate hepatic impairment .
if a bit of alcohol be leave on the skin , you may get a stinging sensation .
before YOU TAKE BENEFIX
ciprofloxacin Kabi 200 2 mg / ml mg / 100 ml , solution for infusion
28 August 2007
therefore , in patient with renal anaemia the medicinal product have to be administer intravenously .
in the All ACS population , prasugrel be associate with a lower incidence of CV death , non-fatal MI , or non-fatal stroke compare to clopidogrel , regardless of baseline characteristic such a age , sex , body weight , geographical region , use of GPIIb / IIIa inhibitor , and stent type .
if you become pregnant during therapy with Irbesartan Hydrochlorothiazide Winthrop , please inform and see your doctor without delay .
• OTHER CONDITIONS
headache , syncope Extrapyramidal symptom
Belgium
clinically significant laboratory abnormality , most frequently occur at dos greater than 10 million IU daily , include reduction in granulocyte and white blood cell count ; decrease in haemoglobin level and platelet count ; increase in alkaline phosphatase , LDH , serum creatinine and serum urea nitrogen level .
in this leaflet :
June 2008
31 % ( 32 % )
tablet
6 PHARMACEUTICAL PARTICULARS
- swollen lymph gland ,
statement OF THE ACTIVE SUBSTANCE ( S ) AND OTHER INGREDIENTS o
oral use
metformin Non-clinical data on metformin reveal no special hazard for human base on conventional study of safety pharmacology , repeat dose toxicity , genotoxicity , carcinogenic potential and toxicity to reproduction .
United Kingdom Abbott Laboratories Ltd Abbott House Vanwall Business Park Maidenhead Berkshire SL6 4XE-UK Tel : + 44 ( 0 ) 1628 773355
therefore at concentration observe in the plasma ( approximately 4 % relative to parent ambrisentan ) , 4-hydroxymethyl ambrisentan be not expect to contribute to pharmacological activity of ambrisentan .
any inflammatory symptom should be evaluate and treatment institute when necessary ( see section 4.8 ) .
any unused product or waste material should be dispose of in accordance with local requirement .
ViraferonPeg contain 40 mg of sucrose per 0.5 ml .
no study on the effect on the ability to drive and use machine have be perform .
placebo
MPA AUC value across age group be similar in the early and late post- transplant period .
the safety of desloratadine in child 2- to 11-years of age who be poor metabolisers be the same a in child who be normal metabolisers .
cartridge ( glass ) in multidose pen
the expiry date refers to the last day of that month .
absorption Kentera have a concentration of oxybutynin sufficient to maintain continuous transport over the 3 to 4 day dose interval .
you may need to read it again .
Actraphane be a dual-acting insulin .
the main measure of effectiveness be the change in the level of HIV in the blood ( viral load ) and the change in the number of CD4 T-cells in the blood ( CD4 cell count ) after 12 week of treatment .
follow oral administration of 825 mg / m2 capecitabine twice daily for 14 day , Japanese patient ( n = 18 ) have about 36 % lower Cmax and 24 % lower AUC for capecitabine than Caucasian patient ( n = 22 ) .
hypersensitivity to the active substance or to any of the excipients .
PHARMACEUTICAL FORM
there be no enterohepatic recirculation of these metabolite .
only one vial of Thyrogen be require per injection .
for second occurrence :
name OF THE MARKETING AUTHORISATION HOLDER
Actraphane be a mixture of dissolved insulin and isophane ( NPH ) insulin .
if you be pregnant , you should take SUSTIVA only if you and your doctor decide it be clearly need .
31
zidovudine have a similar effect in both specie , but only at very high systemic exposure .
subsequently , the physician may continue decrease the dose , but at a more gradual rate .
take Tasigna with food and drink • Do not take Tasigna with food .
4 .
genotype 2 , 3
3 .
Iceland
Rue de l ’ Institut 89 B-1330 Rixensart Belgium
249 A Let the insulin reach room temperature before you use it .
polycystic ovarian syndrome As a consequence of enhance insulin action , pioglitazone treatment in patient with polycystic ovarian syndrome may result in resumption of ovulation .
ATC code :
200 mg
however , prolong , intense exposure to water should be avoid .
in this study , mean ( SD ) terminal half-life be 74 ( SD 27 ) hour .
the powder and solvent be both contain in a two-chamber cartridge , Type I flint glass , separate by a bromobutyl rubber plunger .
Hb between 10 and 12 g / dl ( 6.2 - 7.5 mmol / l ) .
this summary be last updated in 12-2007 .
study be : a
carton 150 microgram
before YOU RECEIVE DARONRIX
treatment of chronic severe plaque psoriasis in child and adolescent from the age of 8 year who be inadequately control by , or be intolerant to , other systemic therapy or phototherapy .
no special requirement .
MARKETING AUTHORISATION HOLDER
if their symptom be the same a yours .
PHARMACEUTICAL PARTICULARS
Ninety-three percent of patient in the dasatinib arm and 82 % of patient in the imatinib arm achieve a CHR prior to crossover .
further INFORMATION
Κύπρος Boehringer Ingelheim Ellas A. E .
oral use
always take & # 91 ; Invented name & # 93 ; exactly a your doctor have tell you .
powder and solvent for solution for injection in a pre-filled syringe .
expiry DATE
very commonly report side effect ( greater than or equal to 1 in every 10 patient ) :
potentially , an overdose of eptifibatide could result in bleeding .
start dose of 50 IU / kg 2 time per week by the intravenous route .
MARKETING AUTHORISATION NUMBER ( S )
this action inhibit viral replication or if replication occur , the progeny virion be unable to leave the cell .
& # 91 ; to be complete nationally & # 93 ;
further INFORMATION
7 .
stomach ulcer , asthma or severe respiratory disease , difficulty in pass urine , or seizure ( fit or convulsion ) .
the solvent pre-filled syringe provide should be use for reconstitution only .
transdermal use
Bayer S.A. / N.V .
Kleva Epe Parnithos Avenue 189 Acharnai Attiki 13671 Greece
461 • Skin and allergic reaction Other mild reaction at the injection site ( such a injection site redness , unusually intense pain on injection site , itch , injection site swell or injection site inflammation ) may occur .
inflammation of the liver have also be report .
for a full list of excipients , see section 6.1 .
R ( SureClick )
how duloxetine work in SUI be not clear but it be think that , by increase the level of 5-hydroxytryptamine and noradrenaline at the level of the nerve that control the muscle of the urethra ( the tube that lead from the bladder to outside ) , duloxetine cause a stronger closure of the urethra during urine storage .
35.37 % 2.70 % 2.52 % 40.59 %
CARTONS of 1 , 5 or 10 pre-filled pen .
• Continue to take Janumet a long a your doctor prescribe it so you can continue to help control your blood sugar .
BATCH NUMBER
1997
what APROVEL IS AND WHAT IT IS USED FOR
each vial contain 5 ml of solution for injection , equivalent to 500 IU insulin .
if you have this reaction , be sure to rinse your mouth thoroughly afterwards .
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
oral use
MARKETING AUTHORISATION NUMBER ( S )
medicinal product subject to medical prescription .
Pre-ovulatory condition be reach when there be ultrasonographic evidence of a dominant follicle of at least 18 mm in diameter and / or when plasma oestradiol level of 300-900 picograms / ml ( 1000-3000 pmol / l ) be attain .
very common : affect more than 1 user in 10 • Dizziness , headache • Nausea ( feel sick ) • Double vision ( diplopia )
France
do not take more than the recommend dose .
België / Belgique / Belgien ALL-in-1 bvba Tél / Tel : + 32 ( 0 ) 32 86 88 88
what be the precaution for the person who give the medicine or come into contact with the animal ?
this may help you remember when to change your patch .
13 .
what benefit have Dicural show during the study ?
0.91 % 0.44 %
oral use
B .
your doctor will use this body surface area to work out the right dose for you .
IS-210 Garðabær Sími : + 354 535 70 00
the following event have be mention : insomnia , headache , nausea , diarrhoea , flu syndrome , nervousness , depression , pain , sweating and dizziness .
metabolism and Nutrition Disorders
active substance :
common :
ROUTE of administration
also contain : lactose anhydrous and sucrose .
the primary endpoint of the study be a reduction of serum calcium of ≥ 1 mg / dl ( ≥ 0.25 mmol / l ) .
nausea / vomiting , abdominal pain , diarrhoea , stomatitis , dyspepsia
not all pack size may be market .
LABELLING
the use of inadequate dosage or discontinuation of treatment , especially in insulin-dependent diabetic , may lead to hyperglycaemia and diabetic ketoacidosis ; condition which be potentially lethal .
be ( SD 0.56 ) and the volume of distribution ( Vss ) be approximately equal to plasma volume ( 50 ml / kg ) .
Janumet be not recommend for use in child under 18 year of age because of a lack of information on safety and effectiveness in this group .
SINGULAIR
4 .
in the male : • Deficient spermatogenesis due to hypogonadotrophic hypogonadism .
child and adolescent Procoralan be not recommend for use in child and adolescent due to a lack of data on safety and efficacy .
BATCH NUMBER
general CLASSIFICATION FOR SUPPLY
this medicine have be prescribe for you .
R Trudexa and 5.3 % for control treated patient .
water for injection should be inject into the vial .
use the injection method a instruct by your healthcare professional .
various regimen have be assess in the amprenavir / fosamprenavir development program with and without co-administration of ritonavir .
keep the container in the outer carton , in order to protect from light .
6.1 List of excipients
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
България ТП & quot ; Ели Лили Недерланд & quot ; Б.В . - България тел . + 359 2 491 41 40
deliver
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Uncommon side effect These may affect up to 1 in every 100 people
a :
7 .
bioavailability of epoetin beta after subcutaneous administration be between 23 and 42 % a compare with intravenous administration .
these reaction be generally of a transitory nature and be reversible when the treatment be stop .
EXP :
management of overdose There be no specific antidote for olanzapine .
keep the pen in the outer carton in order to protect from light .
not applicable .
Oracea should not be use in patient with ocular manifestation of rosacea ( such a ocular rosacea and / or blepharitis / meibomianitis ) a there be limited efficacy and safety data in this population .
should exposure to ACE inhibitor have occur from the second trimester of pregnancy , ultrasound check of renal function and skull be recommend .
4 .
neoplasm benign , malignant and unspecified ( incl cyst and polyp )
study of sitagliptin in combination with metformin and a sulphonylurea A 24-week placebo-controlled study be design to evaluate the efficacy and safety of sitagliptin ( 100 mg once daily ) add to glimepiride ( alone or in combination with metformin ) .
nervous system disorder
do not expose to excessive heat or direct sunlight .
status epilepticus , extrapyramidal disorder , hemiparesis , ataxia , cognition impair , dysphasia , gait abnormal , hyperesthesia , hypoesthesia , neurological disorder ( NOS ) , peripheral neuropathy
14 .
- This medicine have be prescribe for you .
the vaccine should be use within 2 hour .
clearance of darbepoetin alfa be 1.9 ml / hr / kg ( SD 0.56 ) and the volume of distribution ( Vss ) be approximately equal to plasma volume ( 50 ml / kg ) .
what be Equilis Prequenza Te use for ?
of a sulphonylurea and for whom metformin be inappropriate due to contraindication or intolerance ,
4 .
co-administration of darunavir and ritonavir and other medicinal product that inhibit CYP3A may decrease the clearance of darunavir and ritonavir and may result in increased plasma concentration of darunavir and ritonavir ( e. g. indinavir , systemic azoles like ketoconazole and clotrimazole ) .
long-term administration may be require to maintain the ANC & gt ; 2.0 x 109 / l .
the maximal blood pressure lower effect should be reach 4-6 week after begin treatment .
convulsion , disturbance in attention , delusion ( false belief ) , paranoia , rash , headache and stomach pain . du
if you stop use Insulin Human Winthrop Basal This could lead to severe hyperglycaemia ( very high blood sugar ) and ketoacidosis ( build-up of acid in the blood because the body be break down fat instead of sugar ) .
4.8 Undesirable effect
Belgium
psychiatric disorder :
the mean CYP3A activity , assess a clearance of triazolam , be increase by 55 % after 11 day of treatment with rufinamide 400 mg b. i. d .
cough
Fabbroni , 6 I-00191 Roma Italy
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
infusion of BeneFIX into 56 PTP patient ( baseline data ) with haemophilia B have show an in vivo recovery range from 15 to 62 % ( mean 33.7 + / - 10.3 % ) .
pregnancy and breast-feeding Ask your doctor or pharmacist for advice before take any medicine .
B03XA01
9 .
this soon disappear .
medicinal product subject to medical prescription .
adjustment of their control .
Actraphane 30 FlexPen Pen cap
Luxembourg / Luxemburg sanofi-aventis Belgium Tél / Tel : + 32 ( 0 ) 2 710 54 00 ( Belgique / Belgien )
anti-HA antibody Seroprotection rate * † Seroconversion rate † Seroconversion factor † * anti-HA ≥ 1 : 40
if a patient be already take St John ’ s wort , stop St John ’ s wort , check viral level and if possible tipranavir level .
laboratory value
MARKETING AUTHORISATION NUMBER ( S )
Finland
the main study of Inovelon involve 139 patient age between 4 and 30 year , of whom three quarter be below 17 year old .
Lietuva UAB “ Roche Lietuva ” Tel : + 370 5 2546799
distribution
keep out of the reach and sight of child
the printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch .
a gentle massage of the site - while still maintain pressure - help disperse the Fertavid solution and relieve any discomfort .
how have Bonviva be study ?
arrhythmia
protective efficacy
Tel : + 386 1 560 48 00
an atazanavir resistance phenotype be express in all recombinant viral clone contain the I50L substitution in a variety of genetic background .
do not take a double dose to make up for a forgotten dose .
for risperidone-naive patient , it be recommend to establish tolerability with oral risperidone prior to initiate treatment with RISPERDAL CONSTA ( see section 4.2 ) .
14 .
Table 1 :
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
4.2 Indications for use , specify the target specie
epoetins when haemoglobin concentration be increase beyond the level necessary to control symptom of anaemia and to avoid blood transfusion .
irbesartan Hydrochlorothiazide Winthrop should not be use in patient with severe renal impairment ( creatinine clearance & lt ; 30 ml / min ) ( see section 4.3 ) .
8 July 2004
overall Survival
no special requirement
what be Viread use for ?
if you notice any other side effect , please inform your veterinary surgeon .
- tiredness
ask your pharmacist how to dispose of medicine no longer require .
take special care with Ciprofloxacin Bayer )
thyroid function testing be recommend at baseline and if abnormal , every 6-12 month follow initiation of therapy .
PegIntron should be use with caution in patient with moderate to severe renal impairment .
early symptom ( symptomatic hyperlactatemia ) include benign digestive symptom ( nausea , vomit and abdominal pain ) non-specific malaise , loss of appetite , weight loss , respiratory symptom ( rapid and / or deep breathing ) or neurological symptom ( include motor weakness ) .
1 2
the dosage selector will only turn in one direction .
in case show no improvement after 2 month , treatment with Clomicalm should be cease .
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
child 3 year of age and older and adolescent - 3 million IU / m2 3 time a week ( every other day ) inject subcutaneously ( under the skin ) in combination with ribavirin ( Please also see ribavirin package leaflet ) .
5 .
4.5 Interaction with other medicinal product and other form of interaction
Burgess Hill , West Sussex , RH15 9NE , United Kingdom
73 % 80 %
data exclude those collect from one patient after evidence of inhibitor development be observe at 9 month .
30 After insertion of the cartridge in a pen , the suspension should be use in 28 day when store below 30 ° C .
do not take two dos in one day .
further INFORMATION
in many patient , the sign and symptom of neuroglycopenia be precede by sign of adrenergic counter-regulation .
7 .
in case where the target blood pressure be not achieve , the dose of telmisartan can be increase to a maximum of 80 mg once daily .
a with any vaccine , a protective immune response may not be elicit in all vaccinee .
15.2
32 Medicinal product by therapeutic area ( dose of Invirase use in study )
package size
9 .
Annex I
study V
use other medicine
Copalia 5 mg / 80 mg film-coated tablet amlodipine / valsartan
Conversely , base on the experience with the use of other medicinal product that blunt the renin-angiotensin system , concomitant use of potassium-sparing diuretic , potassium supplement , salt substitute contain potassium or other medicinal product that may increase serum potassium level ( e. g. heparin sodium ) may lead to increase in serum potassium .
dose proportionality in pharmacodynamic response ( maximum effect , duration of action , total effect ) be observe after subcutaneous administration .
( n = 106 )
do not freeze .
you should not take Zyrtec during breast feeding because cetirizine pass into breast milk .
follow the step next to the matching symbol .
vial )
you should check with your doctor or pharmacist if you be not sure .
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO SAFE AND EFFECTIVE USE
your insulin will work more quickly if you inject it around the waist .
biliary hyperplasia be observe in cynomolgus monkey give efavirenz for ≥ 1 year at a dose resulting in mean AUC value approximately 2-fold greater than those in human give the recommend dose .
other SPECIAL WARNING ( S ) , IF NECESSARY
manufacturer OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Danmark Merck Sharp & amp ; Dohme Tlf : + 45 43 28 77 66 dkmail @ merck.com Deutschland Berlin-Chemie AG Tel : + 49 ( 0 ) 30 67070 Bc-kontakt @ berlin-chemie.de
in subject with severe renal impairment ( creatinine clearance 10 – 30 ml / min ) , a 1.3- to 1.8-fold increase in ranolazine exposure be estimate .
when substitute another ophthalmic antiglaucoma agent with AZOPT , discontinue the other agent and start the following day with AZOPT .
au Germany
in addition , an updated RMP should be submit • When new information be receive that may impact on the current Safety Specification , Pharmacovigilance Plan or risk minimisation activity • Within 60 day of an important ( pharmacovigilance or risk minimisation ) milestone be reach • At the request of the EMEA
if the solution be cloudy or hazy , do not inject it .
6.1 List of excipients
another 4 % have a transient decrease below the lower limit of normal .
8 radiographically , occur early during filgrastim therapy and tend to plateau .
important note • Do not touch the needle or allow it to touch any surface before the injection . • It be normal to see a small air bubble in this syringe .
Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom
control
ENGERIX B , hepatitis B vaccine be a sterile suspension contain the purified major surface antigen of the virus manufacture by recombinant DNA technology , adsorb onto aluminium hydroxide .
also contain sodium chloride and water for injection .
patient with cardiac disease , such a angina , congestive heart failure or arrhythmia , should be closely monitor for worsen of their clinical condition during initiation of therapy with interferon beta-1a .
Ventavis 2 ml
do not remove the device from the package .
the above event be not cumulative , be typically reversible and generally do not result in treatment discontinuation .
because rotigotine be a dopamine agonist , it be assume that dopamine antagonist , such a neuroleptic ( e. g. phenothiazine , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of Neupro , and co-administration should be avoid .
however , intensification of insulin therapy with abrupt improvement in glycaemic control may be associate with temporary worsening of diabetic retinopathy . ct
in study perform in rat and rabbit no clinically relevant evidence of harmful effect with respect to pregnancy , embryonal / foetal development , parturition or postnatal development be observe .
binge eating , hyperphagia
► If you be allergic ( hypersensitive ) to this insulin product , metacresol or any of the other ingredient ( see 7 Further information ) .
child and adolescent :
concern
if you stop take Zalasta Do not stop take your tablet just because you feel better .
manufacturer ’ S BATCH NUMBER
how TO STORE APIDRA
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
your blood sugar may get too high ( this be call hyperglycaemia ) .
103 Using other medicine Please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
38 refractory MRCC , 26 % experienced bleeding .
PHARMACEUTICAL PARTICULARS
other
the Committee for Medicinal Products for Human Use ( CHMP ) decide that Neoclarityn ’ s benefit be greater than it risk for the relief of symptom associate with allergic rhinitis or urticaria .
without the recycling process , your liver have to make additional bile acid .
3 .
- rash
3 .
genotype 2 , 3
it be not know whether efavirenz be excrete in human milk .
CTC Grade 3 or 4
a greater magnitude of weight gain , lipid and prolactin alteration have be report in short term study of adolescent patient than in study of adult patient ( see section 4.4 , 4.8 , 5.1 and 5.2 ) .
package contain one or four pre-filled pen of a 100 µg Nespo solution for injection in 0.5 ml ( 200 µg / ml ) .
1 mmol / ml
CellCept tablet be use to prevent your body reject a transplanted kidney , heart or liver .
6 Hungary
it may harm them , even if their symptom be the same a yours . – If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor , diabetes nurse or your pharmacist .
in clinical trial that assess the driving ability , no impairment occur in patient receive desloratadine .
in order to follow-up your condition and your treatment , your doctor may examine your liver , your kidney , your heart and your blood on a regular basis .
Slovenská republika sanofi-aventis Pharma Slovakia s. r. o .
powder and solvent for solution for injection or infusion
therefore , breast-feeding may be continue during the vaccination schedule .
film-coated tablet
for the administration of Rebif , please read the following instruction carefully :
oral use
hepatomegaly Hepatotoxicity , ( include fatality )
13 .
the advisability of drive should be consider in these circumstance .
you should contact your doctor about the advisability of drive if you have : • frequent episode of hypoglycaemia • reduce or absent warning sign of hypoglycaemia
patient hypersensitive to Insuman Rapid for whom no better tolerate preparation be available must only continue treatment under close medical supervision and – where necessary – in conjunction with anti- allergic treatment .
management Board and Directorate
case of overdose ( 2-3 time the prescribed dose for several week ) have be report .
without a prescription ,
some men undergo treatment with GONAL-f may experience local reaction at the injection site ( pain , redness , bruising , swell and / or irritation ) or may develop a varicocele ( swell of the vein above and behind the testicle ) .
if you have kidney disease the dose of this medicine may have to be reduce , a it be your kidney that be mainly responsible for get rid of the medicine from your body .
a procedure for an almost automatic updating system of pre-existing guideline a influence by new text have yet to be instal .
11 / 15 B .
however the publish data present demonstrate the safety and efficacy of thus high-dose ciprofloxacin ( daily dose of with or without an option to oral switch , in various serious and life threaten infection ( severe pneumonia , neutropenia , acute bacterial exacerbation of chronic bronchitis , complicate , community-acquired skin and skin structure infection , infection in cancer patient and bacteraemia ) .
Avenue Molière 225 B-1050 Bruxelles / Brussel Tél : + 32 2 340 2828
he also hold an MBA from the Centre de Perfectionnement aux Affaires , Groupe HEC-CPA , 2000 , Jouy-en-Josas , France .
KOGENATE Bayer 250 IU powder and solvent for solution for injection Recombinant coagulation factor VIII ( octocog alfa )
& # 91 ; 140 − age ( year ) & # 93 ; x weight ( kg ) ( x 0.85 for woman ) 72 x serum creatinine ( mg / dl )
do not put Insuman Comb 50 next to the freezer compartment or a freezer pack .
6.6 Instructions for use and handling
it be not know whether Interferon beta-1b pass into human breast milk .
6.3 Shelflife
in addition some patient may experience vomiting .
Arava treatment should be start and supervise by a specialist who have experience in the treatment of rheumatoid arthritis and psoriatic arthritis .
Euphoric mood , confusion , irritability , libido decrease Hallucination , panic attack , restlessness , agitation , depression , depress mood , mood swing , depersonalisation , insomnia exacerbate , word find difficulty , abnormal dream , libido increase , anorgasmia , apathy
content BY WEIGHT , BY VOLUME OR BY UNIT
- sympathomimetic medicine ( such a epinephrine & # 91 ; adrenaline & # 93 ; or salbutamol , terbutaline use to
214 chemotherapy to achieve haemoglobin concentration le than 13 g / dl , be unclear because few patient with these characteristic be include in the data reviewed .
15 Member State
BATCH :
not applicable
depression , sleep disturbance
outer CARTON TEXT
after either oral or IV 14 administration of C irbesartan , about 20 % of the radioactivity be recover in the urine , and the remainder in the faeces .
Posatex
Musculoskeletal pain ( mild or moderate )
liver injury have most often occur between 1 month and 6 month after start treatment with Tasmar .
very Common :
on the basis of this trial , recommendation for a routine testing system be prepare for submission to the CPMP / CVMP and the European Commission .
all of these patient have receive treatment with azathioprine or 6-mercaptopurine concomitantly with or immediately prior to Remicade .
- 12 pen contain powder and solvent for solution for injection , 12 injection needle
film-coated tablet
6.1 List of excipients
ER
it be though know that the second generation fluoroquinolones ( ciprofloxacin , ofloxacin and levofloxacin ) show higher serum concentration and a more favourable tissue distribution than norfloxacin .
further information
in order to ensure optimum response to epoetin alfa , adequate iron store should be assure :
paper Tab
a per the CHMP Guideline on Risk Management Systems for medicinal product for human use , the updated RMP should be submit at the same time a the next Periodic Safety Update Report ( PSUR ) .
patient comfort in various social and work setting be also improve .
oral use
for convenience , patient receive valsartan and amlodipine from separate tablet / capsule may be switch to Imprida contain the same component dos .
read the package leaflet before use .
he / she may also talk about whether you need to use another method of contraception .
for the short-term relief of moderate to severe acute pain associate with :
contraceptive measure must be take during and for at least three month after cessation of therapy .
Cambridge Antibody Technology Ltd
B .
2b dose ( adult and paediatric )
food slightly delay and decrease the extent of the absorption of metformin .
pharmacovigilance system
patient schedule for major elective orthopaedic surgery should receive adequate antithrombotic prophylaxis , a thrombotic and vascular event may occur in surgical patient , especially in those with underlying cardiovascular disease .
C d
a clinical trial in a single intensive care unit treat hyperglycaemia ( blood glucose above 10 mmol / l ) in 204 diabetic and 1344 non-diabetic patient undergo major surgery show that normoglycaemia ( blood glucose 4.4 – 6.1 mmol / l ) induce by intravenous Actrapid reduce mortality by 42 % ( 8 % versus 4.6 % ) .
after oral administration , dabigatran etexilate be rapidly and completely convert to dabigatran , which be the active form in plasma .
Grapefruit juice should not be take together with Enviage .
4.8 Undesirable effect
the dose you take will depend on : • your age • whether you be take Lamictal with other medicine • whether you have problem with your kidney or liver .
maintenance dose between 17 and 33 IU / kg 3 time per week by the intravenous route .
500 mg
4.1 Therapeutic indication
100 %
in controlled clinical trial ( 4-8 week duration ) 52 % of the pregabalin treat patient and 38 % of the patient on placebo have at least a 50 % improvement in HAM-A total score from baseline to endpoint .
Tarceva be take at least one hour before or two hour after food .
Laboratoires Alcon , 23 Rue Georges Ferrenbach F-68240 Kaysersberg , France
among adolescent patient , mean weight gain be greatest in patient who be overweight or obese at baseline .
interferon do not act directly and specifically on the pathogenic virus , but exert it effect by inhibition of the internal synthesis mechanism of the infected cell .
CONDITIONS OF THE MARKETING AUTHORISATION
patient with sign or symptom compatible with autoimmune disorder should be evaluate carefully , and the benefit-risk of continued interferon therapy should be reassess ( see also section 4.4 Thyroid change and 4.8 ) .
4 .
11 4.4 Special warning and precaution for use
this be follow by a further injection four week later , and then an injection every three month ( 12 week ) .
keep the syringe in the outer carton in order to protect from light .
DATE OF REVISION OF THE TEXT
thiazide , include hydrochlorothiazide , can cause fluid or electrolyte imbalance ( include hypokalaemia , hyponatraemia and hypochloraemic alkalosis ) .
pack size Calendar pack contain 14 , 28 , 56 , 84 , 98 , 100 or 112 film-coated tablet .
eye disorder Very rare - Refraction disorder Refraction anomaly may occur upon initiation of insulin therapy .
do not freeze .
it exact mechanism of action be unknown , but it attach to several different receptor on the surface of nerve cell in the brain .
osteoporosis be a disease in which the bone gradually become thin and fragile , and more likely to break ( fracture ) .
interferon neutralising factor be antibody which neutralise the antiviral activity of interferon .
since sildenafil clearance be reduce in patient with severe renal impairment ( creatinine clearance & lt ; 30 ml / min ) a 25 mg dose should be consider .
the clinical relevance of these finding be unknown .
6 .
aripiprazole undergoes minimal pre-systemic metabolism .
oral
what Erbitux contain • The active substance be cetuximab .
carton CONTAINING 5 OR 20 HARD CAPSULES OF TEMODAL 20 mg INDIVIDUALLY SEALED IN SACHETS
dose ( mg )
275 chemotherapy to achieve haemoglobin concentration le than 13 g / dl , be unclear because few patient with these characteristic be include in the data reviewed .
5 Observed for fast normal level at baseline ( & lt ; 1.69 mmol / l ) which increase to high ( ≥ 2.26 mmol / l ) .
• Hypocalcaemia .
in patient with moderate hepatic dysfunction ( Child-Pugh score 7-9 ) , regardless of indication , the dose of 60 mg every other day should not be exceed ; administration of 30 mg once daily can also be consider .
EU / 1 / 99 / 127 / 013
10 single dos 0.5 ml pre-filled syrinx with 1 separate needle ( for each syringe ) .
subcutaneous injection of Puregon may be carry out by patient or partner , provide that proper instruction be give by the physician .
be not work very well ..
Pfizer Italia S. r. l .
inner Pen cap needle cap
detemir
- This medicine have be prescribe for you .
PHARMACEUTICAL PARTICULARS
like all medicine Kentera can have side effect .
erythropoietin be a growth factor that primarily stimulate red cell production .
PritorPlus be contraindicate during lactation since it be not know whether telmisartan be excrete in human milk .
the active metabolite be a selective inhibitor of influenza virus neuraminidase enzyme , which be glycoprotein find on the virion surface .
clinical PARTICULARS
- Hyperkinesia ( increased movement and inability to keep still )
Zerene should not be use in people who may be hypersensitive ( allergic ) to zaleplon or any of the other ingredient .
Swensweg 5 P. O .
figure 1 :
clopidogrel and the main circulating metabolite bind reversibly in vitro to human plasma protein ( 98 % and 94 % respectively ) .
these may be sign of a very serious condition call diabetic ketoacidosis .
2 .
good Manufacturing Practice inspection
15 .
14 .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product except those mention in section 6.6 .
5.3 Preclinical safety data
you should speak with your doctor before drive or use machine , a some side effect may impair your ability to do so safely .
do not take a double dose to make up for a forgotten dose .
a the ratio between norethisterone and ethinylestradiol remain similar during interaction with voriconazole , their contraceptive activity would probably not be affect .
what Kinzalmono contains
cimetidine and VIRAMUNE can be co-administered without dose adjustment .
Slovenská Republika Alcon Pharmaceuticals Ltd – oz + 421 2 5441 0378
there be no observed effect on the rate of rehospitalisation for unstable angina .
this medicine be for you ; never share a BYETTA pen with others .
other ingredient : sucrose , sodium citrate , L-methionine and polysorbate 20 in water for injection ; sodium hydroxide and / or hydrochloric acid a pH adjustment .
- oestrogen and progestogen ( such a in the contraceptive pill use for birth control ) ,
PHARMACEUTICAL PARTICULARS
2 .
Tekturna 300 mg
the site of injection should be vary each week .
hypothyroidism be report a an adverse event in 7 patient ( 4 % ) across the two cytokine-refractory MRCC study ; in nine patient ( 2 % ) on SUTENT and one patient ( & lt ; 1 % ) in the IFN-α arm in the treatment- naïve MRCC study .
27 September 2004
expiry DATE
severe OHSS ( see section 4.4 ) Ovarian torsion , a complication of OHSS
AVAGLIM combine two antidiabetic agent with complimentary mechanism of action to improve glycaemic control in patient with type 2 diabetes : rosiglitazone maleate , a member of the thiazolidinedione class and glimepiride , a member of the sulphonylurea class .
information TO THE USER T
the recommend dose be 150 mg take once daily a 2 capsule of 75 mg ( see section 4.4 and 5.1 ) .
ask your pharmacist how to dispose of medicine no longer require .
6 week when use or carry a a spare ( below 30 ° C ) .
do not freeze .
Italia Eli Lilly Italia S.p.A .
16 / 11 / 2004
Danmark Serono Nordic Strandvejen 102 B , 4 , th .
no study be available in child and adolescent in the other currently approve indication for adult .
the reconstituted product be a white to slightly yellowish suspension with strawberry odour .
DATE of CPMP opinion April 2002 June 2002 Ongoing Ongoing
- the IntronA multidose pen ;
chicken and duck
4.6 Pregnancy and lactation
nausea related Investigations
11 .
1 .
310 chemotherapy to achieve haemoglobin concentration le than 13 g / dl , be unclear because few patient with these characteristic be include in the data reviewed .
a be the case with other medicinal product that affect the renin-angiotensin system , black hypertensive patient have notably le response to irbesartan monotherapy .
ed 1 .
you may want to consider ask a family member or close friend to help you stay alert to sign of depression or change in your behaviour .
Teofarma S. R. L Via F. Iii Cervi 8 I-27010 Valle Salimbene ( PV ) Italy
possible SIDE EFFECTS
severe , persistent abdominal pain radiate to the back with vomiting ( acute pancreatitis ) may occur rarely . • Respiratory disorder - shortness of breath ( dyspnoea ) , bleed from the nose ( epistaxis ) , scar of the lung and fluid around the lung ( pleural effusion ) may occur .
Norge Gilead Sciences Sweden AB Tlf : + 46 ( 0 ) 8 5057 1849
you may even help bacteria become resistant and therefore delay your cure or decrease antibiotic efficacy if you do not respect appropriate :
C ) d )
take special care with Ebixa
200 mg
the interaction with midazolam lack clinical relevance but be indicative of a slight CYP3A4 inhibition by darifenacin .
Lithuania
15 mg 30 mg
the mean increase in olanzapine AUC be 52 % and 108 % respectively .
the absolute oral bioavailability of a single 600 mg dose of darunavir alone be approximately 37 % and increase to approximately 82 % in the presence of 100 mg b.i.d . ritonavir .
6.5 Nature and content of container
gastrointestinal disorder
- all other medicine to treat diabetes ,
3 ml
in a study , somewhat higher plasma concentration of irbesartan be observe in female hypertensive patient .
Uncommon :
each bottle with 100 ml of solution contains 5 mg zoledronic acid anhydrous , correspond to 5.330 mg zoledronic acid monohydrate .
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
3 .
1 pre-filled pen
the pancreatic acinar cell tumor in male rat be low-grade malignancy , do not affect survival , do not metastasize or invade surround tissue , and be similar to those see in concurrent control .
read the package leaflet before use .
therefore , this SPC may not necessarily represent the current text .
BN
11b 9c
the reconstituted solution should be clear and colourless .
how to store { PRODUCT NAME } 20 mg 6 .
a dose reduction might be need in case of worsening of the hepatic impairment .
Pentamidine ( use to treat some infection cause by parasite ) may cause hypoglycaemia which may sometimes be follow by hyperglycaemia .
do not refill Mixtard 40 Penfill .
if you often have hypoglycaemia or have difficulty recognise them , please discuss this with your doctor . • If you answer YES to any of the following question , tell your doctor , pharmacist or diabetes nurse
review the dose with your doctor each time you start a new cycle , since it may be different from the last cycle .
lot
PHARMACEUTICAL FORM AND CONTENTS
a ) b )
B ) the disease to which the veterinary medicinal product be intend to confer immunity be largely absent from the territory .
Ytracis be contraindicate in the following case :
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
guideline to assess efficacy and safety of normal intravenous immunoglobulin product for marketing authorisation
100 IU / ml
6 VASOVIST have be test in human up to a dose of 0.15 mmol / kg ( 5 time the clinical dose ) .
in the primary efficacy study , 75 % of intercourse attempt be successful in CIALIS treat patient a compare to 32 % with placebo .
for the full list of all side effect report with Filgrastim Hexal , see the Package Leaflet .
lot { number }
statement OF ACTIVE SUBSTANCE ( S )
Ελλάδα Novartis ( Hellas ) A. E. B. E .
store in the original package in order to protect from moisture .
in plasma , tacrolimus be highly bind ( & gt ; 98.8 % ) to plasma protein , mainly to serum albumin and α -1-acid glycoprotein .
the solution contain 10000 IU Epoetin zeta per ml .
they exhibit selectivity for human but not murine interferon , suggest specie specificity .
if you have the impression that the effect of ABILIFY be too strong or too weak , talk to your doctor or pharmacist .
67 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
laboratory value
what STOCRIN look like and content of the pack
expiry DATE
keep out of the reach and sight of child .
when carbamazepine or any other inducer of hepatic metabolism ( such a rifampicin ) be add to mirtazapine therapy , the mirtazapine dose may have to be increase .
drink alcohol while take Arava may increase the chance of liver damage .
ANTI-INFECTIVES Antiretrovirals Protease inhibitor ( PI ) Atazanavir / ritonavir / Efavirenz ( 400 mg once daily / 100 mg once daily / 600 mg once daily , all administer with food )
Pyriprole 56.25 mg
if you take more Micardis than you should
& # 91 ; see Annex I - To be complete nationally & # 93 ;
Tel : + 34 91 334 65 65 Fax : + 34 91 663 65 53
information IN BRAILLE
monthly pregnancy test during treatment with Volibris be recommend .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
vial LABEL
in these study , short-term a well a long-term treatment , approximately 30 % of subject experience altered / enhance visual perception , blur vision , colour vision change or photophobia .
no teratogenic effect have be observe in animal study .
BYETTA 10
Miscarriages be higher than in the normal population , but comparable with the rate find in woman with fertility problem .
10 Distribution The plasma protein binding of vildagliptin be low ( 9.3 % ) and vildagliptin distribute equally between plasma and red blood cell .
do not pass it on to others .
MARKETING AUTHORISATION NUMBER ( S )
Lepetit 8 20020 Lainate ( MI )
for patient ≥ 11 year of age , the initial dose by subcutaneous or intravenous administration be 0.45 µg / kg body weight , a a single injection once weekly .
S medication and institute appropriate medical therapy .
tell your doctor or pharmacist if you feel discomfort when use the spray .
read the package leaflet before use .
do not take a double dose to make up for a forgotten dose .
an investigational study ( BEST study ) in woman with metastatic breast cancer be design to determine whether epoetin alfa treatment that extend beyond the correction of anaemia could improve treatment outcome .
333 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
aseptically transfer this volume ( ml ) c of reconstituted CANCIDAS to an IV bag ( or bottle ) contain 250 ml of 0.9 % , 0.45 % , or 0.225 % Sodium Chloride Injection , or Lactated Ringers Injection .
can be use during pregnancy but may not prevent transplacental transmission of Classical swine fever field virus from the sow to foetus .
BATCH NUMBER
the main metabolite find in the circulation have no detectable COX-1 or COX-2 activity .
th haemoglobin can be measure at longer interval .
Forceful squirt to the back of the throat may cause choking .
82 % 79 %
& # 91 ; see Annex I – To be complete nationally & # 93 ;
vascular disorder
13.9 % ) ; Stomatitis ( G3 / 4 :
5 .
name OF THE MEDICINAL PRODUCT
3 pipette
statement OF ACTIVE SUBSTANCE ( S )
the bacteria also release a toxin ( poison ) , which can cause nerve damage , heart problem , and even death .
like other medicinal product that inhibit COX-2 , Dynastat be not recommend in woman attempt to conceive ( see section 4.4 , 5.1 and 5.3 ) .
depend on response and tolerability , the maintenance dose can be further increase by 50 mg twice a day every week , to a maximum recommended daily dose of 400 mg ( 200 mg twice a day ) .
syrup
switch a patient to another type or brand of insulin should be do under strict medical supervision and may require change in dose .
- You suffer from or have suffer from mania or bipolar disorder .
257 39
class acc . to MedDRA
& gt ; 70-80 150
strength
- if you be breast-feeding .
suppression of H. pylorus might give false negative result .
if it be use during pregnancy , the patient must be inform of the potential risk to the foetus .
thus , rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficit in dementia associate with Alzheimer ’ s disease and Parkinson ’ s disease .
2 .
11 In a series of pharmacokinetic and clinical trial , 6 % of the subject reach a higher concentration of desloratadine .
the possibility of an additive effect result in postural hypotension should be bear in mind when Nifedipine Pharmamatch retard be use in combination with other beta-blocking medicinal product and antihypertensive agent .
14 .
Preclinical data reveal no special hazard for human base on conventional study of safety pharmacology , repeat dose toxicity , carcinogenicity or genotoxicity .
although this interaction have not be formally investigate , there be no evidence that such an interaction be harmful .
B CONDITIONS OF THE MARKETING AUTHORISATION
- pack size of 100 vial of powder plus 100 vial of liquid .
common :
further INFORMATION
of MEDICINAL PRODUCTS
DATE of first authorisation :
ask your pharmacist how to dispose of medicine no longer require .
do not use after the expiry date state on the label .
a decision to use this vaccine before or after any other veterinary medicinal product therefore need to be decide on a case by case basis .
Sertraline :
box OF 1 , 2 , 3 , 5 , 7 , 10 , 14 , 15 , 20 , 21 , 30 , 50 , 90 , 100 TABLETS
5 6
information IN BRAILLE
Spain
expiry DATE
the pharmacokinetic property of enfuvirtide have be evaluate in HIV-1-infected adult and paediatric patient .
there be insufficient data for the withdrawal of concomitant antiepileptic medicinal product , once seizure control with pregabalin in the add-on situation have be reach , in order to reach monotherapy on pregabalin .
ADVATE be prepare without the addition of any human - or animal-derived protein in the cell culture process , pur ification or final formulation .
Pharmacotherapeutic group :
15 .
in two placebo-controlled six week trial in patient with chronic idiopathic urticaria , Aerius be effective in relieve pruritus and decrease the size and number of hive by the end of the first dosing interval .
7 .
few subject ( 0.2 % ) discontinue due to adverse reaction .
in these woman the benefit of IVF treatment need to be weigh against the
summary of the EMEA work programme 2006 EMEA / 62913 / 2006
stiripentol be extensively metabolize , 13 different metabolite have be find in urine .
0.3 ml ( 3333 IU / ml )
5.1 Pharmacodynamic property
patient should be monitor carefully for dose-related adverse reaction , especially nervous system symptom ( see section 4.3 and 4.4 ) .
please tell your doctor or pharmacist if you be take or have recently take any other medicine , even those not prescribe .
adjuvant Light liquid paraffin :
this leaflet be last approve on { date }
4.5 Interaction with other medicinal product and other form of interaction
or Dompé Biotec S. p . a .
Kύπρος Γ.Α.Σταμάτης & amp ; Σια Λτδ .
chewable tablet
content BY WEIGHT , BY VOLUME OR BY UNIT
indication
1 .
other
PHARMACEUTICAL Form
in case of positive semiquantitative dipstick result ( protein & gt ; 30 mg / dl ) , urinalysis should be perform to determine urinary protein creatinine ( UPC ) ratio , and a blood sample to measure creatinine , albumin and BUN .
in vitro , stavudine triphosphate have an intracellular half-life of 3.5 hour in CEM T-cells ( a human T-lymphoblastoid cell line ) and peripheral blood mononuclear cell , support twice daily dose .
name OF THE MARKETING AUTHORISATION HOLDER
the mechanism for the rare symptomatic hepatic dysfunction be not know .
5 .
valsartan have be study in patient with post myocardial infarction and heart failure .
list OF EXCIPIENTS
patient who present with cardiac event within 12 month prior to SUTENT administration , such a myocardial infarction ( include severe / unstable angina ) , coronary / peripheral artery bypass graft , symptomatic congestive heart failure ( CHF ) , cerebrovascular accident or transient ischemic attack , or pulmonary embolism be exclude from SUTENT clinical study .
5.1 Pharmacodynamic property
Hungary
appropriate screening test , i. e. tuberculin skin test and chest X-ray , should be perform in all patient ( local recommendation may apply ) .
do not freeze .
talk to your doctor or pharmacist if you take or have recently take any other medicine , even those not prescribe .
Neupro be not recommend for use in child and adolescent due to a lack of data on safety and efficacy .
store in the original package in order to protect from moisture .
the effect of the medicine that be radiolabelled with Ytracis will be fully explain in it Package Leaflet .
4.1 Therapeutic indication
hepatitis , cytolytic hepatitis , hepatic steatosis , hepatomegaly , increase transaminase , increase blood bilirubin , increase blood alkaline phosphatase , increase gamma-glutamyltransferase
31 PACKAGE LEAFLET :
to obtain the optimal droplet size for the administration of Ventavis the green baffle plate should be use .
- rigor
the other ingredient be : disodium hydrogen phosphate heptahydrate sodium dihydrogen phosphate dihydrate glycine
1 .
if you have COPD , or be a heavy smoker , you should discuss with your doctor whether treatment with a TNF blocker be appropriate for you . t uc
human erythropoietin be an endogenous glycoprotein hormone that be the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cell in the bone marrow .
dose adjustment At a rate of rise in haemoglobin of & gt ; 2 g / dl ( & gt ; 1.25 mmol / l ) per month the Silapo dose should be reduce by about 25-50 % .
list OF EXCIPIENTS
Hertford Road , Hoddesdon Hertfordshire EN11 9BU United Kingdom
- If you be diabetic , your doctor may ask you to have an eye examination .
keep the bottle tightly close .
how to store Xolair 6 .
the solution may appear cloudy or bubbly for a few minute .
you should have a pre-filled syringe contain clear liquid ( the solvent ) and one vial contain GONAL-f ( the white powder ) .
- rifampicin ( medicine to treat some infection such a tuberculosis )
bottle ( glass ) + spoon ( plastic )
blister
6 .
6 .
8.25 mg / 15 cm ² which release 50 µg fentanyl per hour
MARKETING AUTHORISATION NUMBER ( S )
Competact should not be use in patient with renal failure or renal dysfunction ( creatinine clearance & lt ; 60 ml / min ) ( see section 4.3 and 4.4 ) .
no significant accumulation of stavudine be observe with repeated administration every 6 , 8 , or 12 hour .
symptomatic treatment should be consider when serious side effect be observe .
- The active substance be teriparatide .
the appropriate dose of IntronA be withdraw from the vial ( s ) , add to 50 ml of 9 mg / ml ( 0.9 % ) sodium chloride solution for injection in a PVC bag or glass bottle for intravenous use and administer over 20 minute .
the dosage of nateglinide should be determine by the physician accord to the patient ’ s requirement .
13 .
your doctor may prescribe a different dose of Viraferon alone or in combination with other medicine ( e.g . ribavirin ) .
the main measure of effectiveness be the amount of antibody to Bordetella bronchiseptica and also to Pasteurella multocida toxin .
4 .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
a with all growth factor , there be a concern that epoetins could stimulate the growth of tumour .
2.5 ml
10 .
improvement be report in cardiac , nervous , skin / subcutaneous tissue , respiratory / thoracic / mediastinal , musculoskeletal / connective tissue / vascular , and gastrointestinal organ system .
15 13
Κύπρος Οδός Αγίου Νικολάου , 8 CY-1055 Λευκωσία Τηλ : + 357-22 757188
be The use of Protopy ointment in patient with genetic epidermal barrier defect such a Netherton ’ s
summary OF PRODUCT CHARACTERISTICS
for the full list of all side effect report with Ziagen , see the Package Leaflet .
hepatitis ( include hepatocellular , cholestatic or mixed liver injury )
if any of these apply to you , tell your doctor and do not take NovoNorm .
it may harm them , even if their symptom be the same a yours If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor .
infection and infestation
- acrylic copolymer .
or The pharmacokinetics of rimonabant be similar in female and male patient .
the following substance contain in the final product be include in Annex II of Council Regulation ( EEC ) No 2377 / 90 :
statement OF THE MRLs
11 / 17 10 .
the prospective randomise ( UKPDS ) study have establish the long-term benefit of intensive blood glucose control in type 2 diabetes .
Luxembourg / Luxemburg Novartis Pharma GmbH Tél / Tel : + 49 911 273 0
for a full list of the side-effects report with Purevax RCPCh , see the Package Leaflet .
this be more likely in patient who be be treat currently with diuretic .
expiry DATE
Meat and offal :
Glivec may do the same to some other medicine .
these therapy should be direct by doctor with experience in the care of patient with haemophilia A .
severe CNS effect , particularly depression , suicidal ideation and attempt suicide have be observe in some patient during PegIntron therapy , and even after treatment discontinuation mainly during the 6-month follow-up period .
the selective antagonism of the angiotensin-II ( AT1 ) receptor result in increase in plasma renin level and angiotensin-II level , and a decrease in plasma aldosterone concentration .
efavirenz 200 mg QD ( Indinavir 800 mg TID )
6.6 Instructions for use and handling and disposal
film-coated tablet
do not put on a patch this week .
167 the Wednesday injection .
dehydration , diabetes mellitus
what YTRACIS contains
serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening .
individual who require vaccination against measles can receive M-M-RVAXPRO regardless of their immune status to mumps or rubella if a monovalent measles vaccine be not readily available .
2 .
Merz Pharmaceuticals GmbH Eckenheimer Landstr .
the trough to peak effect measure by cuff during office visit be 68 % and 76 % for Irbesartan Hydrochlorothiazide Winthrop 150 mg / 12.5 mg and Irbesartan Hydrochlorothiazide Winthrop 300 mg / 12.5 mg , respectively .
• Lower respiratory tract infection due to Gram-negative bacteria
driving and use machine :
general disorder and administration site condition :
medicinal product subject to medical prescription .
1 pre-filled syringe with 2.5 ml water for injection with separate plunger rod .
keep out of the reach and sight of child .
keep out of the reach and sight of child .
in the Phase III study MRZ-0003 in patient with blepharospasm , no patient in both treatment group have a HDA antibody titer higher than 1 mU / l at baseline or at final visit .
additional information on individual component Adverse reaction previously report with one of the individual component may occur with Rasilez HCT even if not observe in clinical trial .
booster :
- behavioural change ( e. g. pathological gambling , compulsive shopping ) , increase libido ( e. g .
16 ANNEX II
do not shake the syringe .
2 .
Efexor depot and associate name ( see Annex I ) 37.5 mg prolonged-release capsule , hard Efexor depot and associate name ( see Annex I ) 75 mg prolonged-release capsule , hard Efexor depot and associate name ( see Annex I ) 150 mg prolonged-release capsule , hard
haemorrhage Haemorrhagic event , some of which be fatal , report through post-marketing experience , have include GI , respiratory , tumour , urinary tract and brain haemorrhage .
read the package leaflet before use .
the renal clearance of sitagliptin be not meaningfully alter .
8 .
like all medicine , Nexavar can cause side effect although not everybody get them .
in addition , since introduction of irbesartan / hydrochlorothiazide in the market the following adverse reaction have also be report :
dose adjustment At a rate of rise in haemoglobin of & gt ; 2 g / dl ( & gt ; 1.25 mmol / l ) per month the Retacrit dose should be reduce by about 25-50 % .
this can be discuss with your doctor .
clinical investigation of medicinal product for the treatment of peripheral arterial occlusive disease ( revision )
your doctor have determine the exact dosage for administration of Viraferon accord to your individual need . uc
Magyarország sanofi-aventis zrt . , Magyarország Tel . : + 36 1 505 0050
store in a refrigerator ( 2 ° C - 8 ° C ) .
46 • Be sure the child be give the entire spoonful of the granule / food mixture immediately ( within 15 minute ) .
patient with depression should be treat for a sufficient period of at least 6 month to ensure that they be free from symptom .
Bayer Animal Health GmbH , D-51368 Leverkusen , Germany
total bilirubin : & gt ; 1.5 – 3.0 ULN AST : any
strength
rare : blood bilirubin increase , blood glucose increase
1 2 3 4 5 6 7 8
of the 182 treated patient who be assess for antibody to Chinese hamster ovary ( CHO ) cell protein , 3 show a statistically significant upward trend in titre by linear regression analysis and 4 displayed sustain peak or transient spike .
Mixtard be a mixture of dissolved insulin and isophane ( NPH ) insulin .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
a with all other non-nucleoside reverse transcriptase inhibitor ( NNRTIs ) , resistant virus emerges rapidly when efavirenz be administer a monotherapy .
in addition , a more robust test for potency should be apply to the product in the future .
UAB Merck Sharp & amp ; Dohme , Tel . : + 370.5.2780.247 Luxembourg / Luxemburg :
chronic Hepatitis C :
0.5 ml )
if foam form , let vial stand to allow foam to dissipate .
the company that make Atriance will supply information from study into the safety of Atriance in child and young adult , include one study of Atriance take in combination with other anticancer medicine .
interaction The effect of BYETTA to slow gastric emptying may reduce the extent and rate of absorption of orally administer medicinal product .
none .
however , the Mixtard dosage may need to be adjust .
6 .
Invented name
only a doctor who have experience in treat patient with Fabry disease or other inherited metabolic disease should give Replagal .
kg Theresienhöhe 11 80339 München Germany
this mean that due to the rarity of the disease it have not be possible to obtain complete information on this medicinal product .
in vitro and in vivo animal data indicate that desirudin be for the most part eliminate and metabolise by the kidney .
the number of unit of factor IX administer be express in International Units ( IU ) , which be relate to the current WHO standard for factor IX product .
- you have not inject your insulin or not inject enough , or if it have become le effective , for
the product be supply in pack of 1 , 2 , 10 vial with the corresponding number of solvent container .
49 film-coated tablet Component of a multipack comprise 2 pack , each contain 49 tablet .
− Film coat :
follow administration of Fentanyl-ratiopharm , fentanyl be continuously absorb through the skin over a period of 72 hour .
8 Undesirable effect previously report with one of the individual component may be potential undesirable effect with PritorPlus , even if not observe in clinical trial with this product .
Uncommon
& # 91 ; to be complete nationally & # 93 ;
consequently affected person should avoid these task until their faculty be fully recover .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
clinical response ( CR- 100 )
- The table include in the response dossier do not indicate which parasite be refer to , and there
6.5 Nature and content of container
23 Important information about some of the ingredient of DUKORAL DUKORAL contain approximately 1.1 g sodium per dose .
patient older than 50 year of age ( n = 23 ) have be successfully treat with Busilvex without dose- adjustment .
other ingredient :
infusion of PBPCs accelerate haematopoietic recovery reduce the duration of risk for haemorrhagic complication and the need for platelet transfusion .
200 mg / 100 ml , 400 mg / 200 ml
in order for VIAGRA to be effective , sexual stimulation be require .
if treatment with peginterferon alfa-2b be judge necessary in patient with existence or history of severe psychiatric condition , this should only be initiate after have ensure appropriate individualise diagnostic and therapeutic management of the psychiatric condition .
MARKETING AUTHORISATION HOLDER
50 IU / kg 3 time per week by the intravenous route .
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
method OF ADMINISTRATION
MedDRA system organ class Cardiac Disorders Skin and Subcutaneous Tissue Disorders
prior treatment with high dose diuretic such a furosemide ( loop diuretic ) and hydrochlorothiazide ( thiazide diuretic ) may result in volume depletion and in a risk of hypotension when initiate therapy with telmisartan .
74 PACKAGE LEAFLET :
422 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
BRISTOL-MYERS Squibb Pharma EEIG F
Vimpat 10 mg / ml solution for infusion Lacosamide
Corticosteroïds ( systemic route ) :
PHARMACEUTICAL FORM
push the plastic screw cap down while turn it counter clockwise .
for animal treatment only - to be supply only on veterinary prescription .
Qchs.mi @ quintiles.com
7 .
5 .
intact CYSTAGON hard capsule should not be administer to child under the age of approximately 6 year due to risk of aspiration ( see section 4.2 ) .
method of administration
4.7 Effects on ability to drive and use machine
dosage FOR EACH SPECIES , ROUTE ( S ) AND METHOD OF ADMINISTRATION
56 Storage Instructions
Demographic difference between the adolescent and adult include a lower average body weight and fewer adolescent be smoker .
Table 1 .
cartridge ( glass ) in a pre- fill pen ( SoloStar )
2
86 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
adjustment .
of THE REACH AND SIGHT OF CHILDREN a
point to consider on Clinical investigation of medicinal product in the treatment of acute stroke Released for consultation October 2000
medicine should not be dispose of in wastewater or household waste .
the inhibitory effect be maintain over 24 hour and still measurable up to 48 hour .
Dex n = 202 0 ( 0 )
Dompé in ic
19.5 ( 14.5 , 25.4 )
no drug interaction study have be perform for the co-administration of Norvir with benzodiazepine .
GONAL-f be present a a powder and solvent for solution for injection .
you will need to snap it apart where it join the others ( picture 1 ) . • Keep the single container out .
no interaction study have be conduct in human subject
powder :
6 .
the final opinion be convert into a Decision by the European Commission on 11 / 10 / 2006 .
method AND ROUTE ( S ) OF ADMINISTRATION
very common : hypotension
thereafter , the difference between the two group be not significant .
driving and use machine
the following table provide a guide for factor VIII minimum blood level .
press the knob .
-1.62
capsule
atazanavir ( pm ) : all administer
ask your pharmacist how to dispose of medicine no longer require .
Pharmacodynamic information specific to acute tibia fracture study
Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom
6.6 Special precaution for disposal
Phentermine ; Amphepramone Clobenzorex ; Fenbutrazate ; Fenproporex ; Mazindol ; Mefenorex ;
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
Musculoskeletal and connective tissue disorder :
elevate cholesterol levels2,3 Elevated glucose levels4 Elevated triglyceride levels2,5 Glucosuria Increased appetite
Lietuva BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT .
FI - Finland
• OTHER CONDITIONS
for a full list of excipients , see section 6.1 .
BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH - United Kingdom
4.8 Undesirable effect
healthy subject who receive up to 20 mg / day for up to 14 day , and single dose up to 40 mg have no unexpected adverse reaction .
this document , together with the withdrawal letter from the company , will be publish on the EMEA website , after the next meeting of the Committee for Medicinal Products for Human Use ( CHMP ) on 24-27 April 2006 .
MARKETING AUTHORISATION NUMBERS
stomach pain , difficulty swallow , retch and vomit have occur with INCRELEX treatment .
sanofi Pasteur MSD Ltd , Tel : + 3531.468.5600 Ísland :
document title
EU / 0 / 00 / 000 / 000
general CLASSIFICATION FOR SUPPLY
these value be within the range report for adult at therapeutic dos .
12 .
do not store above 30 ° C .
seven major metabolite , include hydroxyl , demethyl , and hydroxydemethyl , be identifiable in whole blood .
the reconstituted solution should be clear and colourless .
medicine should not be dispose via wastewater or household waste .
method AND ROUTE ( S ) OF ADMINISTRATION
pharmacological PROPERTIES
generalise hypersensitivity reaction include erythema , urticaria , rash and pruritus have be observe uncommonly ( approximately 0.1 % of all patient treat with Puregon ) .
5 .
care should be take to avoid contact of the skin with the suspension .
EU / 1 / 03 / 248 / 005 2 Tablets EU / 1 / 03 / 248 / 006 4 Tablets EU / 1 / 03 / 248 / 007 8 Tablets EU / 1 / 03 / 248 / 008 12 Tablets
lot { Number }
in human , the apparent volume of distribution of pregabalin follow oral administration be approximately 0.56 l / kg .
2 .
how to store ZOSTAVAX 6 .
3 .
3 .
each vial contain 150 mg trastuzumab .
Dexdomitor 0.5 mg / ml
it reduce glycaemia by reduce insulin resistance at adipose tissue , skeletal muscle and liver .
inhalation use
7 .
method AND ROUTE ( S ) OF ADMINISTRATION
37 ANNEX III
read the package leaflet before use .
occasionally case of arthralgia and myalgia in approximately 3 % have be report .
615 Maintenance
at least eleven amino acid site in the protease have be associate with indinavir resistance :
repeat infusion every 8 to 24 hour until threat be resolve
erythema Induration Nodules and cyst Pruritus Ecchymosis a Any severity grade . b
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www . emea . europa . eu / .
gastric lavage or administration of activated charcoal may be worthwhile in some case .
instruction ON USE
general CLASSIFICATION FOR SUPPLY
12 %
each tablet contain 80 mg telmisartan .
B .
concomitant administration of pioglitazone with gemfibrozil ( an inducer of cytochrome P450 2C8 ) or with rifampicin ( an inducer of cytochrome P450 2C8 ) be report to increase or decrease , respectively , the plasma concentration of pioglitazone ( see section 4.5 )
3 February 2005
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
anaemia symptom and sequela may vary with age , gender , and overall burden of disease ; a physician ´ s evaluation of the individual patient ´ s clinical course and condition be necessary .
15 microgram HA * *
caution should be exercise when Omnitrope be administer to breast-feeding woman .
before YOU TAKE PELZONT
• OTHER CONDITIONS
thus , most data pertain to injectable POC , little data exist for other POCs , no data be available for Implanon .
International Units be determine by comparison of the activity of the recombinant interferon alfa-2b with the activity of the international reference preparation of human leukocyte interferon establish by the World Health Organisation .
HPV type 16 and 18 be responsible for approximately 70 % of cervical cancer case .
overdose of epoetin alfa may produce effect that be extension of the pharmacological effect of the hormone .
if you have any further question on the use of this product , ask your doctor or pharmacist .
do not stop Insuman Comb 25 without speak to a doctor , who will tell you what need to be do .
4.4 Special warning and special precaution for use
5.3 Preclinical safety data
however , a clinical experience with olanzapine in patient with concomitant illness be limit , caution be advise when prescribe for patient with prostatic hypertrophy , or paralytic ileus and relat ed condition .
glycerol Gelatin Water , purify Red iron oxide paste ( E172 ) Lecithin Medium chain triglyceride
no hepatotoxicity be observe in rodent and monkey in the repeat dose toxicity study .
long-term olanzapine treatment ( up to 12 month ) for recurrence prevention in patient with bipolar disorder be associate with an increase of ≥ 7 % from baseline body weight in 39.9 % of patient .
( if the use of a 0.2 micrometre syringe filter be not feasible , the sterile concentrate should be pre-filtered with a 5 micrometre filter , dilute and then administer through a 0.22 micrometre in-line filter . )
ABILIFY may increase the effect of medicine use to lower the blood pressure .
for a full list of excipients , see section 6.1 .
reversible increase in serum lithium concentration and toxicity have be report during concomitant administration of lithium with angiotensin convert enzyme inhibitor .
Special STORAGE CONDITIONS
you should complete this card and take it to your doctor at your next visit so that your doctor or gynaecologist can assess whether you need additional or alternative reliable contraceptive method .
GMP compliance of the production system 2 .
PHARMACEUTICAL FORM AND CONTENTS
32 9 .
the adult patient report in the published literature be treat with either 400 mg ( 4 case ) or 800 mg ( 1 case ) Glivec daily .
47 •
because of the potential for adverse reaction in nursing infant , nursing should be discontinue prior to initiation of treatment .
tablet core :
3 .
before administration the Aranesp solution should be inspect for visible particle .
oral use .
at the start of Cycle 2 , the dose be escalate to 200 mg / m2 if the CTC non- haematological toxicity for Cycle 1 be Grade ≤ 2 ( except for alopecia , nausea and vomiting ) , absolute neutrophil count ( ANC ) be ≥ 1.5 x 109 / l , and the thrombocyte count be ≥ 100 x 109 / l .
respiratory , thoracic and mediastinal disorder Uncommon : dyspnoea , hypoventilation .
effect of Age :
among adolescent patient , mean weight gain be greatest in patient who be overweight or obese at baseline .
dos below 1025 mg of this medicinal product contain le than 1 mmol sodium ( 23 mg ) , i. e. essentially ‘ sodium free ’ .
Č eská republika sanofi -aventis , s. r. o .
thromboembolic Events
pharmacovigilance Plan or risk minimisation activity ,
PHARMACEUTICAL FORM AND CONTENTS
what Olanzapine Mylan be and what it be use for 2 .
intravenous use
{ MM / YYYY }
lipid disorder should be manage a clinically appropriate ( see section 4.8 ) .
* The potency ( International Units ) be determine use the European Pharmacopoeia chromogenic assay .
4.4 Special warning and precaution for use
53 1 .
- you miss meal or delay them ,
common ( ≥ 1 / 100 to & lt ; 1 / 10 )
Latvija sanofi-aventis Latvia SIA Tel : + 371 67 33 24 51
this can be discuss with your doctor .
base on ANCOVA with treatment and country a factor and baseline ADAS-Cog a a covariate .
carcinogenic potential be assess in a 2-year rat study and a 6-month transgenic mouse study .
very common Common Skin and subcutaneous tissue Uncommon
how to store Insulin Human Winthrop Comb 15 6 .
23 Cologno Monzese , 20093 , Milano , Italy
L-proline , water for injection .
14 .
patient with extensive tumour burden due to metastatic disease have be rarely report to experience progressive hepatic coma and death during azacitidine treatment , especially in such patient with baseline serum albumin & lt ; 30 g / l .
solution for injection
combination antiretroviral therapy have be associate with redistribution of body fat ( lipodystrophy ) in HIV patient include the loss of peripheral and facial subcutaneous fat , increase intra-abdominal and visceral fat , breast hypertrophy and dorsocervical fat accumulation ( buffalo hump ) .
Hb between 10 and 12 g / dl ( 6.2-7.5 mmol / l ) .
a single patch be apply and wear for one full week ( 7 day ) .
microcrystalline cellulose pregelatinized starch sodium starch glycolate magnesium stearate butylate methacrylate copolymer crospovidone sodium hydrogen carbonate citric acid colloidal silicon dioxide ferric oxide mannitol aspartame ( E951 ) flavour Tutti-Frutti
- if you have an active , severe infection .
very common ( ≥ 1 / 10 ) , Common ( ≥ 1 / 100 to & lt ; 1 / 10 ) , Uncommon ( ≥ 1 / 1,000 to & lt ; 1 / 100 ) , Rare ( ≥ 1 / 10,000 to & lt ; 1 / 1,000 ) , Very rare ( & lt ; 1 / 10,000 ) .
130 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SOLVENT PRE-FILLED SYRINGE
1mg / ml
tube tip
VIAGRA 100 mg film coat tablet Sildenafil
box 23490 Acropolis 1683 Lefkosia Cyprus
121 PACKAGE LEAFLET :
the plasma AUC of midazolam be increase by 1.5-fold .
store in a refrigerator ( 2 ° C – 8 ° C ) Do not freeze . lp
for routine use , do not repeat the New Pen Setup .
depression , emotional lability , insomnia Suicidal ideation , aggressive reaction , confusion , behaviour disorder , agitation , somnambulism , anxiety , nervousness , sleep disorder , abnormal dreaming , apathy
Astellas Pharma GmbH Neumarkter Str .
the most common side effect with Cervarix ( see in more than 1 patient in 10 ) be headache , myalgia ( muscle pain ) , reaction at the site of injection include pain , redness and swelling , and fatigue ( tiredness ) .
5 %
- If you be under 18 year of age because use in such patient be not recommend .
- atypical antipsychotic medication ( such a olanzapine and clozapine ) .
82 1 .
the use of this medicinal product be contraindicate in patient with
MARKETING AUTHORISATION HOLDER
the CHMP agree with the follow proposed indication for 4mg oral granule :
ER every three week be comparable to once weekly administration with respect to the incidence of subject receive at least one red blood cell transfusion from week 5 to the end of treatment phase . ng In a prospective , randomised double-blind , placebo-controlled study conduct in 344 anaemic lo patient with lymphoproliferative malignancy receive chemotherapy there be a significant reduction in transfusion requirement and an improvement in haemoglobin response ( p & lt ; 0.001 ) . no
2
summary OF PRODUCT CHARACTERISTICS
instruction ON USE
InductOs should be use by an appropriately qualified surgeon .
animal study have show excretion of clopidogrel in breast milk .
if ALT flare during IntronA therapy to greater than or equal to 2 time baseline , IntronA therapy may be continue unless sign and symptom of liver failure be observe .
16 / 94 Marketing Member state
there be limited clinical experience with NovoMix 50 in pregnancy .
there be limited information on the use of AVONEX in pregnancy .
a with any intravenous protein product , allergic-type hypersensitivity reaction be possible .
there be no clinical experience in patient with severe hepatic impairment .
the active substance in Isentress , raltegravir , be an integrase inhibitor .
follow subcutaneous administration of 40 mg of Humira every other week in adult rheumatoid arthritis ( RA ) patient the mean steady-state trough concentration be approximately 5 µg / ml ( without concomitant methotrexate ) and 8 to 9 µg / ml ( with concomitant methotrexate ) , respectively .
the pharmacokinetics of duloxetine in patient who be poor metabolisers with respect to CYP2D6 have not be specifically investigate .
33 ( 0 ) 4 92 08 73 00 Deutschland VIRBAC Tierarzneimittel GmbH West Rögen 20 D-23843 Bad Oldesloe Tel :
- shock
consistent with the mechanism of action , rosiglitazone reduce insulin resistance and improve pancreatic ß-cell function .
31 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING
possible side effect 5 .
if you be a man :
2 .
for PBPC mobilisation in normal donor , filgrastim should be administer at 1.0 MIU ( 10 μ g ) / kg / day subcutaneously for 4 to 5 consecutive day .
3 .
6.4 Special precaution for storage
• 7.2.2002
base on in vitro data , cinacalcet be a strong inhibitor of CYP2D6 , but be neither an inhibitor of other CYP enzyme at concentration achieve clinically , include CYP1A2 , CYP2C8 , CYP2C9 , CYP2C19 , and CYP3A4 nor an inducer of CYP1A2 , CYP2C19 and CYP3A4 .
please discus with your doctor what you should do if you be to take too much or too little EXUBERA , or if you miss a dose , so that you know what to do .
you should take the tablet with or just after food to reduce the chance of an upset stomach .
intravenous use
5 / 17 ANNEX II
if more convenient for patient , the Kaletra 200 / 50 mg tablet may also be consider alone or in combination with the Kaletra 100 / 25 mg tablet to achieve the recommend dose .
0.5 ml of solution in 3 ml vial ( type I glass ) with stopper ( chlorobutyl rubber ) .
active substance that may decrease dasatinib plasma concentration When dasatinib be administer follow 8 daily even administration of 600 mg rifampicin , a potent CYP3A4 inducer , the AUC of dasatinib be decrease by 82 % .
tissue disorder Musculoskeletal , connective tissue i dic
4.5 Interaction with other medicinal product and other form of interaction
when drive vehicle or operate machine , it should be take into account that occasionally dizziness or weariness may occur during treatment of hypertension .
since many medicinal product and immunoglobulin be secrete into human milk , and because of the potential for serious adverse reaction in nursing infant , lactation should be discontinue during treatment and up to 5 month after treatment .
this may be due to the small number of higher dose study .
tho must be closely monitor by your doctor .
if a treatment with interferon alfa-2b be judge necessary in adult patient with existence or history of severe psychiatric condition , this should only be initiate after have ensure appropriate individualise diagnostic and therapeutic management of the psychiatric condition .
there be no residual product which need to be remove , the entire sponge be dissolve ( resorb ) !
20 7 .
the majority of MRSA be resistant to erythromycin A by a constitutive MLSB mechanism .
if after a dose reduction , haemoglobin continue to increase , the dose should be temporarily withhold until the haemoglobin begin to decrease , at which point therapy should be reinitiated at approximately 25 % lower than the previous dose .
Slovenija Generics & # 91 ; UK & # 93 ; Ltd Tél : + 44 1707 853000 ( United Kingdom )
if your liver be not work properly , the usual dose should not exceed 40 mg once daily .
Calcimagon-D3
manufacturer ’ S BATCH NUMBER
Sverige Eli Lilly Sweden AB Tel : + 46- ( 0 ) 8 7378800
- or
6 FURTHER INFORMATION
10 .
injection site pain
- Leave the cartridge in the pen , put the cap on the pen , and store it
- - - -
after reconstitution , the solution be clear , colourless and free from foreign particle .
Bayer S. A . / N. V .
further INFORMATION
in vitro study indicate that irbesartan be primarily oxidise by the cytochrome P450 enzyme CYP2C9 ; isoenzyme CYP3A4 have negligible effect .
if it contact mucous membrane , the membrane should be flush thoroughly with water .
- somatropin ( growth hormone ) ,
3 year .
increase transparency
co-administration of tipranavir and vitamin E have not be study in dog .
common ( & gt ; 1 % , & lt ; 10 % ) Common ( & gt ; 1 % , & lt ; 10 % )
Κύπρος Οδός Αγίου Νικολάου , 8 CY -1055 Λευκωσία Τηλ : + 357-22 757188
very common adverse Common adverse reaction reaction ≥ 10 % of patient ≥ 1 to & lt ; 10 % of patient
13 .
Orodispersible tablet Oral use
in a 24-week study of initial combination therapy with sitagliptin and metformin administer twice daily ( sitagliptin / metformin 50 mg / 500 mg or 50 mg / 1000 mg ) , the overall incidence of adverse reaction consider a drug-related in patient treat with the combination of sitagliptin and metformin compare to patient treat with placebo be 14.0 % and 9.7 % , respectively .
the clinical relevance of relate in vitro measure to drug potency and clinical outcome have not be establish .
in general , adverse event occur more frequently among elderly patient and patient with renal impairment ; however , the type of event in these subgroup be similar to those observe in the general population .
• 17.7.2001 • 25.7.2002 • 203 day
357 What Enbrel look like and content of the pack
the treatment-free period , however , should take into account the pharmacological property of the product use previously .
do not inject ViraferonPeg into an area where the skin be irritate , red , bruise , infect , or have scar , stretch mark , or lump .
oral use Bottle ( HDPE )
if VIAGRA be take with food , the onset of activity may be delay compare to the fast state ( see section 5.2 ) .
these be the side effect report by people take Viani .
solvent for RISPERDAL CONSTA 12.5 mg / 25 mg / 37.5 mg / 50 mg and associate name ( see Annex I ) & # 91 ; See Annex I – To be complete nationally & # 93 ;
osteonecrosis Although the etiology be consider to be multifactorial ( include corticosteroid use , alcohol consumption , severe immunosuppression , higher body mass index ) , case of osteonecrosis have be report particularly in patient with advanced HIV-disease and / or long-term exposure to combination antiretroviral therapy ( CART ) .
intravenous use .
skin and subcutaneous tissue disorder Uncommon - Lipodystrophy Lipodystrophy may occur at the injection site a a consequence of failure to rotate injection site within an area .
EXP
dry mouth Hepato-biliary disorder Very common :
metabolic and nutrition disorder :
illness If you be ill , especially if you feel sick or be sick , the amount of insulin you need may change .
EXP :
in rare case severe ovarian hyperstimulation syndrome occurs , which may be life-threatening .
severe case of generalised allergy may be life-threatening .
113 4.5 Interaction with other medicinal product and other form of interaction
Viraferon
6 .
20 mg
information FOR THE USER
au The use of Protopy at the same time a other preparation to be use on the skin or while take oral corticosteroid ( e. g. cortisone ) or medicine which affect the immune system have not be study .
4.4 Special warning and precaution for use
Revenues
in study in pregnant animal , interferon have sometimes cause miscarriage .
all special warning and precaution associate with autologous predonation programme , especially routine volume replacement , should be respect .
180
10 .
5 .
insulin human
however , since TMZ do not undergo hepatic metabolism and exhibit low protein binding , it be unlikely that it would affect the pharmacokinetics of other medicinal product ( see section 5.2 ) .
- three time per week - and by further increment of 20 IU / kg if need , three time per week ,
6.4 Special precaution for storage
name OF THE VETERINARY MEDICINAL PRODUCT
pharmacological PROPERTIES
2 .
always vary the site you inject , to avoid lump ( see 5 Possible side effect ) .
solvent Water for injection
13 .
keep out of the reach and sight of child .
injection site reaction
dosage It be very important that you take your Seretide every day a direct , until you be advise to stop by your doctor .
Germany
what be Focetria ?
infection During the first 13 week after treatment with Zevalin , patient very commonly developed infection .
before YOU TAKE EMSELEX
pregnancy and breast-feeding
powder for oral solution .
itching , loss of appetite or abdominal pain ( uncommon ) .
very rare :
G03AA13 .
the intend dose of 1.5 μ g / kg of PegIntron to be use in combination with ribavirin may be deliver in weight category with the pen / vial strength accord to Table 1 .
Tlf : + 45 - 36 39 99 99
if OptiClik do not function well , you can draw the insulin from the cartridge into an injection syringe .
Hold the syringe barrel and gently take the cover from the needle without twist .
0 %
the duration of treatment should not exceed that evaluated during clinical trial ( mean 7 day ) ( see section 4.2 , 4.3 and 5.2 ) .
16 .
no malformation be observe in foetus from efavirenz-treated rat and rabbit .
other
medicinal product subject to medical prescription .
like all medicine , Lantus can cause side effect , although not everybody get them .
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
- previously require high insulin dos due to the presence of insulin antibody .
for instruction on preparation , see section 6.6 .
what XENICAL IS AND WHAT IT IS USED FOR
wait and take the next dose at the regular time .
ocular use
child and adolescent :
European PUBLIC ASSESSMENT REPORT ( EPAR )
10.12.1999 24.03.2000 27.03.2000 OJ C 120 , 28.04.2000
the following additional adverse reaction have be report during post – marketing experience ; they be derive from spontaneous report for which incidence can not be determine :
content BY WEIGHT , BY VOLUME OR BY UNIT
respiratory tract
therefore , on 20 April 2005 further to a request from the EC , the CHMP broaden the scope of the procedure under Article 31 of Directive 2001 / 83 / EC , a amend and the review procedure under Article 18 of Council Regulation ( EEC ) No 2309 / 93 , to include the assessment of serious skin reaction in the ongoing class review in addition to the cardiovascular safety aspect .
during Trudexa treatment :
BRISTOL-MYERS SQUIBB PHARMA EEIG
5 4.7 Effects on ability to drive and use machine
Uncommon - Diabetic retinopathy Long-term improved glycaemic control decrease the risk of progression of diabetic retinopathy .
pull straight a show in picture 1 and 2 .
MARKETING Authorisation Holder and Manufacturer Marketing Authorisation Holder :
Glivec should not be use during pregnancy unless clearly necessary .
multipack comprise 2 pack , each contain 56 film-coated tablet .
adjustment in dosage of the medicinal product , meal pattern , or physical activity may be need .
MARKETING AUTHORISATION NUMBER ( S )
29 % ( 3-56 ) 10 % ( 0-28 )
base on a multiple dose clinical trial in adult and adolescent , in which up to 45 mg of desloratadine be administer ( nine time the clinical dose ) , no clinically relevant effect be observe .
MARKETING AUTHORISATION NUMBER ( S )
adsorb on aluminium hydroxide , hydrate 3
B .
fluticasone furoate GSK be available in pack size 30 , 60 and 120 spray .
3 .
to prepare the IntronA solution insert the needle through the rubber top of the IntronA vial and gently place the needle tip against the glass wall of the vial without touch the cleaned top of the vial with your hand .
2 vial + 2 vial
small particle may be visible in the solution and will not affect the effectiveness of the medicinal product .
haemorrhage , increase blood pressure 5
- INOmax be not to be give to baby who have an abnormal circulation within the heart .
50 / 100
European PUBLIC ASSESSMENT REPORT ( EPAR ) BETAFERON EPAR summary for the public
do not shake .
store in a refrigerator ( 2 ° C - 8 ° C ) .
in diabetic hypertensive patient , Enviage provide additive blood pressure reduction when add to ramipril , while the combination of Enviage and ramipril have a lower incidence of cough ( 1.8 % ) than ramipril ( 4.7 % ) .
a for any vaccine , vaccination with ProQuad may not result in protection in all vaccine recipient .
oral use
capecitabine be a ‘ prodrug ’ that be convert to 5-fluorouracil ( 5-FU ) in the body , but more be convert in tumour cell than in normal tissue .
the WORDS “ FOR ANIMAL TREATMENT ONLY ”
vial ( glass )
store in a refrigerator .
overall , vildagliptin improved glycaemic control when give a monotherapy or when use in combination with metformin , a sulphonylurea , and a thiazolidinedione , a measure by clinically relevant reduction in HbA 1c from baseline at study endpoint ( see Table 5 ) .
if the factor VIII level of your plasma fail to reach expected level , or if bleeding be not control after apparently adequate dosage , the presence of factor VIII inhibitor should be suspect .
for patient who have be receive olanzapine for treatment of manic episode , continue therapy for prevent recurrence at the same dose .
2 ( 0.2 % )
common :
Musculoskeletal and connective tissue disorder :
medicinal product subject to medical prescription .
tablet core : lactose monohydrate , croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate .
4.4 Special warning and precaution for use
in case of shock , the current medical standard for shock treatment should be observe .
PHARMACEUTICAL FORM
18 PACKAGE LEAFLET :
Liofora
237 in vivo activity .
inform your doctor if you be plan to become pregnant , or if you be already pregnant .
some patient may benefit from start treatment at a dose of 20 mg twice daily for two week before increase to the recommend dose of 40 mg twice daily .
statement OF ACTIVE SUBSTANCE ( S )
8 .
take other medicine Please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
cartridge ( glass )
EMEA / CVMP / 183 / 96
injection site reaction .
when consider the clinical relevance of these kinetics , it be more appropriate to examine the glucose utilisation curve ( a discuss in 5.1 ) .
survival outcome and tumour progression in lp
11 .
2 year
the following additional adverse reaction have be report during post – marketing experience ; they be derive from spontaneous report and therefore , the frequency of these adverse reaction be not know :
John ’ s wort ( Hypericum perforatum ) must not be use while take nelfinavir due to the risk of decreased plasma concentration and reduced clinical effect of nelfinavir ( see section 4.5 ) .
this combination be also indicate in relapse patient and patient who have not respond previously to interferon alpha ( pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy .
sodium hydroxide and / or hydrochloric acid may have be use to adjust acidity .
in 61 of these 117 patient FIP1L1-PDGFRα fusion kinase be identify .
gastrointestinal bleeding
question 6 - The first part of question 5 of the LoQ , “ The Applicant should discuss the storage stability of the product , in light of study demonstrate that the inverted and lying orientation of the device be the most stable ” have not be fully answer , since only discussion about upright and lying position , but not about invert orientation have be submit .
400 mg
lot
11 4.8 Undesirable effect
Vantas
HPV 16 / 18-related CIN 3
how to store CRIXIVAN 6 .
expiry DATE
accidental ingestion can be lethal for child .
pioglitazone do not cause statistically significant increase in LDL cholesterol level compare with placebo , whilst reduction be observe with metformin and gliclazide .
headache Dizziness
efavirenz 600 mg 750 mg TID QD
therefore , concomitant use should be undertake with caution ( see section 4.4 ) .
th Medicinal product subject to medical prescription .
manufacturer Janssen-Cilag SpA , Via C .
most of the case of tuberculosis occur within the first eight month after initiation of therapy and may reflect recrudescence of latent disease .
if you have be tell by your doctor that you have an intolerance to some sugar ( e. g. lactose ) , contact your doctor before take this medicine .
stavudine and VIRAMUNE can be co-administered without dose adjustment .
hypersensitivity to sulphonamides ( see section 4.4 ) .
general CLASSIFICATION FOR SUPPLY
suspension for injection
posaconazole / Efavirenz -- / 400 mg once daily
it inhibit glycogenolysis and gluconeogenesis ,
2 year .
10 .
in rat , the concentration of active substance-related radioactivity be higher in breast milk than in plasma .
1 .
100 IU / ml
list OF EXCIPIENTS
what Dynepo be and what it be use for
4.1 Therapeutic indication Symptomatic relief of allergic rhinitis and conjunctivitis and of allergic skin disorder
5 .
a telbivudine be a nucleoside analogue , this risk can not be exclude .
5.3 Preclinical safety data
detail in structions for subcutaneous administration be provide with this leaflet ( see HOW TO SELF INJECT VIRAFERON at the end of the leaflet ) .
20
- Put use syrinx into the puncture-proof container and keep this container out of the reach and
4.1 Therapeutic indication
ed Ísland Hörgatún 2 IS-210 Garðabær
4
50 mg
& # 91 ; to be complete nationally & # 93 ; & # 91 ; For referral procedure & # 93 ;
woman take hormonal contraceptive The use of an ethinyloestradiol / levonorgestrel ( 30 µg / 150 µg ) combination increase the clearance of lamotrigine by approximately two-fold , result in decreased lamotrigine level .
Special precaution for storage
for patient with severe renal impairment , see section 4.3. ee section 4.2 for information on patient with mild or moderate renal dysfunction .
0.5 ml
Almac Pharma Services 22 Seagoe Industrial Estate Craigavon BT63 5QD United Kingdom
during post – marketing surveillance , case of interference between daptomycin and particular reagent use in some assay of Prothrombin Time / International Normalised Ratio ( PT / INR ) have be report .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
method AND ROUTE ( S ) OF ADMINISTRATION
serious undesirable effect be experience in 2.4 % of the patient in the Keppra and 2.0 % of the patient in the placebo group .
EXP
a with ACE inhibitor , concomitant use of angiotensin II antagonist and NSAIDs may lead to an increase risk of worsening of renal function , include possible acute renal failure , and an increase in serum potassium , especially in patient with poor pre-existing renal function .
Rapinyl and associate name ( see Annex I ) 50 microgram sublingual tablet & # 91 ; See Annex I - To be complete nationally & # 93 ; Rapinyl 100 microgram sublingual tablet Rapinyl 200 microgram sublingual tablet Rapinyl 300 microgram sublingual tablet Rapinyl 400 microgram sublingual tablet Rapinyl 600 microgram sublingual tablet Rapinyl 800 microgram sublingual tablet
7 .
study in lactate rat have demonstrate the presence of low level of ibandronic acid in the milk follow intravenous administration .
store in the original package .
12 .
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
sodium hydroxide or hydrochloric acid may have be use to adjust the acidity .
6 .
significant increase in antibody ( measure by ELISA ) to all vaccine serotypes be see after administration of single dos of Prevenar to child age 2 to 5 year .
Tel : + 39 06 361911 doccen @ merck . com
nervous system disorder Not know :
in pregnant rabbit , gross lesion of the stomach and intestine be observe in dead or moribund do at maternal dos 2 and 4 time the highest dose administer in the definitive embryo-development study .
the clinical significance of these reduction in serum testosterone be unknown .
it will also instruct you when you need to change the cartridge .
2.5 ml / 100 kg body weight ) in combination with antibiotic therapy or with oral re-hydration therapy , a appropriate .
8 .
any subject with miss data in and after the Follow-Up Week 12 window be consider to be a non-responder at Week 24 of follow-up .
pioglitazone IN TRIPLE ORAL COMBINATION THERAPY WITH METFORMIN AND SULPHONYLUREA
7 .
Noxafil belong to a group of medicine call triazole antifungal agent .
very Rare
expiry DATE
co-administration of darunavir and ritonavir and medicinal product which be primarily metabolise by CYP2D6 ( such a flecainide , propafenone , metoprolol ) may result in increased plasma concentration of these medicinal product , which could increase or prolong their therapeutic effect and adverse reaction .
DFSP ( at dose 800 mg )
they can also spread around the injection site .
in the 100 mg ICC database ( N = 204 ) , the drug-related adverse reaction ( MedDRA ) list below be report with frequency correspond to Common ( ≥ 1 / 100 to & lt ; 1 / 10 ) or Uncommon ( ≥ 1 / 1,000
12 ANNEX III
Par- and Dysaesthesia Hypoaesthesia Tremor Seizures ( see section 4.4 ) Vertigo
there be no evidence of mutagenicity , clastogenicity or carcinogenicity .
cat
skin and subcutaneous tissue disorder :
if their symptom be the same a yours .
0.7 % on placebo ) .
10 .
expiry DATE
the result of these test allow your doctor to choose the correct dose of Fertavid from day to day .
before YOU USE INTRONA
suspension for injection in pre-filled syringe .
Tel : + 356 21493022
for any information about this medicine , please contact the local representative of the Marketing Authorisation Holder :
22 B .
Paroxetiphar 20 mg
effect of food on gastrointestinal absorption : maximum plasma concentration and area under the plasma concentration-time curve be consistently 2 to 3-fold higher under feed condition compare to fast .
a decrease in haemoglobin , which be not clinically significant , have be observe in 1.7 % ( i. e. common ) of hypertensive patient with advanced diabetic renal disease treat with irbesartan .
∅
what KINZALKOMB IS AND WHAT IT IS USED FOR
3 .
visual colour distortion
animal reproduction study have not reveal any difference between insulin aspart and human insulin regard embryotoxicity or teratogenicity .
the in vivo micronucleus test be negative .
each tablet contain : irbesartan 150 mg and hydrochlorothiazide 12.5 mg
•
possible SIDE EFFECTS
Refraction anomaly may occur upon initiation of insulin therapy .
secondary dose adjustment
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Insuman Basal must not be use if this can not be achieve , i. e. if the suspension remain clear , for example , or if clump , particle or flocculation appear in the insulin or stick to the wall or bottom of the cartridge .
treatment with sitagliptin at 100 mg once daily a monotherapy provide significant improvement in HbA1c , fast plasma glucose ( FPG ) , and 2-hour post-prandial glucose ( 2-hour PPG ) , compare to placebo in two study , one of 18- and one of 24-weeks duration .
keep out of the reach and sight of child .
PHARMACEUTICAL FORM AND CONTENTS
in this leaflet :
0.15 50 0.2 50 0.25 50 0.3 80 0.4 80 0.5 100 0.4 120
name OF THE MEDICINAL PRODUCT
the reason for this difference be that the five 2-year study include a 4-week diet and placebo lead-in period during which patient lose on average 2.6 kg prior to commence treatment .
in clinical study , & gt ; 90 % of patient respond at these dos , achieve reversal of neutropenia in a median of 2 day .
schizophrenia
magnesium chloride sodium hydroxide
the colour of the dose button be different for each strength of the PegIntron pre-filled pen .
memory loss in Alzheimer ’ s disease be due to a disturbance of message signal in the brain .
CONDITIONS OF THE MARKETING AUTHORISATION
EU / 1 / 06 / 335 / 001
PsA study I with 24 week duration , treat 313 adult patient who have an inadequate response to non-steroidal anti-inflammatory drug therapy and of these , approximately 50 % be take methotrexate .
survival and tumour progression have be examine in five large control study involve a total of 2 ’ 833 patient , of which four be double-blind placebo-controlled study and one be an open- label study .
• OTHER CONDITIONS
how to take Imprida 4 .
4.5 Interaction with other medicinal product and other form of interaction
blood pressure and heart rate Duloxetine have be associate with an increase in blood pressure and clinically significant hypertension in some patient .
only clear and colourless solution without particle should be use .
CPMP / 4060 / 03 9 .
degree of haemorrhage /
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
keep out of the reach and sight of child .
take special care with Procoralan :
400 mg twice daily to 400 mg three time a day
4.5 Interaction with other medicinal product and other form of interaction
most atopic dermatitis patient ( adult and child ) treat with single or repeated application of tacrolimus ointment ( 0.03 - 0.1 % ) , and infant from age of 5 month treat with tacrolimus ointment ( 0.03 % ) have blood concentration & lt ; 1.0 ng / ml .
39 Hungary :
7 to 14 day
B CONDITIONS OF THE MARKETING AUTHORISATION o
Sverige BRISTOL-MYERS SQUIBB AB Tel : + 46 8 704 71 00
these be list earlier in Section 2 , under ‘ Do not take Norvir ’ .
if you have a rash while take another NNRTI , you may be at a higher risk of get a rash with STOCRIN .
in some case , your doctor may adapt the dose of Agenerase when other drug be administer concomitantly with Agenerase .
if this reaction occur , they should be advise to rinse out their mouth thoroughly afterwards .
tho Rheumatoid arthritis
3 .
Net content per vial :
9 .
not applicable
remove an adequate volume of the sodium chloride solution from the infusion bag , use an appropriate sterile syringe with a suitable needle .
BATCH NUMBER
in female versus male subject the mean elimination half life be somewhat prolonged ( 36.7 versus 32.3 hr ) and the clearance be reduce ( 18.9 versus 27.3 l / hr ) .
oral use
50 mg / 2 ml
clinical PARTICULARS
overdose can result in manifestation of an exaggerated pharmacodynamic effect , e. g. excessive erythropoiesis .
patient on the TPF arm receive antibiotic prophylaxis with ciprofloxacin 500 mg orally twice daily for 10 day start on day 5 of each cycle , or equivalent .
do not use alcohol . • When prim a new cartridge , you may need to repeat Part I , step 8 and 9 up to a total of 6 time ( 0.6 mg ) to remove air bubble .
some improvement have also be show in patient with class II PAH . ‘ Class II ’ involve slight limitation of physical activity .
4 .
management of overdose There be no specific antidote for olanzapine .
follow once daily dosing , steady state of plasma level be obtain after 3 to 4 day with a 1.3-fold increase in Cmax and AUC .
G-CSF ) or to dose reduce to maintain neutrophil count .
4.2 Posology and method of administration
the excretion of filgrastim in milk have not be study in animal .
( % )
if these symptom occur , they should be advise to discontinue use of the product immediately and contact their physician .
what benefit have Tasmar show during the study ?
CNS medicinal product : the risk of use duloxetine in combination with other CNS-active medicinal product have not be systematically evaluate , except in the case describe in this section .
the following data be finding in study perform with sitagliptin or metformin individually .
any unused product or waste material should be dispose of in accordance with local requirement .
- certain other medicine for the prevention or control of infection ( antibiotic ) , such a
medicine that may cause your blood sugar level to fall ( hypoglycaemia ) include :
15 45 70 14 1 2 8 17 21 13 37 50 50 100 143
memory impairment , syncope , weakness , migraine , hypoaesthesia , hyperaesthesia , paraesthesia , tremor , taste disturbance , nightmare , somnolence
in overdose accompany by severe nausea and vomiting , the use of antiemetic should be consider .
the Cmax , AUC and Cmin of amprenavir be unchanged .
keep the vial in the outer carton in order to protect from light .
if you take more Irbesartan BMS than you should If you accidentally take too many tablet , contact your doctor immediately .
1 .
the incidence of serious infection be higher in Kineret-treated patient compare with patient receive placebo ( 1.8 % v .
8.8
Malta sanofi-aventis Malta Ltd .
point to consider on application with 1 ) meta-analyses and 2 ) one pivotal study
the work undertake by the CVMP in 1997 to clarify it position through guideline on a number of critical issue relate to establishment of MRLs be expect to pay dividend in facilitate the review process for new application in the year ahead .
MARKETING AUTHORISATION NUMBER ( S )
keep out of the reach and sight of child .
additional supportive care should be provide a necessary .
complete
Slovenská republika NEOMED , s. r. o . , poboč ka Bratislava Šť astná 11 SK-821 05 Bratislava Tel . : + 421 2 434 150 12 E-mail : UK _ medinfo @ allergan . com
endpoint
therefore , since the impact of the choice of an antibiotic therapy for AECB on the outcome of the patient remain unclear , the safety profile of the different antibiotherapy option must be consider .
no data on the influence of antacid on the absorption of levetiracetam be available .
slowly pull the plunger down to the dosage mark on the syringe that match your dose .
your doctor will decide on the dose of Puregon to be give .
a total of 33 application for designation be withdraw in 2002 since the sponsor be not able to fully justify their request .
before you take VIRACEPT 3 .
this mean that atosiban block the action of oxytocin .
the hazard ratio for the treatment effect be 0.58 ( 95 % CI :
carefully dispose of any Enbrel solution that have not be inject within 6 hour .
do not use Irbesartan Krka after the expiry date which be state on the carton and on the blister after EXP .
after either oral or intravenous administration of 14C irbesartan , about 20 % of the radioactivity be recover in the urine , and the remainder in the faeces .
Nespo
driving and use machine :
1 .
your doctor will monitor the different chemical level in your blood include : creatinine , potassium .
250 IU
NutropinAq 10 mg / 2ml
it will be open to industry and the general public .
- concomitant treatment with certain other medicinal product .
about erection difficulty At least one in ten men have trouble get or keep an erection at some time .
there be limited clinical experience with insulin aspart in pregnancy .
animal study be insufficient with respect to effect on pregnancy and embryofoetal development ( see section 5.3 ) .
medicinal product subject to medical prescription
12 pre-filled syrinx
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
ONSENAL contains lactose ( a type of sugar ) .
the unabsorbed fraction of ibandronic acid be eliminate unchanged in the faeces .
in these patient , erythropoietin deficiency and a reduced response of erythroid progenitor cell to endogenous erythropoietin both contribute significantly towards their anaemia .
zinc chloride Glycerol Metacresol Phenol Disodium phosphate dihydrate Sodium hydroxide ( for pH adjustment ) Hydrochloric acid ( for pH adjustment ) Protamine sulphate Water for injection
in rare case , the presence of such anti-insulin antibody may necessitate adjustment of the insulin dose in order to correct a tendency to hyper- or hypoglycaemia .
Aranesp therapy should be discontinue approximately four week after the end of chemotherapy .
haemoglobin variability should be address through dose management , with consideration for the haemoglobin target range of 10 g / dl ( 6.21 mmol / l ) to 12 g / dl ( 7.45 mmol / l ) .
- supply of insulin , injection syrinx etc . ,
information IN BRAILLE
step 5 - Checking the correct needle position If the needle position be correct the plunger should be quite difficult to draw back .
general disorder and administration site condition Common Uncommon Immune system disorder
5 .
pre-filled pen ( glass )
Everyone who take Foscan will become sensitive to light for about 15 day after injection .
5.3 Preclinical safety data
2 .
EXP
administration
lot :
each patch release 1 mg of rotigotine per 24 hour .
these occur more frequently at higher zidovudine dosage ( 1200-1500 mg / day ) and in patient with poor bone marrow reserve prior to treatment , particularly with advanced HIV disease .
read the package leaflet before use .
it be recommend that the application site should be rotate on a daily basis ( e. g. from the right side to the left side and from the upper body to the lower body ) .
the most frequent adverse reaction be an increase in blood pressure or aggravation of exist hypertension .
after subcutaneous dosing , fondaparinux be completely and rapidly absorb ( absolute bioavailability 100 % ) .
Hepatobiliary disorder uncommon
au 2 ) Choosing and prepare an injection site
careful monitoring of full blood count and adverse reaction to rifabutin ( e. g. uveitis ) be recommend when rifabutin be coadministered with voriconazole .
do not use Ferriprox after the expiry date which be state on the carton and the label after EXP .
208 Days
result of clinical study in child have show that , on average , the younger the patient , the higher the NeoRecormon dos require .
Special STORAGE CONDITIONS
FlexPen be design and test to be use with NovoFine or NovoTwist disposable needle up to a length of 8 mm .
44 MINIMUM PARTICULARS TO APPEAR ON BLISTERS
6 Metabolism and nutrition disorder :
( 11.8 )
biliary hyperplasia be observe in cynomolgus monkey give efavirenz for ≥ 1 year at a dose resulting in mean AUC value approximately 2-fold greater than those in human give the recommend dose .
Gastro-resistant capsule , hard
4 .
one case of Stevens-Johnson syndrome be report a a serious adverse event in a patient receive aprepitant with cancer chemotherapy .
these adverse event be predictable base on the known adverse reaction to each of the three drug individually .
Tekturna 150 mg film-coated tablet Aliskiren
insulin be a substance which help to lower the level of sugar in the blood , especially after meal .
the contribution of the major metabolite ( a para-hydroxy-sulphate ) to the overall antihyperglycaemic activity of rosiglitazone have not be fully elucidate in man and it can not be rule out that the metabolite may contribute to the activity .
Tilt the product vial when transfer the solvent to allow the solvent to flow down the side of the vial .
in the 26-week open-label period of this trial the most frequent laboratory abnormality observe be creatinine increase ( 6.5 % ) and elevate CK value in 2 % of child recipient .
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www.emea.europa.eu /
beta-blockers like other sympatholytic medicine ( such a clonidine , guanethidine , and reserpine ) may weaken or suppress entirely the first warning symptom which help you to recognise a hypoglycaemia .
the patient study have an MMSE ( Mini-Mental State Examination ) score of 10 – 24 .
these measure will help to protect the environment .
hypoglycaemia be the most frequent undesirable effect of insulin therapy that a patient with diabetes may suffer .
( 1.5 µg / kg /
dysuria , enuresis , pollakiuria , urinary incontinence
tablet
GlaxoSmithKline Biologicals s. a .
5.3 Preclinical safety data
before you use IntronA 3 .
consideration should be give to official guidance on the appropriate use of antibacterial agent .
Musculoskeletal system , connective tissue , and bone
the product should not be use during the 2nd and 3rd trimester of pregnancy , or while breast-feeding .
MARKETING AUTHORISATION NUMBER ( S )
since CoAprovel contains hydrochlorothiazide , it be not recommend during the first trimester of pregnancy .
Rectal use
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
regard the ground for appeal lodge by the marketing authorisation holder , the CPMP considers that :
36 ( 44 / 123 )
53-55 Sector 1 , Bucuresti Romania
via San Martino 12 I-20122 Milan Italy
EXP
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor , diabetes nurse or pharmacist .
mean ± SD
1 .
genotype 1
general
name OF THE MEDICINAL PRODUCT
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
injection of human recombinant interferon alfa-2b for up to three month have show no evidence of toxicity in mouse , rat , and rabbit .
it be recommend that you measure your blood glucose regularly .
4.11 Withdrawal period ( s )
in another clinical trial , the efficacy and safety of Rasilez HCT be also assess in 489 obese hypertensive patient who do not respond to hydrochlorothiazide 25 mg ( baseline systolic / diastolic blood pressure 149.4 / 96.8 mmHg ) .
the Applicant should focus in particular on the patient with a history of revascularisation but without history of MI , a this population be heterogeneous in term of severity of lesion , revascularisation technique and concomitant treatment .
dose increase must not be make more frequently than once every four week .
Profender 50 mg / 10 mg tablet for medium dog
outcome Events
the combined effect of these two active substance result in additional IOP reduction compare to either compound alone .
lot
other
during treatment with olanzapine , adolescent gain significantly more weight compare with adult .
oral contraeptives , thiazide , glucocorticoid , thyroid hormone and beta-sympathomimetics , growth hormone and danazol .
0.4 ml
5.1 Pharmacodynamic property
cyst and polyp )
1.3 ( 0.5-2.1 )
hypersensitivity reaction , include anaphylactic / anaphylactoid reaction , angioedema , exfoliative dermatitis , and hypersensitivity vasculitis , have be associate with the administration of sirolimus ( see section 4.8 ) .
you should contact your doctor for advice on drive if :
Terfenadin & quot ; Stada & quot ;
5 .
patient who skip a meal ( or add an extra meal ) should be instruct to skip ( or add ) a dose for that meal .
Tél : + 33 / ( 0 ) 1 47 29 44 35
4.8 Undesirable effect
load Dose Regimen
factor IX to induce immune tolerance in haemophilia B patient with factor IX inhibitor and a history of allergic reaction .
these symptom have be report more frequently when shosaikoto , a Chinese herbal medicine , be administer concomitantly with interferon alpha ( see section 4.4 ) . t uc
- If you have be tell that you have poor immunity to infection for any reason , such a due to
4 .
content
what CEREZYME IS AND WHAT IT IS USED FOR
6 .
most of this decrease of haemoglobin concentration be detect during the first few week of treatment and haemoglobin level stabilize by 4 week of Thelin treatment .
16 % 15 %
346 8 .
13 .
100 mg
NovoSeven 5 mg ( 250 KIU ) powder and solvent for solution for injection eptacog alfa ( activate )
the most serious adverse reaction report in clinical trial with deferiprone be agranulocytosis ( neutrophil & lt ; 0.5x109 / l ) , with an incidence of 1.1 % ( 0.6 case per 100 patient-years of treatment ) ( see section 4.4 ) .
51 10 .
when the instruction be follow carefully , Puregon will be administer properly and with minimal discomfort .
limited safety data ( N = 25 ) be available in co-infected patient with CD4 + cell count & lt ; 200 / µl ( see section 4.4 ) .
absorption of hydrochlorothiazide be impair in the presence of anionic exchange resin .
epoetin alfa should be use with caution in the presence of epilepsy and chronic liver failure .
when Pradaxa be coadministered with pantoprazole , a decrease in the dabigatran area under the plasma concentration - time curve of approximately 30 % be observe .
ask your doctor or pharmacist for advice before take any medicine .
Humalog Mix50 be a substitute for your own insulin and be use to control glucose in the long term .
it contain microspheres ( tiny bubble ) of heat-treated human albumin contain perflutren gas a the active substance .
Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ : + 357 22 89 95 01
Tel : + 356 2298 3217
you should receive a total of one litre of 0.9 % ( normal ) saline solution intravenously with each infusion of VISTIDE .
16 .
56 ( 48-63 )
name OF THE MARKETING AUTHORISATION HOLDER
EPAR summary for the public
patient with hepatic impairment No adjustment of the start dose nor of the dose modification rule be require in patient with hepatic impairment ( see section 5.2 ) .
your doctor must take blood sample to test whether CELSENTRI be an appropriate treatment for you .
4.3 Contraindications
EMEA / 306065 / 2006
film-coated tablet
tell your doctor before you start to take this medicine :
mouth ulceration , esophagitis , nausea and vomiting , gastritis , dysphagia , dry mouth , flatulence , gingivitis , taste perversion
EU / 2 / 07 / 073 / 001-004
due to different pharmacodynamic and pharmacokinetic profile among antipsychotic medicinal product , supervision by a clinician be need when switch to another antipsychotic product be consider medically appropriate .
do not store above 30 ° C .
Conference on Harmonisation ( VICH ) towards finalise guideline on the scope of pharmacovigilance and the definition of standard for electronic reporting take into
directly in the mouth ; mixed with a spoonful of cold or room temperature soft food ( for example , applesauce , ice cream , carrot and rice ) .
the mean ( ± SD ) AUC0-tau and CL be 1306 ± 374 mcg • day / ml and 4.9 ± 1.4 ml / kg / day , respectively .
the incidence of febrile neutropenia be lower for patient randomise to receive pegfilgrastim compare with placebo ( 1 % versus 17 % , p & lt ; 0.001 ) .
keep out of the reach and sight of child .
this summary be last updated in 08-2008 .
3.3 Key function for the evaluation of medicine for human use Provision of CPMP secretariat , regulatory affair , relation with national competent authority and EU institution
3 .
Remicade 100 mg powder for concentrate for solution for infusion Infliximab For intravenous infusion
Tracleer 62.5 mg film-coated tablet .
in responder patient to on-demand regimen who anticipate a frequent use of CIALIS ( i. e . , at least twice weekly ) a once daily regimen with the lowest dos of CIALIS might be consider suitable , base on patient choice and the physician ’ s judgement .
EPAR summary for the public
it be not further metabolise and be eliminate in the urine .
Posology for CML in child Dosing for child should be on the basis of body surface area ( mg / m2 ) .
R In the following case , your doctor can determine the right time and scheme of vaccination for
the study last 26 and 18 week , respectively .
3 .
5 .
treatment of symptomatic anaemia in adult and paediatric chronic renal failure patient
- renal impairment
MARKETING AUTHORISATION NUMBER ( S )
• 19.12.2000 • 5.12.2001
Tel : + 40 ( 0 ) 21 317 31 36
if severe adverse event develop during interferon alfa-2b treatment , particularly if granulocyte decrease to & lt ; 500 / mm3 or alanine aminotransferase / aspartate aminotransferase ( ALT / AST ) rise to & gt ; 5 x upper limit of normal , discontinue treatment temporarily until the adverse event abates .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
what Azomyr orodispersible tablet look like and content of the pack
some patient have actually commit suicide .
information FOR THE USER
expiry DATE
sodium chloride Medium 199 contain principally amino acid , mineral salt , vitamin Water for injection
in case of accidental contact with either the skin or the eye , rinse thoroughly with water .
EU / 1 / 04 / 288 / 001
electrolyte disturbance such a hypokalaemia , hypomagnesaemia and hypocalcaemia should be monitor and correct , if necessary , prior to initiation and during voriconazole therapy ( see section 4.4 ) .
7 h post-ref .
1 bottle
PHARMACEUTICAL PARTICULARS
16 .
in patient with endocrine disorder , include growth hormone deficiency , slip epiphysis of the hip may occur more frequently than in the general population .
in an animal model of familial adenomatous polyposis ( FAP ) , treatment with two other thiazolidinediones increase tumour multiplicity in the colon .
Angiox be compare with heparin .
common :
itraconazole ( a potent CYP3A4 inhibitor ) at 200 mg / day give orally for four day have no significant effect on the pharmacokinetics of intravenous fentanyl .
Uncommon
3 .
MARKETING AUTHORISATION NUMBER ( S )
4 .
you should know these factor so that you be able to react correctly to change in your blood sugar level and to prevent it from become too high or too low .
154 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS GONAL-f 450 IU / 0.75 ML ( 33 MICROGRAMS / 0.75 ML ) PEN , CARTRIDGE LABEL
your blood sugar level may either rise or fall if you take :
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
telmisartan be an orally effective and specific angiotensin II receptor subtype 1 ( AT1 ) antagonist .
Allogeneic bone marrow transplantation
Hepatobiliary disorder liver function disorder Hepatitis
the CHMP have recommend the granting of the Marketing Authorisation ( s ) for which the Summaries of Product Characteristics , labelling and package leaflet be set out in Annex III for Nifedipinr Pharmamatch Retard 30 / 60 mg and associate name ( see Annex I ) .
EU / 1 / 97 / 046 / 033
a greater magnitude of weight gain , lipid and prolactin alteration have be report in short term study of adolescent patient than in study of adult patient ( see section 4.4 , 4.8 , 5.1 and 5.2 ) .
- The active substance be lutropin alfa 75 IU ( International Units ) .
two of these trial be sponsor by the MAH ( HCJE and X065 ) and be review during the MR variation procedure .
4.7 Effects on ability to drive and use machine
Waarderweg 39 P. O Box 581 2031 BN Haarlem
PHARMACEUTICAL FORM
what be the risk associate with Gliolan ?
ask your doctor or pharmacist for advice before take any medicine . ct
dental and periodontal disorder :
statement OF ACTIVE SUBSTANCE ( S )
47 Olanzapine tablet contain lactose monohydrate .
( n = 1434 )
content BY WEIGHT , BY VOLUME OR BY UNIT
content BY WEIGHT , BY VOLUME OR BY UNIT
PREZISTA co-administered with 100 mg ritonavir should not be use in combination with these medicine , a co-administration may cause significant decrease in darunavir plasma concentration .
11 .
for lower respiratory tract infection such a bronchitis and pneumonia :
when completely reconstitute , the vaccine be a clear yellow liquid .
Norge Aventis Pharma Norge AS Tlf : + 47 67 10 71 00
subcutaneous use
insulin Human Winthrop Comb 15 in cartridge for OptiClik have be develop for use with OptiClik only .
for a full list of excipients , see 6.1 .
how to store PREZISTA 6 .
EMEA / CHMP / 46089 / 2006 / EN
Annex I
a a result , the dose of Effentora should be individually titrate to achieve the desired effect ( see section 4.2 ) .
the extent of this effect be dependent on the absolute degree of hyperhomocysteinemia , be higher in severe hyperhomocysteinemia .
platelet count below 100 x 109 / l be observe in 7 % of patient treat with MIRCERA and 4 % of patient treat with other ESAs .
- The active substance be irbesartan .
it be not know whether irbesartan be excrete in human milk .
4 .
potential for other medicinal product to affect ABILIFY :
6.3 Shelflife
the therapeutic margin of NeoRecormon be very wide .
the patient should be inform and more frequent blood glucose monitoring perform , especially at the beginning of treatment .
in the all-randomised population , test for difference of Xeloda v 5-FU / LV in disease-free and overall survival show hazard ratio of 0.88 ( 95 % CI 0.77 – 1.01 ; p = 0.068 ) and 0.86 ( 95 % CI 0.74 – 1.01 ; p = 0.060 ) , respectively .
Nederland Maarssenbroeksedijk 4 NL-3542 DN Utrecht Tel : + 31- ( 0 ) 800 778 78 78
this can result in serious vision loss and even blindness .
3 .
solution for injection
MARKETING AUTHORISATION NUMBER ( S )
the syringe be pre-assembled with a needle safety guard to prevent needle stick injury .
PHARMACEUTICAL FORM AND CONTENTS
regard cardiac dysfunction , this be one of the exclusion criterion so the study give no information on use of the product in animal with such a condition but there be also no data suggesting that the cardiac patient must not be treat with the substance .
BATCH
4.3 Contraindications
( Invented ) Name
overall , sitagliptin improved glycaemic control when use in combination with metformin ( a initial or add-on therapy ) and in combination with a sulphonylurea and metformin , a measure by clinically relevant reduction in HbA1c from baseline at study endpoint ( see Table 3 ) .
or non-myeloid malignancy receive multi-cycle chemotherapy .
if the recommended schedule can not be follow exactly , the interval between the first two dos should be approximately two month and the interval between the second and third dose should be a close a possible to eight to eleven month .
ivabradine do not influence intracardiac conduction , contractility ( no negative inotropic effect ) or ventricular repolarisation :
immune system disorder
Tel : + 31 23 567 2567 Fax : + 31 23 567 2599
II - IV GvHD GvHD
Italy
LABELLING
for child unable to swallow tablet , please refer to the Kaletra oral solution Summary of Product Characteristics .
fatigue
clinical PARTICULARS
ViraferonPeg
back pain , muscle spasm , myalgia Arthralgia , muscle cramp , pain in limb
Tritazide 2.5 mg / 12.5 mg Tabletten , Tritazide 5 mg / 25 mg Tabletten Hypren Plus 2.5 mg / 12.5 mg Tabletten , Hypren Plus Forte 5 mg / 25 mg Tabletten
10 4.8 Undesirable effect
genotype 1 / 4
list OF EXCIPIENTS
important information about some of the ingredient of ViraferonPeg :
ReFacto AF can be use in patient of all age , include newborn .
Valnemulin be an antibiotic belonging to the pleuromutilin group , which act by the inhibition of the initiation of protein synthesis at the level of the bacterial ribosome .
do not attempt to inject unless you be sure you understand the procedure and requirement for injection .
7 .
for a full list of excipients , see section 6.1 .
chronic Hepatitis C :
Fertavid solution for injection come in a glass vial .
more extensive haemarthrosis , muscle bleeding or haematoma .
in LH and FSH deficient woman ( hypogonadotrophic hypogonadism ) , the objective of GONAL-f therapy in association with lutropin alfa be to develop a single mature Graafian follicle from which the oocyte will be liberate after the administration of human chorionic gonadotrophin ( hCG ) .
how TO USE Filgrastim ratiopharm
254 Picture 2 .
saquinavir AUC ↑ 348 % .
if co-administered with ritonavir , CRIXIVAN may be administer with or without food .
56 Medicinal product by therapeutic area
Tecnimede - Sociedade Técnico- Medicinal , S. A .
if Risperdal Consta be use in accordance with the SPC recommendation for dose , no particular safety or efficacy risk for the patient would be foreseen , even if acutely ill .
statistically significant
for Aranesp no clinical data on exposed pregnancy be available .
Austria – Ciprofloxacin Hikma 200mg / 100ml Infusionslösung Germany – Ciprofloxacin Hikma 200mg / 100ml Lösung zur Intravenösen Anwendung Ireland – Ciprofloxacin Hikma 200mg / 100ml Solution for Infusion Italy – Ciprofloxacin Hikma 200mg / 100ml Soluzione per Infusione Endovenosa United Kingdom – Ciprofloxacin Hikma 200mg / 100ml Solution for Infusion The Netherlands – Ciprofloxacine Hikma 200mg / 100ml Oplossing voor Intraveneuze Infusie
Norge Wyeth Tlf : + 47 40 00 23 40 Fax : + 47 40 00 23 41
EU / 1 / 06 / 368 / 139
information IN BRAILLE
subcutaneous injection into the abdominal wall ensure a faster absorption than from other injection site .
do not store above 25 ° C .
name OF THE MEDICINAL PRODUCT
Tel : + 48 22 457 1000 Fax : + 48 22 457 1001
abnormal Laboratory Findings In the event of an abnormal blood count or liver function test finding , the clinical decision for continue use or adjust the dose of Diacomit in conjunction with adjust the dos of clobazam and valproate need to be make on an individual patient basis take into consideration the potential clinical benefit and risk ( See , section 4.4 ) .
granule
no study on the effect on the ability to drive and use machine have be perform .
EMEA ; EMEA / MB / 013 / 97 ) .
the patient & apos ; s ability to concentrate and react may be impair a a result of hypoglycaemia or hyperglycaemia or , for example , a a result of visual impairment .
keep out of the reach and sight of child .
- compartment syndrome * , characterise by pain , swell and neurological symptom , a well a
- monoamine oxidase ( MAO ) inhibitor ( use to treat depression ) ,
Emtriva 200 mg hard capsule Emtricitabine
the text of these and other provision may be also be find in the series Rules govern medicinal product in the European Community , volume I to VII .
Invented name
9 .
13 .
the start dose will generally be between 300 mg and 900 mg each day .
- pentoxifylline , propoxyphene , salicylate ( such a aspirin , use to relieve pain and lower fever ) ,
nevertheless , because human experience be limit , olanzapine should be use in pregnancy only if the potential benefit justify the potential risk to the foetus .
repaglinide be detect in the milk of experimental animal .
au 15 .
in the once every three week group , 72 % of patient require dose reduction .
the full EPAR for Flebogammadif can be find here .
dose reduction of rifabutin and dose increase of Crixivan have not be confirm in clinical
Special caution must be take to avoid accidental needle injury and transmission of infection .
ground FOR THE AMENDMENT OF THE MARKETING AUTHORISATION
store in a refrigerator ( 2ºC - 8ºC ) .
Portugal Fort Dodge Veterinaria S. A .
intravenous use Read the package leaflet before use Keep this container in the outer carton Store in a refrigerator
B-1180 Bruxelles / Brussel / Brüssel Tél / Tel : + 32- ( 0 ) 2 370 92 11
content BY WEIGHT , BY VOLUME OR BY UNIT
oral explanation be give on 20 April 2004 .
Novartis Finland OY Metsänneidonkuja 10 FIN-02130 Espoo
61 % * * *
25 mg / ml
serum potassium level should be monitor regularly during Aranesp therapy .
550 PACKAGE LEAFLET :
Shelf-life of the veterinary medicinal product a package for sale :
- angiotensin convert enzyme ( ACE ) inhibitor ( use to treat certain heart condition or high blood
↔
you should check with your doctor or pharmacist if you be not sure .
Lietuva UAB sanofi-aventis Lietuva Tel : + 370 5 2755224
Malta sanofi-aventis Malta Ltd .
it weakly inhibits dopamine reuptake with no significant affinity for histaminergic , dopaminergic , cholinergic and adrenergic receptor .
for intravenous or subcutaneous use .
it be a solution for injection contain within a glass pre-filled syringe .
155 Minor side effect include bruising , pain , redness , swell and itch at the site of the injection .
this product contain mineral oil .
Dex n = 110 2 ( 2 )
the usual starting dose be between 0.1 and 0.4 MU per kg bodyweight each day .
Neurontin
pharmacological PROPERTIES
rare : renal failure ( acute and chronic ) , proximal renal tubulopathy include Fanconi syndrome , increase creatinine , proteinuria Very rare : acute tubular necrosis Not know : nephritis ( include acute interstitial nephritis ) , nephrogenic diabetes insipidus .
Paroxetina
15 .
България sanofi-aventis Bulgaria EOOD Тел . : + 359 ( 0 ) 2 970 53 00
age : pharmacokinetic difference have be identify between younger and elderly female ( ≥ 65 year ) ( AUC increase by about 25 % and half-life be about 25 % longer in the elderly ) , although the magnitude of these change be not sufficient to justify adjustment to the dose .
information IN BRAILLE
for urticaria , the duration of treatment may be variable from patient to patient and therefore you should follow the instruction of your physician .
6 .
where treatment be interrupt due to vomit , it be recommend that when treatment be resume , the product should be administer after a meal .
before YOU USE KEPPRA
C )
indication
name OF THE MEDICINAL PRODUCT
250 IU
64 / 72
cardiac disorder
gastrointestinal disorder :
take special care with Neoclarityn
Furthermore , there be an increased background lymphoma risk in rheumatoid arthritis patient with long-standing , highly active , inflammatory disease , which complicate the risk estimation .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Österreich Novartis Pharma GmbH Tel : + 43 1 86 6570
the 50 μg / 0.5 ml vial must be use if necessary since the pen can only deliver a minimum volume of 0.3 ml .
4.1 Therapeutic indication
store in the original package .
40 8 .
Gooimeer 10 1411 DD Naarden The Netherlands
clinical PARTICULARS
5 / 17 ANNEX II
powder :
other SPECIAL WARNING ( S ) , IF NECESSARY
6.4 Special precaution for storage
how to deal with mild hypoglycaemia .
Additionally , serious skin reaction , some of them fatal , include toxic epidermal necrolysis , have be report through postmarketing surveillance in patient receive valdecoxib ( the active metabolite of parecoxib ) and can not be rule out for parecoxib ( see section 4.8 ) .
experience from non-Hodgkin ’ s lymphoma and chronic lymphocytic leukaemia .
35 For any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder .
if you stop take ReFacto AF
repeat treatment course with MabThera be possible .
6 3 2 & lt ; 1 2
the vaccine should be store at + 2 ° C to + 8 ° C .
concomitant vaccination with yellow fever vaccine ( see section 4.5 ) .
5 The patient & apos ; s ability to concentrate and react may be impair a a result of hypoglycaemia or hyperglycaemia or , for example , a a result of visual impairment .
the first study include 653 ‘ treatment-naïve ’ adult ( patient who have not take treatment for HIV infection before ) , compare Kaletra with nelfinavir ( another antiviral medicine ) .
8 .
oral use
other SPECIAL WARNING ( S ) , IF NECESSARY
Verification of the dose to be administer and patient identification be necessary prior to administration of QUADRAMET .
o nce you start treatment , your doctor will check your lung function again after 6 month and at other time to see how well you be tolerate EXUBERA .
common : nausea / vomiting , abnormal urination , fatigue and dizziness ( include when get up from a lying or sit position ) .
morning Dose Evening Dose 2 ml 2 ml 3 ml 2 ml 3 ml 3 ml 4 ml 3 ml 4 ml 4 ml 5 ml 4 ml 5 ml 5 ml 6 ml 5 ml 6 ml 6 ml 7 ml 6 ml 7 ml 7 ml 8 ml 7 ml 8 ml 8 ml 9 ml 8 ml
in patient with parathyroid carcinoma or primary hyperparathyroidism , the recommend starting dose of Mimpara for adult be 30 mg twice a day .
oral use
general CLASSIFICATION FOR SUPPLY
2.2 * *
information FOR THE USER
if it can not be use immediately , the solution may be refrigerate for up to 24 hour .
1 .
Belivon 1 mg Filmtabletten
6.2 Incompatibilities
EPAR summary for the public
instruction ON USE
treatment with NeoRecormon should be temporarily discontinue if haemoglobin level exceed 13 g / dl ( 8.1 mmol / l ) .
- Occasionally , patient receive Cubicin may develop tender or ache muscle or muscle
talk to your doctor to see if this be appropriate for you .
14 , 28 , 30 , 49 , 56 , and 98 tablet in polyvinyl chloride laminate with
in their entirety , the available data on the risk of myocardial ischaemia be inconclusive .
this will usually be in the range of 20 to 60 IU of octocog alfa per kg of body weight , administer at interval of 2 to 3 day .
Eesti Merck Sharp & amp ; Dohme OÜ Tel : + 372 613 9750 msdeesti @ merck . com
- if you be take a sulphonylurea , a diabetes medicine , together with Velmetia , a you may
the potential risk in human be unknown .
PHARMACEUTICAL PARTICULARS
other bind protein may be elevate in serum .
change the injection site with each injection may help to prevent such skin change . • Skin and allergic reaction Other mild reaction at the injection site ( such a injection site redness , unusually intense pain on injection site , itch , injection site swell or injection site inflammation ) may occur .
at high dos , animal study have show reversible bone effect in the offspring of rat and rabbit treat during pregnancy ( see section 5.3 ) .
angiotensin I be convert into the hormone angiotensin II , which be a powerful vasoconstrictor ( it narrow blood vessel ) .
INOmax have also be study in 421 neonate from 34 week gestation with pulmonary hypertension in two main study .
name OF THE MEDICINAL PRODUCT
when an optimal response be obtain , a single injection of 5,000 IU to 10,000 IU hCG should be administer 24-48 hour after the last GONAL-f and lutropin alfa injection .
3 .
MARKETING AUTHORISATION NUMBER ( S )
if their symptom be the same a yours .
9 Weight gain ≥ 7 % of baseline body weight ( kg ) be very common and ≥ 15 % of baseline body weight be common .
metabolite be then excrete in the bile a either free or glucuronidated metabolite .
eye disorder Very rare - Refraction disorder Refraction anomaly may occur upon initiation of insulin therapy .
6.6 Special precaution for disposal
significant advantage for Enbrel in combination with methotrexate compare with Enbrel monotherapy and methotrexate monotherapy be also observe after 24 month .
pregnancy and breast-feeding Ask your doctor or pharmacist for advice before take any medicine .
reconstitute product should be inspect visually for particulate matter prior to administration .
very rare :
hypertension , hypertension aggravate d
5.1 Pharmacodynamic property
5 .
Leukopenia Neutropenia
film-coated tablet
0.9 3.9 2.4 9.5
9 The combination of hydrochlorothiazide and irbesartan produce dose-related additive reduction in blood pressure across their therapeutic dose range .
42 % ( 49 / 118 ) * 52 % ( 37 / 71 ) 26 % ( 12 / 47 )
lot
13 .
it may harm them , even
- ketoconazole , itraconazole ( use to treat fungal disease )
0 %
20 mg / cap
Danmark Novartis Healthcare A / S Tlf : + 45 39 16 84 00
17 , biroul 501 Bucureş ti 020011 – RO Tel : + 40 21 527 03 02
due to the chronic nature of the disease process , FABLYN be intend for long-term use ( see section 5.1 ) .
Zerit should not be use during pregnancy unless clearly necessary .
6.1 List of excipients
in an exploratory clinical trial evaluate the use of another anti-TNF agent , infliximab , in patient with moderate to severe chronic obstructive pulmonary disease ( COPD ) , more malignancy , mostly in the lung or head and neck , be report in infliximab-treated patient compare with control patient .
read the package leaflet before use .
DK
10 .
Special STORAGE CONDITIONS
the plasma concentration of duloxetine display large inter-individual variability ( see 5.2 ) .
Morphine
secondary packaging material The sachet be pack in a carton .
in an animal model for familial adenomatous polyposis ( FAP ) , treatment with rosiglitazone at 200 time the pharmacologically active dose increase tumour multiplicity in the colon .
27 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
2 .
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Tel .
blood and lymphatic system disorder
6.4 Special precaution for storage
3 ml ( 90 mg / ml ) Solvent :
10 ml
chronic lymphocytic leukaemia
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
Netherlands
International non-proprietary name ( INN )
do not store them in or too near the freezer section or cool element .
rarely :
- In chronic renal failure patient , epoetin alfa should be use in pregnancy only if the potential
a sustained haemoglobin level of greater than 12 g / dl ( 7.5 mmol / l ) should be avoid ; guidance for appropriate dose adjustment for when haemoglobin value exceed 12 g / dl ( 7.5 mmol / l ) be observe be describe below .
in the event of an overdose , haematological evaluation be need .
- Confusion
mean systemic AUC of valsartan be higher by 70 % in the elderly than in the young therefore caution be require when increase the dosage .
cardiac disorder
6 .
note for Guidance on clinical investigation of steroid contraceptive in woman Adopted February 2000
the effect of an overdose of Luveris be unknown , nevertheless there be a possibility that ovarian hyperstimulation syndrome may occur , which be further describe in ‘ Possible side effect & apos ; .
the product when kept in it outer carton may be store at ambient room temperature ( up to 25 ° C ) for a limited period of 3 month .
your doctor will decide if ADVATE may be use during pregnancy and breast-feeding .
adjust recovery and terminal half-life ( t1 / 2 ) be approximately 20 % lower in young child ( le than 6 year of age ) than in adult , which may be due in part to the know higher plasma volume per kilogram body weight in younger patient .
take special care with CellCept :
- your blood sugar level be almost normal or be unstable ,
steady state Cmax be 14.1 μ M , steady state Cmin be 5.6 μ M , and AUC be 216 μ M · h .
Table 1 :
in the future , if the bird be expose to the avian flu virus , their immune system will be able to make those antibody quicker and this will help them fight the disease .
clear colourless solution .
very rare :
10.11.2006
method OF ADMINISTRATION
the product when kept in it outer carton may be store at ambient room temperature ( up to 25 ° C ) for a limited period of 3 month .
information IN BRAILLE
hydrochlorothiazide be 68 % protein-bound in the plasma , and it apparent volume of distribution be 0.83-1.14 l / kg .
for intravenous , single dose administration
in general , to prevent hypoglycaemia you must eat more food and monitor your blood sugar .
if the dose can not be administer orally a a result of the clinical condition of the patient , intravenous therapy of 0.01 - 0.05 mg / kg / day should be initiate a a continuous 24-hour infusion .
patient who develop jaundice or other sign suggestive of liver dysfunction should discontinue Xiliarx .
monoclonal antibody be proteins that recognise and bind to other unique protein .
gently pull back the plunger to check if blood be aspirate .
4.3 Contraindications
instruction ON USE
keep treated animal away from fire and other source of ignition for at least 30 minute or until the hair coat be dry .
like all medicine , Temodal can cause side effect , although not everybody get them .
Suomi / Finland Oy Eli Lilly Finland Ab Puh / Tel : + 358- ( 0 ) 9 85 45 250
7 .
•
read the package leaflet before use .
EU / 1 / 07 / 432 / 007 EU / 1 / 07 / 432 / 008
6 .
4.9 Overdose
on an assessment of the individual patient & apos ; s overall risk .
MARKETING Authorisation Holder Celgene Europe Ltd . , Riverside House , Riverside Walk , Windsor , SL4 1NA , United Kingdom .
it be important that you follow this advice .
it contain a protein ( antigen ) from the porcine circovirus type 2 virus ( PCV2 ) .
if a dose of Lucentis be miss Contact your doctor or hospital a soon a possible to re-schedule your appointment .
160 mg
a hypo mean your blood sugar level be too low .
respiratory , thoracic and mediastinal disorder
your doctor or pharmacist need to know about other medicine because some medicine could affect your kidney and because Sebivo mainly leave the body via the kidney in the urine .
78-88 year ) .
approximately 29 % of the dose be excrete after metabolism in the faeces .
the population include 27.8 % woman , 58.4 % patient ≥ 60 year ( 26 % ≥ 70 year ) and 54.5 % patient who receive fibrinolytics .
absorption Febuxostat be rapidly ( tmax of 1.0-1.5 h ) and well absorb ( at least 84 % ) .
the treatment should be continue for at least 3 to 4 month before any improvement in spermatogenesis can be expect .
Avenue Molière 225 B-1050 Bruxelles / Brussel / Brüssel Tél / Tel : + 32 2 340 2828
gastrointestinal disorder :
further information
the free drug clearance of imatinib be probably similar between patient with renal impairment and those with normal renal function , since renal excretion represent only a minor elimination pathway for imatinib ( see section 4.2 and 4.4 ) .
instruction ON USE
comparison with historical data suggest that the ovulation rate obtain with GONAL-f / LH be similar to what can be obtain with hMG .
• You might get infection more easily while you be receive Trudexa treatment include serious infection , tuberculosis , opportunistic infection and sepsis that may , in rare case , be life-threatening .
appropriate antihypertensive drug must usually replace CoAprovel before start a pregnancy .
Alternatively , intrauterine insemination ( IUI ) may be perform .
11 .
the first revaccination be give not later than 17 month after the primary vaccination course .
in a study in young beagle dog , ciprofloxacin cause severe articular change at therapeutic dos after two week of treatment , which be still observe after 5 month .
• Blood and lymphatic system disorder
patient who be receive concomitant anticonvulsant medicinal product primarily metabolise by the liver , such a phenytoin , carbamazepine and phenobarbital , may require periodic monitoring of plasma level .
Insuman Rapid
- You have a condition of hardening of artery ( also know a atherosclerosis ) , and
low viral load = ≤ 800,000 IU / mL ; High viral load = & gt ; 800,000 IU / mL RVR = rapid viral response ( HCV RNA undetectable ) at week 4
AUC12 : ↓ 45 % ( ↓ 38 to ↓ 51 ) Cmax : ↓ 51 % ( ↓ 37 to ↓ 62 ) Efavirenz concentration not measure , no effect be expect .
bone marrow depression Bone marrow depression , usually present a granulocytopenia or agranulocytosis , have be report during treatment with Remeron .
any unused veterinary medicinal product or waste material derive from such veterinary medicinal product should be dispose of in accordance with local requirement .
solution for injection in a pre-filled syringe
Medoraxil
18 No study on the effect on the ability to drive and use machine have be perform .
DATE OF REVISION OF THE TEXT
expiry DATE
avoid introduction of contamination during use .
your doctor will then test your blood to see how well your treatment be work and to find the dose that be best for you .
the most common undesirable effect with ivabradine be dose dependent and relate to the pharmacological effect of the medicinal product .
5.3 Preclinical safety data
patient with renal impairment :
not applicable
dosage :
30 , 50 x 1 and 100 tablet
read the package leaflet before use .
lot
if the number of your blood platelet be fewer than 150,000 / mm3 after chemotherapy
Xolair 150 mg powder and solvent for solution for injection Omalizumab
treatment should be initiate only by physician who be experience in the treatment of cystic fibrosis and / or severe infection in child and adolescent ( see section 4.4 and 5.1 ) .
pharmacological PROPERTIES
the veterinary medicinal product contain the active substance hydrocortisone aceponate .
the active substance in Taxotere / Docetaxel Winthrop , docetaxel , belong to the group of anticancer medicine know a the ‘ taxanes ’ .
standard haematologic test , blood chemistry and a test of thyroid function must be conduct in all patient prior to initiate therapy .
Luxembourg / Luxemburg UCB Pharma S. A . / N. V .
the usual dose be either 0.5 mg ( 10 ml ) or 1 mg ( 20 ml ) once daily orally ( by mouth ) .
very rare : • severe skin reaction .
6.1 List of excipients
61 Kinzalmono should not be use during the second and third trimester of pregnancy .
each vial contain 20 mg basiliximab * .
no study on the effect on the ability to drive and use machine have be perform .
pramipexole be rapidly and completely absorb follow oral administration .
disorder : dizziness , orthostatic dizziness *
this be especially important if you take medicine to treat heart problem ( see also above & quot ; Take special care & quot ; ) .
other INFORMATION
XENICAL only work in the presence of dietary fat .
myopathy , back pain , musculoskeletal pain , myalgia
7 , 10 , 14 , 20 , 21 , 30 , 50 , 100
patient , ( and caregiver of patient ) should be alert about the need to monitor for the emergence of suicidal ideation / behaviour or thought of harm themselves and to seek medical advice immediately if these symptom present .
the Committee recommend that Optruma be give market authorisation .
on 15 November 2007 , the Committee for Medicinal Products for Human Use ( CHMP ) adopt a negative opinion , recommend the refusal of the marketing authorisation for the medicinal product CIMZIA 200 mg powder and solvent for solution for injection , intend for the treatment of severe , active Crohn ’ s disease .
Amgen Europe B. V .
atrial fibrillation , palpitation Congestive cardiac failure , pulmonary oedema , heart valve insufficiency , atrial flutter , arrhythmia , ventricular trigeminy , bradycardia , tachycardia , QT prolongation , sinus tachycardia
1 . Combivir be a fixed dose combination of lamivudine and zidovudine 2 . include three non-virological failure and four unconfirmed virological failure .
12.5 mg
inhibitor of CYP 1A2 : because CYP1A2 be involve in duloxetine metabolism , concomitant use of duloxetine with potent inhibitor of CYP1A2 be likely to result in higher concentration of duloxetine .
NovoMix 70 be a biphasic suspension of insulin aspart ( rapid-acting human insulin analogue ) and protamine-crystallised insulin aspart ( intermediate-acting human insulin analogue ) .
5.3 Preclinical safety data
two other smaller , randomise , placebo-controlled trial fail to show a significant improvement in quality of life parameter on the EORTC-QLQ-C30 scale or CLAS , respectively .
10 pre-filled pen
ritonavir 100 mg once
you be recommend to have sexual intercourse on the day of the administration of this second medicine and the following day .
keep out of the reach and sight of child .
the half-life of tacrolimus be long and variable .
gastrointestinal disorder
film-coated tablet
if Docetaxel Winthrop concentrate , premix solution or infusion solution should come into contact with mucous membrane , wash immediately and thoroughly with water .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
at the time of the original analysis , three of the four patient with detected PDGFR gene rearrangement develop haematological response ( 2 CHR and 1 PHR ) .
CL ( ml / min )
7 % * *
MARKETING AUTHORISATION NUMBER ( S )
follow rosiglitazone treatment , there be no new safety concern note in child compare to adult patient with type 2 diabetes mellitus .
take special care with PhotoBarr Tell your doctor if any of the following applies to you :
it may be accompany by other reaction include mood change , anxiety , or sleep disturbance and restlessness .
pregnancy
15 .
when look only at woman of 74 year of age or older with particularly weak thighbone , the result suggest a reduction of the risk of hip fracture with OSSEOR .
MabCampath n = 149
treatment of adult patient schedule for major elective orthopaedic surgery :
Raynaud ’ s disease , flushing , pallor t
the lower systemic exposure to timolol follow AZARGA administration be not clinically relevant .
concomitant administration with food do not reduce the extent of pramipexole absorption , but the rate of absorption be reduce .
do tell your doctor that you miss a dose .
when replace another heartworm preventative product in a heartworm prevention programme , the first treatment with Advocate must be give within 1 month of the last dose of the former medication .
it purpose be to explain how the assessment do by the Committee for Medicinal Products for Veterinary Use ( CVMP ) on the basis of the documentation provide , lead to the recommendation on the condition of use .
it explain how the Committee for Medicinal product for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
statement OF ACTIVE SUBSTANCE ( S )
PHARMACEUTICAL FORM
- a regimen with only regular insulin to one with a longer-acting insulin .
5 .
general CLASSIFICATION FOR SUPPLY
the amount of duloxetine in breast milk be approximately 7 µg / day while on 40 mg twice daily dose .
16 July 2007
expiry DATE
the injection be give slowly into a muscle ( for instance in the buttock , upper leg or upper arm ) or just under the skin ( in the abdominal wall , for example ) .
72 PACKAGE LEAFLET :
139
two of the study compare sitagliptin a an add-on to metformin with placebo ( in 701 patient ) and with glipizide ( a sulphonylurea ) ( in 1,172 patient ) .
your doctor may take some regular laboratory test during a long term treatment with Stalevo .
it be important to institute medication a early a possible in an outbreak of swine dysentery .
6.2 Incompatibilities
reproductive system and breast disorder
65 / 40 LT-08124 Vilnius Tel : + 370 52 101868
significant advantage for Enbrel in combination with methotrexate compare with Enbrel monotherapy and methotrexate monotherapy be also observe after 24 month .
chronic renal failure patient
Special STORAGE CONDITIONS
metabolite 25-O-desacetylrifabutin AUC ↑ 1.24 ( 0.84-1.84 ) Metabolite 25-O-desacetylrifabutin Cmin ↑ 1.22 ( 0.86-1.74 ) Metabolite 25-O-desacetylrifabutin Cmax ↑ 1.29 ( 0.98-1.68 ) A clinically not relevant increase in the apparent clearance of nevirapine ( by 9 % ) compare to historical data be report .
NUMBER of tablet
you may need to read it again .
do not inject directly into a vein .
tumour development be precede by pneumocyte proliferation in the lung which be not observe in rat , dog , or monkey , indicate that a key event in lung tumour development observe in mouse likely be species-specific .
select the dose
Co-infection with HIV-1 and hepatitis B :
all patient in these trial receive 3 MIU of Viraferon three time a week .
10 .
• patient with significantly impair bone marrow function or significant anaemia , leucopenia , neutropenia or thrombocytopenia due to cause other than rheumatoid or psoriatic arthritis ,
prophylaxis with appropriate antihistamine prior to initiate therapy with efavirenz in child may be consider .
neuroleptic malignant syndrome Symptoms suggestive of neuroleptic malignant syndrome have be report with abrupt withdrawal of dopaminergic therapy ( see section 4.2 ) .
which would have the following symptom : a reduced ability to exercise , inability to lie flat in bed , shortness of breath or swollen ankle
after reconstitution this medicinal product contain 0.45 mmol sodium ( 10 mg ) per vial .
Bondronat 50 mg p-value n = 287
Österreich Gilead Sciences GesmbH Tel : + 43 1 260 8 30
name and address of the manufacturer responsible for batch release
FI - Finland
one ( 1 ) additional low-titre de novo inhibitor be observe .
autoimmune disease :
publish on the Heads of Agencies website , which be
placebo ( n = 37 )
lot
9 Table 3
the full EPAR for Ytracis be available here .
sodium benzoate
amlodipine have an effect on hypertension by a directly relax effect on the smooth muscle in the arterial blood vessel .
Malta Fort Dodge Animal Health The Netherlands Tel : + 31 35 699 3365
list OF THE NAMES , PHARMACEUTICAL FORM , STRENGTHS OF THE MEDICINAL PRODUCTS , ROUTE OF ADMINISTRATION , MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
PHARMACEUTICAL Form
Special STORAGE CONDITIONS
in double-blind , control clinical trial , the incidence of peripheral oedema by dose be a follow :
uth Relapse patient :
tenofovir disoproxil fumarate 300 mg qd ( saquinavir / ritonavir 1000 / 100 mg bid )
402 382
SVR % ( n / N ) 99 % CI
4 .
Alternatively , it may be disperse in a full glass of water or other suitable beverage ( orange juice , apple juice , milk or coffee ) immediately before administration .
4.6 Pregnancy and lactation
very common : at least 1 in 10 patient or more Common : at least 1 in 100 and le than 1 in 10 patient Uncommon : at least 1 in 1000 and le than 1 in 100 patient
not all pack size may be market .
0.017 0.007
EXP
& # 91 ; 88 % -99 % & # 93 ; ) at 2 year .
4.6 Pregnancy and lactation
GONAL-f 300 IU / 0.50 ml ( 22 microgram / 0.50 ml ) powder and solvent for solution for injection .
PhD in public health from the University of Bordeaux .
interaction study have only be perform in adult .
Alternatively , if a patient have stop Humira and sign and symptom of disease recur , Humira may be re-administered .
polysorbate 80 Octoxynol 10 Thiomersal Sodium chloride ( NaCl ) Disodium hydrogen phosphate ( Na2HPO4 ) Potassium dihydrogen phosphate ( KH2PO4 ) Potassium chloride ( KCl ) Magnesium chloride ( MgCl2 ) Water for injection
if use of the oral solution be not possible , Sebivo film-coated tablet could be use a an alternative and dosing should be adjust by increase the time interval between dos , a detail in Table 1 .
due to this short action NovoRapid should normally be take in combination with intermediate-acting or long-acting insulin preparation .
pre-filled pen
each 400 mg hard capsule contain 400 mg of gabapentin .
7 .
undesirable effect Leukocytosis , thrombocytopenia Spleen disorder Elevated alkaline phosphatase , elevate LDH SGOT increase , hyperuricaemia
capsule
these measure will help to protect the environment .
a .
survival probability
15 .
risperidone
what Preotact look like and content of the pack
Милко Бичев & quot ; № 7 , ет.3 BG-София 1504 Тел . : + 359 2 944 1073
Uncommon
the active substance be ciprofloxacin .
most minor reaction to insulin usually resolve in a few day to a few week .
Tel : + 386 1 300 75 77
few subject ( 0.2 % ) discontinue due to adverse reaction .
solution for injection ( injection ) in a pre-filled syringe .
1.5 mg of meloxicam 5 mg of sodium benzoate
when perform haematologic assessment during the preoperative period , if the haemoglobin level reach 15 g / dl , or higher , administration of epoetin alfa should be stop and further dos should not be give .
1 cartridge
Hold a glass or cup under the nozzle ( see picture ) .
information IN BRAILLE
7 Results from study in pig show that the application of von Willebrand Factor ( vWF , 66 I. U . / kg body weight ) markedly reduce the bleeding time .
genotype 2 or 3
( 16.4 , 28.0 ) ( 8.0 , 17.5 ) ( 17.0 , 28.2 )
subcutaneous use
( 95 % CI ) 2-year estimate ( % ) Hazard ratio
maintenance
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
very Common ( & gt ; 1 / 10 )
S-P Veterinary Shire Park Welwyn Garden City Hertfordshire AL7 1TW United Kingdom
inner
13 Data on concomitant administration of Prevenar with Infanrix hexa ( DTaP / Hib ( PRP-T ) / IPV / HepB vaccine ) have show no clinically relevant interference in the antibody response to each of the individual antigens when give a a 3 dose primary vaccination .
each film-coated tablet contain 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine .
1 .
endpoint
further INFORMATION
stomach pain , fast and deep breathing , sleepiness or even loss of consciousness may be sign of a serious condition ( ketoacidosis ) result from lack of insulin .
it be obtain from a clone of E. coli , which harbour a genetically engineer plasmid hybrid encompass an interferon alfa-2b gene from human leukocyte . rod
143 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
your doctor will instruct you how to switch from the previous treatment to Irbesartan Hydrochlorothiazide BMS .
6 ( 1.7 ) 1 ( 0.3 )
21 Oral use .
further INFORMATION
patient with HIV-1 RNA & lt ; 200 copy / ml PVR ( KM )
it may harm them , even if
2.3 % ) ; Peripheral motor neuropathy ( G3 / 4 :
in order to ensure optimum response to erythropoietin , adequate iron store should be assure : − iron supplementation , e.g .
the active metabolite of leflunomide , A771726 , have a long half-life , usually 1 to 4 week .
the difference in mean improvement between the two active treatment arm be not significant .
the effect of ORENCIA be first test in experimental model before be study in human .
a it exhibit in vitro dopamine antagonism , olanzapine may antagonize the effect of direct and indirect dopamine agonist .
when indicate , dose escalation should be perform with caution in these patient .
MARKETING AUTHORISATION NUMBER ( S )
the following information be intend for medical or healthcare professional only :
Luxembourg / Luxemburg ( Voir / siehe Belgique / Belgien )
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
6 .
reduction in fast plasma glucose ( FPG ) be observe at 3 week , the first time point at which FPG be measure .
the frequency of this be unknown ( see section 4.4 ) .
Mistakes in dosage
10 .
- timing of meal and insulin administration while travel ,
contains glycerol , zinc oxide , dibasic sodium phosphate 7 H20 with m-cresol a a preservative in water for injection .
follow subcutaneous administration of 2.25 µg / kg to adult cancer patient a mean peak ic
worsen or onset of diabetes may occur .
5 .
summary OF PRODUCT CHARACTERISTICS , LABELLING AND PACKAGE LEAFLET
subcutaneous use Levemir Penfill cartridges for use with Novo Nordisk insulin device Levemir Penfill be for use by one person only Read the package leaflet before use
Neupro be a transdermal patch .
capsule content : anhydrous lactose , colloidal anhydrous silica , sodium starch glycolate type A , tartaric acid , stearic acid .
the preferred site be the deltoid area of the upper arm or in the higher anterolateral area of the thigh .
other
GlaxoSmithKline α .ε .β .ε 266 Kifissias Ave 152 32 Halandri Athens Greece
depression , irritability , insomnia , anxiety * , concentration impair , emotional lability *
Norge Eli Lilly Norge A.S .
each prolonged-release capsule contain 53.64 mg of lactose monohydrate
transferrin saturation be below 20 % .
other bind protein may be elevate in serum , i.e . corticoid bind globulin ( CBG ) , sex-hormone-binding globulin ( SHBG ) lead to increase circulating corticosteroid and sex steroid , respectively .
on May 17 , 1995 Germany present a referral under Article 12 of Council Directive 75 / 319 / EEC a amend , and ask the CPMP to formulate an opinion on risk and benefit of medicinal product which be classify a centrally act anorectic agent .
38 40
withdrawal PERIOD
EU / 1 / 06 / 357 / 020
this be particularly important in those who have reduce or absent awareness of the warning sign of hypoglycaemia or have frequent episode of hypoglycaemia .
elimination Based on the recovery of compound ( s ) after an oral 14C-labelled dose of imatinib , approximately 81 % of the dose be recover within 7 day in faeces ( 68 % of dose ) and urine ( 13 % of dose ) .
Medochemie Ltd , Limassol Constantinoupoleos St .
Myositis
such mechanism be particularly important for an independent and free- standing regulatory authority like the EMEA .
4 .
psychiatric
oral use
what Eucreas look like and content of the pack Eucreas 50 mg / 850 mg film-coated tablet be yellow , oval tablet with “ NVR ” on one side and “ SEH ” on the other .
if you have any further question on the use of this product , ask your doctor or pharmacist .
0.80 ( p = 0.003 )
each vial contain 5 ml of suspension for a single injection .
nervous system disorder Rare case of convulsion or transient loss of consciousness have be observe with docetaxel administration .
1 .
1 ml contains 330.9 mg gadoversetamide , equivalent to 500 micromol .
296a 70 % * 36 % 12 % 325
common Common Common Common Uncommon Very common
any unused veterinary medicinal product or waste material derive from such veterinary medicinal product should be dispose of in accordance with local requirement
España sanofi-aventis , S. A .
use the dose prescribe by the veterinarian .
6 / 20 A .
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
51 % 25 % 52 %
the greatest amelioration be see in the domain of practical problem and daily activity limit by symptom .
0.003
DATE of first authorization :
use an alcohol swab to wipe the rubber seal on the end of the Cartridge Holder .
oral use
42 % 38 % 48 %
expiry DATE
4.8 Undesirable effect
Self-administration of GONAL-f should only be perform by patient who be well motivate , adequately trained and with access to expert advice .
dosage in adult The usual dose of Glubrava be 30 mg / day pioglitazone plus 1700 mg / day of metformin hydrochloride ( this dosage be achievable with one tablet of Glubrava 15 mg / 850 mg , take twice a day ) .
such reaction to insulin or to the excipients can cause large-scale skin reaction ( rash and itch all over the body ) ; severe swelling of skin or mucous membrane ( angiooedema ) , shortness of breath , a fall in blood pressure with rapid heart beat and sweating .
PHARMACEUTICAL FORM
MARKETING AUTHORISATION NUMBER ( S )
Tel : + 40 ( 0 ) 21 272 16 00
only the ethinyloestradiol component of oral contraceptive have be study .
topotecan do not inhibit human P450 enzyme ( see section 5.2 ) .
Expires & lt ; mm / yyyy & gt ;
C .
- you have recently change from an animal insulin to a human insulin such a Insulin Human
not all pack size be market .
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
ask your doctor or pharmacist for advice before take any medicine .
-1.9
category and Grade
in the process of heal the wound , becaplermin induces cell proliferation .
Profender for Small Cats Profender for Medium Cats Profender for Large Cats
this be particularly important in those who have reduce or absent awareness of the warning symptom of hypoglycaemia or have frequent episode of hypoglycaemia .
solution for injection
if you have be recommend to take the tablet twice daily , this will help you remember to take a tablet every day in the morning and in the evening .
protein build-up in the air sac of the lung that may interfere with breathing
Slovenská republika sanofi-aventis Pharma Slovakia s.r.o .
ge Evropská 2590 / 33d CZ-160 00 Praha 6 Tel : + 420 267 292 111
there be no evidence from clinical study that abacavir be hepatotoxic .
for introduction of the carbon dioxide into the analyser many sample inlet system be available .
side effect report commonly ( Seen in le than 1 in 10 but more than 1 in 100 patient ) • Oedema Insulin treatment may cause temporary build-up of water in the body with swell in the calf and ankle . • Injection site reaction
1 .
France sanofi-aventis France Tél :
Tél / Tel : + 32 2 352 74 60
however , MPA Cmax be decrease by 40 % in the presence of food .
the Committee recommend that Zalasta be give market authorisation .
reaction ( such a swollen face or tongue ) in patient attempt to quit smoke with CHAMPIX .
at least 14 day before you start treatment with Soliris , your doctor will administer a vaccine against meningitis if it be not previously administer or if your vaccination be outdated .
separate one blister cell from the strip .
24 6.4 Special precaution for storage
female rat receive duloxetine ( 45 mg / kg / day ) before and during mating and early pregnancy have a decrease in maternal food consumption and body weight , oestrous cycle disruption , decrease live birth index and progeny survival , and progeny growth retardation at systemic exposure level estimate to be at the most at maximum clinical exposure ( AUC ) .
oral use .
haematological toxicity VELCADE treatment be very commonly associate with haematological toxicity ( thrombocytopenia , neutropenia and anaemia ) .
do not freeze ; discard if vaccine have be freeze .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
no data be available with regard to overdose of Zomarist .
blister
MARKETING AUTHORISATION NUMBER ( S )
2.881
your doctor need to assess the benefit and potential risk of give you the vaccine if you be pregnant .
your doctor may consider give you an alternative medicine or change the dose of the protease inhibitor .
58 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
summary OF PRODUCT CHARACTERISTICS , LABELLING AND PACKAGE LEAFLET
Wilzin 25 mg hard capsule Wilzin 50 mg hard capsule zinc acetate dihydrate
in this leaflet :
PHARMACEUTICAL Form
Simi : + 354 530 3700
107 Posology
the patient improve following discontinuation of therapy .
- in whom glycaemic control be markedly improve ,
the modified intention to treat ( ITT ) population include woman regardless of baseline HPV status at Day 1 , who receive at least one vaccination and in whom case counting start at 1 month Postdose 1 .
somatropin may be lose if treatment be stop before final height be reach .
administration of RotaTeq should be postpone in infant suffer from acute severe febrile illness .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
Soliris 300 mg , concentrate for solution for infusion Eculizumab
6.2 Incompatibilities
the daily dose be 30mg of combined active per kg bodyweight by oral administration .
be careful not to bend or twist the cover during removal to avoid damage to the needle .
when consider raise the dose , it must be bear in mind that the maximum antihypertensive effect be generally attain four to eight week after the start of treatment ( see section 5.1 ) .
Uncommon Uncommon Uncommon Common
5 .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
thromboembolic complication may occur if the preparation be unintentionally apply intravascularly ( see section 4.4 ) .
3 .
olanzapine be bind predominantly to albumin and α 1-acid-glycoprotein .
consider double the rifabutin dose in regimen where rifabutin be give 2 or 3 time a week in combination with efavirenz .
overall Survival
subcutaneous injection A maximum volume of 1 ml at one injection site should generally not be exceed .
hypokalaemia , Hyperuricaemia , hyponatraemia
2 year
Novo Nordisk A / S Novo Allé , DK-2880 Bagsværd , Denmark
24 A reduction of rifabutin dosage of at least 50 % be recommend when administer with Agenerase .
1 .
woman appear to be at higher risk than men of develop rash , whether receive VIRAMUNE or non- VIRAMUNE contain therapy .
the company do apply for an authorisation to use INCRELEX in these child , but withdraw it application after the end of the medicine ’ s assessment , a this disease be not list in the medicine ’ s ‘ orphan ’ designation .
in cancer patient receive chemotherapy , the 2-3 week delay between erythropoietin administration and the appearance of erythropoietin-induced red cell should be take into account when assess if Silapo therapy be appropriate ( patient at risk of be transfuse ) .
EXP { MONTH – YYYY }
41 Decreased haemoglobin , haematocrit , elevate serum glucose and white blood cell , bacteria and blood in the urine have be report .
Hearing loss
6 .
le than 1 per 10 , but more than 1 per 100 treated people le than 1 per 100 , but more than 1 per 1,000 treated people le than 1 per 1,000 , but more than 1 per 10,000 treated people le than 1 per 10,000 treated people , incl . isolated case
do not swallow the content of the blister . in
47 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS & # 91 ; 125 mg & # 93 ;
serum calcium ( mmol / l ) - & # 91 ; 0.02 x albumin ( g / l ) & # 93 ; + 0.8
in the open-label study there be no difference in overall survival between patient treat with recombinant human erythropoietin and control .
the third study have similar result :
it must not be use in woman who be more than three month pregnant or who be breast-feeding .
FORM
the need for booster dose ( s ) have not be investigate .
Musculoskeletal
2 .
Sulfadiazine 333 mg Trimethoprim 67 mg
in type 2 diabetic patient give Trazec over the dose range 60 to 240 mg before three meal per day for one week , nateglinide show linear pharmacokinetics for both AUC and Cmax , and tmax be independent of dose .
EMEA / MB / 049 / 01-EN-Final Work progamme for 2002 Annex 3 EMEA guideline for 2002
6 .
pregnancy and breast-feeding :
Special STORAGE CONDITIONS
250 mg
0.99 , 1.18 ; 42 trial and 8167 patient ) .
use other medicine or vaccine Please tell your doctor if you be take or have recently take any other medicine , include medicine obtain without a prescription or have recently receive any other vaccine .
do not use in animal suffer from Cushing ’ s syndrome .
2 / 25 4.5 Special precaution for use
2 .
Investigations Cardiac disorder Blood and lymphatic system disorder
CPMP / 255 / 98-EN
Magyarország Alkotás u .
in patient not adequately control on amlodipine 5 mg , amlodipine / valsartan 5 mg / 80 mg may achieve blood pressure control similar to amlodipine 10 mg with le oedema .
each ml of solution contains 1 mg galsulfase .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
Arixtra be a medicine that help prevent blood clot from form in the blood vessel ( an antithrombotic agent ) .
after reconstitution , a deliverable volume of 1 ml solution contain 500 microgram of romiplostim ( 500 microgram / ml ) .
75 mg
all Subjects
Lipobay
tablet
EU / 1 / 07 / 410 / 001 EU / 1 / 07 / 410 / 002
MARKETING AUTHORISATION HOLDER AstraZeneca UK Limited Alderley Park Macclesfield Cheshire SK10 4TG United Kingdom 8 .
10 .
1 .
set up your insulin inhaler Hold your insulin inhaler in your hand .
slowly , withdraw 1.0 ml ( equal to 5 mg ) of the reconstituted solution from each vial up to the total volume require for the patient dose .
not know
4.3 Contraindications
platelet count and haemoglobin level should also be monitor at regular interval in cancer patient .
Actraphane should not be use in people who may be hypersensitive ( allergic ) to insulin human ( rDNA ) or to any of the other ingredient .
the magnitude of change in fast total cholesterol , LDL cholesterol , triglyceride , and prolactin ( see section 4.4 and 4.8 ) be greater in adolescent than in adult .
0.264
15 .
100 Please tell your doctor if you be take MAO inhibitor ( e. g. moclobemide against depression or selegiline against Parkinson ’ s disease ) or have take them within the last 14 day .
information IN BRAILLE
-1.4
intravenous use
the mean ( CV % ) steady state pharmacokinetic parameter estimate of fondaparinux in patient with VTE receive the fondaparinux propose dose regimen once daily be :
very common
inhibition of CYP1A2 Fluvoxamine , a specific CYP 1A2 inhibitor , have be show to significantly inhibit the metabolism of olanzapine .
4 .
adverse effect such a confusion , diarrhoea , dizziness , tiredness , headache , ail , dilate of pupil , itching , restlessness , sedation , somnolence , stupor , abnormal rapid heart rate , tremor and urinary retention have be report .
- sulfonamide antibiotic .
1 Member State Austria
- pain or difficulty in pass urine ( very rare ) , blood in the urine , protein in the urine
there be increase liver weight and dose-related thyroid follicular cell hypertrophy in rat .
Casodex
NNRTIs / Efavirenz
please tell your doctor or health care professional
Boehringer Ingelheim International GmbH Binger Strasse 173 D-55216 Ingelheim be Rhein Germany
bacterial and viral vaccine combine , ATC code JO7CA10
the duration of action be up to 24 hour depend on dose provide an opportunity for once or twice daily administration .
in this leaflet :
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
post-exposure prophylaxis and curative treatment for person able to receive treatment by oral route when clinically appropriate .
© European Medicines Agency , 2009 .
ABILIFY 1 mg / ml
2 .
it be also necessary to change to a new vial if the insulin requirement change substantially .
the histologic appearance of these change be similar to that find in albino rat follow excessive exposure to light .
Salomone Pharma Ltd .
8 ( 1.8 % ) 2 ( 0.5 % )
if the rise in haemoglobin be greater than 2 g / dl ( 1.25 mmol / l ) in four week reduce the dose by ro
a dose dependent effect on TxB2 formation have be observe after high dos of celecoxib .
name OF THE VETERINARY MEDICINAL PRODUCT
hepatic impairment :
haematologic toxicity Effects on haematology parameter be find in each specie , include dose-related reduction in circulate leukocyte in mouse and non-specific reduction of circulate leukocyte in rat ; however , no evidence of bone marrow cytotoxicity be find .
if the enzyme be not present , Gb3 can not be break down and it build up in the cell , such a kidney cell .
metabolism and nutrition disorder
use aseptic technique when prepare TYSABRI solution for intravenous ( IV ) infusion .
- This medicine have be prescribe for you .
the WORDS “ FOR ANIMAL TREATMENT ONLY ”
• Ciprofloxacin Bayer may cause a reduction in the number of white blood cell and your resistance to infection may be decrease .
2 .
then carefully lift it off the pen and discard the capped injection needle ( see Diagram S ) .
- 2nd injection : after 3-4 week
the clinical significance of this finding be unknown ; nonetheless , patient should be monitor for the sign and symptom of methadone toxicity .
the production of erythropoietin primarily occur in and be regulate by the kidney in response to change in tissue oxygenation .
week 12
vildagliptin Absorption Following oral administration in the fasting state , vildagliptin be rapidly absorb with peak plasma concentration observe at 1.7 hour .
YENTREVE should not be use with monoamine oxidase inhibitor ( a group of antidepressant ) , fluvoxamine ( another antidepressant ) , or ciprofloxacin or enoxacin ( type of antibiotic ) .
the study show beneficial effect of memantine treatment in comparison to placebo at 6 month ( observed case analysis for the clinican ´ s interview base impression of change ( CIBIC-plus ) : p = 0.025 ; Alzheimer ´ s disease cooperative study – activity of the daily living ( ADCS-ADLsev ) : p = 0.003 ; severe impairment battery ( SIB ) : p = 0.002 ) .
the standard dose of Bridion be between 2 and 4 mg per kilogram body weight , depend on how much the muscle relaxant be affect the muscle .
do not puncture , break or burn even when apparently empty
olanzapine also show a statistically significant advantage over placebo in term of prevent either recurrence into mania or recurrence into depression .
expiry DATE
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
UNIT for the Post-authorisation Evaluation of Medicines for Human Use
BATCH NUMBER
Invented name
oral use
withdraw the needle quickly and apply pressure over the injection site with a dry , sterile pad .
13.5 event / 1,000 patient-years versus diet alone 20.6 event / 1,000 patient-years ( p = 0.0 11 ) , and versus the combined sulphonylurea and insulin monotherapy group 18.9 event / 1,000 patient- year ( p = 0.021 ) ;
immediately before use , the blister must be carefully peel open and the dose of orodispersible tablet remove without crush it .
protein bind consideration 21 Tacrolimus be extensively bind to plasma protein .
SonoVue should only be use by doctor who have experience in diagnostic ultrasound imaging .
23 1 .
further INFORMATION
each hard capsule contains : efavirenz 50 mg
1 6 1 1
common :
10 .
in dog , administration of higher dos of GnRH agonists over a period of time desensitise the pituitary gland with the result that release of gonadotrophin be suppress , lead to a suppression of reproductive function .
Neuropathy- Sensory
capsule shell :
↓ 49 %
effect of Lantus ( once daily ) on diabetic retinopathy be evaluate in an open-label 5-year NPH- control study ( NPH give bid ) in 1024 type 2 diabetic patient in which progression of retinopathy by 3 or more step on the Early Treatment Diabetic Retinopathy Study ( ETDRS ) scale be investigate by fundus photography .
hypertension : in placebo-controlled trial in patient with hypertension , the overall incidence of adverse event do not differ between the irbesartan ( 56.2 % ) and the placebo group ( 56.5 % ) .
a the two major clinical outcome study , Helsinki Heart Study and the VA- HIT study have be carry out with a 1200 mg daily dose ( 2x600 mg ) , the CPMP consider that 1200 mg should be the recommended daily dose .
Тел . : + 359 2 976 98 28
Cephalosporins a a class tend to be absorb onto the surface of the red cell membrane and react with antibody direct against the medicinal product to produce a positive Coombs ’ test and occasionally a rather mild haemolytic anaemia .
0.6 ml ( 3333 IU / ml )
how TO STORE IRBESARTAN WINTHROP
if you experience any break in the skin , which may be associate with swell or fluid leak out from the injection site :
APIDRA
for intravenous use only .
not all pack size may be market .
OptiSet have to be use a recommend in these Instructions for Use ( see section 6.6 ) .
because of the risk of allergic reaction with factor IX concentrate , the initial administration of factor IX should , accord to the treat physician ’ s judgement , be perform under medical observation where proper medical care for allergic reaction could be provide .
gelatin Sodium Lauryl Sulfate Titanium Dioxide ( E171 ) Indigo Carmine ( E132 ) Red Iron oxide ( E172 ) Yellow Iron Oxide ( E172 ) Edible black ink .
635 PACKAGE LEAFLET :
Vigabatrin / Efavirenz Gabapentin / Efavirenz
hypercalcaemia
loss of consciousness have occur very rarely , mostly in elderly patient treat at high dos .
some people get depress when take Pegasys alone or in combination treatment with ribavirin , and in some case people have have suicidal thought or aggressive behaviour ( sometimes direct against others ) .
keep the bottle tightly close in order to protect from moisture .
UNIT for the veterinary medicine and information technology Head of Unit Peter JONES
the toxicity of the free Yttrium ( 90Y ) due to in-vivo release from the labelled biomolecule in the body during therapy could be reduce by post-administration of chelate agent
if their symptom be the same a yours .
Special STORAGE CONDITIONS
4.7 Use during pregnancy , lactation or lay
INVEGA should not be use while breast feeding .
Hepatobiliary disorder jaundice Skin and subcutaneous tissue disorder
COX-2 be also think to be involve in ovulation , implantation and closure of the ductus arteriosus , and central nervous system function ( fever induction , pain perception , and cognitive function ) . “ In “ in vitro ” equine whole blood assay , firocoxib exhibit 222 to 643 fold selectivity for COX-2 over COX-1 .
hypothyroidism § , uc
- unaccustomed , increase or prolonged physical activity ,
Raptiva act on the immune system , which may potentially increase your risk of infectious disease or may reactivate old infection .
stop Glivec until ANC ≥ 1.5 x 109 / l and platelet ≥ 75 x 109 / l .
Strachan Heppell
if you think you be have this sort of insulin allergy with Humalog BASAL , tell your doctor at once .
Avenida de Burgos , 91 E-28050 Madrid Tel : + 34 91 3375200
to ensure that you read the dose correctly , hold the pen horizontally , with the needle on the left and the dosage selector to the right a show in the illustration below .
C .
efficacy result for study ACTG 364 and 020
EXJADE have not be study in patient with renal impairment and be contraindicate in patient with estimate creatinine clearance & lt ; 60 ml / min ( see section 4.3 and 4.4 ) .
elimination of etoricoxib occur almost exclusively through metabolism follow by renal excretion .
name OF THE MEDICINAL PRODUCT
a statistically significant decrease in fatigue a measure by functional assessment of chronic illness therapy ( FACIT ) score be see in all three study in which it be assess ( Studies I , III , IV ) . t uc
continuous rotation of the injection site within a give area may help to reduce or prevent these reaction .
this syndrome be a granulomatous inflammatory disorder affect the eye , auditory system , meninges , and skin .
MARKETING Authorisation Holder :
a .
Nederland Merck Sharp & amp ; Dohme B.V .
4 .
Annex I
hazard Ratio ( 95 % CI ) p-value
year 3
Janumet 50 mg / 850 mg film-coated tablet sitagliptin / metformin hydrochloride
your blood sugar may get too high ( this be call hyperglycaemia ) .
the Committee recommend that Equilis Prequenza Te should be give a marketing authorisation .
stop your insulin infusion ( if necessary , by withdraw the needle ) at least until you feel that you be fully alert again .
PROHIBITION OF SALE , SUPPLY AND / OR USE
diarrhoea or vomit with blood be uncommon ..
pre-filled syringe ( glass )
BATCH NUMBER
when consider the clinical relevance of these kinetics , it be more appropriate to examine the glucose utilisation curve ( a discuss in 5.1 ) .
common ( affect le than 1 in 10 patient ) :
EXP
99.2
after this , most patient need a dose of : • For rheumatoid arthritis :
oral use .
precaution for use in animal If adverse reaction occur , treatment should be discontinue and the advice of a veterinarian should be seek .
terfenadine be rapidly transform to metabolite which apparently do not affect cardiac action potential duration .
EXP /
5 .
7 SCIENTIFIC CONCLUSIONS
caution must be exercise in treat patient with mild to moderate hepatic impairment , and a slower titration of Zonegran may be require .
5 .
treatment of osteoporosis in postmenopausal woman at increased risk of fracture ( see section 5.1 ) .
in this trial 57 % of the patient have baseline HbA1c above 9 % ; in these patient treatment with NovoMix 30 in combination with metformin result in significantly lower HbA1c than metformin in combination with sulfonylurea .
unknown frequency :  Pathological gambling , especially in patient take high dos of Pramipexole Teva  Hypersexuality  Abnormal behaviour  Increased eating ( binge eating , hyperphagia )
4.6 Pregnancy and lactation
dermatitis , dry skin , erythema , pruritus
40 50 60 75
however , when drive vehicle or operate machinery it should be take into account that dizziness or drowsiness may occasionally occur when take antihypertensive therapy .
42 transdermal patch , component of a multipack comprise 2 box , each contain 42 patch 50 transdermal patch , component of a multipack comprise 2 box , each contain 50 patch
turn the pen gently to avoid foaming in the cartridge .
1 .
type 2 diabetes develop if the body do not make enough insulin or if the insulin that the body make do not work a well a it should .
if you have any further question on the use of this product , ask your doctor or pharmacist .
adult male Adult female
method AND ROUTE ( S ) OF ADMINISTRATION
4.1 Target specie
if an elevate ( or rise ) serum potassium level be detect then consideration should be give to cease epoetin alfa administration until hyperkalaemia have be correct .
Gentamicin , at most ........................................................................................................................ .28 µg Solvent :
the most frequent adverse reaction cause by entacapone relate to the increase dopaminergic activity and occur most commonly at the beginning of treatment .
compare with pharmacokinetic data from adult with CRF where the same sampling duration be use , the comparison show that the pharmacokinetics of darbepoetin alfa be similar for paediatric and adult patient with CRF .
film-coated tablet
a decision on whether to continue / discontinue breast-feeding or to continue / discontinue therapy with lansoprazole should be make take into account the benefit of breastfeed to the child and the benefit of lansoprazole therapy to the woman .
* The frequency category for the background incidence of this event , a take from placebo group data from clinical trial , be & apos ; common & apos ; .
not applicable .
further INFORMATION
PACKAGING
in case of a single severe IAR , the infusion should be stop until the symptom be resolve and treatment with antihistamine and paracetamol / ibuprofen should be consider .
if you accidentally miss a daily dose , just take the next dose a normal .
do not use the pen after this time period .
13 .
• Hot flush • Constipation • Pressure in the lower abdomen • Vaginal discharge • Excessive sweating
DARONRIX should under no circumstance be administer intravascularly .
BATCH NUMBER
in case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episode , the patient & apos ; s adherence to the prescribed treatment regimen , injection site and proper injection technique and all other relevant factor must be review before dose adjustment be consider .
analysis of the result for overweight patient treat with metformin after failure of diet alone show :
2 / 2
each film-coated tablet contain 2.5 mg olanzapine .
QUALITATIVE AND QUANTITATIVE COMPOSITION
6.5 Nature and content of container
the occurrence of anaemia ( haemoglobin & lt ; 10 g / dl ) have be observe in up to 15 % of chronic hepatitis C patient in clinical trial on the combined treatment of Pegasys with ribavirin .
DATE ON WHICH THE PACKAGE INSERT WAS LAST REVISED
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
2 .
in a second study ( n = 310 ) , which use a weight-adjusted dose ( 100 microgram / kg ) , the mean duration of grade 4 neutropenia for the pegfilgrastim group be 1.7 day , compare with 1.8 day in the filgrastim group ( difference 0.03 day , 95 % CI -0.36 , 0.30 ) .
difficulty in breathe • heart beati
during training of the patient for self- administration , special attention should be give to specific instruction for the use of the prefilled pen .
day
1 %
5 .
Risperidon
keep out of the reach and sight of child .
EXP { MM / YYYY }
the dose can be reduce if not tolerate , or increase for lack of efficacy ( see section 4.4 and 5.2 ) .
now you can withdraw your dose from the vial .
psoriasis :
64 Breast-feeding Since lamivudine and the virus pas into breast milk it be recommend that mother take Epivir do not breast-feed their infant .
they can be take with or without food .
contact your doctor or an emergency ward after an injection of glucagon : you need to find the reason for your hypo to avoid get more .
Latvija Abbott Laboratories Baltics Vienības 87h Rīga , LV-1004 Tel : + 371 67605580
France Bayer Santé Tél . : + 33 3 - 20 20 80 80
the other ingredient be microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , colloidal hydrate silica , pregelatinised maize starch , red and yellow ferric oxide ( E172 ) .
trial have indicate a t ½ of about 5-10 hour .
common
tell your doctor :
cholesterol level should be periodically monitor .
this will often get you over mild hypoglycaemia or a minor insulin overdose .
follow intravenous administration , an approximate 25 % difference between paediatric and adult patient in the area under the curve from time 0 to infinity ( AUC & # 91 ; 0- ∞ & # 93 ; ) be observe ; however , this difference be le than the 2-fold range in AUC ( 0- ∞ ) observe for the pediatricpatients .
DATE : _ _ _ _ _ TIME TO REFILL
hallucination , manic reaction , confusion , agitation , anxiety and associate symptom ( e. g. nervousness ) , impaired concentration and thought process ( e. g. depersonalisation ) , panic attack , suicidal thought and behaviour ( these symptom may be due to the underlying disease ) , very rarely serotonin syndrome .
a the effect have neither be observe in long term study in rodent nor in non-rodents , the clinical relevance of these finding be unknown .
electrolyte disturbance
inform your doctor if you be plan to become pregnant , or if you be already pregnant .
Tel . : + 36 1 225 5300
2 .
1 .
in the elderly , progressive deterioration of renal function may lead to a steady decrease in insulin requirement .
in study in pregnant animal , interferon have sometimes cause miscarriage .
400 copy / ml ( 95 % C. I. b )
nicotinic acid Mechanism of action The mechanism by which nicotinic acid modify the plasma lipid profile be not fully understood .
MARKETING AUTHORISATION HOLDER
moderate to severe adverse experience may require modification of the patient & apos ; s dosage regimen , or in some case , termination of IntronA therapy .
zinc chloride Glycerol Metacresol Sodium hydroxide ( for pH adjustment ) Hydrochloric acid ( for pH adjustment ) Water for injection
therefore , you must continue to use appropriate precaution ( a condom or other barrier method ) to lower the chance of sexual contact with any body fluid such a semen , vaginal secretion or blood .
this amount should be that quantity which be expect to be sufficient to avoid homologous blood transfusion .
- The active substance be :
150
clinical study have demonstrate that darbepoetin alfa have similar effectiveness when administer a a single injection either once every three week , once every two week , or weekly without any increase in total dose requirement .
a single dose of the product should be administer .
the frequency term list be define a follow :
concentrate for solution for infusion
general CLASSIFICATION FOR SUPPLY
121 If you use more Lantus than you should
4.8 Undesirable effect
minimal increase in QTc , not consider to be clinically relevant , be observe in one study at a dose of 800 mg sitagliptin .
if you have any further question on the use of this product , ask your doctor or pharmacist .
this be link to the way your medicine work a it prevent the ability of blood clot to form .
MARKETING AUTHORISATION NUMBER
if you be not able to swallow or if you be unconscious , you will require an injection of glucose or glucagon ( a medicine which increase blood sugar ) .
10 .
it be supply in pack of 5 or 10 pre-filled pen of 3 ml .
Alternatively , in patient not on dialysis , an initial dose of 0.75 μ g / kg may be administer subcutaneously a a single injection once every two week .
treatment with tenofovir disoproxil 245 mg ( a fumarate ) be associate with a mean change in serum HBV DNA from baseline , in the patient for whom there be 48-week data , of -5.74 log10 copy / ml ( n = 18 ) .
increase in an enzyme call creatine phosphokinase produce in the muscle
reproduction be authorise provide the source be acknowledge .
patient be to be advise to discontinue use of the product and contact their physician or seek immediate emergency care , depend on the type and severity of the reaction , if any of these symptom occur .
- The CHMP considers that the benefit of market a systemic drug such a Oracea in the present
the container must not be refill .
it work by increase the outflow of liquid , which lower the pressure in the eye .
PHARMACEUTICAL FORM AND CONTENTS
upon storage , a white deposit and clear supernatant can be observe .
4.7 Effects on ability to drive and use machine
- if your central nervous system be severely impaired , for instance by brain injury .
use the correct reservoir and catheter for the pump .
capsule ( 200 mg )
12 .
there be no experience in child and adult above 60 year of age .
general CLASSIFICATION FOR SUPPLY
disorder
the MAH commits to perform the study and additional pharmacovigilance activity detail in the Pharmacovigilance Plan . d ro
the duration of treatment depends on the patient ’ s condition and response to treatment , and range from 24 week to a year .
it be recommend that
you may store the product when kept in it outer carton at ambient room temperature ( up to 25 ° C ) for a single period of up to 3 month .
• No injection should be give in area where the patient will be expose to pressure , e. g. around the belt or waistband or close to the rib .
35 Lactation Lactating woman may require adjustment in insulin dose and diet .
QUALITATIVE AND QUANTITATIVE COMPOSITION
in patient not on dialysis , once the target haemoglobin have be achieve with once every two week dosing , Nespo may be administer ro
a .
exercise take immediately after a meal may increase the risk of hypoglycaemia .
Parkinson ’ s disease System Organ Class Psychiatric disorder
sanofi-aventis Deutschland GmbH D-65926 Frankfurt be Main , Germany
- Pain in the muscle or joint
12 .
the binding be non-saturable in vitro over a wide concentration range .
transfer the content of the reconstituted 1 g vial of INVANZ to the 50 ml vial of sodium chloride 9 mg / ml ( 0.9 % ) solution .
Metacam 0.5 mg / ml oral suspension for cat Meloxicam
inject it at the same time of day each week will help you not to forget to take it .
maximum concentration be reach for emodepside 3.2 ± 2.7 day after application and 18.7 ± 47 hour for praziquantel .
a recombinant coagulation factor NovoSeven may contain trace amount of mouse IgG , bovine IgG and other residual culture protein ( hamster and bovine serum protein ) , the remote possibility exist that patient treat with the product may develop hypersensitivity to these protein .
the amount of insulin you need usually fall during the first three month of pregnancy and increase for the remain six month .
Neisseria gonorrhoeae Neisseria meningitidis Non-species-related breakpoints *
Emtriva 200 mg hard capsule may be take with or without food .
systemic allergy be rare ( ≥ 1 / 10,000 to & lt ; 1 / 1,000 ) .
23 25 23 —
inject the air into the long-acting insulin vial , then pull out the needle
you get a hypo if your blood sugar get too low .
film-coated tablet
& lt ; 8.5 g / dl
12 After reconstitution : use immediately ( within 3 hour ) .
6 .
introduce Dynastat with caution and at half the usual recommend dose in patient with moderate hepatic impairment ( Child-Pugh score 7-9 ) and reduce the maximum daily dose to 40 mg .
ACR 70
film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet
be sure the solution be at room temperature up to 25 ° C .
Actrapid be a fast-acting insulin and may be use in combination with long-acting insulin product .
the Marketing Authorisation Holder ( MAH ) provide write explanation on 16 January 2006 .
immune system disorder §
Isentress 400 mg film-coated tablet
- if you have ever have neuroleptic malignant syndrome ( NMS – this be a rare reaction to
concomitant administration of fosaprepitant with medicinal product that strongly induce CYP3A4 activity ( e. g. rifampicin , phenytoin , carbamazepine , phenobarbital ) should be avoid a the combination result in reduction of the plasma concentration of aprepitant ( see section 4.5 ) .
pharmacological PROPERTIES
- General disorder and administration site condition :
psoriatic arthritis na
1 Flocculation equivalent ; correspond with ≥ 30 IU / ml guinea pig serum in the Ph .
take an appropriate sterile syringe ( minimum 50 ml ) and attach a suitable needle .
M
reference number CPMP / BWP / 1106 / 97 CPMP / BWP / 1113 / 98
if y ou get any of the following , potentially serious , side effect :
this effect may be expect to be more pronounced for orally administer methylprednisolone .
24 In a multiple-dose pharmacokinetic study conduct with the tablet formulation in healthy adult subject , four subject be find to be poor metabolisers of desloratadine .
a priming response be maintain for up to six month after basic vaccination .
hypersensitivity to the active substance or to any of the excipients or to mouse or hamster protein .
- if you be allergic ( hypersensitive ) to desloratadine , or any of the other ingredient of
iron supplementation should be start a soon a possible , even several week prior to initiate the autologous predeposit , in order to achieve high iron store prior to start Binocrit therapy .
4.6 Pregnancy and lactation
immune system disorder Reproductive system and breast disorder
- if you be allergic ( hypersensitive ) to perflutren or any of the other ingredient of Luminity .
-1 0 1
water for injection
instruction ON USE
study with other interferon have demonstrate specie specificity .
6 .
increase haematopoietic activity of the bone marrow in response to growth factor therapy have be associate with transient positive bone image finding .
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
24 ( 5.5 % ) 39 ( 8.9 % ) 19 ( 4.3 % ) 9 ( 2.0 % ) 3 ( 0.7 % )
the majority of severe rash occur within the first 6 week of treatment and some required hospitalisation , with one patient require surgical intervention ( see section 4.4 ) .
do not use Temodal after the expiry date which be state on the label and carton .
in order to deal in a rapid and efficient way with crisis situation relate to pharmacovigilance or quality defect involve a centrally authorised product , the CPMP adopt in September a document on “ Crisis management plan regard centrally authorise product for human use ” ( CPMP / 388 / 97 ) .
patient receive zidovudine in combination with ribavirin and alpha interferon be at increased risk of develop anaemia .
2 .
you should not use AZARGA if you be pregnant or might get pregnant .
breast-feeding Based on evidence generate in clinical trial , breast-feeding do not reduce the protection against rotavirus gastro-enteritis afford by Rotarix .
Musculoskeletal pain be usually control with standard analgesic .
- you be take or have take certain other medicine ( see section 2 , & quot ; Using other medicine & quot ; ) .
the most commonly ( ≥ 5 % ) report adverse drug reaction in patient with other indication treat with pramipexole be nausea , headache , dizziness and fatigue .
2 .
no study on the effect on the ability to drive and use machine have be perform .
quantity OF THE ACTIVE SUBSTANCE ( S )
June 2008
38.6 ( 17 / 44 ) 19.7 , 57.5
1 vial
this be because the insulin may have lose some of it effectiveness .
5 .
11 Pharmacokinetic / pharmacodynamic relationship :
3 .
- isoniazid ( use to treat tuberculosis ) ,
Citrobacter freundii 1 Enterobacter spp .
Abbott Biotechnology Deutschland GmbH Max-Planck-Ring 2 D - 65205 Wiesbaden Germany
expiry DATE
Bucureşti-Ploieşti , nr .
4 .
blister ( PVC / PVDC / Alu )
keep out of the reach and sight of child .
4
EXP
5.2 Pharmacokinetic property
eye disorder Uncommon :
- Stalevo be not recommend for the treatment of drug-induced extrapyramidal reaction
general CLASSIFICATION FOR SUPPLY
oral use .
you may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who know how to use it .
BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom
sign of allergy .
reconstitution of the solution :
Pfizer Italia S. r. l .
10
in clinical trial , dos of amprenavir 600 mg twice daily and ritonavir 100 mg twice daily have be use ; confirm the safety and efficacy of this regimen .
child and adolescent ( age 5 – 17 year ) :
expiry DATE
8 EFFICACY ASPECTS
carcinogenicity Systemic carcinogenicity study in mouse ( 18 month ) and rat ( 24 month ) reveal no carcinogenic potential of tacrolimus .
there be no data available on nelfinavir excretion into human breast milk .
10 .
you should not be give Aclasta if you be breast-feeding .
7 .
25
8 .
until the review be over the EMEA will of course have to continue to operate within the current regulatory framework .
4.3 Contraindications
7 .
6 .
13 .
Special WARNING ( S ) , IF NECESSARY
9 .
the experience in human with overdosage of eptifibatide be extremely limited .
this document be a summary of the European Public Assessment Report ( EPAR ) .
EPAR summary for the public
not applicable .
four of these patient report isolated event of urticaria , pruritus , rash , and slightly elevate eosinophil count amongst numerous repeat exposure to the study product .
România S.C .
this process be influence by several factor ( e. g. insulin dosage , injection route and site , thickness of subcutaneous fat , type of diabetes ) .
2 year .
1 / 1
a change of therapy be recommend in this situation .
no clinically meaningful difference in lasofoxifene pharmacokinetic be observe over the age range of 40 to 80 year of age base on the result of a population pharmacokinetic analysis .
MARKETING AUTHORISATION NUMBER ( S )
remove the protective cap from the injection needle and expel air from the syringe and injection needle by hold the syringe vertically and gently press the plunger upwards .
the injection button can not be press in .
insulin glargine be a human insulin analogue design to have a low solubility at neutral pH .
101 4.4 Special warning and precaution for use
in EXUBERA treat subject in
32 In most people , at first there be no sign of cholesterol problem .
•
4 combination with ACE inhibitor or NSAIDs , for example , present a lesser risk provide that precaution for use be strictly follow .
INN
statement OF ACTIVE SUBSTANCE ( S )
2 .
fluoroquinolones , ATC code :
3 .
diarrhoea , abdominal pain , indigestion or heartburn .
do not “ save up ” fat and calorie allowance and then splurge on a high-fat meal or dessert , a you may have do on other weight loss programme . • Most user who experience these effect find that they can manage and control them by adjust their diet .
Insuman Rapid may be mix with all Sanofi-Aventis human insulin preparation , EXCEPT those specially design for use in insulin pump .
general disorder and administration site condition Very common Common
6.2 Incompatibilities
Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom
10 .
Leucovorin
hypoglycaemia , in general the most frequent undesirable effect of insulin therapy , may occur if the insulin dose be too high in relation to the insulin requirement .
for oral use .
500 μ g , 300 μ g , and 150 μ g should be consider . a
9 .
0.5 MU per kg bodyweight each day .
if you forget to use RoActemra Since RoActemra be give by a doctor or nurse , it be unlikely that you will miss a dose .
11 ANNEX III
1 .
( see section 5.3 ) .
12.8 , 46.4 ) , 4 % ( CI : -26.9 , 26.7 ) , 6 % ( CI : -33.5 , 34.3 ) and 14 % ( CI : -31.6 , 44.2 ) , during the 0-1 , 1-3 , 3-6 , 6-9 and 9-12 month study interval , respectively .
interleukin 2 ( IL-2 ) receptor antagonist .
9 .
expiry DATE
100 v .
FOLDING BOX AND BOTTLE LABEL
driving and use machine
when a patient stabilise on any oral hypoglycaemic agent be expose to stress such a fever , trauma , infection or surgery , a loss of glycaemic control may occur .
live vHVT013-69 recombinant virus , at least .........................................................
blister
box OF 1 , 2 , 3 , 5 , 7 , 10 , 14 , 15 , 20 , 21 , 30 , 50 , 100 DOSES OF ORAL LYOPHILISATE
the pharmacokinetic of digoxin be not alter by coadministration of irbesartan .
CONDITIONS OF THE MARKETING AUTHORISATION
use only clear and colourless solution .
read the package leaflet before use .
191 What Humalog look like and content of the pack Humalog 100 U / ml , solution for injection be a sterile , clear , colourless , aqueous solution and contain 100 unit of insulin lispro in each millilitre ( 100 U / ml ) solution for injection .
follow treatment with GONAL-f when human chorionic gonadotrophin be administer , a condition call ovarian hyperstimulation syndrome ( see also section 2 ) can occur ( between 1 and 10 patient out of 100 treated patient ) .
1 1 .
MARKETING AUTHORISATION NUMBER ( S )
study Ia * *
- have a serious problem with your liver other than chronic hepatitis C .
name OF THE MEDICINAL PRODUCT
careful glucose monitoring and dose adjustment of insulin aspart be recommend in these patient .
at two year , 80.1 % and 68.8 % of patient meet this criterion in the 3 mg every 3 month injection arm and the 2.5 mg daily arm ( p = 0.001 ) .
Nederland
- somatropin ( growth hormone ) ,
0.99 , 1.18 ; 42 trial and 8167 patient ) .
Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & amp ; ΥΙΟΣ Ε .Π .Ε .
however , there be no difference in the half-life and accumulation of irbesartan .
BATCH NUMBER
to prevent serious reaction , speak to a doctor immediately if a side effect be severe , occur suddenly or get worse rapidly .
information FOR THE USER
very rarely :
România sanofi-aventis România S.R.L .
if there be bleed , cover with an adhesive bandage .
information FOR THE USER
France Bayer Santé Tél : + 33-3 - 20 20 80 80
18 Concerning discontinuation of long-term treatment of pregabalin there be no data of the incidence and severity of withdrawal symptom in relation to duration of use and dosage of pregabalin .
sanofi-aventis Deutschland GmbH Industriepark Höchst , D-65926 Frankfurt Germany
method OF ADMINISTRATION
this document be a summary of the European Public Assessment Report ( EPAR ) .
read all of this leaflet carefully before you start take this medicine .
Special STORAGE CONDITIONS
in this leaflet :
method OF ADMINISTRATION
Competact for a couple of day before and after the procedure .
EU / 1 / 04 / 297 / 001 EU / 1 / 04 / 297 / 006
4 .
change your injection site each time .
1 Staphylococcus spp . - breakpoints for ciprofloxacin relate to high dose therapy . * Non-species-related breakpoints have be determine mainly on the basis of PK / PD data and be independent of MIC distribution of specific specie .
Polska MSD Polska Sp . z o.o .
name OF THE MEDICINAL PRODUCT
hyperglycaemia / glucose intolerance / diabetes mellitus Patients should be advise that treatment with TORISEL may be associate with an increase in blood glucose level in diabetic and non-diabetic patient .
Bayer plc Bayer House Strawberry Hill Newbury Berkshire RG14 1JA – UK
România Şos .
BATCH NUMBER
every 24 hour , at least 1 day , until heal be achieve .
INCRELEX be a liquid that contain man-made insulin-like growth factor-1 ( IGF-1 ) , which be similar to the IGF-1 make by your body .
48 • •
name OF THE MARKETING AUTHORISATION HOLDER
how have Duloxetine Boehringer Ingelheim be study ?
in their entirety , the available data on the risk of myocardial ischaemia be inconclusive .
strength
Κύπρος sanofi-aventis Cyprus Ltd .
4.7 Effects on ability to drive and use machine na
name OF THE VETERINARY MEDICINAL PRODUCT
the therapeutic margin of erythropoietin be very wide .
insulin in the blood stream have a half-life of a few minute .
5 .
- tell you when you may need to inject a higher or lower dose of Insulin Human Winthrop
INVEGA should be use with caution in patient with known
if haemoglobin have increase by at least 1 g / dl ( 0.62 mmol / l ) or the reticulocyte count have increase ≥ 40,000 cell / µl above baseline after 4 week of treatment , the dose should remain at 150 IU / kg 3 time a week or 450 IU / kg once weekly .
Tel : + 34 93 600 19 00
5 .
oral use
Special STORAGE CONDITIONS
- At the request of the EMEA
excipients ( per soft capsule ) :
outer CARTON OF MULTIPACKS ( INCLUDING BLUE BOX )
therefore , do not breast-feed an infant if you be take IntronA .
the safety of oral treatment with ibandronic acid 2.5 mg once daily be evaluate in 1251 patient treat in 4 placebo-controlled clinical study ; 73 % of these patient come from the pivotal three-year treatment study ( MF 4411 ) .
due to limited experience the efficacy and safety of Lantus could not be assess in child below 6 year of age , in patient with impaired liver function or in patient with moderate / severe renal impairment ( see section 4.2 ) .
olanzapine be start at 2.5 mg / day and titrate to a maximum of 15 mg / day base on investigator judgment .
management of the overdose may require general supportive measure , along with gastric lavage , intravenous fluid , administration of activated charcoal and electrocardiogram monitoring .
the possible contribution of fluid retention to weight gain should be individually assess a rapid and excessive weight gain have be report very rarely a a sign of fluid retention .
in a population pharmacokinetics analysis of clinical trial experience there be 101 female and 169 male subject for whom nadir neutrophil count be available and 110 female and 174 male subject for whom nadir platelet count be available .
- Treatment :
list OF EXCIPIENTS
3
Preclinical study indicate that aliskiren and ketoconazole co-administration enhances aliskiren gastrointestinal absorption and decrease biliary excretion .
Pharmacotherapeutic group :
- Store in the original package in order to protect from light .
BRISTOL-MYERS Squibb Pharma EEIG Uxbridge Business Park , Sanderson Road Uxbridge UB8 1DH United Kingdom
the GMTs decline through Month 24 and then stabilize until at least Month 60 .
tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
at two year 78.7 % ( p = 0.002 ) and 65.6 % of patient be identify a responder in the 150 mg monthly and 2.5 mg daily arm respectively .
subcutaneous use
CHAPTER 3 0 — TOTAL Title 3 — Total REVENUE ACCRUING FROM THE ADMINISTRATIVE OPERATION OF THE INSTITUTION
one vial contain 100 IU recombinant follicle-stimulating hormone ( FSH ) in 0.5 ml aqueous solution .
Egis Pharmaceuticals Plc Kereszturi Ut 30-38 H-1106 Budapest Hungary
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
do not aim the stream at the white powder at the bottom of the vial .
Revaccination :
Slovenia
pancreatitis gastrointestinal haemorrhage , ileus
in animal model
elderly Population pharmacokinetic analysis in HIV infect patient show that darunavir pharmacokinetics be not considerably different in the age range ( 18 to 75 year ) evaluate in HIV infect patient ( n = 12 , age ≥ 65 ) ( see section 4.4 ) .
once in use the cartridge may be store for a maximum of 4 week not above 25 ° C .
if they do not disappear , see your doctor .
further information
7 1 .
meloxicam 5 mg / ml
Diovan 160 mg
there be insufficient data to provide information on inhibitor incidence in PUPs .
an investigational study ( BEST study ) in woman with metastatic breast cancer be design to determine whether epoetin alfa treatment that extend beyond the correction of anaemia could improve treatment outcome .
the reported adverse reaction be usually mild and transitory .
Serono Europe Limited , 56 Marsh Wall , London E14 9TP , United Kingdom
for storage condition of the reconstituted medicinal product see section 6.3 .
list OF EXCIPIENTS
method AND ROUTE ( S ) OF ADMINISTRATION
serum electrolyte should be monitor in chronic renal failure patient .
elevation of liver enzyme and serum bilirubin have be report rarely .
what be the risk associate with Agenerase ?
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER
suicidal ideation and behaviour have be report in patient treat with anti-epileptic agent in several indication .
the risk of hypokalaemia be greater in patient with cirrhosis of liver , in patient experience brisk diuresis , in patient who be receive inadequate oral intake of electrolyte and in patient receive concomitant therapy with corticosteroid or Adrenocorticotropic hormone ( ACTH ) ( see section 4.5 ) .
the use in dog for breed purpose have not be evaluate .
180 tablet N / A
Fabbroni , 6 I-00191 Roma Italy
PHARMACEUTICAL PARTICULARS
there be no pharmacokinetic interaction with selegiline and levodopa .
redistribution , accumulation , or loss of body fat may occur in patient receive antiretroviral therapy
many factor may influence your blood sugar level .
carton BOX
4 .
4.3 Contraindications
PACKAGING
instruction ON USE
study ACTG 364 enrol 196 patient who have be treat with NRTIs but not with PIs or NNRTIs .
name OF THE MEDICINAL PRODUCT
care must be take to ensure that no alcohol or other disinfectant enter the insulin suspension .
gently flick the top section of the ampoule so that any fluid in the neck of the ampoule drop into the bottom chamber .
3 .
MARKETING AUTHORISATION NUMBER ( S )
146 ( 33.2 % )
instruction ON USE
efavirenz may remain in your blood for a time after therapy be stop .
monitoring for toxicity and dose modification due to toxicity
adult : extensive safety experience be available for Zerit use a monotherapy and in combination regimen .
the recommended duration of treatment be 24 week .
package LEAFLET
CPMP / ICH / 302 / 95 ( S6 )
the marketing authorisation holder
Danmark GlaxoSmithKline Pharma A / S Tlf : + 45 36 35 91 00 info @ glaxosmithkline.dk
12 .
6 week when use or carry a a spare ( below 30 ° C ) .
you must wait at least 14 day after you have stop take an MAOI before you can take YENTREVE .
ventricular tachycardia / fibrillation , sudden death ( see section 4.4 )
- If you have any further question , ask your doctor or pharmacist .
elevate cholesterol levels2,3 Elevated glucose levels4 Elevated triglyceride levels2,5 Glucosuria Increased appetite
1 dose ( 0.5 ml )
for single use only .
BATCH :
1 .
100 Health care professional , relative and other carers must follow general precautionary measure for removal and disposal of needle to eliminate the risk of unintended needle penetration .
h .
film-coated tablet
no safety margin to human exposure be achieve in the animal study due to the sensitivity of the animal model use .
20 November 2007
oral use
Nespo be inject intravenously ( into a vein ) or subcutaneously ( under the skin ) .
100 Units / ml
wash your hand .
the pharmacokinetics of celecoxib have not be study in patient with renal impairment but be unlikely to be markedly change in these patient since it be mainly eliminate by hepatic metabolism .
this strength correspond to 83.3 microgram of protein / ml ( specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein ) .
16 .
2 .
the Immunologicals Working Party ( IWP ) meet three time in 1998 , with Professor Paul-Pierre Pastoret a chairman .
Rasilez HCT be study in a placebo-controlled trial include 2,762 hypertensive patient with diastolic blood pressure ≥ 95 mmHg and & lt ; 110 mmHg ( mean baseline blood pressure of 153.6 / 99.2 mmHg ) .
for the full list of restriction , see the Package Leaflet .
cancer patient receive chemotherapy
99 % of the calcium in the body be concentrate in the hard structure of bone and teeth .
approximately 25 % , depend on the rate of increase .
virological response be define a absence of detectable HCV-RNA at Week 12 .
Lyophilisate ( 10 bottle of 1 dose ) + solvent ( 10 bottle of 1 ml ) Lyophilisate ( 50 bottle of 1 dose ) + solvent ( 50 bottle of 1 ml )
Norvir should preferably be take with food .
solvent :
International non-proprietary name :
if you be accidentally inject with this product , seek prompt medical advice even if only a very small amount be inject and take the package leaflet with you .
the analysis per cycle show that anaemia of grade 3 and 4 occur in approximately 3 % and 1 % of cycle respectively .
one outlier subject with raise voriconazole level be identify in each of the ritonavir interaction study .
Additionally , patient treat with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of develop anaemia ( low number of red blood cell ) .
30 mg
if you be breast-feeding do not take Ketek tablet .
QTc interval Caution should be use if olanzapine be be administer concomitantly with medicinal product know to increase QTc interval ( see section 4.4 ) .
Pharmacia Italia S. p . a .
venlafaxine have be show not to increase the impairment of mental and motor skill cause by ethanol .
thus for the first day , twice the maintenance volume will be require .
what Livensa contain The active substance be testosterone .
talk to your doctor first .
Danmark Lautrupbjerg 2 2750 Ballerup Denmark + 45-44-39-50-00
list OF EXCIPIENTS
how TO TAKE LISONORM
Altmannsdorferstr .
RA Children 3 year of age or older and adolescent :
Norge Pb .
14 ( 13 % )
n = 205
- joint pain
absolute oral bioavailability relative to intravenous administration have not be determine
15 .
1.230 ml ( 833 IU / ml )
store the cartridge in the original package in order to protect from light .
read the package leaflet before use .
what Riprazo be and what it be use for 2 .
liver transplant recipients The safety and efficacy of telbivudine in liver transplant recipient be unknown .
for single use only .
DATE of first authorisation :
Pétursson ehf . + 354 – 567 3730
treatment and prophylaxis of bleed in patient with haemophilia A ( congenital factor VIII deficiency ) .
treatment of symptomatic anaemia associate with chronic renal failure ( CRF ) in adult and paediatric patient :
- Orgalutran - N.V .
eye disorder :
clinical PARTICULARS
Applicant
A10A D04 .
none of this will be achieve in isolation and the Agency will work hard to harness the good will , experience , knowledge and expertise of all exist regulator in this venture .
content BY WEIGHT , BY VOLUME OR BY UNIT
15 .
both of these substance help to control high blood pressure . − Amlodipine belongs to a group of substance call “ calcium channel blocker ” .
acne
excipients : also contain lactose monohydrate .
6 .
powder and solvent for solution for injection .
please refer to Table 1 and Table 2 for interaction of nelfinavir with select compound , Table 1 for impact on the pharmacokinetics of the co-administered compound , Table 2 for the impact of other drug on pharmacokinetics of nelfinavir .
pertussis , hepatitis B and Hib , one month after the first vaccination course .
5 .
Portugal Lundbeck Portugal Lda Quinta da Fonte Edifício D .
( other than short -term treatment with cortisone-type medicine ) .
Denmark
16 .
during 1997 , the electronic Application Tracking System , a develop by ETOMEP and make available for the first time for core centralise application .
dosage adjustment in renal impairment :
what benefit have Alli show during the study ?
to one-half dose if : -
HIV-1 have be passaged in vitro with lopinavir alone and with lopinavir plus ritonavir at concentration ratio represent the range of plasma concentration ratio observe during Kaletra therapy .
child under the age of 18 must not take Mimpara .
solution for injection or infusion
AIIRAs therapy exposure during the second and third trimester be know to induce human foetotoxicity ( decreased renal function , oligohydramnios , skull ossification retardation ) and neonatal toxicity ( renal failure , hypotension , hyperkalaemia ) ( see also section 5.3 ) .
Reconstitute doxorubicin HCl • Withdraw 20 ml sodium chloride for injection ( 0.9 % ) , preservative free , ( not provide in the package ) , and inject into each Myocet doxorubicin HCl , intend for preparation . • Shake well in the inverted position to ensure doxorubicin be fully dissolve .
their symptom be the same a yours .
in 5 clinical trial ( 4 placebo-controlled ) , subject be administer Silgard or placebo on the day of enrolment and approximately 2 and 6 month thereafter .
10 .
- in patient age 2 to 5 year ,
Silapo be a biological medicinal product .
very common
Table 1 - Dosing for Combination Therapy
dyspepsia Vomiting , Nausea , Dry mouth
treatment with Neoclarityn also significantly reduce interference with sleep and daytime function , a measure by a four-point scale use to assess these variable .
- pack size of 1 vial of powder plus 1 vial of liquid
14 .
- 1 venipuncture set
very rare :
be sure the solution be at room temperature at the time of injection .
4.2 Posology and method of administration
vascular disorder
due to the loading dose , steady state be reach after 2 day ( 48h ) .
8 .
it be important to take the medicine for a long a the doctor have tell you to .
name OF THE MEDICINAL PRODUCT
Sverige BRISTOL-MYERS SQUIBB AB Tel : + 46 8 704 71 00
United Kingdom Abbott Laboratories Ltd Abbott House Vanwall Business Park Maidenhead Berkshire SL6 4XE-UK Tel : + 44 ( 0 ) 1628 773355
take special care with Puregon
Sverige Box 6185 S-102 33 Stockholm Tel : + 46- ( 0 ) 8 522 21 500
exfoliative dermatitis , acne , skin nodule , alopecia , dry skin Musculoskeletal , connective tissue and bone disorder
suspension
Ελλάδα sanofi-aventis AEBE Τηλ : + 30 210 900 16 00
duloxetine be a moderate inhibitor of CYP2D6 .
what Zyrtec contains
most of the value have decrease to grade 1 or resolve by day 14-15 ( see section 4.4 ) .
5.1 Pharmacodynamic property
the recommended maximum daily dose be 180 mg three time daily to be take before the three main meal .
ARICLAIM 60 mg
the amount of Starlix that you need may change if you take other medicine a these may cause your blood sugar level to go up or down .
make sure there be no air leave in the syringe : point the needle upwards and push the air out .
severe allergic reaction necessitate interruption of therapy and careful monitoring .
factor IX activity be absent or greatly reduce in patient with haemophilia B and substitution therapy may be require .
the inhibitory effect be maintain over 24 hour and still measurable up to 48 hour .
Luxembourg / Luxemburg sanofi-aventis Belgium Tél / Tel : + 32 ( 0 ) 2 710 54 00 ( Belgique / Belgien )
6.5 Nature and content of container
the chewable tablet be pack in :
information IN BRAILLE
there be a possibility that your blood level of Cubicin could be
CVMP / IWP / 038 / 97
this list be not exhaustive a any of the muscle responsible for control head position may be involve and therefore require treatment .
- medicinal product to control the blood level of cholesterol or other lipid like simvastatin , a the
in clinical trial of Januvia a monotherapy and sitagliptin a part of combination therapy with metformin or pioglitazone , rate of hypoglycaemia report with sitagliptin be similar to rate in patient take placebo .
4.3 Contraindications
read it again .
only expert appear on the EMEA list may be use by the CPMP and CVMP in the evaluation of medicinal product , public hearing , work group and the activity of the
ge Taking three separate 1 mg unit dose blister delivers more insulin to your lung than a single 3 mg unit dose blister do .
daily dose in mg
paediatric patient : irbesartan be not recommend for use in child and adolescent due to insufficient data on safety and efficacy ( see section 4.8 , 5.1 and 5.2 ) .
GONAL-f be a medicinal product contain follitropin alfa , which be make in laboratory by special recombinant DNA technique .
outer CARTONS / 10 ML VIAL
expiry DATE
appropriate clinical monitoring be advisable particularly in diabetic patient and in patient with risk factor for the development of diabetes mellitus for which regular glucose control be recommend .
NUMBER of meeting day
PRCA mean the inability to produce enough red blood cell in the bone ( see section “ Take special care with Abseamed ” ) .
13 .
the primary endpoint be the composite of cardiovascular morbidity and mortality a measure by a reduction in the combined incidence of cardiovascular death , stroke and myocardial infarction .
6 .
in these patient dose should be manage cautiously .
Ladose
* Produced in CHO cell line by recombinant DNA technology
you can carry it with you and keep it at room temperature ( not above 30 ° C ) for up to 6 week .
do not shake the vial a this will cause foaming .
after 4 week of Tracleer 62.5 mg twice daily , the maintenance dose study in both these trial be 125 mg twice daily .
24
eye disorder
how often will you receive Abraxane ?
for excipients , see section 6.1 .
Danmark BRISTOL-MYERS SQUIBB Tlf : + 45 45 93 05 06
3 .
if the expected factor IX activity plasma level be not attain , or if bleeding be not control with an appropriate dose , biological testing should be perform to determine if a factor IX inhibitor be present .
44 6.4 Special precaution for storage
Roche Pharma AG Emil-Barell-Str.1 D-79639 Grenzach-Wyhlen Germany
1 .
other
however , intensification of insulin therapy with abrupt improvement in glycaemic control may be associate with temporary worsening of diabetic retinopathy .
this might just be for the first injection or it may be a gradual change over several week or month . • Inject Humalog under the skin .
wash your hand thoroughly with soap and water before prepare the medicine .
the mean steady state volume of distribution range from 130 to 165 ml / kg , the mean value of clearance range from 33.3 to 37.2 ml / kg . h , and the mean terminal half-life range from 3.9 to 6.0 hour .
keep the container in the outer carton , in order to protect from light . a
throw the swab away .
no dosage adjustment be necessary .
instruction for handle and disposal
no statistically significant effect of prednisone on the pharmacokinetics of docetaxel be observe .
12.5 mg + 50 mg
Thromboprophylaxis should be administer for at least the first 5 month of treatment especially in patient with additional thrombotic risk factor .
5 .
Italia GlaxoSmithKline S. p . a .
2.0 ( 0-24 )
for a full list of excipients , see section 6.1 .
the fimbrial adhesins F4ab , F4ac , F5 , and F6 be responsible for the virulence of E. coli strain , which cause neonatal enterotoxicosis in piglet .
close blood glucose monitoring be therefore recommended .
Malta
driving and use machine Fuzeon have not be specifically test for it possible effect on your ability to drive a car or operate machine .
Novartis Europharm Limited Wimblehurst Road Horsham West Sussex , RH12 5AB United Kingdom
the therapeutic margin of erythropoietin be very wide .
these may be increase when first start antidepressant , since these medicine all take time to work , usually about two week but sometimes longer .
pulmonary oedema
3 .
• Your doctor will prescribe Emtriva with other antiretroviral medicine .
daily to 750 mg
Fuzeon should be prescribe by a doctor who have experience in the treatment of HIV infection .
in the docetaxel plus trastuzumab arm , 64 % have receive a prior anthracycline a adjuvant therapy compare with 55 % in the docetaxel arm alone .
limited experience be available in patient with severe renal impairment or haemodialysis .
Österreich Badener Strasse 23 A-2514 Traiskirchen Tel : + 43- ( 0 ) 2252 502-0
15 .
each pipette of Prac-tic delivers the following :
57 / 61
data be available up to the end of month 24 .
2 .
hyperkalaemia : a with other medicinal product that affect the renin-angiotensin-aldosterone system , hyperkalaemia may occur during the treatment with Irbesartan BMS , especially in the presence of renal impairment , overt proteinuria due to diabetic renal disease , and / or heart failure .
avoid use in any dehydrated , hypovolaemic or hypotensive animal , a there be a potential risk of renal toxicity .
name OF THE MEDICINAL PRODUCT
motor neuropathy
* Includes vertebral and non-vertebral fracture * * Accounts for all skeletal event , the total number a well a time to each event during the trial NR Not Reached NA Not Applicable
it be recommend that the rate of administration should not exceed 2 ml / min .
how to store Neoclarityn orodispersible tablet 6 .
insulin and analogue for injection , intermediate-acting combine with fast-acting , insulin ( human ) .
if normal or decreased value for glycated haemoglobin be note , the possibility of recurrent , unrecognised ( especially nocturnal ) episode of hypoglycaemia must be consider .
do not use KOGENATE Bayer 500 IU if you be allergic ( hypersensitive ) to octocog alfa , to mouse or hamster protein or to any of the other ingredient of KOGENATE Bayer 500 IU .
what be the risk associate with Sebivo ?
hepatic insufficiency Tadalafil exposure ( AUC ) in subject with mild and moderate hepatic impairment ( Child-Pugh Class A and B ) be comparable to exposure in healthy subject when a dose of 10 mg be administer .
in rare case , the presence of such insulin antibody may necessitate adjustment of the insulin dose in order to correct a tendency to hyper- or hypoglycaemia .
in addition , 303 patient receive interferon alfa-2b ( 3 million International Units & # 91 ; MIU & # 93 ; three time a week ) a a comparator .
5.3 Preclinical safety data
be ( SD 0.56 ) and the volume of distribution ( Vss ) be approximately equal to plasma volume ( 50 ml / kg ) .
Pegasys 180 mcg & amp ; Lamivudine 100 mg
Schematic diagram of the pen
15
when you first start take Xyrem , until you know whether it make you sleepy the next day , use extreme care while drive a car , operate heavy machinery or do anything else that could be dangerous or need you to be fully mentally alert .
4 .
instruction ON USE uc rod
1 .
- you be take or have take certain other medicine ( see section 2 , & quot ; Using other medicine & quot ; ) .
14 .
this medicinal product do not require any special storage condition .
this ensure that the full dose of insulin have be inject .
- the coordination of the scientific evaluation of the quality , safety and efficacy of medicinal product
why do hyperglycaemia occur ?
bleed time prolong , neutrophil count decrease , platelet count decrease
Lietuva Pfizer Luxembourg SARL Filialas Lietuvoje Tel . + 3705 2514000
one of the three study achieve a significant difference in the proportion of relapsers between paroxetine ( 38 % ) compare to placebo ( 59 % ) .
not all pack size may be market .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
a diagnosis of RPLS require confirmation by brain imaging .
3 .
read it again .
5 .
content 10 ml ( 3.5 mg / ml )
medicinal product subject to medical prescription .
other SPECIAL WARNING ( S ) , IF NECESSARY
in vitro study have show no evidence that pioglitazone inhibit any subtype of cytochrome P450 .
in a meta-analysis of six clinical trial , TAMs be not select by regimen contain abacavir without zidovudine ( 0 / 127 ) , but be select by regimen contain abacavir and the thymidine analogue zidovudine ( 22 / 86 , 26 % ) ..
increase rate of spontaneous abortion , stillbirth , congenital defect , and prematurity have be observe subsequent to wild-type measles during pregnancy .
14 .
ProQuad - Powder in vial and solvent in pre-filled syringe with 1 unattached needle - Pack of 1 , 10 , 20
1 .
dos higher than 300 mg irbesartan / 25 mg hydrochlorothiazide once daily be not recommend .
Special STORAGE CONDITIONS
the follow other side effect ( not list above ) have occur with the combination of PegIntron and ribavirin capsule ( adult ) in HCV / HIV co-infected patient receive HAART : oral candidiasis ( oral thrush ) , defective metabolism of fat , CD4 lymphocytes decrease , appetite decrease , back pain , hepatitis , limb pain , and various laboratory blood value abnormality .
- Hypersensitivity to Zestril , to any of the excipients or any other angiotensin convert enzyme
four hour after oral administration of 20 mg / kg body weight 5-ALA HCl , the maximum PPIX plasma level be reach .
do not freeze .
for subject randomize to either active treatment , dose begin with one 8 mg tablet of buprenorphine on Day 1 , follow by 16 mg ( two 8 mg tablet ) of buprenorphine on Day 2 .
sanofi PASTEUR MSD SNC 8 , rue Jonas Salk F-69007 Lyon France
common ( ≥ 1 / 100 to & lt ; 1 / 10 )
BATCH
add 1.2 ml water for injection to the Thyrogen powder in the vial .
5 .
they include : increased urination ; feel thirsty ; lose your dic
list OF EXCIPIENTS
PHARMACEUTICAL PARTICULARS
method AND ROUTE ( S ) OF ADMINISTRATION
BATCH NUMBER
patient with active malignant disease receive neither chemotherapy nor radiation therapy .
severe sepsis be define a sepsis associate with acute organ dysfunction .
multipack contain 3 pack each contain 30 film-coated tablet
once the medicine be reconstitute ( make up with the solvent ) , it should be use immediately .
three measure spoon be provide which dispense either 100 mg , 150 mg or 1 g of betaine anhydrous .
hypersensitivity to the active substance or to any of the excipients .
study in patient with pre-existing liver impairment have not be conduct .
BATCH NUMBER
intravenous administration of insulin :
severe cardiovascular disease In case of severe cardiovascular disease , care should be take .
other information about Osigraft :
none
B .
2 BG-София 1407 Тел . : + 359 2 806 3030
3 Aortic and mitral valve stenosis , obstructive hypertrophic cardiomyopathy :
in addition , a SPECT imaging study in schizophrenic patient reveal that olanzapine-responsive patient have lower striatal D2 occupancy than some other antipsychotic- and risperidone-responsive patient , while be comparable to clozapine-responsive patient .
expiry DATE
the following information be intend for medical or healthcare professional only :
if treatment with interferon alfa-2b be judge necessary in adult patient with existence or history of severe psychiatric condition , this should only be initiate after have ensure appropriate individualise diagnostic and therapeutic management of the psychiatric condition .
injection into a lifted skin fold minimise the risk of unintended intramuscular injection .
if you forget to take Imprida If you forget to take this medicine , take it a soon a you remember .
statement OF THE MRLs
treatment should be continue in patient who exhibit negative HCV-RNA .
try to take Glustin 30 mg tablet daily a prescribed .
increase in BMD at the total hip be 0.3 , 1.9 , and 3.0 % for the 3 group , respectively .
this summary be last updated in 12-2007 .
2 .
take the injection needle with the grey mark and remove it wrapping .
the disease it be be use for .
haematuria / proteinuria occur in a small number of patient .
the remain half of the total dose be swallow and slowly absorb from the gastrointestinal tract .
irbesartan AUC and Cmax value be also somewhat greater in elderly subject ( ≥ 65 year ) than those of young subject ( 18-40 year ) .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
1
peak plasma concentration be attain at 1.5 - 2 hour after oral administration .
other ingredient : sucrose , sodium citrate , L-methionine , polysorbate 20 and benzyl alcohol in water for injection ; sodium hydroxide and / or hydrochloric acid a pH adjustment .
297
these mean concentration be similar to those see in adult patient with plaque psoriasis treat with 25 mg etanercept twice weekly .
duloxetine
Actraphane should not be dispose of via wastewater or household waste .
maintenance phase :
Karvezide be take by mouth , with or without food .
3 .
not applicable
oseltamivir
Invented name
15 .
6.5 Nature and content of container
the study demonstrate that foetus expose in utero to the combination sustain a higher level of nucleoside analogue- DNA incorporation into multiple foetal organ , and show evidence of more telomere shorten than in those expose to zidovudine alone .
280 1 .
6.2 Incompatibilities
tell your doctor or pharmacist .
6 .
no untoward effect on cardiac conduction be observe follow concomitant administration of digoxin and rivastigmine .
oral use .
Analogous result have be find in animal experiment in uraemic and normal rat .
patient with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product .
during concomitant therapy with xanthine agent , serum theophylline level must be monitor and dosage adjust if necessary .
the Working Party ’ s agenda be now structure to allow emphasis on veterinary quality matter , when require , in the presence of veterinary expert .
insulin Human Winthrop Rapid be a solution for injection under the skin .
blister
combination therapy with ribavirin :
Actrapid be a solution for injection .
not applicable .
Hb between 10 and 12 g / dl ( 6.2 - 7.5 mmol / l ) .
no data have be generate with Focetria in pregnant woman .
depression , insomnia , anxiety , emotional lability * , agitation , nervousness
this be because small amount of it enter the milk .
the patient ’ s ability to concentrate and react may be impair a a result of hypoglycaemia .
any woman who have miss a period should be assume to be pregnant until proven otherwise .
cardiovascular / thromboembolic event include myocardial infarction , stroke / TIA , pulmonary embolus and deep vein thrombosis ( see section 4.3 and 5.1 ) .
dispose of it carefully .
of the eye ) .
the solution for injection contain the active substance follitropin beta , produce by genetic engineering of a Chinese hamster ovary ( CHO ) cell line .
Down-titration of Ranexa may be require ( see section 4.2 and 4.4 ) .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
inadequate dosage or discontinuation of treatment , especially in type 1 diabetes , may lead to hyperglycaemia .
skin and subcutaneous tissue disorder Common :
the manufacturer responsible for batch release be :
how to handle the vial
do not use ADVATE after the expiry date , which be state on the label after EXP .
recovery of the total radioactivity range from 88 - 94 % of the administer dose by 168 hour post dose .
leukaemia be a cancer of white blood cell .
Sweden
Celvapan suspension for injection Pandemic influenza vaccine ( whole virion , Vero cell derive , inactivate )
Norge MSD ( Norge ) AS Tlf : + 47 32 20 73 00 msdnorge @ msd . no
Special precaution for use in animal
you should continue to take CELSENTRI for a long a instruct by your doctor .
7 .
( 44-20 ) 74 18 84 00 Fax ( 44-20 ) 74 18 84 16 E-mail : mail @ emea . europa . eu http : / / www . emea . europa . eu
clear , colourless solution .
like all medicine , PritorPlus can cause side effect , although not everybody get them .
no clinically significant pharmacodynamic interaction be observe when clopidogrel be co-administered with atenolol , nifedipine , or both atenolol and nifedipine .
Methicillin-resistant S. aureus very commonly express co-resistance to fluoroquinolones .
in June 2006 a Mutual Recognition Procedure start with The Netherlands a Reference Member State and six Concerned Member States .
1.35 , 2.06 , 35 trial and 6769 patient ) be observe in patient treat with recombinant human erythropoietin .
2.0 & # 91 ; 1.7 , 2.3 & # 93 ;
Hyperhidrosis , pruritus Erythema , angioedema , urticaria Drug eruption , toxic skin eruption , rash , eczema
do not take a double dose to make up for a forgotten dose .
beneficial effect of telmisartan on mortality and cardiovascular morbidity be currently unknown .
PRILACTONE tablet should not be use in dog use for , or intend for use in breeding , a it have be demonstrate that spironolactone might cause harm to newborn or young laboratory animal .
if any of the side
name OF THE VETERINARY MEDICINAL PRODUCT
triple pack 4 4th dosage step ( 1.0 ml ) for treatment day 19 , 21 , 23
other SPECIAL WARNING ( S ) , IF NECESSARY
renal toxicity be observe in monkey treat for 2 week , with focal mineralisation and dilation of the renal tubule and tubular nephrosis .
Cerenia tablet can also be use in a higher dosage for a maximum of two day to prevent vomit due to motion ( travel ) sickness when a dog tend to vomit when travel by car .
0.43 0.43 0.43
D-83607 Holzkirchen
12 .
treatment with Prometax should be initiate and supervise by a doctor who have experience in the diagnosis and treatment of Alzheimer ’ s disease or dementia in patient with Parkinson ’ s disease .
additional response after this time be unlikely ( see 5.1 ) .
Malta
if you be a newly-diagnosed patient , treatment will occur in two phase :
clinical PARTICULARS
each film-coated tablet contain 300 mg aliskiren ( a hemifumarate ) .
Malta 168 Christopher Street MT-VLT02 Valletta Tel : + 356-21 23 21 75
severe case of generalised allergy may be life-threatening .
consequently , caution be advise when treat patient with these infection .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
379 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON
MSD Polska Sp . z o. o . , Tel . : + 48.22.549.51.00 Portugal :
tho Clinical Trials
read all of this leaflet carefully before you start use this medicine .
insulin overdose may lead to severe and sometimes long-term and life-threatening hypoglycaemia .
45 % ( 134 / 298 ) 53 % ( 61 / 115 ) 40 % ( 73 / 182 )
54 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
lot { number }
3 .
insulin suspension be not to be use in insulin infusion pump .
in a clinical pharmacology trial , in which desloratadine be administer at a dose of 45 mg daily ( nine time the clinical dose ) for ten day , no prolongation of QTc interval be see .
Special STORAGE CONDITIONS
method AND ROUTE ( S ) OF ADMINISTRATION
България MERCK d. o. o .
common Nervous system disorder
pregnancy ATryn be not indicate for use in pregnant patient .
store in refrigerator .
25000 20000
Investigations Common
Axura 10 mg film-coated tablet Memantine hydrochloride
BATCH NUMBER
maintenance
België / Belgique / Belgien S. C. S .
excipients : sodium dihydrogen phosphate dihydrate , disodium phosphate dihydrate , sodium chloride , glycine , polysorbate 80 , hydrochloric acid ( for pH-adjustment ) , sodium hydroxide ( for pH-adjustment ) , and water for injection
Silapo have no or negligible influence on the ability to drive and use machine .
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
if you have them , you may have have a serious allergic reaction to IntronA .
each tablet contain 60 mg of cinacalcet ( a hydrochloride )
9 .
phosphate dihydrate , glycerol , sodium hydroxide , hydrochloric acid ( for pH adjustment ) and water for injection .
4.6 Pregnancy and lactation
- If you be not eat enough , your blood sugar level may become too low ( hypoglycaemia ) .
GlaxoSmithKline Export Ltd 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom
hypersensitivity
read the package leaflet before use .
20 / 44
during antipsychotic treatment , improvement in the patient & apos ; s clinical condition may take several day to some week .
Nederland sanofi-aventis Netherlands B.V .
- Amnesia ( memory disturbance )
a complete and illustrated set of instruction be provide in the Annex to the Package Leaflet .
you should consult your doctor if you have a rash , since some rash may be serious ; however , most case of rash disappear without any change to your treatment with STOCRIN .
before you take ( Invented name ) ® 3 .
name OF THE MEDICINAL PRODUCT
the safety and efficacy of MIRCERA therapy have not be establish in patient with haemoglobinopathy , seizure , bleed or a recent history of bleed require transfusion or with platelet level greater than 500 x 109 / l .
see Fig .
liver Disease
it could be show with the aid of cell culture of human bone marrow cell that epoetin alfa stimulates erythropoiesis specifically and do not affect leucopoiesis .
Magyarország GlaxoSmithKline Kft .
Sverige Novartis Sverige AB Tel : + 46 8 732 32 00
this be because almost all of the filtered active substance be rapidly endocytosed and ultimately transport back to the systemic circulation .
3 .
in clinical trial , weight do not change from baseline when vildagliptin 100 mg daily be add to metformin ( + 0.2 kg and -1.0 kg for vildagliptin and placebo , respectively ) .
vial ( glass )
do not take your tablet at bedtime or before you get up for the day .
Italia Merck Serono S. p . a .
6 .
bleed with Activelle Activelle will not cause regular monthly bleeding , but when first start the tablet , many woman experience slight vaginal bleeding or spotting .
patient develop sign or symptom of hepatitis , severe skin reaction or hypersensitivity reaction must discontinue VIRAMUNE and seek medical evaluation immediately .
2 .
Table 1
21 make sure the edge of the patch stick to the skin .
Calcium-Sandoz 500mg brustablett
name OF THE MARKETING AUTHORISATION HOLDER
common : fatigue
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
- alcohol consumption ,
AUC : ↓ 35 % ( ↓ 13 to ↓ 40 ) Cmax : ↓ 13 % ( ↓ 0 to ↓ 23 ) 4-hydroxy atorvastatin :
if you be a woman :
Janssen Pharmaceutica N. V .
metformin
3 Hepatic Impairment :
4.1 Therapeutic Indication
0.1 % ) .
4.5 Interaction with other medicinal product and other form of interaction
patient should be advise to immediately report any emergent skin condition to their physician .
in 1998 he be coordinator Director for the creation of the Spanish Medicines Agency and Executive Director of the Spanish Medicines Agency from 1999-2000 .
16 .
it may harm them , even
2 .
vial ( glass )
375
ocular adverse event ( see section 4.8 ) include retinal haemorrhage , cotton wool spot , and retinal artery or vein obstruction have be report in rare instance after treatment with alpha interferon .
9 .
8 , sector 1 RO-013682 Bucureş ti Tel . + 40 21 233 35 30
monotherapy should be the most desirable achievement , a the safety concern tend to be reduce when only one drug be use , but at the present it be rarely obtain .
no new toxicity associate with the combination be identify .
different injectable vaccine should always be give at different injection site .
medicine should not be dispose of via wastewater or household waste .
these change sometimes give the cartridge a frosted appearance .
not applicable .
the corresponding suite for veterinary medicine will be roll out in September 2006 .
common :
EXP
6.1 List of excipients
the factor which determine the safety of a product be the measure apply in the production and control procedure .
Tel : + 421 - 2 52638201
see section 4.4 .
Anti-anaemic ATC Code :
needle must not be reuse .
ABILIFY 10 mg orodispersible tablet
30 - 60
Κύπρος Boehringer Ingelheim Ellas A. E .
Eesti Järvevana tee 9 EE-11314 Tallinn Tel : + 372 654 96 86
BATCH NUMBER
no significant pharmacokinetic or pharmacodynamic interaction be observe when irbesartan be coadministered with warfarin , a medicinal product metabolise by CYP2C9 .
ViraferonPeg alone :
5 / 23 Reconstituted vaccine should be use within 4 hour .
9 .
therefore , mix of rapid act insulin with Levemir should be avoid .
MARKETING AUTHORISATION NUMBER
- diazoxide ( use to treat high blood pressure ) ,
Antiinflammatory and antirheumatic product , non-steroids ( oxicams ) ATC vet code :
- The active substance be peginterferon alfa-2b , 120 microgram / 0.5 ml .
& lt ; 124
no interaction study have be perform .
on a trial basis , the EMEA will accept more electronic submission of product information relate to both full application and variation use the PIM approach in parallel to assess the feasibility of electronic submission in this area .
lot :
dosage adjustment be not require in elderly patient .
600 mg twice daily 750 mg twice daily 1500 mg twice daily
treatment with somatropin .
4 .
BATCH NUMBER
RA with ribavirin , inject the recommended dose a soon a you remember and continue treatment a usual Do not take a double dose to make up for a forgotten dose .
Infanrix Hexa have be study in nine study , involve a total of almost 5,000 infant who be at least six week of age .
per 0.5 ml dose * propagate in egg * * haemagglutinin * * *
analysis of breath sample and test specification for laboratory
14 .
n = 505
oral contraceptive , rifampicin , barbiturate , carbamazepine , thiazide , corticosteroid , danazol , thyroid hormone and sympathomimetics .
if an adjustment be need when switch the patient to Insulatard , it may occur with the first dose or during the first several week or month .
3 .
CYP3A4 Inducers Following induction of CYP3A4 by coadministration of rifampicin 600 mg once a day , Cmax and AUC of the active metabolite of fesoterodine decrease by approximately 70 % and 75 % , respectively , after oral administration of fesoterodine 8 mg .
ribavirin Teva should be use in combination with interferon alfa-2b ( 3 million international unit ( MIU ) per m2 body surface three time a week , every other day .
BRISTOL-MYERS Squibb Pharma EEIG
0.6 ml ( 667 µg / ml )
1 .
all patient should have a baseline eye examination .
MEDIPO
headache , Lethargy Dizziness , Parasthesia Dysgeusia
do not stop Insuman Infusat without speak to a doctor , who will tell you what need to be do .
they disappear once treatment have stop .
2.7
some patient have actually commit suicide .
via G .
this be particularly important in those who have reduce or absent awareness of the warning symptom of hypoglycaemia or have frequent episode of hypoglycaemia .
amlodipine
74 PACKAGE LEAFLET :
pregnancy and breast-feeding
Danmark sanofi-aventis Denmark A / S Tlf : + 45 45 16 70 00
6.3 Shelf life
44 Metabolism and nutrition disorder
hypertensive encephalopathy
1 ml ( 60 µg / ml )
this can be discuss with your doctor .
the E2 glycoprotein be consider to be the main immunogen of the CSF virus against which the neutralising antibody be direct .
-1.69
B .
DRAXXIN should only be use if pig be expect to develop the disease within 2-3 day .
a with any insulin therapy , lipodystrophy may occur at the injection site and delay local insulin absorption .
on 11 July 2007 , France present to the EMEA a referral of TRIBRISSEN ORAL PASTE FOR HORSES ( include associate name ) and authorised product for which this product serve a a reference product , under Article 35 of Directive 2001 / 82 / EC , a amend .
9 .
5 .
if the rise in haemoglobin be greater than 2 g / dl ( 1.25 mmol / l ) in four week reduce the dose by approximately 25 % .
Autoantibody formation
additional information on irbesartan interaction : in clinical study , the pharmacokinetic of irbesartan be not affect by hydrochlorothiazide .
• OTHER CONDITIONS
if clinically indicate , phlebotomy may be perform .
name OF THE MEDICINAL PRODUCT
rare : vasodilatation .
14 .
three , 6-month , double-blind , placebo-controlled clinical study be conduct in ESRD patient with uncontrolled secondary HPT receive dialysis ( n = 1136 ) .
NovoRapid should never be mixed with any other insulin when use in a pump .
- correct storage of your insulin while travel ,
it be for single use only .
haemoglobin variability should be address through dose management , with consideration for the haemoglobin target range of 10 g / dl ng ( 6.2 mmol / l ) to 12 g / dl ( 7.5 mmol / l ) .
a with other haematopoietic growth factor , G-CSF have show in vitro stimulating property on human endothelial cell .
18 / 12 / 2007
5.3 Preclinical safety data
medicine & quot ; ) .
Tel : + 34 91 456 53 00
Gram-positive anaerobe
then , if ANC remain & gt ; 1.0 x 10 / l for 3 more consecutive day
patient should be monitor closely to ensure that the lowest approve dose of Retacrit be use to provide adequate control of the symptom of anaemia .
PHARMACEUTICAL FORM AND CONTENTS
6 .
if you be pregnant , plan a pregnancy or breast-feeding : please contact your doctor for advice .
solution for Injection in prefilled
- who be elderly ,
drink alcohol while take Arava may increase the chance of liver damage .
12 .
1.7 ( 1.0-2.4 ) 1.3 ( 0.5-2.1 )
after a single dose of 14C-labelled telmisartan the glucuronide represent approximately 11 % of the measured radioactivity in plasma .
- thyroid hormone ( use to treat the thyroid gland disorder ) ,
this card should be remove and keep with you at all time .
VIRAMUNE oral suspension contain 150 mg sucrose and 162 mg sorbitol per ml of VIRAMUNE oral suspension .
from a microbiological point of view , the product should be use immediately .
solution for injection or infusion
3 hour .
4.8 Undesirable effect
Astellas Pharma B. V .
Grootslag 1-5 , NL-3991 RA , Houten The Netherlands
n = 133
do not use PegIntron if you notice discolouration of the powder .
rare
all other section of the SPC be harmonise a a result of the referral procedure ( except See Below ; Administrative Issues ) .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
expiry DATE
for your convenience , you may store Fertavid at or below 25 ºC ( at room temperature ) for a single period of not more than 3 month .
Humalog Mix50 Pen be use to treat diabetes .
the most frequent report adverse drug reaction be amnesia , paraesthesia , somnolence and dysmenorrhea .
for oral use .
nevertheless , the concentration of this metabolite remain low .
placebo
13 / 28 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
loop diuretic be prefer to thiazide in this population .
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
check your blood sugar frequently .
patient co-infected with hepatitis C and treat with alpha interferon and ribavirin may constitute a special risk .
therefore , no dosage adjustment be recommend in patient with hepatic impairment .
1 .
MARKETING AUTHORISATION NUMBER ( S )
general CLASSIFICATION FOR SUPPLY 32 & # 91 ; To be complete nationally & # 93 ;
CA be define a the proportion of all subject treat who do not smoke ( not even a puff of a cigarette ) from Week 9 through Week 52 and do not have an exhale CO measurement of & gt ; 10 ppm .
plasma concentration Average plasma concentration of ertapenem follow a single 30 minute intravenous infusion of a 1 g dose in healthy young adult ( 25 to 45 year of age ) be 155 microgram / ml ( Cmax ) at 0.5 hour postdose ( end of infusion ) , 9 microgram / ml at 12 hour postdose , and 1 microgram / ml at 24 hour postdose .
keep the vial ( s ) in the outer carton .
eye Disorders
in the phase III dose optimisation study , grade 3 or 4 elevation of transaminase or bilirubin be report in ≤ 1 % of patient with chronic phase CML with similar low
for a full list of excipients , see section 6.1 .
a minority of CHMP member be of the opinion that this indication should be delete from section 4.1 , and a statement should be include in section 4.2 , to indicate that longer-term treatment may also be appropriate for prevention of recurrence of major depressive episode .
skin and subcutanous tissue disorder : Uncommon : urticaria , pruritus , rash
it be recommend that in patient with thrombocytopenia or bleeding disorder the vaccine be administer subcutaneously ( see section 4.4 . ) .
4.5 Interaction with other medicinal product and other form of interaction
remove any air bubble .
pharmacological PROPERTIES
reproductive toxicity Olanzapine have no teratogenic effect .
any unused product or waste material should be dispose of in accordance with local requirement .
CV mortality , a well a overall mortality , be similar between the etoricoxib and diclofenac treatment group .
even at very high serum level , no symptom of overdose have be observe . ct du
bupropion be primarily metabolise by CYP2B6 .
diarrhoea * , nausea * , abdominal pain *
Reclose the bottle properly after use accord to the instruction on the cap .
13 ( 0.5 ) 4 ( 0.2 )
3 .
be
rare case report a NMS have also be receive in association with olanzapine .
13 .
blood and Lymphatic system disorder
caution should be use when prescribe carbamazepine , phenobarbital , and phenytoin .
- after transfer from animal insulin to human insulin ,
15 .
only injection syrinx design for this insulin concentration ( 100 IU per ml ) must be use .
4.5 Special precaution for use
België / Belgique / Belgien Nycomed Belgium Chaussée de Gand 615 Gentsesteenweg B-1080 Bruxelles / Brussel / Brüssel Tél / Tel : + 32 2 464 06 11 nycomed-belgium @ nycomed . com
each effervescent tablet of 500 mg contains :
blister
dose to one-half dose if :
in this leaflet :
European Medicines Agency
hard gelatine capsule
10 .
European Medicines Agency Veterinary Medicines
PHARMACEUTICAL Form
LABELLING
dose adjustment should not be make more frequently than once a month .
5.1 Pharmacodynamic property
if you have any further question on the use of this product , ask your doctor or pharmacist .
this leaflet be last approved in { MM / YYYY } .
10 pre-filled pen
although no study have be conduct with Caelyx , doxorubicin hydrochloride , the pharmacologically active ingredient of Caelyx , be mutagenic and carcinogenic .
renal handling also involve tubular reabsorption , probably mediate by cation transport protein .
• Tell your doctor if you or a member of your family be know to have a deficiency in glucose-6- phosphate dehydrogenase ( G6PD ) , since you may experience a risk of anemia with ciprofloxacin .
the solvent contain benzyl alcohol and benzalkonium chloride in water for injection .
metabolism and nutrition disorder
not know : pulmonary hypertension .
2.7
Musculoskeletal and connective tissue disorder :
for the full description of all side effect report with Actrapid , see the Package Leaflet .
MARKETING Authorisation Holder :
BN :
solution for injection
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Special STORAGE CONDITIONS
example include :
Article Item
Dynastat 40mg
Nephrolithiasis , include flank pain with or without haematuria ( include microscopic haematuria ) , have be report in approximately 10 % ( 252 / 2,577 ) of patient receive CRIXIVAN in clinical trial at the recommend dose compare to 2.2 % in the control arm .
if seal be break before first use , contact pharmacist .
13 .
intermittent allergic rhinitis ( presence of symptom for le than 4 day per week or for le than 4 week ) should be manage in accordance with the evaluation of patient ’ s disease history and the treatment could be discontinue after symptom be resolve and reinitiated upon their reappearance .
irbesartan Hydrochlorothiazide BMS
your doctor may recommend that you take paracetamol if you develop these symptom .
the predominant pharmacologic activity be from the parent olanzapine .
14 .
incidence of clinical vertebral fracture
darifenacin be metabolise by CYP3A4 and CYP2D6 .
QT interval prolongation may lead to an increase risk of ventricular arrhythmia include Torsade de pointes .
keep out of the reach and sight of child .
interaction link to valsartan Concomitant use not recommend Lithium Reversible increase in serum lithium concentration and toxicity have be report during concurrent use of ACE inhibitor .
tell your doctor if you be take thalidomide or medicine know to be harmful to your kidney .
sachet LABEL
554 If you use more Insuman Basal than you should
Actraphane be a mixture of dissolved insulin and isophane ( NPH ) insulin .
( microgram / once monthly ) 120 200 360
EMEA / CVMP / 005 / 00 Rev 1
8
Alli 60 mg hard capsule :
EU / 1 / 96 / 008 / 037
50 mg
Allée de la Recherche 60 B-1070 Bruxelles BELGIUM
lansoprazole be rapidly inactivate by gastric acid and consequently administer a enteric-coated granule in gelatin capsule .
how TO TAKE REVATIO
France Laboratoire GlaxoSmithKline 100 route de Versailles 78163 Marly-le-roi Cedex France
Retinal degeneration be not observe during the routine histopathological evaluation of the eye in any of the toxicology study in any specie use .
4
RADIOGRAPHIC PROGRESSION :
expiry DATE
2 x administer IU body weight ( kg )
EU / 1 / 03 / 260 / 007
4.6 Pregnancy and lactation
meta-analysis of overall survival data produce a hazard ratio point estimate of 1.08 in favour of control ( 95 % CI :
mechanism of Action Paliperidone be a selective blocking agent of monoamine effect , whose pharmacological property be different from that of traditional neuroleptic .
12 March 1999 Date of latest renewal :
base on the evaluation of the currently available data and the ( Co- ) Rapporteurs ’ assessment report , the CHMP adopt an opinion on 27 July 2005 recommend the variation of the Marketing Authorisations for the addition of the follow new indication :
if you be think of become pregnant or breastfeed discus it with your doctor first .
what benefit have Cholestagel show during the study ?
dose escalation , when indicate , should be conservative in such patient .
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
Belgique / België / Belgien BRISTOL-MYERS SQUIBB BELGIUM S. A . / N. V .
pregnancy
Alfred HILDEBRANDT , then Barbara VAN ZWIETEN-BOOT *
268 increase , the dose should be temporarily withhold until the haemoglobin begin to decrease , at which point therapy should be reinitiated at approximately 25 % lower than the previous dose .
it be evident that penicillin residue have cause allergic reaction in consumer and that some of these reaction have be serious .
Ratiograstim
take other medicine Please inform your doctor or pharmacist if you be take or have recently take any other medicine , even those not prescribe .
ed
-
name OF THE VETERINARY MEDICINAL PRODUCT
other SPECIAL WARNING ( S ) , IF NECESSARY
1 Not for use in lactate cattle produce milk for human consumption .
dog
Poorly control hypertension .
the risk of undesirable effect may be reduce by use & lt ; Nimesulide- contain medicinal product & gt ; for the shortest possible duration .
in patient with normal renal function , metabolism , include via CYP3A4 , play only a small role in the clearance of sitagliptin .
not all pack size may be market .
the effect be reach within 24 hour after the first patch have be apply and it effect fall gradually after the patch be remove .
infection viral *
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Switchboard :
in patient whose blood pressure be not adequately control , the dose may be increase to 300 mg once daily .
sodium phenylbutyrate be negative in 2 mutagenicity test , i. e. the Ames test and the micronucleus test .
4 .
Mavacoxib be 4- & # 91 ; 5- ( 4-fluorophenyl ) -3- ( trifluoromethyl ) -1H-pyrazol-1-yl & # 93 ; -benzenesulfonamide .
recommend dose adjustment during treatment and restart of treatment Dose adjustment , a summarise below , be recommend to manage grade 3 or 4 neutropenia or thrombocytopenia , or other grade 3 or 4 toxicity judge to be relate to lenalidomide .
BATCH
all dose / schedule of Humira in all four study show statistically significantly greater improvement in the disability index of the HAQ from baseline to Month 6 compare to placebo and in RA study III the same be see at Week 52 .
the safety of reinitiating Avastin therapy in patient previously experience RPLS be not know .
instruction ON USE
PHARMACEUTICAL FORM AND CONTENTS
RP & gt ; 1 in accordance with the EP
driving and use machine Your doctor will tell you whether your illness allow you to drive and to use machine safely .
there be therefore consistent evidence to suggest that there may be significant harm to patient with cancer who be treat with recombinant human erythropoietin .
in clinical trial mean total and LDL cholesterol decline by 15-31 % .
hypertension
injection site pain
medicinal product subject to medical prescription .
R bruise or bleed very easily or look very pale , call your doctor right away .
therefore , the use of Irbesartan Winthrop be not recommend .
- If you have any further question , ask your doctor or pharmacist .
important information about some of the ingredient of Insulin Human Winthrop Comb 25
other SPECIAL WARNING ( S ) , IF NECESSARY
hand should be wash .
d
safety study for veterinary drug residue in human food :
gastrointestinal disorder Common : alveolar osteitis ( dry socket ) , dyspepsia , flatulence Uncommon : gastroduodenal ulceration
6.5 Nature and content of container
insulin administration may cause anti-insulin antibody to form .
2 .
Tel : + 34 91 456 53 00
MARKETING Authorisation
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
eye disorder Post-marketing report of new-onset or worsen diabetic macular oedema with decreased visual acuity have be report with thiazolidinediones , include rosiglitazone .
medicinal product subject to medical prescription .
detailed information on this product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu /
package LEAFLET
list OF EXCIPIENTS
115 mg
15 .
for section 4.4 , the CHMP implement a revise wording for the hyperprolactinaemia section , exclude specific mention of prolactinoma and breast cancer , a although data support a possible relationship between hyperprolactinaemia and risk of some prolactin-dependent tumour exists , the data be still largely inconclusive from a clinical perspective .
32 A .
inject RELISTOR use a pack contain injection syringe with retractable injection needle
in a clinical study in young healthy subject no relevant effect of memantine on the pharmacokinetics of galantamine be observe .
6 .
lactose monohydrate , microcrystalline cellulose , croscarmellose sodium , magnesium stearate
serum level of LH , FSH and progesterone be not significantly affect .
the subcutaneous route of administration should be use .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
13 .
27 %
because of this , there be an increased risk of skin cancer .
infection of the upper respiratory
effect on unbound exposure could be expect ( have not be study ) therefore caution be advise in patient with moderate hepatic impairment .
keep a record of where and when you last give yourself an injection .
10 pre-filled pen
170 5.2 Pharmacokinetic property
the immunisation schedule should be adapt in order to ensure that the anti-HBs antibody titre remain above the accepted protective level of 10 IU / l .
- Epilepsy and / or compromised central nervous system ( CNS ) function ( see section 4.4 ) .
solution for injection ( injection ) .
245 unusual tiredness and weakness ; nervousness or tremor ; feel anxious ; feel confuse ; difficulty in concentrate .
tadalafil ( 10 mg except for study with angiotensin II receptor blocker and amlodipine in which a 20 mg dose be apply ) have no clinically significant interaction with any of these class .
there have be no clinical trial in severe sepsis specifically study drotrecogin alfa ( activate ) re- administration .
possible SIDE EFFECTS
the WORDS “ FOR ANIMAL TREATMENT ONLY ” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE , if applicable
subcutaneous use
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
217 000
no special requirement .
3 .
the following side effect have occur with the combination of Rebetol and interferon alfa-2b in child and adolescent :
clinical PARTICULARS
QI 09 AD 01
ethinyloestradiol :
3 .
the expiry date refers to the last day of the month concern .
oral use
store in a refrigerator ( 2 ° C - 8 ° C ) .
4 .
161 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
concurrent Enbrel and abatacept treatment
& # 91 ; to be complete nationally & # 93 ;
- you have hyperglycaemia ( high blood sugar level ) ,
particular caution should be use when prescribe REYATAZ in association with medicinal product which have the potential to increase the QT interval and / or in patient with pre-existing risk factor ( bradycardia , long congenital QT , electrolyte imbalance ( see section 4.8 and 5.3 ) .
Magyarország Alkotás u .
H-1123 Budapest Tel . : + 36 1 457-8500
the injection of Ibraxion may cause a temporary tissue reaction at the site of injection , which may last for three week and rarely up to five week .
- Major surgery , biopsy of a parenchymal organ , or significant trauma within the past 2 month
mannitol Sodium citrate ( to adjust pH ) Citric acid monohydrate ( to adjust pH ) Polysorbate 80
6.3 Shelf life
your SoloStar be design to work accurately and safely .
= 168 ) 13.3
patient should be aware of circumstance where warn symptom of hypoglycaemia be diminish .
dose adjustment be not expect to be necessary with hepatic impairment .
other dermatologicals , ATC code :
name OF THE MEDICINAL PRODUCT
however , when drive vehicle or operate machinery it should be take into account that dizziness or drowsiness may occasionally occur when take antihypertensive therapy .
common
not all pack size may be market .
3 .
10 .
if need the dose may be decrease or injection stop if the side effect be too great .
MIRCERA 800 mcg
2 .
erythema , pigmentation abnormal , sweat increase
( 95 % CI ) Hazard ratio
ATC code :
when use in spinal fusion surgery , the most common side effect with InductOs ( see in more than 1 patient in 10 ) be accidental injury , neuralgia ( nerve pain ) , back pain and bone disorder ( such a delayed healing ) , but these be see a frequently in patient receive standard care .
Table 2 :
67 9 .
7 .
common
240 ml oral suspension
10 .
the dose-finding study show that , after 48 hour , Fasturtec at a dose of 0.20 mg / kg reduce the uric acid level to normal value in 95 % of patient .
your doctor or nurse will give you Foscan by injection into a vein .
manufacturer :
administration
if blood pressure be difficult to control by initiation of appropriate measure , the haemoglobin may be reduce by decrease or withhold the dose of Aranesp ( see section 4.2 ) .
package size
in both specie , increase plasma renin activity and hypertrophy / hyperplasia of the renal juxtaglomerular cell be observe .
Kivexa , Trizivir ) , MUST NEVER be restart in patient who have stop therapy due to a hypersensitivity reaction .
the product should not be use during the 2nd and 3rd trimester of pregnancy , or while breast-feeding .
medicine & quot ; ) .
not know :
driving and use machine Mycophenolate mofetil Teva have not be show to impair your ability to drive or operate machine .
there be no known antidote for VIRAMUNE overdosage .
the physician should be consult when use other medication in addition to Liprolog Basal 100 U / ml Pen .
8 .
do not take a double dose to make up for a forgotten dose .
the time of dose ( morning versus even ) have no clinically relevant effect on the rate and extent of absorption .
Nederland Roche Nederland B.V .
- 16.02.1999 - 21.06.2000 - 206 day - 284 day
121 Skin and subcutaneous tissue disorder
after 16 week treatment , the difference in response rate be statistically significant in favour of methotrexate for the JRA Definition of Improvement ( DOI ) ≥ 30 % ( p = 0.02 ) .
there be no experience in the use of cefuroxime axetil in child under 3 month of age .
Tél / Tel : + 32 2 773 33 11
LABELLING AND PACKAGE LEAFLET
Slovenija Dunajska 22 SI-1000 Ljubljana Tel : + 386 01 3001070
prompt discontinuation of interferon alpha administration and treatment with corticosteroid appear to be associate with resolution of pulmonary adverse event .
therefore CYP450 mediate drug interaction be unlikely to occur with entecavir .
any unused solution must be discard not later than 28 day after first opening .
the range and frequency of detection of quantifiable plasma 9-cis-retinoic acid concentration in patient with KS apply the medicinal product to up to 64 lesion be comparable to respective value in untreated patient .
ViraferonPeg be recommend for use in fertile woman only when they be use effective contraception during the treatment .
Organon , Kloosterstraat 6 , Postbus 20 , 5340 BH Oss , The Netherlands • Organon ( Ireland ) Ltd . , P. O .
not all pack size may be market .
1 ml
5 .
9 A .
if any of these apply to you , tell your doctor before take Exforge .
United Kingdom Glaxo Wellcome UK Limited , Stockley Park West , Uxbridge , Middlesex UB11 1BT United Kingdom
08 June 2006
interferon alpha / ribavirin
a wide variety of autoimmune and immune-mediated disorder have be report with alpha interferon include thyroid disorder , systemic lupus erythematosus , rheumatoid arthritis ( new or aggravate ) , idiopathic and thrombotic thrombocytopenic purpura , vasculitis , neuropathy include mononeuropathy ( see also section 4.4 ) .
it be use in combination with other antiviral medicine to treat adult and child infect with human immunodeficiency virus type 1 ( HIV-1 ) , a virus that cause acquire immune deficiency syndrome ( AIDS ) .
hyperglycaemia can be bring about by : • not take your Humalog or other insulin ; • take le insulin than your doctor tell you to ; • eat a lot more than your diet allows ; or • fever , infection or emotional stress .
filgrastim HEXAL be use in child and adult to increase the number of white blood cell and reduce the occurrence and duration of infection relate to specific form of severe chronic neutropenia : congenital ( inborn ) , cyclic ( recur ) , or idiopathic ( without know cause ) .
• •
21.1 ; 100 ) , 45.4 % ( 95 % CI : -81.5 ; 86.6 ) , 74.7 ( 95 % CI : -386.2 ; 99.6 ) .
the extent to which the finding of an increase risk of fatal outcome can be attribute to the toxicity of venlafaxine in overdosage , a oppose to some characteristic of venlafaxine-treated patient , be not clear .
Committee FOR MEDICINAL PRODUCTS FOR HUMAN USE ( CHMP )
sanofi-aventis Deutschland GmbH , D-65926 Frankfurt be Main , Germany
Italy
you and your partner & apos ; s fertility should be evaluate before the treatment be start .
however , it can be interrupt at any time , if necessary .
11 .
4 .
42 Continuing to take Bondenza It ’ s important to keep take Bondenza every month , a long a your doctor prescribes it for you .
anaphylactic reaction Thromboembolic event
structure of the EMEA EMEA and the European network
Roaccutane
Implant
entacapone bind to human albumin bind site II which also bind several other medicinal product , include diazepam and ibuprofen .
5.1 Pharmacodynamic property
- have autoimmune hepatitis or any other problem with your immune system ; if you be take
- you have almost normal or , at least , greatly improve blood sugar level ,
dose reduction and discontinuation during the monotherapy phase should be apply accord to Tables 2 and 3 .
administer
Bovilis BVD
600 mg / day * , paediatric to 7.5 mg / kg , if :
very common : nausea , vomit , diarrhoea , abdominal pain and loss of appetite Common : a metallic taste Very rare : decrease vitamin B12 level , hepatitis ( a problem with your liver ) , redness of the skin ( rash ) or itch , lactic acidosis ( excess of lactic acid in your blood ) particularly in patient whose kidney be not work properly .
it primary therapeutic action be analgesia and sedation .
loss of consciousness have occur very rarely , mostly in elderly patient treat at high dos .
multiple dosing of mycophenolate mofetil in patient with severe chronic renal impairment have not be study .
I / R
cancer patient
400 mg twice daily to 400 mg three time a day
if the number of respond follicle be too high or oestradiol level increase too rapidly , i. e. more than a daily double for oestradiol for two or three consecutive day , the daily dose should be decrease .
5 .
relative Risk ( 95 % CI ) of GvHD and TRM Following treatment with G-CSF after bone marrow transplantation
blood and the lymphatic disorder :
10 .
body fat may occur in patient receive a combination of antiretroviral medicine .
Moreover , monitoring of the blood pressure be recommend particularly at the start of therapy .
thiazide should be use with caution in patient with impaired hepatic function .
Selecting your dose
Parareg 60 mg tablet Cinacalcet
4 .
these side effect may be see with sitagliptin and any glitazone ( e. g . , rosiglitazone ) .
Deutschland Astellas Pharma GmbH Neumarkter Str .
VIAGRA potentiate the hypotensive effect of nitrate ( see section 4.3 ) .
a for the secondary endpoint of fatal and non-fatal cardiovascular event , there be no difference among the three group in the overall population , although an increased incidence of non-fatal MI be see for woman and a decreased incidence of non-fatal MI be see in male in the irbesartan group versus the placebo- base regimen .
( n = 478 )
the frequency of adverse reaction identify from placebo-controlled clinical study
• Before each use , a new needle must always be carefully attach and a safety test must be perform .
Kύπρoς Baxter Hellas EPE Εθνάρχου Μακαρίου 34 Ηλιούπολη GR – 163 41 Αθήνα , Ελλάδα Τηλ : + 30-210-99 87 000
2 x 200 mg in even 2 x 200 mg in morning ,
push up the plunger slowly back to the correct dose .
administration of crushed tablet with a small amount of semi-solid food or liquid would not be expect to have an impact on the pharmaceutical quality , and would therefore not be expect to alter the clinical effect .
what Ambirix look like and content of the pack
the active substance of Kineret be anakinra produce by DNA technology use the micro-organism E. coli and work in the same way a your natural blocking protein .
injection site pain be report a attributable to treatment in study where Nespo be administer via subcutaneous injection .
the risk of opportunistic infection and tuberculosis ( TB ) in patient treat with Remicade .
chill / feel cold , injection site inflammation , injection site reaction , injection site pain
very rare
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
in anovulation the risk of OHSS be increase by a serum oestradiol level & gt ; 900 pg / ml ( 3,300 pmol / l ) and by the presence of more than 3 follicle of 14 mm or more in diameter .
metabolism Zaleplon be primarily metabolise by aldehyde oxidase to form 5-oxo-zaleplon .
seroconversion / Significant increase rate GMR
excipients
epoetin alfa Hexal
Investigations :
rotate the inner part of the syringe assembly a show below so that the label can be read in the viewing window .
au There have be report of serious allergic reaction include anaphylactic reaction , angioedema , dyspnoea , skin rash and urticaria associate with darbepoetin alfa .
16 .
like all medicine , Insulin Human Winthrop Basal can cause side effect , although not everybody get them .
small bowel obstruction no
Dublin , Ireland • Organon S. A. , Usine Saint Charles , 60590 Eragny sur Epte , France
-
to be swallow whole without crush or opening .
BATCH NUMBER
each Remeron 45 mg film-coated tablet contain 325 mg lactose ( a monohydrate ) .
in addition , persistence of vaccine-induced immunologic memory for hepatitis B virus surface antigen ( HBsAg ) have be demonstrate through an anamnestic antibody response to a booster dose of a previous formulation of Merck ’ s recombinant hepatitis B vaccine in healthy adult .
MARKETING AUTHORISATION NUMBERS
creatinine Clearance & # 91 ; mL / min / 1.73 m ² & # 93 ;
treatment with filgrastim significantly reduce the duration of febrile neutropenia , antibiotic use and hospitalisation after induction chemotherapy for acute myelogenous leukaemia or myeloablative therapy follow by bone marrow transplantation .
therefore , caution should be exercise when potent noradrenaline uptake inhibitor such a desipramine , maprotiline , or venlafaxine be administer to Parkinson ’ s disease patient be treat with Tasmar and levodopa preparation .
Puregon be usually not effective in such case .
pharmacological PROPERTIES
39 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
each pack contain 10 ampoule . ina
speak to a doctor immediately if you be not able to control the hypoglycaemia or if it recur .
ed Keep the container in the outer carton During use : do not refrigerate or store above 25 ° C
contact your doctor or pharmacist for advice . • if you have severe liver disease • if you be currently take any of the following medicine :
note for Guidance on clinical investigation of medicinal product in the treatment of depression
do not freeze .
Romania
31 9 5
lot
7 .
Cross-reactive immune response against variant of A / Vietnam / 1194 / 2004 ( H5N1 ) :
© EMEA 2007
EU / 1 / 96 / 007 / 028
Vectibix + BSC
cancer Patients with Metastatic Bone Disease )
avoid introduction of contamination during use .
• Hypersensitivity to the active substance , to other quinolones or to any of the excipients ( see section 6.1 ) .
the concurrent use of Kineret with etanercept or any other TNF antagonist be not recommended ( see section 4.4 ) .
other SPECIAL WARNING ( S ) , IF NECESSARY lp
S After withdrawal of the dose , any remain solution must be discard .
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER
caution :
1 vial :
what FORSTEO contains
each tablet contain 10 mg of amlodipine ( a amlodipine maleate ) .
oral use .
Uncommon
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www.emea.europa.eu / .
some patient take combination antiretroviral therapy may develop a bone disease call osteonecrosis ( death of bone tissue cause by loss of blood supply to the bone ) .
olanzapine be start at 2.5 mg / day and titrate to a maximum of 15 mg / day base on investigator judgement .
each tablet contain 20 mg tadalafil
Bleomicina Teva 15 UI polvo para solución inyectable EFG
method AND ROUTE ( S ) OF ADMINISTRATION
EU / 1 / 04 / 293 / 009-011 EU / 1 / 04 / 293 / 012
keep out of the reach and sight of child .
medicine should not be dispose of via wastewater ( do not flush it down the toilet ) .
Excipient ( s ) :
when the total amount of solvent be combine with the full amount of ViraferonPeg powder , the solution will be at the correct concentration to measure your dose ( i.e . , the labelled amount be contain in 0.5 ml ) .
psychiatric Disorders
physician should consider the nicotinic acid intake from vitamin and nutritional supplement when prescribe Trevaclyn .
patient with homozygous sickle cell disease and renal failure should where possible be maintain at ic
common :
positive predictive value of 45 % ( 50 / 110 ) and 70 % ( 59 / 84 ) be observe for genotype 1 and genotype 2 / 3 HIV-HCV co-infected patient receive combination therapy .
70
3 .
very common (  1 / 10 )
in these study , seizure be observe in 1.4 % of Mimpara treat patient and 0.4 % of placebo-treated patient .
MARKETING authorisation holder :
name OF THE MEDICINAL PRODUCT
remove ViraferonPeg pre-filled pen from the refrigerator before administration to allow the solvent to
lithium :
particular attention should be pay to sudden stab migraine- like headache a a possible warning signal .
excipients :
after repeat IM injection with 150 to 300 mg ZYPADHERA every two week , the 10th to 90th percentile of steady-state plasma concentration of olanzapine be between 4.2 and 73.2 ng / ml .
sanofi Pasteur MSD , Tel : + 31.23.567.96.00 Norge :
1 .
how to take You should not chew or break the tablet .
QUALITATIVE AND QUANTITATIVE COMPOSITION
from an efficacy and safety viewpoint , for the dose regimen of 200-400 mg ciprofloxacin twice daily for the treatment of complicated UTI .
3 .
however , in controlled clinical study no increased incidence of hypersensitivity reaction be find .
10 .
please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
laboratory value
2 .
Luxembourg / Luxemburg GlaxoSmithKline s. a . / n. v .
since the CAPRIE trial be not power to evaluate efficacy of individual subgroup , it be not clear whether the difference in relative risk reduction across qualify condition be real , or a result of chance .
12 .
in child and adolescents the fosamprenavir oral suspension should be take with food .
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
3 .
MARKETING AUTHORISATION HOLDER
CNS disorder
PHARMACEUTICAL PARTICULARS
patient should then return to take their dose once a month on their originally schedule date .
serious adverse reaction report during the post-marketing period include : – Arterial thrombotic event such a myocardial infarction or ischaemia , cerebrovascular disorder and bowel infarction .
Ropinirole should be administer with caution to patient with moderate hepatic impairment .
rare :
content BY WEIGHT , BY VOLUME OR BY UNIT
these measure will help to protect the environment .
similar effect have be very rarely report with irbesartan so far .
the summary of opinion of the Committee for Orphan Medicinal Products for Firazyr be available here .
0.5 ml
psychiatric disorder
if you become pregnant during therapy with Pritor , please inform and see your doctor without delay .
enough insulin , your blood sugar level may become too high ( hyperglycaemia ) .
thromboembolic event be commonly observe in woman with advanced breast cancer and have be observe in clinical trial with Faslodex ( see section 4.8 ) .
insert the needle into your skin .
EXP
under no circumstance should more than one dose be administer per syringe ; the medicinal product be for single use only .
further information
15 .
if any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor
a with all interferon , discontinue treatment with ViraferonPeg in patient who develop prolongation of coagulation marker which might indicate liver decompensation .
EU / 2 / 03 / 041 / 004 DRAXXIN 100 mg / ml
the first symptom which alert you to hypoglycaemia ( & quot ; warn symptom & quot ; ) may change , be weaker or may be miss altogether if
for a full list of excipients , see section 6.1 .
information FOR THE USER
- If you have any further question , ask your doctor or pharmacist .
although not study , voriconazole may increase the plasma level of the vinca alkaloid ( e. g. vincristine and vinblastine ) and lead to neurotoxicity .
66 I .
14 .
6 .
4.1.2 Using a syringe fit with a needle , aseptically withdraw the entire content of the solvent for TAXOTERE vial by partially invert the vial .
Sprycel be an anticancer medicine .
expiry DATE
swallow Epivir tablet with water or another drink .
the binding be long-lasting .
the CHMP agree that an Urgent Safety Restriction ( USR ) on cardiovascular safety be need to introduce new contraindication and strengthen warning and information on side effect in the SPC and the Package Leaflet ( PL ) .
ZYPREXA VELOTAB 15 mg orodispersible tablet Olanzapine
patient with rare hereditary problem of fructose intolerance , glucose galactose malabsorption or sucrase- isomaltase insufficiency should not take this medicine .
in the main study , Fabrazyme produce a highly significant and almost complete clearance of GL-3 in the kidney cell after 20 week of treatment :
2 mg / ml
use the syringe and needle only once .
DATE of first authorisation :
EXP . : ed
mark hypercalcaemia may be evidence of hidden hyperparathyroidism .
in study with a maximal duration of three year , rosiglitazone give once or twice daily produce a sustained improvement in glycaemic control ( FPG and HbA1c ) .
the WORDS & quot ; FOR ANIMAL TREATMENT ONLY & quot ; AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE , if applicable
when these medicinal product be administer to or withdraw from patient receive nateglinide , the patient should be observe closely for change in glycaemic control .
when infuse into a haemophiliac patient , factor VIII bind to vWF in the patient ’ s circulation .
if psychiatric symptom persist or worsen , or suicidal ideation be identify , it be recommend that treatment with Pegasys be discontinue , and the patient follow , with psychiatric intervention a appropriate .
there may be additional information in those leaflet about situation when Norvir should be avoid .
warm both unopened vial in your hand to a comfortable temperature ( do not exceed 37 ° C ) .
rare
myalgia ( G3 / 4 :
the standard dose of Cystadane for patient age over 10 year be 6 g a day , divide into two equal dos .
C
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
- a needle for the subcutaneous injection ( for example 0.4 x 13 mm & # 91 ; 27 gauge 0.5 inch & # 93 ; ) ;
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
expel air , large bubble , and any excess solution in order to obtain the required 0.6 ml dose .
outer CARTON
in patient with significant renal impairment the activity of radioiodine should be carefully select by the nuclear medicine physician .
name OF THE VETERINARY MEDICINAL PRODUCT
iron supplementation should be start a soon a possible , even several week prior to initiate the autologous predeposit , in order to achieve high iron store prior to start Silapo therapy .
5 .
30 tablet
you must not use the bottle if the tamper-proof seal on the bottle neck be break before you first use it .
DATE OF REVISION OF THE TEXT
in a six-month multicentre double-blind randomise trial , 0.1 % tacrolimus ointment be administer twice-a-day to adult with moderate to severe atopic dermatitis and compare to a topical corticosteroid base regimen ( 0.1 % hydrocortisone butyrate on trunk and extremity , 1 % hydrocortisone acetate on face and neck ) .
general CLASSIFICATION FOR SUPPLY
general CLASSIFICATION FOR SUPPLY
follow an additional week the dosage may be increase to 450 mg per day .
most reaction be transitory and disappear during continued treatment .
general disorder and administration site condition Very common :
very common :
if you have any further question on the use of this product , ask your doctor or pharmacist .
Actraphane 20 NovoLet 100 IU / ml suspension for injection Insulin human ( rDNA ) SC use
in addition , dexamethasone do not affect protein binding of docetaxel .
common :
no effect be see on the pharmacokinetics of the COMT substrate carbidopa .
tell your doctor immediately if you be pregnant or intend to become pregnant .
28 Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder :
overdosage of Mimpara may lead to hypocalcaemia .
list OF EXCIPIENTS
general CLASSIFICATION FOR SUPPLY
case people have suicidal thought or aggressive behaviour ( sometimes direct against others ) .
63 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Special precaution to be take by the person administer the veterinary medicinal product to animal
no significant difference be find in the psychomotor test result between desloratadine and placebo group , whether administer alone or with alcohol .
14 4.6 Pregnancy and lactation
the needle shielding system be design to cover the micro-needle after use .
5.3 Preclinical safety data
9.0 , 18.7 month ) ; ORR be 5.6 % ( 95 % CI :
NeoRecormon be administer twice weekly over 4 week .
mix thoroughly .
metformin stimulate intracellular glycogen synthesis by act on glycogen synthase .
0.5 1.0 1.5 2.0 2.5
vial label
efficacy versus placebo be significant across a range of subgroup which include patient separate by the following baseline characteristic : age ( all subgroups up to age 65 year ) ; body weight ( up to 80 kg ) and oophorectomy ( up to 15 year ago ) .
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd , Denmark
Justification for not include Braille accept .
do not freeze the vaccine .
this be normal . )
Cheadle Royal Business Park Highfield , Cheadle Sk8 3gy United Kingdom
the follow regimen have be use in adult and elderly in the treatment of advanced or metastatic colorectal cancer and be give a example .
the other ingredient of the powder contain in the hard capsule be : sodium laurilsulfate , lactose monohydrate , magnesium stearate and sodium starch glycolate .
in a large observational study where patient be well-matched at baseline , the incidence of the composite endpoint myocardial infarction and coronary revascularization be 17.46 event per 1000 person year for rosiglitazone containing regimen and 17.57 event per 1000 person year for other anti-diabetic agent & # 91 ; Hazard ratio 0.93 ( 95 % confidence interval 0.80 - 1.10 ) & # 93 ; .
this be the abnormal growth of blood vessel under the macula , the central part of the retina ( the light- sensitive membrane at the back of the eye ) .
7 TABLET OPA-ALU-PVC / ALU BLISTER
• The pen must be prim before each injection to make sure the pen be ready to dose .
Romania
Diltiazem / Efavirenz Diltiazem :
the pharmacokinetic variability observe in the elderly be within the range for the non-elderly .
relief of these symptom last a full day and help you to resume your normal daily activity and sleep .
DATE of first authorisation :
prepare the injection
metabolism Human insulin be report to be degrade by insulin protease or insulin-degrading enzyme and possibly protein disulfide isomerase .
the majority of the report refer to cancer patient , but such case have also be report in patient treat for osteoporosis .
clear , yellow solution .
MINIMUM delivery for pen be 0.3 ml . * * For patient & gt ; 120 kg , use 80 μg / 0.5 ml vial
three separate 5-day treatment must be perform at day 0 , day 14 and day 60 .
189 Dose reduction for patient who use 0.5 μg / kg ViraferonPeg monotherapy must be accomplish by reduce the prescribed volume by one-half .
back layer :
if seal be break before first use , contact pharmacist .
EU Number
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
mother should be instruct not to breast-feed if they be take adefovir dipivoxil tablet .
Slide the vial into the transparent sleeve of the transfer system and press firmly to lock the vial in place .
from 1979 to 1984 Dr Teeling be employ a a hospital doctor in various teach hospital in Dublin .
arthralgia pain in extremity back pain bone pain cough
follow them exactly and visit your diabetes clinic regularly . • If you change the type of insulin you use ( for example from a human or animal insulin to a Humalog product ) , you may have to take more or le than before .
1 pre-filled syringe of 1.0 ml solution for injection 6 pre-filled syrinx of 1.0 ml solution for injection
EU / 1 / 07 / 411 / 013 EU / 1 / 07 / 411 / 014
do not use Fertavid
expiry DATE
PHARMACEUTICAL PARTICULARS
distribution , rather than excretion or biotransformation , be the dominant mechanism influence plasma clearance .
this medicine do not require any special storage condition .
lactation
Liprolog Basal have an activity profile that be very similar to that of a basal insulin ( NPH ) over a period of approximately 15 hour .
for the full list of all side effect report with ZIMULTI , see the Package Leaflet .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
- atypical antipsychotic medication ( such a olanzapine and clozapine ) .
EU / 1 / 02 / 222 / 001
the concomitant administration of activated charcoal be show to reduce the oral bioavailability of olanzapine by 50 to 60 % .
however , chemical and physical in-use stability have be demonstrate for 48 hour at 30 ° C .
therefore , use of BYETTA be not recommend in this age group .
renal transplantation There be no experience in patient with recent kidney transplantation .
since co-administration of a high-fat meal with sitagliptin have no effect on the pharmacokinetics , sitagliptin may be administer with or without food .
the Member States ’ competent authority will continue to keep the product under regular review .
60 5 3
781 Insulin Human Winthrop Comb 50 suspension for injection in a pre-filled pen .
the most frequent report adverse reaction be hypertension ( common ) .
effect on tumour growth
Enbrel 50 mg be supply a a white powder for solution for injection .
( E ) Always prime the pen ( check the insulin flow ) before each injection .
when ViraferonPeg be use alone , some of these effect be le likely to occur , and some have not occur at all .
BATCH NUMBER
read all of this leaflet carefully before you start take this medicine . − Keep this leaflet .
what Zerene be and what it be use for 2 .
& lt ; Prescription & gt ;
like all medicine , Xyrem can have side effect .
4.4 Special warning and precaution for use
all patient with PWS should be monitor for sign of respiratory infection which should be diagnose a early a possible and treat aggressively .
filgrastim should be permanently discontinue in patient who experience a serious allergic reaction .
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
8 .
Teva
before YOU TAKE MICARDIS
- Increase in cough
in general , the adverse event in paediatric patient be similar in frequency and type to those see in adult patient .
Tel : + 386 1 560 48 00
what should I do if BYETTA do not come out of the needle tip after four try during New Pen Setup ? • Remove the needle by carefully put the outer needle shield back over the needle .
co-administration of amprenavir with methadone lead to a decrease of methadone concentration .
Tel : + 351 21 000 8600
Pseudomembranous colitis have be rarely report include case in patient who have not be concomitantly treat with antibiotic .
four additional large placebo-controlled supportive study of 28 to 52 week duration in 1,722 adult and adolescent ( study 3 , 4 , 5 , 6 ) assess the efficacy and safety of Xolair in patient with severe persistent asthma .
keep out of the reach and sight of child .
0.25
physician should exercise caution when consider the use of filgrastim in patient with sickle cell disease and only after careful evaluation of the potential risk and benefit .
no formal interaction study have be do .
( see section 4.4 ) .
do not use if there be discolouration of the reconstituted solution or if particulate matter be present .
what ViraferonPeg be and what it be use for 2 .
other
when compare to only 8.2 % of patient that can reach target BP somewhat faster compare to a stepwise approach , the risk benefit ratio be negative both for patient with severe and for patient with mild to moderate hypertension .
26 Children and adolescent Imprida be not recommend for use in patient age below 18 year due to a lack of data on safety and efficacy .
Salomone Pharma Ltd .
product .
6 .
- The other ingredient of the oral solution be sorbitol , propylene glycol , sucralose E 955 ,
the recommend starting dose be 10 mg / day .
lot
the vaccine , a formulate with the mineral oil and the emulsifier , induces protection in pig against clinical sign cause by the Classical Swine Fever ( CSF ) virus .
Italia Lundbeck Italia S. p . a .
the pharmacokinetics of abacavir in patient with end-stage renal disease be similar to patient with normal renal function .
Special activity to be earmark 20 %
insomnia , hallucination , confusion , nightmare , agitation
therefore CYMBALTA should not be administer in combination with potent inhibitor of CYP1A2 like fluvoxamine ( see section 4.3 ) .
monitoring of lipid level be , therefore , recommend .
Tel : + 420 233 086 111
- a high concentration of eosinophil , a type of white blood cell , increase or decrease amount
not applicable .
chest pain1
sanofi-aventis Deutschland GmbH Industriepark Höchst Brüningstraße 50 D-65926 Frankfurt / Main Germany
8 .
medicinal product with pH dependent absorption Lansoprazole may interfere with the absorption of drug where gastric pH be critical to bioavailability .
it use in this indication must be balance against the report risk of thromboembolic event .
Salmonella spp . * Shigella spp . * Vibrio spp .
after repeat dos of 75 mg clopidogrel per day , plasma level of the main circulating metabolite be lower in subject with severe renal disease ( creatinine clearance from 5 to 15 ml / min ) compare to subject with moderate renal disease ( creatinine clearance from 30 to 60 ml / min ) and to level observe in other study with healthy subject .
EXP
use your index finger , push back the colour needle protection device towards the syringe .
( d ) Hold the pen with needle point up and tap the clear cartridge holder gently with your finger so any air bubble collect near the top .
Rexer Rexer Rexer
1 .
the fifth study include 799 patient , none of whom have take methotrexate in
do not freeze .
the instruction for use , handle and disposal be give in section 6.6 .
3,275 ( 25 ) 29,774 ( 26 )
3.0 ( 1.7-4.3 )
note for guidance on comparability r-DNA-derived medicinal product ( joint with Efficacy and Safety Working Parties )
United Kingdom sanofi-aventis Tel : + 44 ( 0 ) 1483 505 515
6 .
6.6 Special precaution for disposal and other handling
Tasigna be a potent inhibitor of the Abl tyrosine kinase activity of the Bcr-Abl oncoprotein both in cell line and in primary Philadelphia-chromosome positive leukaemia cell .
concomitant use of these substance may require decreased tacrolimus dos in nearly all patient .
7 .
the daily dose be administer in two equally divided dos .
before you be give Angiox 3 .
the recommended oral dose in hepatic transplant patient be 1.5 g administer twice daily ( 3 g daily dose ) .
Otsuka Pharmaceutical Europe Ltd .
3 .
in this leaflet :
IVF A start dose be set by your doctor .
how to take Zerit 4 .
2 mg
cancer patient receive chemotherapy in
196 ( 58.7 % )
various regimen have be assess in the amprenavir / fosamprenavir development program with and without co-administration of ritonavir .
3 pen of 3 ml 4 pen of 3 ml 5 pen of 3 ml 6 pen of 3 ml 9 pen of 3 ml 10 pen of 3 ml
use sterile syrinx and needle .
the full EPAR for Neupro can be find here .
Connect the syringe to BAXJECT II ( Fig . d ) .
additional information on hydrochlorothiazide interaction : when administer concurrently , the following medicinal product may interact with thiazide diuretic :
8 .
1
the overall rate of symptom be 4.4 % , 6 % of those with Grade 3 VFD and 12.5 % of those with Grade 4 VFD .
sanofi PHARMA BRISTOL-MYERS SQUIBB SNC
MARKETING AUTHORISATION NUMBER ( S )
& lt ; EXP { month / year } & gt ; Shelf-life of opened bottle :
hypersensitivity ; Angioedema ; Surgery ; Anaesthesia ; Haemodialysis ; Kidney transplant ; Black patient ; Obstructive valvular disease .
nine hundred and twenty eight patient be randomise to receive either a single dose of pegfilgrastim or placebo approximately 24 hour ( Day 2 ) after chemotherapy in each cycle .
if there be le than 12 unit leave , use a new one .
4.5 Interaction with other medicinal product and other form of interaction
effect on tumour growth :
further INFORMATION
6.5 Nature and composition of immediate packaging
this leaflet be last approved in
for patient who use 1.0 μg / kg ViraferonPeg monotherapy , dose reduction may be accomplish by reduce the prescribed volume by one-half or by utilize a lower dose strength a show in Table 3b .
statement OF ACTIVE SUBSTANCE ( S )
do not expose to excessive heat or direct sunlight .
although a treatment effect be demonstrate in the overall study population , the data suggest that a larger treatment effect relative to placebo be see in the subgroup of patient with moderate dementia associate with Parkinson ’ s disease .
- acute or chronic disease which may cause tissue hypoxia such a :
the European Commission grant a marketing authorisation valid throughout the EU for Neulasta to Amgen Europe B. V. on 22 August 2002 .
Actrapid NovoLet be design to be use with NovoFine needle .
keep the vial in the outer carton in order to protect from light .
Manx Healthcare Taylor Group House Wedgnock Lane Warwick CV34 5YA United Kingdom
Special STORAGE CONDITIONS
cutaneous vasculitis anaphylaxis hepatosplenic T-cell lymphoma
your doctor will discuss with you the possible risk and benefit of have Twinrix Paediatric during pregnancy .
the maximum dose should not exceed 200 IU / kg 3 time per week .
read this guide prior to the preparation and administration of Busilvex .
Circadin may cause drowsiness .
film-coated tablet
solution To reset the FORSTEO , follow the step below .
if you have be tell by your doctor that you have an intolerance to some sugar , discus with your doctor before take this medicinal product .
advice ON CORRECT ADMINISTRATION
additional supportive care should be provide a necessary .
24 A .
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
12 A .
overall survival outcome in the trial could not be satisfactorily explain by difference in the incidence of thrombosis and related complication between those give recombinant human erythropoietin and those in the control group .
PegIntron
Phosphodiesterase inhibitor : phosphodiesterase inhibitor which be dependent on CYP3A4 metabolism , such a tadalafil and sildenafil , be expect to result in an approximately 2-fold and 11-fold increase in AUC respectively , when co-administered with ritonavir contain regimen include Kaletra and may result in an increase in PDE5 inhibitor associate adverse reaction include hypotension , synope , visual change and prolonged erection .
content BY WEIGHT , BY VOLUME OR BY UNIT
Humalog BASAL have an activity profile that be very similar to that of a basal insulin ( NPH ) over a period of approximately 15 hour .
erythropoietin be a growth factor that primarily stimulate red cell production .
06516 Carros France
- Vincristine , vinblastine and doxorubicin .
adult Schizophrenia :
because omalizumab clearance at clinical dos be dominate by the reticular endothelial system ( RES ) it be unlikely to be alter by renal or hepatic impairment .
very common
MARKETING AUTHORISATION HOLDER
11.9 6.3 2.1 3.3 2.7
the shelf life be 2 year for the product pack for sale .
these difference be of no clinical significance , result in no clinically significant difference in lipid effect among men and woman . − Renal insufficiency :
25 %
4.8 Interaction with other medicinal product and other form of interaction
in some case , a prior increase in body weight have be report which may be a predisposing factor .
- you have recently change from an animal insulin to a human insulin such a Insulin Human
1 KIU equal 1000 IU ( International Units ) .
each single-dose vial of solvent contains 13 % ( w / w ) ethanol 95 % in water for injection .
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Tel .
triglyceride increase
Romania
prevention of acute bone loss :
12 Elevated plasma prolactin level be report in 47.4 % of adolescent patient .
patient with high blood pressure and type 2 diabetes with kidney disease In patient with high blood pressure and type 2 diabetes , 300 mg ( two tablet a day ) once daily be the preferred maintenance dose for the treatment of associated kidney disease .
9 .
ask your doctor / health care professional if you want more information about side effect for RotaTeq .
powder and solvent for solution for injection
equipment that you need To give yourself a subcutaneous injection you will need :
not applicable
objective :
the overall incidence of adverse event report with telmisartan ( 41.4 % ) be usually comparable to placebo ( 43.9 % ) in placebo control trial .
the Committee note that some Member States ( MSs ) have a limitation of the use of Diovan after MI to patient intolerant to ACE inhibitor .
metabolism The metabolism be qualitatively similar in rat , mini-pigs , human , cattle and pig although quantitatively there be difference .
a rat fertility study up to a dose of 1500 mg / kg / day demonstrate no adverse effect on either sex .
name OF THE MEDICINAL PRODUCT
MARKETING Authorisation Holder
adverse effect not observe in clinical study , but see in animal at exposure level similar to clinical exposure level and with possible relevance to human use be myelofibrosis of the bone marrow in the mouse carcinogenicity study .
in case of accidental self-injection , seek medical advice immediately and show the package leaflet or the label to the physician .
Furthermore , rare increase in PR interval have be report during Kaletra therapy ( see section 4.4 : section pancreatitis and lipid elevation ) .
if you be inject PegIntron yourself , please be sure that the dose that have be prescribe for you be clearly provide on the package of medicine you receive .
the frequency of adverse reaction report in association with BeneFIX would be categorize a uncommon ( ≥ 1 / 1000 to ≤ 1 / 100 ) or rare ( ≥ 1 / 10,000 to ≤ 1 / 1000 ) .
36 daily result in plasma amprenavir concentration ( data from study APV30003 in antiretroviral experienced patient ) which result in protein adjust median ratio of Cmin / IC50 and Cmin / IC95 of 21.7 ( range 1.19-240 ) and 3.21 ( range 0.26-30.0 ) , respectively .
t EU / 1 / 01 / 192 / 003 EU / 1 / 01 / 192 / 004
olanzapine be effective in maintain the clinical improvement during continuation therapy in patient who have show an initial treatment response .
expiry DATE
- The other ingredient be protamine sulphate , m-cresol , phenol , glycerol , dibasic sodium
• 26.8.2002 • 12.11.2002 • 14.11.2002 •
6 .
73.6 ( 53 / 72 ) ( 60.2 , 87.0 )
pioglitazone IN COMBINATION THERAPY WITH INSULIN
asthenia , Fatigue
Nespo should also be use with caution in those patient with sickle cell anaemia or epilepsy . ct
Adjunctively with chemotherapy , interferon alfa-2b may be administer subcutaneously , at a dose of 5 million IU three time a week ( every other day ) for a duration of 18 month .
respiratory , thoracic and mediastinal disorder Very common :
ATC code :
10 .
6 .
MERIAL 29 avenue Tony Garnier FR-69007 Lyon France .
5.1 Pharmacodynamic property
7 .
a with all insulin therapy , the most frequent side effect be hypoglycaemia ( low blood sugar ) .
after 12 week of treatment the baseline IRLS score improve from 23.5 to 14.1 point for placebo and from 23.4 to 9.4 point for pramipexole ( dos combine ) .
blood pressure
225
excipients :
the company that make Glivec will carry out further study into Glivec , include an examination of it interaction with other medicine , it effect on the outcome of future bone marrow transplant and it effectiveness in patient with GIST , particularly at high dosage .
88 Actrapid must be protect from excessive heat and sunlight .
general CLASSIFICATION FOR SUPPLY
be careful only to push the push- button when inject • Keep the push-button fully depress after the injection until the needle have be withdraw from the skin .
hypertensive crisis with encephalopathy-like symptom can occur .
6.4 Special precaution for storage
patient with low CD4 count :
pre-filled pen ( cartridge , glass ) Solvent : ampoule ( glass )
mean change from
prevention of cardiovascular disease
6 .
they may cause a decrease in placental perfusion , foetal electrolyte disturbance and possibly other reaction that have occur in the adult .
1 .
store in a refrigerator ( 2 ° C – 8 ° C ) .
in the following situation , the management of your diabetes may require a lot of care :
not know :
1 bottle 1 bottle 1 bottle 28 tablet 56 tablet 112 tablet 49 x 1 tablet 100 x 1 tablet 1000 tablet ( 20 x 50 tablet )
Tel : + 353 ( 0 ) 1 403 56 00
UNIT total
adult surgery patient in an autologous predonation programme
appoint rapporteur or co-rapporteur in 6 case , whereas member from Austria and Italy be appoint in 5 case .
do not pass it on to others .
what ( Invented name ) ® look like and content of the pack
in vitro , stavudine triphosphate have an intracellular half-life of 3.5 hour in CEM T-cells ( a human T-lymphoblastoid cell line ) and peripheral blood mononuclear cell , support twice daily dose .
the reaction normally disappear after a few hour when you remove the patch .
6.4 Special precaution for storage
measure spoonful )
the pH be adjust with hydrochloric acid , and if necessary sodium hydroxide .
16 .
clearance for woman be approximately 25 % lower than the value for men .
3 .
cerebrovascular adverse reaction An approximately 3-fold increase risk of cerebrovascular adverse reaction have be see in randomised placebo-controlled clinical trial in the dementia population with some atypical antipsychotic , include risperidone , aripiprazole , and olanzapine .
cutaneous use
Slovenská republika Amgen Switzerland AG , Slovakia Tel : + 42 1 25939 6456
the development of ISRs in patient who have not previously experience ISRs be uncommon after the first month of therapy .
≤ 600,000 IU / ml
always take Rasilez exactly a your doctor have tell you .
7 .
5.2 Pharmacokinetic property
all patient in the chronic hepatitis C study have a liver biopsy before inclusion , but in certain case ( i.e . patient with genotype 2 and 3 ) , treatment may be possible without histological confirmation .
rash , erythema and pruritus will usually disappear within one day after the patch have be remove .
6 ( − 21 , 9 ) c
oral use
infection and infestation
five hundred and sixty one patient have a duration of voriconazole therapy of greater than 12 week , with 136 patient receive voriconazole for over 6 month .
the expiry date refers to the last day of that month .
summary OF PRODUCT CHARACTERISTICS
15 .
however , an adjustment in the dose or infusion time be recommend in patient be treat for the prevention of skeletal event in patient with breast cancer and bone metastasis ( see section 4.2 ) .
start dose of 50 IU / kg 3 time per week by the intravenous route , follow if necessary by a dose increase with 25 IU / kg increment ( 3 time per week ) until the desired goal be achieve ( this should be do in step of at least four week ) .
however , cyclosporine , a p-glycoprotein inhibitor , do not reduce the renal clearance of sitagliptin .
Amber polyethylene terephthalate ( PET ) bottle with child resistant closure ( polypropylene ) , and a graduated measuring cup ( polypropylene ) .
you don ’ t hear click while inject .
ask your doctor or pharmacist for advice before take any medicine .
name OF THE MEDICINAL PRODUCT
& # 91 ; see Annex I - To be complete nationally & # 93 ;
Uncommon : proteinuria .
& lt ; 1 %
for psoriasis in patient from the age of 8 year , the dose recommend be 0.8 mg of Enbrel per kg bodyweight ( up to a maximum of 50 mg ) , and should be give once weekly .
higher maximum serum level ( Cmax ) and systemic exposure ( AUC ( 0-tlast ) ) a well a a shorter time to reach maximum serum concentration ( tmax ) be find follow Ventavis inhalation via the I-Neb AAD in comparison to the ProDose nebulizer .
one blister contain 7 , 10 or 14 film-coated tablet .
- contact your doctor or nearest hospital casualty department immediately for advice .
statement OF ACTIVE SUBSTANCE ( S )
the dose range be 150 to 600 mg per day give in either two or three divide dos .
close monitoring of serum potassium in patient at risk be recommend ( see section 4.5 ) .
93 Injection site reaction
skin and subcutaneous tissue disorder common
deliverable volume from pen = 0.5 ml .
250 6 .
expiry DATE
vascular disorder , include veno-occlusive disease and fluid volume disturbance , have be report occasionally in patient undergoing high dose chemotherapy follow by autologous bone marrow transplantation .
there have be report of fatality associate with the use of growth hormone in paediatric patient with PWS who have one or more of the following risk factor : severe obesity , history of respiratory impairment , sleep apnoea or unidentified respiratory infection .
there be no adequate data from the use of sirolimus in pregnant woman .
insulin lispro be make in the laboratory by a ‘ recombinant
550
122 Duration of the treatment with Vimpat solution for infusion Your doctor will decide for how many day you will receive the infusion .
how do Zeffix work ?
oral use
Lyrica have be study in 21 study , where it be compare with a placebo ( a dummy treatment ) .
in case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episode , the patient & apos ; s adherence to the prescribed treatment regimen , injection site and proper injection technique and all other relevant factor must be review before dose adjustment be consider .
carton
the marketing authorisation be renew on 28 December 2005 .
daily dose in mg and in mL
6 .
13 .
& quot ; flu-like & quot ; symptom such a headache , joint pain , feeling of weakness , dizziness , and tiredness may occur , especially at the start of treatment .
correction phase :
12 .
before you mix the ViraferonPeg , make sure it be at room temperature .
use of injection site should be rotate so that the same site be not use more than approximately once a month .
transferrin saturation should be at least 20 % , and ct
32 7 .
00-minute-value Sampling time :
at very high dos ( ≥ 500 mg / kg / day ) degenerative change in the kidney ( such a interstitial nephritis , tubular distention , basophilic tubule , increase plasma concentration of urea and creatinine ) be induce by irbesartan in the rat and the macaque and be consider secondary to the hypotensive effect of the medicinal product which lead to decrease renal perfusion .
Österreich sanofi-aventis GmbH Tel : + 43 1 80 185 – 0
steady-state plasma concentration be attain within 3 day after initiation of a once-daily dosing regimen .
injection site reaction
cutaneous use
after 4 week of Tracleer 62.5 mg twice daily , the maintenance dose study in these trial be 125 mg twice daily in AC-052-351 and 125 mg twice daily and 250 mg twice daily in AC-052-352 .
some people feel dizzy or tire when they be treat for high blood pressure .
the syringe be now ready for use .
hypoglycaemia may occur if the insulin dose be too high in relation to the insulin requirement ( see section 4.8 and 4.9 ) .
within muscle tissue this include increase glycogen , fatty acid , glycerol and protein synthesis and amino acid uptake , while decrease glycogenolysis , gluconeogenesis , ketogenesis , lipolysis , protein catabolism and amino acid output .
170 • A few people who have have hypoglycaemia after switch from animal insulin to human insulin have report that the early warning symptom be le obvious or different .
2
no patient discontinue therapy due to anaemia .
5 .
Österreich Sanofi Pasteur MSD GmbH Tel : + 43.1.866.70.22.202
4.10 Overdose ( symptom , emergency procedure , antidote ) , if necessary
5 .
6.5 Nature and content of container M
le than 1 % of the dose be excrete unchanged in urine .
insulin Human Winthrop Comb 25
ZBN .
not supply in the pack
other infrequently report side effect :
expiry DATE
the effect of rotigotine on reproduction have be investigate in rat , rabbit and mouse .
Fertavid 150 IU / 0.5 ml solution for injection follitropin beta
5 – 8 x 108 perflutren-containing microspheres with a mean diameter range of 2.5 – 4.5 μ m ; equivalent to 0.19 mg perflutren gas per ml
20 mg
4.1 Therapeutic indication
the full EPAR for Protopy be available here . in ic ed
1 vial :
63,775.42
it be available a modified-release tablet . ‘ Modified-release ’ mean that the two active substance be release at different rate from the tablet over a few hour .
Tel : + 34 - 91 324 81 00
lactation ( see section 4.6 ) .
please tell your doctor or pharmacist if you be take or have recently take any other medicine , include medicine obtain without a prescription .
7 ) It be important that you continue take Alendronate HEXAL for a long a your doctor prescribes the medicine .
cefuroxime axetil will be absorb by the body , your doctor will recommend an injection of cefuroxime ;
REFLUDAN - 50 mg - Powder for solution for injection or infusion - 1 vial REFLUDAN - 50 mg - Powder for solution for injection or infusion - 10 vial
12 .
Conversely amprenavir retain activity against some isolates with resistance to other PIs and this retained activity would depend on the number and type of protease resistance mutation present in the isolates .
renal excretion of unchanged pramipexole be the major route of elimination .
first symptom of ovarian hyperstimulation be pain in the lower abdominal region , possibly in combination with nausea , vomit and weight gain .
Xolair 150 mg powder and solvent for solution for injection Omalizumab
if overdose occurs , the patient should be monitor for evidence of toxicity ( see section 4.8 ) , and standard supportive treatment provide a necessary .
3 .
exposure could lead to change in the skin color .
therefore it may be harmful for people with phenylketonuria .
such reaction should be differentiate from generalise or local flushing , which be common non-allergic effect of calcitonin ( see 4.8 ) .
you should not take VIAGRA if you be a woman .
medicinal product subject to medical prescription .
1 .
hepatic impairment :
no death reduction be observe in the subgroup of patient with lower disease severity .
a number of substance affect glucose metabolism and may require dose adjustment of human insulin .
caution be recommend in case of co-administration .
celecoxib should be discontinue at the first appearance of skin rash , mucosal lesion , or any other sign of hypersensitivity .
gender and race : no dosage adjustment base on gender or race be require .
in patient who develop these symptom , increase the dose may be detrimental .
in all patient , IVIg administration require : − adequate hydration prior to the initiation of the infusion of IVIg − monitoring of urine output − monitoring of serum creatinine level − avoidance of concomitant use of loop diuretic
4.7 Effects on ability to drive and use machine
pack size of 1 and 4 vial .
Ísland Icepharma hf .
cartridge ( glass ) for OptiClik
the duration of treatment with { PRODUCT NAME } 40 mg be determine by your doctor .
Penfill cartridge be design to be use with Novo Nordisk insulin delivery system and NovoFine needle .
4.7 Effects on ability to drive and use machine
then , you will have 23 day without Temodal .
5 .
Ethnic origin :
common ( ≥ 1 / 100 to & lt ; 1 / 10 ) peripheral1 Fatigue
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
additional adverse event that occur more frequently in patient treat with sitagliptin ( not reach the 5 % level , but occur with an incidence of & gt ; 0.5 % higher with sitagliptin than that in the control group ) include osteoarthritis and pain in extremity .
inhalation use
the mean age of patient be 52.5 year , 13 % be ≥ 65 year of age , and just 2 % be ≥ 75 year of age .
Paxene concentrate for solution for infusion be use to treat : • advance AIDS-related Kaposi ’ s sarcoma when certain other treatment ( liposomal anthracyclines ) have be try but have not work .
significant difference have be identify with regard to the propose indication , posology and contraindication in the product information and the demonstration of bioequivalence and this be consider to be of serious public health concern .
outer CARTON
4 .
24 January 2006
in animal reproduction study , glucocorticosteroids have be show to induce malformation ( cleft palate , skeletal malformation ) .
concomitant stable dos of aminosalicylates , corticosteroid , and / or immunomodulatory agent be permit and 79 % of patient continue to receive at least one of these medication . lon Induction of clinical remission ( define a CDAI & lt ; 150 ) be evaluate in two study , CLASSIC I and GAIN .
statement OF ACTIVE AND OTHER SUBSTANCES
all patient should have a baseline eye examination .
list OF EXCIPIENTS
ROUTE of administration
the Cozaar 12.5 mg tablet also may contain carnauba wax ( E903 ) , titanium dioxide ( E171 ) , indigo carmine ( E132 ) aluminum lake .
solvent for parenteral use :
Cleanse and disinfect the skin where the injection be to be make .
expiry DATE
-13.7 %
oral use
improvement of exercise duration be statistically significant compare to placebo for all three dos of ranolazine from 24 second at 500 mg twice daily to 46 second at 1500 mg twice daily , show a dose-related response .
if you take more Tracleer than you should If you take more tablet than you have be tell to take , contact your doctor at once .
clinical PARTICULARS
dosage FOR EACH SPECIES
treatment with Nespo should be temporarily discontinue if haemoglobin level exceed 13 g / dl ( 8.1 mmol / l ) .
4 .
the addition of the entire content of the solvent vial to the content of the Docetaxel Winthrop 20 mg concentrate for solution for infusion vial ensure a premix concentration of 10 mg / ml docetaxel .
4.1 Therapeutic indication
other INFORMATION
6.2 Incompatibilities
all oral olanzapine- and placebo-treated patient who experience a cerebrovascular event have pre-existing risk factor .
Processing timeline , which be the key performance indicator for centralised procedure , be meet for all application .
several adverse event be report more commonly in 69 juvenile idiopathic arthritis patient receive 3 month of Enbrel compare to the 349 adult rheumatoid arthritis patient .
other information about Vistide :
Perfektastrasse 84A A-1230 Wien Tel : + 43 1 891 22
method AND ROUTE ( S ) OF ADMINISTRATION
1789
rash
therefore , KOGENATE Bayer should be use during pregnancy and lactation only if clearly indicate .
360 ELISA Units 10 microgram
ed baseline FEV1 & lt ; 70 % predict have not be establish and the use of inhaled human insulin in this population be not recommend .
the safety and efficacy of Naglazyme in patient with renal or hepatic insufficiency have not be evaluate .
5 .
- One empty reaction vial
1 ml
BATCH :
15 .
50 D-65929 Frankfurt
in addition , an increase in hepatic adverse reaction with CELSENTRI be observe during study of treatment-experienced subject with HIV infection , although there be no overall increase in ACTG Grade 3 / 4 liver function test abnormality ( see section 4.8 ) .
in case of accidental exposure , rinse the affected area with copious quantity of water .
knowledge about the mechanism be incomplete .
235 In patient with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure , the target haemoglobin should be determine individually .
dosage
powder for solution for infusion and intravesical instillation
for your own safety , it be very important that you have regular blood test .
Clomicalm be administer twice daily at a dose of 1-2 mg / kg clomipramine to give a total daily dose of 2 - 4 mg / kg accord to the follow table :
driving and use machine & # 91 ; Invented name & # 93 ; may make you feel dizzy or light-headed .
a above
58 ( 28 )
Belgium
hypoglycaemia
the safety and efficacy of Revatio when co-administered with other PDE5 inhibitor have not be study in pulmonary arterial hypertension patient .
the safety of the vaccine in pregnant queen have not be investigate .
final OPINION OF THE COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS PURSUANT TO ARTICLE 12 OF COUNCIL DIRECTIVE 75 / 319 / EEC AS AMENDED FOR
6 .
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
each pack contain 10 ampoule .
not all pack size may be market .
they can also spread around the injection site .
2 ml oral solution in a tube pack size of 1 tube pack size of 10 tube
follow intravenous administration to healthy adult , the volume of distribution ( Vdss ) of nevirapine be 1.21 ± 0.09 l / kg , suggest that nevirapine be widely distribute in human .
10 .
BATCH NUMBER
Bellaria , 35 I-53010 Torri-Sovicille ( SI ) Italy
manufacturer responsible for batch release :
Humalog : insulin lispro solution Humalog NPL : insulin lispro protamine suspension Humalog Mix25 :
in the 12 week acute phase of three clinical trial of duloxetine in patient with diabetic neuropathic pain , small but statistically significant increase in fast blood glucose be observe in duloxetine- treated patient .
be sure to tell your doctor if you be take the Chinese herbal medication Shosaikoto .
Actos 45 mg tablet .
during implantation , use forceps to handle InductOs to avoid excessive loss of fluid .
ROUTE of Administration
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
while this have be report more often in patient with chronic i dic
12 ANNEX III
4.8 Undesirable effect
Tel : + 39 02 393 91
12 .
biotransformation Hepatic metabolism of anidulafungin have not be observe .
if you want more information on the basis of the CVMP recommendation , read the Scientific Discussion ( also part of the EPAR ) .
paediatric patient on haemodialysis The treatment be divide into two stage :
50.8 %
Vimpat be use a a long term treatment .
the number of certificate request fell from 9 652 in 1999 to 8 357 in 2000 .
9 .
inhalation anthrax
lactation :
dispose of waste material in accordance with local requirement .
good blood management practice should always be use in the perisurgical setting .
- Vaccinate only healthy animal .
co-administration of rosiglitazone with rifampicin ( an inducer of CYP2C8 ) result in a 66 % decrease in rosiglitazone plasma concentration .
& # 91 ; to be complete nationally & # 93 ;
KOGENATE Bayer 1000
instruction ON USE
6.3 Shelf life
47 %
1 full turn ( 5 click )
content BY WEIGHT , BY VOLUME OR BY UNIT
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
Magyarország MSD Magyarország Kft .
Seroxat
it work by prevent the neurotransmitter 5-hydroxytryptamine ( also call serotonin ) and noradrenaline from be take back up into nerve cell in the brain and spinal cord .
these may be sign of a very serious condition call diabetic ketoacidosis .
nevertheless the risk of liver toxicity may be increase in this population .
nevertheless , corticosteroid replacement therapy should be optimise before initiation of Omnitrope therapy .
6.5 Nature and content of container
785 Storage Instructions
- runny nose
104 The doctor may advise a lower dose , especially when start treatment in certain patient such a those on haemodialysis , or those over the age of 75 year .
15 .
these could interfere with the effect of Cubicin in the kidney .
Tel : + 372 640 1301
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www.emea.europa.eu / .
cellulose microcrystalline Crospovidone Type A Silica , colloidal anhydrous Magnesium stearate
Pharmacotherapeutic group :
39
6 .
Musculoskeletal disorder
expiry DATE
in this study , the immune response to both antigen component be comparable to that see after a 3-dose regimen of the combined vaccine contain 360 ELISA Units of formalin inactivate hepatitis A virus and 10µg of recombinant hepatitis B surface antigen in a dose volume of 0.5 ml .
and throat ( sign of severe allergic reaction ) .
the vial that be not be use be to be store in a refrigerator ( 2 ° C - 8 ° C ) .
EU / 1 / 99 / 109 / 002
for each medication chamber there be a corresponding colour cod control disc :
further information
Sverige BRISTOL-MYERS SQUIBB AB Tel : + 46 8 704 71 00
3 .
clinical examination should include evaluation for physical sign of fat redistribution .
70 ( 50 % ) 4 ( 3 % )
biotransformation : study in human and in vitro study use human liver microsome have demonstrate that efavirenz be principally metabolise by the cytochrome P450 system to hydroxylated metabolite with subsequent glucuronidation of these hydroxylated metabolite .
EXP
multiple pregnancy
your doctor or nurse will advise you where to inject .
© European Medicines Agency , 2008 .
1 .
1 .
method AND , IF NECESSARY , ROUTE ( S ) OF ADMINISTRATION
213 5 .
Healthcare professional administration and monitoring guide
Boehringer Ingelheim International GmbH D-55216 Ingelheim be Rhein Germany
via Casilina 125 I-00176 Roma Tel : + 39-06-70 38 41
serious side effect include : • Sudden severe allergic reaction ( rare - likely to affect between 1 and 10 in every 10,000 patient ) .
in patient with hepatic dysfunction ( mild , moderate or severe ) , peripheral blood count and liver enzyme should be carefully monitor ( see section 4.2 , 4.8 and 5.2 ) .
check carefully how you react to the medicine before drive or use any machinery .
4.9 Overdose
in this study , 53 patient receive placebo , 214 patient receive 50 mg Enbrel once weekly and 153 patient receive 25 mg Enbrel twice weekly .
detailed information on this medicinal product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu / .
cisplatin / Gemcitabine
in a study of oral olanzapine in breast-feeding , healthy woman , olanzapine be excrete in breast milk .
just take the next dose at the scheduled time .
Uncommon
33 Deutschland MSD SHARP & amp ; DOHME GMBH Tel : + 49 ( 0 ) 89 4561 2612 Infocenter @ msd . de
71 %
do NOT remove either of the needle cap and DO NOT push the dose button in until you be ready to self-inject the ViraferonPeg dose .
Uncommon
do not use in case of impaired renal or hepatic function Do not use in case of cardiac insufficiency Do not use in pregnant , breed or lactate animal .
other
5.2 Pharmacokinetic property
name OF THE MEDICINAL PRODUCT
80 - 100 ( pre- and
however , it should be take into account that there be variation between LH measurement perform in different laboratory .
other
kg Tel . : + 49 ( 0 ) 89 36044 8701 produkt . info @ gsk . com
what benefit have Invega show during the study ?
before you take ACOMPLIA 3 .
Gonazon concentrate for solution for injection of female salmonid fish
insufficient data be available in patient with hepatic impairment to provide a dose adjustment recommendation ( see section 5.2 ) .
Agopton should not be give to child .
thrombin and fibrinogen be natural substance that be obtain from human blood .
Tel . : + 36 1 488 37 00
in clinical trial , sustain protection have be observe in female age 15 to 25 year for up to 6.4 year after the first dose .
pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating .
131 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT lP
darbepoetin alfa have five N-linked carbohydrate chain whereas the endogenous hormone and recombinant human erythropoietin ( r-HuEPO ) have three .
powder for concentrate for solution for infusion .
Zero day .
HEXAL AG Industriestrasse 25 , D-83607 Holzkirchen , Germany
keep out of the reach and sight of child
9.5 mg / 24 h
do not use any Neulasta that be leave in the syringe .
efavirenz +
Repeated-dose toxicity In study up to 3 month duration in mouse and up to 1 year in rat and dog , the predominant effect be CNS depression , anticholinergic effect , and peripheral haematological disorder .
• Allergic reaction , include anaphylactic reaction , angioedema , skin rash and urticaria .
overall survival outcome in the trial could not be satisfactorily explain by difference in the incidence of thrombosis and related complication between those give recombinant human erythropoietin and those in the control group .
if bleeding occurs in the brain , this can lead to a stroke , which can be life-threatening .
hepatic impairment :
Rasilez 300 mg
Slovenská republika BRISTOL-MYERS SQUIBB SPOL .
this result ultimately in the conversion of prothrombin to thrombin .
expiry DATE
fluid Retention
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
patient whose blood glucose control be greatly improve e. g. by intensified insulin therapy , may experience a change in their usual warning symptom of hypoglycaemia and should be advise accordingly .
M
this document be a summary of the European Public Assessment Report .
see the package leaflet for further information .
it should also not be use by patient who have porphyria ( an inability to break down porphyrin ) or during pregnancy .
name and address of the manufacturer responsible for batch release
4.1 Therapeutic indication
because T- and B-lymphocytes be critically dependent for their proliferation on de novo synthesis of purine whereas other cell type can utilise salvage pathway , MPA have more potent cytostatic effect on lymphocyte than on other cell .
8 .
2045 Törökbálint Tó park , Hungary
paediatric patient : irbesartan have be study in paediatric population age 6 to 16 year old but the current data be insufficient to support an extension of the use in child until further data become available ( see section 4.8 , 5.1 and 5.2 ) .
Ι talia Merck Sharp & amp ; Dohme ( Italia ) S. p . a .
do not use if discolouration or particulate matter be present .
three trial include 1,764 postmenopausal woman who be treat with OPTRUMA and calcium or calcium supplement placebo .
this medicinal product contain le than 1 mmol sodium ( 23 mg ) per cartridge , i. e. essentially “ sodium-free ” .
information FOR THE USER
both substance be protease inhibitor : they block an enzyme call protease that be involve in the reproduction of HIV .
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
4.8 Undesirable effect
IDflu may be give at the same time a other vaccine .
the powder be a white lyophilised pellet .
6 .
oral use
rare pulmonary adverse reaction , in particular interstitial pneumonia , have be report after G-CSF administration ( see section 4.8 ) .
Ελλάδα ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε .
4.2 Posology and method of administration
CYP3A4 inhibitor and inducer be liable to interact with ivabradine and influence it metabolism and pharmacokinetics to a clinically significant extent .
if their symptom be the same a yours .
- if you be plan on become pregnant , discuss this with your doctor before start to use
96 hour after the administration of Foscan , the treatment site be to be illuminate with light at 652 nm from an approve laser source .
alprazolam , triazolam , oral ( take by mouth ) midazolam ( use to help you sleep and / or to relieve anxiety ) , pimozide ergot derivative such a ergot tartramine and ergot tartramine with caffeine , St .
PHARMACEUTICAL FORM AND CONTENTS
pharmacological PROPERTIES
due to it neurological effect , ciprofloxacin may affect reaction time .
ViraferonPeg be likely to also cause this effect .
in the study in early breast cancer , the risk of the cancer come back within the first year be reduce by about half :
general disorder and administration site condition :
5 mg
no special requirement .
1 transdermal patch per sachet
look out for the sign of allergy in 5 Possible side effect ► If you feel a hypo come on ( a hypo be short for a hypoglycaemic reaction and be a symptom of low blood sugar ) .
Uncommon :
name OF THE MEDICINAL PRODUCT
16 .
140 System Organ
store in the original package in order to protect from moisture .
B CONDITIONS OF THE MARKETING AUTHORISATION
take special care with GONAL-f
4 .
keep out of the reach and sight of child .
there be report in the literature where the transplacental passage of filgrastim in pregnant woman have be demonstrate .
duloxetine be a moderate inhibitor of CYP2D6 .
BATCH NUMBER
in addition , duration a pandemic , resource need for an in-depth evaluation of Periodic Safety Update Reports in the format a define in Volume 9a of the Rules Governing Medicinal Product in the European Union may not be adequate for a rapid identification of a new safety issue .
ViraferonPeg be indicate for the treatment of adult patient with chronic hepatitis C who have elevate transaminase without liver decompensation and who be positive for serum HCV-RNA or anti-HCV , include naïve patient with clinically stable HIV co-infection ( see section 4.4 ) .
120 µg / person .
infrastructure service Evolution of the EMEA budget 1995-2002 The sector come into existence in September 2001 and 80 provide facility management , archive , reprographics and mail room service .
11 .
caution should be exercise when prescribe to pregnant woman .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
16 .
powder and solvent for Intramuscular use suspension for injection
MARKETING AUTHORISATION NUMBER ( S )
2 year
- However , if it be almost time for your next dose , skip the dose you miss and take the next one
the pharmacokinetics of duloxetine and it metabolite have not be study in patient with mild or severe hepatic insufficiency .
there be no clinical experience in patient with severe hepatic insufficiency ( Child-Pugh score & gt ; 9 ) .
123 More significant obtundation and coma , include case of encephalopathy , have be observe in some patient , usually elderly , treat at higher dos .
IntronA , 18 million IU / pen , solution for injection :
after reconstitution with 1.5 ml solvent , 1 ml contains 3.33 mg somatropin ( correspond to 10 IU ) .
16 .
during treatment with somatropin , an enhanced T4 to T3 conversion have be find which may result in a reduction in serum T4 and an increase in serum T3 concentration .
in such case , a new cartridge yield a uniform suspension must be use .
EXP
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
4.1 Therapeutic indication
after re-suspension , milky white suspension .
see also warn in 2 Before you use Protaphane .
SonoVue have not be study in patient age 18 year or younger and should not be use in this group .
PHARMACEUTICAL FORM AND CONTENTS
patient should not be switch to another medicinal product a anti-erythropoietin antibody cross-react with other erythropoietin .
DATE OF FIRST AUTHORISATION / RENEWAL OF AUTHORISATION
Insulatard Penfill and FlexPen
if any of these condition apply to you , please talk with your doctor before take Efexor depot .
8.9 to 36.2 ) and weaker ( not significantly different from ASA ) in stroke patient ( RRR = 7.3 % ; CI : -5.7 to 18.7 & # 91 ; p = 0.258 & # 93 ; ) .
S r. o .
physical activity be an important part of a weight loss programme .
11 .
lamivudine 100 mg ( n = 463 )
if the increase in haemoglobin be inadequate ( le than 1 g / dl ( 0.6 mmol / l ) in four week ) increase the dose by approximately 25 % .
Nplate
- what you should do in emergency situation when you feel unwell or become ill .
cardiac disorder
dosage in child 50 kg or greater be the same a in adult .
in particular , this kind of transmission have be document 3 time out of more than 40 million dos of Varicella Vaccine live ( Oka / Merck ) that have be distribute .
107 D
in these study , Keppra at dos of 1,000 , 2,000 or 3,000 mg per day , be compare with placebo ( a dummy treatment ) over 12 to 14 week .
possible side effect 5 .
interferon beta-1a
- The other ingredient be hypromellose , microcrystalline cellulose , colloidal anhydrous silica ,
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT
fever
10
dose proportionality in serum concentration ( maximum concentration , extent of absorption ) be observe after subcutaneous administration in the therapeutic dose range .
1 dose ( 1 ml ) :
always take CoAprovel exactly a your doctor have tell you .
Nijverheidsweg 26 NL-3641 RR Mijdrecht
please tell your doctor or pharmacist if the person for whom the vaccine be intend be take or have recently take any other medicine , include medicine obtain without a prescription .
Nasopharyngitis , influenza
& lt ; 1
4.7 Effects on ability to drive and use machine na
62 10 .
this medicinal product must not be mix with other medicinal product except those mention in section 6.6 .
8 Based on what be know of other sulphonylureas , hypoglycaemia may be prolong .
20 microgram 40 microgram 40 microgram 20 microgram
do not use solution contain visible particle or that be cloudy .
pruritus
do not take OLANZAPINE NEOPHARMA
România Genzyme CEE GmbH- Reprezentanta pentru Romania Tel : + 40 21 243 42 28
during non clinical study in rat and baboon , the most frequently observed effect be liver change .
the treatment be to be temporarily discontinue during and after surgery .
do not pass it on to others .
the expiry date refers to the last day of the month concern .
the elimination pathways for infliximab have not be characterise .
the other ingredient be glycine , sodium chloride , calcium chloride , histidine , polysorbate 80 , and sucrose .
52 Although there be elimination of radioactivity in urine after administration of radiolabelled etanercept to patient and volunteer , increase etanercept concentration be not observe in patient with acute renal or hepatic failure .
there must be at least a 4-week wait period between end of treatment with sorivudine or it chemically relate analogue such a brivudine and start of Xeloda therapy .
use with antidepressant Caution should be exercise when use XERISTAR in combination with antidepressant .
2 .
the usual dose for prevention of influenza in child depends on the body weight of the child ( see table below ) :
Tel : + 48 - 22 345 18 88
0.85 ( 0.726 , 0.998 ) 0.0479
it be recommend to perform morphologic and cytogenetic bone marrow examination in patient at regular interval ( approximately every 12 month ) .
EU / 1 / 04 / 302 / 002 – 2 ml solution for infusion .
3 % to 36 % , p & lt ; 0.001 ) .
- if you be take any drug , such a acetylsalicylic acid to prevent platelet clump
7 .
EXP
the company that make Prepandrix have agree that it scientific data can be use for this vaccine .
this result be similar to the report value for factor VIII derive from human plasma .
treatment be start at 150 mg once a day and be usually increase to 300 mg once a day .
cutaneous use
EXP { month / year }
refer to the storage condition on the carton .
5.3 Preclinical safety data
tablet
Česká republika sanofi-aventis , s.r.o .
it be recommend to administer adefovir dipivoxil ( one 10 mg tablet ) every 48 hour in these patient .
1 .
CONDITIONS OF THE MARKETING AUTHORISATION
when administer with atorvastatin , steady-state Riprazo AUC and Cmax increase by 50 % .
replace the IntronA , solution for injection , multidose pen cap with the ‘ triangle ’ opposite the dosage indicator a see in Diagram L .
Urogenital system :
the Committee recommend that ECALTA be give market authorisation .
respiratory , thoracic and mediastinal disorder
a dizziness and abnormal vision have be report in clinical trial with vardenafil , patient should be aware of how they react to Levitra , before drive or operate machinery .
Special STORAGE CONDITIONS
common : diplopia , vision blur
29 Polyarticular juvenile idiopathic arthritis
14 tablet 28 tablet 30 tablet 56 tablet 56 x 1 tablet 84 tablet 90 tablet 98 tablet
all EVRA Subjects
4.2 Posology and method of administration
the observed drug accumulation index be ≈ 2 time with once daily dosing , suggest an effective accumulation half-life of about 24 hour .
avoid situation where SoloStar might be damage .
these finding be also observe with lower dos of this other angiotensin-II antagonist when give in combination with hydrochlorothiazide .
generally , the greater and more rapid the decline in blood glucose , the more marked be the phenomenon of counter-regulation and it symptom .
the use of cefuroxime axetil be not recommend in patient with severe intestinal tract disorder accompany by vomit and diarrhoea , since in these situation a sufficient absorption can not be guarantee .
this document be a summary of the European Public Assessment Report ( EPAR ) .
due to it increased carbohydrate content darbepoetin alfa have a longer terminal half-life than r-HuEPO and consequently a greater
4 5 6
Novo Nordisk A / S Novo Allé DK-2880 Bagsværd Denmark
eye disorder uncommon
Uncommon :
the solution should appear clear and colourless .
it may harm them , even if
124 Taking other medicine :
subcutaneous use
the use of AIIRAs be contra-indicated during the 2nd and 3rd trimester of pregnancy ( see section 4.3 and 4.4 ) .
do not freeze .
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
PHARMACEUTICAL PARTICULARS
vial ( glass )
the relevance of these various action of gabapentin to the anticonvulsant effect remain to be establish .
• Administration of the final diluted solution should be complete within six hour from the time that the TORISEL be first add to sodium chloride 9 mg / ml ( 0.9 % ) solution for injection .
EU / 1 / 97 / 057 / 001
in addition , the 69 insertion complex or the Q151M mutation , usually find in combination with A62V , V75I , F77L and F116Y , cause a high level of resistance to abacavir .
the in vitro antiviral activity of amprenavir be evaluate against HIV-1 IIIB in both acutely and chronically infect lymphoblastic cell line ( MT-4 , CEM-CCRF , H9 ) and in peripheral blood lymphocyte .
pharmacological PROPERTIES
30 month
study in vitro have show that sildenafil be selective for PDE5 , which be involve in the erection process .
Special precaution for disposal and other handling
Eli Lilly Nederland B.V. , Grootslag 1-5 , 3991 RA Houten , The Netherlands .
3 .
what benefit have Tredaptive show during the study ?
after dose interruption a haemoglobin decrease of approximately 0.35 g / dl ( 0.22 mmol / l ) per week be expect .
MIRAPEXIN be indicate for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in dosages up to 0.54 mg of base ( 0.75 mg of salt ) ( see section 4.2 . ) .
not applicable .
adult haemodialysis patient :
other SPECIAL WARNING ( S ) , IF NECESSARY
your doctor will order regular blood test to see that this be be achieve .
very common : • pain at the injection site
Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
- The active substance be recombinant interferon alfa-2b , 3 million IU / ml .
Furthermore , suicidal ideation or attempt be report more frequently compare to adult patient ( 2.4 % v 1 % ) during treatment and during the 6 month lp
15 .
eat glucose or sugar after the glucagon injection .
4.4 Special warning and precaution for use
etanercept work by reduce the inflammation associate with the disease that the child under your care have .
further information
the elimination half-life be not change in patient with hepatic impairment .
10 .
if you have any of these condition your doctor will discuss it with you and must treat you with caution .
patient be primarily male ( 76 % ) and white ( 66 % ) with a median age of 34 year ( range 22 to 67 year ) .
except where indicate , the data describe adverse reaction report from clinical study in patient with metastatic colorectal carcinoma who receive panitumumab a a single agent :
by 33 % should be consider ( 4 capsule / ~ 6.5 ml twice daily
pregnancy and breast-feeding Tell your doctor if you be pregnant or intend to become pregnant .
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder :
co-administration with REYATAZ / ritonavir may cause a large increase in the concentration of these benzodiazepine .
monohydrate , edetate disodium , sodium chloride , m-cresol , polysorbate 80 and water for injection .
B .
146 / 177 ( 82 ) 13 / 18 ( 72 )
EMEA / CHMP / 46089 / 2006 / EN
pregnancy and breast-feeding You must tell your doctor if you think that you be ( or might become ) pregnant .
if skin or eye symptom persist , or the product be accidentally swallow , seek medical attention and show the package insert to the physician .
intramuscular injection in sow and gilt of 2 ml per animal in the neck in the area behind the ear .
a / Vietnam / 1194 / 2004 ( H5N1 ) * * *
effect on Ability to Drive and Use Machines
-2.77
chloride deficit be generally mild and usually do not require treatment .
use in child and adolescent
the infusion rate should be calculate base on the clearance and the desired FVIII level .
PHARMACEUTICAL FORM AND CONTENTS
3 mg / ml
this should be take into account when interpret the result of hormonal assay and may result in gynaecomastia .
1 .
it be possible that concomitant use of other photosensitise agent ( e. g . , tetracycline , sulphonamides , phenothiazine , sulphonylurea hypoglycaemic agent , thiazide diuretic , griseofulvin and fluoroquinolones ) could increase the photosensitivity reaction .
indication
rash
rare Drug fever
a VFEND have be know to affect the liver and the kidney , your doctor should monitor the function of your liver and kidney by do blood test .
4.0 % ) ; Pyrexia ( G3 / 4 :
14 .
GONAL-f should be give at a dosage of 150 IU three time a week , concomitantly with hCG , for a minimum of 4 month .
Valtropin
chest pain , asthenia , oedema , injection site pain
Table 2 :
dopamine do not cross the blood-brain barrier .
this include an increase risk of skeletal manifestation , exacerbation of cytopenia , haemorrhage , and an increase need for transfusion .
take Cozaar with food and drink
Slovenská republika BRISTOL-MYERS SQUIBB SPOL .
in the clinical trial , renal deterioration be define a follow :
avoid situation where OptiSet might be damage .
maximum observe plasma concentration be reach within 30 to 120 minute ( median 60 minute ) of oral dosing in the fasted state .
ed while on this medication seek medical help immediately .
106 Interactions between Viraferon and other medicinal product have not be fully evaluate .
powder and solvent for solution for injection 1 vial contain powder 1 ampoule contain 1 ml solvent
PHARMACEUTICAL Form
24 radiographically , occur early during filgrastim therapy and tend to plateau .
contact a doctor , pharmacist or hospital immediately a you may need urgent medical attention .
EMEA 2007
suggested measure include induction of emesis and / or gastric lavage .
stomatitis ( G3 / 4 :
p-value
Actelion Registration Ltd BSI Building 13th Floor 389 Chiswick High Road London W4 4AL United Kingdom
patient with history of stable cardiac disease White blood cell Neutrophils
after the Commission Decision , the Member State competent authority will update Annex III a require .
take special care with Levemir
Stevens- Johnson Syndrome Angioneurotic oedema
4 .
- The other ingredient be glycine , disodium phosphate anhydrous , sodium dihydrogen phosphate
solvent for parenteral use :
9 .
subcutaneous use
6.2 Incompatibilities
contact your doctor or pharmacist if need .
( 90 % CI ) ( 90 % CI ) ( 90 % CI )
6.1 List of excipients
instruction ON USE
2 .
Cerenia 16 mg tablet for dog Cerenia 24 mg tablet for dog Cerenia 60 mg tablet for dog Cerenia 160 mg tablet for dog
resistance :
38 PACKAGE LEAFLET :
Micturition frequency , urine abnormal
25.8 % 23.0 %
Č eská republika MEDA Pharma s. r. o .
you can carry it with you and keep it at room temperature ( not above 30 ° C ) for up to 6 week .
6.5 Nature and content of container
further INFORMATION
5.3 Preclinical safety data
•
do not use in dog le than 6 week of age .
grade 3 n ( % )
1130 Brussels , Belgium
no specific information be available on the treatment of overdose with Irbesartan BMS .
•
see leaflet for further information .
6.5 Nature and content of container
generally , the greater and more rapid the decline in blood glucose , the more marked be the phenomenon of counter-regulation and it symptom .
osteoporosis happens when not enough new bone grow to replace the bone that be naturally break down .
pregnancy
you will find detailed information about the ingredient sorbitol ( a sugar ) in section 2. under the heading “ Important information about some of the ingredient of Tevagrastim ” .
neuropathic pain
clopidogrel Winthrop 75 mg film-coated tablet clopidogrel
please tell your doctor or pharmacist .
4.3 Contraindications
eye disorder Post-marketing report of new-onset or worsen diabetic macular oedema with decreased visual acuity have be report with thiazolidinediones , include pioglitazone .
Special STORAGE CONDITIONS
instruction ON USE
summary of Product Characteristics , 4.2 )
very rare
oral use
you will again receive Temodal once daily for 5 day , follow by 23 day without Temodal .
reaction usually resolve in a few day to a few week .
Tel : + 351-21 433 93 00
Don ’ t use the drop with your lens in .
• 31.1.2002 • 26.3.2002 • 54 day
TAXOTERE in combination with cisplatin be indicate for the treatment of patient with unresectable , locally advance or metastatic non-small cell lung cancer , in patient who have not previously receive chemotherapy for this condition .
general CLASSIFICATION FOR SUPPLY
in post-marketing experience from January 2003 , predominately in patient with rheumatoid arthritis , i dic
Instituto Grifols , S. A .
if you notice any other effect , even one not list in this leaflet tell your doctor or pharmacist .
store in the original package .
clean the skin a instruct .
- Chronic hepatitis with decompensated cirrhosis of the liver .
base on pharmacokinetic data no dose adjustment appear necessary in patient with mild or moderate renal impairment ( see section 5.2 ) .
Lietuva UCB Pharma Oy Finland Tel : + 358 9 229 0100
press the IONSYS system firmly in place on the skin , sticky side down , for at least 15 second .
vial LABEL :
PHARMACEUTICAL PARTICULARS
name OF THE MEDICINAL PRODUCT
the observed difference in Tmax be modest and the Cmax of the test tablet be not higher than the innovator tablet .
8 .
human erythropoietin be an endogenous glycoprotein hormone that be the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cell in the bone marrow .
this combination be indicate in naïve patient include patient with clinically stable HIV co- infection and in patient who have fail previous treatment with interferon alpha ( pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy ( see section 5.1 ) .
QUALITATIVE AND QUANTITATIVE COMPOSITION
cardiac failure Experience with vildagliptin therapy in patient with congestive heart failure of New York Heart Association ( NYHA ) functional class I-II be limit and therefore vildagliptin should be use cautiously in these patient .
reproductive toxicology
irbesartan / hydrochlorothiazide combination :
however , the magnitude of change be not clinically significant , so that Galvus can be give with or without food .
4.9 & # 91 ; 4.1 , 5.7 & # 93 ;
to prepare the PegIntron solution , insert the needle through the rubber top of the PegIntron vial and gently place the needle tip against the glass wall of the vial without touch the cleaned top of the vial with your hand .
see also section 4.4 .
4 Active hepatic disease and hepatic impairment Treatment with RoActemra , particularly when administer concomitantly with MTX , may be associate with elevation in hepatic transaminase ( see section 4.8 ) .
the most common side effect with ‘ Prepandemic influenza vaccine ( H5N1 ) ( split virion , inactivate , adjuvanted ) GlaxoSmithKline Biologicals ’ ( occur with more than 1 in 10 dos of the vaccine ) be headache , arthralgia ( joint pain ) , myalgia ( muscle pain ) , reaction at the site of the injection ( harden , swell , pain and redness ) , fever and fatigue ( tiredness ) .
teratogenicity be a suspected class effect of ERAs .
the bottle of SUSTIVA oral solution should be use within one month after first opening .
keep the outer cap to remove the used needle .
if the haemoglobin increase be & lt ; 1 g / dl ( & lt ; 0.62 mmol / l ) and the reticulocyte count have increase & lt ; 40,000 cell / µl above baseline , increase the dose to 300 IU / kg 3 time per week .
your doctor may tell you to use Humalog Mix25 a well a a longer-acting insulin .
6.1 List of excipients
the mean AUC and Cmax of the N-desmethyl metabolite increase 126 % and 73 % respectively , compare to age-matched volunteer with no renal impairment .
9 Possible interaction with other haematopoietic growth factor and cytokine have not yet be investigate in clinical trial .
half-life be also similar between adult and paediatric patient with lp
change in total fasting cholesterol level from borderline at baseline ( ≥ 4.39 - & lt ; 5.17 mmol / l ) to high ( ≥ 5.17 mmol / l ) be very common .
ephedrine
withdrawal PERIOD
EU / 1 / 03 / 267 / 001 EU / 1 / 03 / 267 / 002 EU / 1 / 03 / 267 / 003 EU / 1 / 03 / 267 / 004 EU / 1 / 03 / 267 / 005 EU / 1 / 03 / 267 / 006
method OF ADMINISTRATION
data on clinical efficacy in patient with glioblastoma multiforme ( Karnofsky performance status & # 91 ; KPS & # 93 ; ≥ 70 ) , progressive or recurrent after surgery and RT , be base on two clinical trial with oral TMZ .
do not use SOMAVERT
ed with existence of or history of severe psychiatric condition be contraindicate ( see section 4.3 ) .
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER
seroprotection rate
ask your pharmacist how to dispose of medicine no longer require .
what VIMPAT IS AND WHAT IT IS USED FOR
uth For a full list of excipients , see section 6.1 .
injection site reaction ( include bleeding , bruising , erythema , itching , pain , swell ) * Common :
fluticasone furoate GSK nasal spray be a predominantly off-white plastic device with a dose indicator window , light blue side actuate lever and lid which contain a stopper .
Luxembourg / Luxemburg Pfizer S. A .
the therapeutic margin of Aranesp be very wide .
20 50
Sverige Nycomed AB Box 27264 SE-102 53 Stockholm Tel : + 46 8 731 28 00
lot :
MIRCERA , like other ESAs , be a growth factor that primarily stimulate red blood cell production .
both regimen be administer every 3 week .
however , the average insulin requirement be often 0.5 to 1.0 IU per kg body weight per day .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
in patient with type 2 diabetes over a wide range of renal function the pharmacokinetic difference between insulin lispro and soluble human insulin be generally maintain and show to be independent of renal function .
9 .
tablet
a treatment effect be achieve after the first dose .
analysis of patient outcome by pain aetiology ( malignant , non-malignant ) , pain mechanism ( neuropathic , non- neuropathic ) , and pain severity ( VASPI score above or below 50 mm at baseline ) will be conduct .
what Ziagen be and what it be use for 2 .
this may be associate with life-threatening complication of the cardiovascular system .
Pentamidine may cause hypoglycaemia which may sometimes be follow by hyperglycaemia .
12 .
* palmar-plantar erythrodysesthesia ( Hand- foot syndrome ) .
information from clinical study Candidaemia and Invasive Candidiasis :
ethanol Macrogol 400 Hydroxypropylcellulose Butylhydroxytoluene
this summary be last updated in 11-2006 .
( 11.6 , 34.5 )
further information
not applicable
aripiprazole and other antipsychotic drug should be use cautiously in patient at risk for aspiration pneumonia .
type 1 ( Mahoney strain ) 4 type 2 ( MEF-1 strain ) 4 type 3 ( Saukett strain ) 4
Pre-gelatinised starch ( maize ) Microcrystalline cellulose Povidone Crospovidone Magnesium stearate Colloidal anhydrous silica
BATCH NUMBER
Musculoskeletal pain ( severe ) Rheumatoid arthritis exacerbation
SOTI study and TROPOS study .
ribavirin therapy be contraindicate in woman who be pregnant .
5.1 Pharmacodynamic property
4.2 Posology and method of administration
skin and subcutaneous tissue disorder
how TO USE CYANOKIT
lacosamide be effectively remove from plasma by haemodialysis .
opportunistic mycosis
EXP
BATCH NUMBER
respiratory , thoracic and mediastinal disorder Very common :
for oral use Read the package leaflet before use .
tablet .
4.7 Effects on ability to drive and use machine
4.3 Contraindications
vision disorder Rare : blur vision .
arthralgia , myalgia , musculoskeletal pain
immune system disorder
this be normal .
for patient who develop the sign and symptom such a fever , malaise , weight loss , sweat , cough , dyspnea , and / or pulmonary infiltrates or other serious systemic illness with or without concomitant shock an invasivie fungal infection should be suspect and administration of Humira should be promptly discontinue and appropriate antifungal therapy should be initiate .
6 .
MARKETING Authorisation Holder Swedish Orphan International AB Drottninggatan 98 SE-111 60 Stockholm Sweden
myopathy , back pain , musculoskeletal pain , myalgia
the potential effect of pramipexole on reproductive function have be investigate in rat and rabbit .
what be the reason give by the company to withdraw the application ?
4.1 Goals and objective for veterinary medicine Within the restructuring plan for the Agency , responsibility for the management of the Sector for information technology transfer to the Unit for Veterinary Medicines and Information Technology at the beginning of 2000 .
BATCH NUMBER
teratogenic effect have , however , not be demonstrate .
the warning sign of a hypo may come on suddenly and can include : cold sweat ; cool pale skin ; headache ; rapid heart beat ; feel sick ; feel very hungry ; temporary change in vision ; drowsiness ; unusual tiredness and weakness ; nervousness or tremor ; feel anxious ; feel confuse ; difficulty in concentrate .
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www . emea . europa . eu
similar result be see in adult and in child .
Glaxo Group Ltd Greenford Middlesex UB6 0NN United Kingdom
step 3 - Preparing the area A few tap at the injection site will stimulate tiny nerve ending and help reduce discomfort when the needle go in .
36 ATC Code :
across the 12 week placebo control Phase III clinical study , mean haemoglobin concentration decrease for patient in the Volibris group and be detect a early a week 4 ( decrease by 0.83 g / dl ) ; mean change from baseline appear to stabilise over the subsequent 8 week .
14 %
at 18 month , in an ongoing long term comparator study , rosiglitazone in dual oral therapy with metformin be non-inferior to the combination of sulphonylurea plus metformin for lower HbA1c .
indication ( S )
please tell your doctor or pharmacist .
hair colour change Rash Dry skin Alopecia Dermatitis Periorbital oedema Skin Reaction Erythema Eczema Pruritus
study 11
however , do not take Ciprofloxacin Bayer suspension with dairy product such a milk or yoghurt or with fortified fruit-juice ( e.g . calcium-fortified orange-juice )
3 .
the second study show the same effect , with a 75 % fall in the Viread group , compare to a fall 7 % in those add placebo , after 24 week .
you normally should be able to recognise when your blood sugar be fall too much so that you can take the right action .
the European Commission grant a marketing authorisation valid throughout the European Union , for Paxene to Norton Healthcare Limited on 19 July 1999 .
it should be note that for none of these procedure CPMP scientific advice have be request .
MAH logo
if insulin do not appear , repeat the procedure until insulin appear .
treatment of symptomatic anaemia in adult chronic kidney disease patient Treatment with MIRCERA have to be initiate under the supervision of a physician experience in the management of patient with renal impairment .
to determine the 13C / 12C-ratio of carbon dioxide in breath by mass spectrometric analysis the carbon dioxide must be separate from the breath and introduce into the mass spectrometer .
another adverse reaction observe be leg cramp ( 5.5 % for OPTRUMA , 1.9 % for placebo in the prevention population and 9.2 % for OPTRUMA , 6.0 % for placebo in the treatment population ) .
name OF THE MEDICINAL PRODUCT
the intravenous route have to be use ( please see section 4.4 - chronic renal failure patient ) .
however , since cyclosporin be bind by red blood cell there be potential for an interaction .
not all pack size may be market .
a hormone call erythropoietin , which be produce by the kidney , stimulate the production of red blood cell from the bone marrow .
the blood pressure lower effect of Karvea be evident within 1-2 week , with the maximal effect occur by 4-6 week after start of therapy .
2 .
4.8 Undesirable effect
MARKETING AUTHORISATION NUMBERS lP
11 .
15 .
Urogenital system :
15 mg
these be :
Olopatadine be absorb systemically , a be other topically administer medicinal product .
oral use
Nederland Serono Benelux BV Tupolevlaan 41-61 NL-1119 NW Schiphol-Rijk Tel : + 3120-6582800
PHARMACEUTICAL PARTICULARS
Printing Ink :
CYMBALTA
thiazide appear in human milk and may inhibit lactation .
chicken and duck
charge 8 %
14 .
for your convenience , you may store Fertavid at or below 25 ºC ( at room temperature ) for a single period of not more than 3 month .
treatment will continue for a long a you need immunosuppression to prevent you reject your transplanted organ .
there be no data to suggest that indinavir affect the ability to drive and use machine .
5.2 Pharmacokinetic particular
for the purpose of ambulatory use , Nespo may be remove from storage once for a maximum single in
the blood-pressure-lowering effect be sustain during long-term treatment , and be independent of age , gender , body mass index and ethnicity .
1 .
do not take a double dose to make up for a forgotten dose .
any unused solution should be discard .
SP Europe , Rue de Stalle 73 , B-1180 Bruxelles , Belgium
this medicine be use to treat the following condition :
Colony stimulate factor , ATC code :
Belgique / België / Belgien Merck Sharp & amp ; Dohme B.V .
keep the cartridge in the outer carton in order to protect from light .
you and your partner must each use an effective contraceptive during the time you be take the treatment and for 4 month after stop treatment .
Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel : + 44- ( 0 ) 1 707 363 636
7 .
in this respect data concern diastolic blood pressure ( DBP ) be inconsistent .
lot
NeoRecormon Multidose 50,000 IU Lyophilisate and solvent for solution for injection ( 5000 IU / ml )
the value for the sensitivity of DaTSCAN in determine probable DLB from non-DLB range from 75.0 % to 80.2 % and specificity from 88.6 % to 91.4 % .
norfloxacin - Eurogenerics
it act selectively on the receptor subtype AT1 , which be responsible for the known action of angiotensin II .
expiry DATE
3 .
the mechanism of efavirenz / atazanavir interaction be CYP3A4 induction . * * base on historical comparison .
1 .
clopidogrel should therefore be use with caution in this population ( see section 4.2 ) .
patient be randomize to receive either pegylated interferon alfa-2b ( 1.5 µg / kg / week ) plus ribavirin ( 800 mg / day ) or IntronA ( 3 MIU TIW ) plus ribavirin ( 800 mg / day ) for 48 week with a follow-up period of 6 month .
6 .
Special population :
this may constitute a risk in situation where these ability be of special importance ( e. g. drive a car or operate machinery ) .
9 month , p = 0.01 ) .
Dispersible Tablet
Two-month treatment duration in adult with oral ciprofloxacin give at the follow dose , 500 mg bid , be consider a effective to prevent anthrax infection in human .
European Medicines Agency
16 .
hypoglycaemia ( low blood sugar ) mean that there be not enough sugar in the blood .
it may harm them , even if their symptom be the same a yours . − If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
instruction ON USE
content BY WEIGHT , BY VOLUME OR BY UNIT
6 pre-filled syrinx , each contain 40 mg adalimumab 6 alcohol pad no
Suomi / Finland ECO Animal Health Ltd . , The Grange , 100 The High Street , London , N14 6BN , Iso-Britannia Tel : + 44 ( 0 ) 20 8447 8899 Email : sale @ ecoanimalhealth.com
* Body surface area can be calculate with the following equation :
4 .
- you have recently suffer hypoglycaemia ( for example the day before ) or if it develop slowly ,
ciprofloxacin VITAL
10 x 1 vial of powder for solution for injection or infusion .
although not study , voriconazole may increase the plasma level of the vinca alkaloid ( e. g. vincristine and vinblastine ) and lead to neurotoxicity .
Avastin have not be show to impair your ability to drive or to use any tool or machine .
7 .
Č eská republika sanofi-aventis , s. r. o .
sudden onset of sleep during daily activity , in some case without awareness or warning sign , have be report uncommonly .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
insulin human
renal function and serum potassium should be monitor .
2 .
5.1 Pharmacodynamic property
- if you experience gastro-intestinal reaction such a nausea ( feel sick ) and vomit ( be
therefore , you should take special care in your dental hygiene .
specific study of the vaccine in pregnant woman be not conduct .
long-term improved glycaemic control decrease the risk of progression of diabetic retinopathy .
meningitis due to the entrance of organism along the catheter track or inadvertent contamination of the infusion system be a known complication of intrathecal medicinal product administration , especially with external system .
eat a meal or snack containing carbohydrate within 30 minute of the injection .
when renal function be impair , renal clearance be decrease in proportion to that of creatinine and thus the elimination half-life be prolong , lead to increase level of metformin in plasma .
during treatment with olanzapine in combination with lithium or divalproex , an increase of ≥ 7 % from baseline body weight occur in 17.4 % of patient during acute treatment ( up to 6 week ) .
only 1 ml should be withdraw equal to 0.9 mg of thyrotropin alfa .
skin and subcutaneous tissue disorder Musculoskeletal and connective Tissue disorder Renal and urinary disorder
Insuman Comb 50
Tél / Tel : + 32 ( 0 ) 2 525 82 11
keep this vaccine out of the reach and sight of child .
4.7 Effects on ability to drive and use machine
expiry DATE
this fix dose combination be indicate in adult patient whose blood pressure be not adequately control on irbesartan or hydrochlorothiazide alone ( see section 5.1 ) .
България MERCK d. o. o .
Бизнес Парк София , Младост 4 , сграда 4 , етаж 3 София 1715 Тел . : + 359 2 489 94 00 ( 05 )
Sabril
EU / 1 / 07 / 418 / 010
you should check with your doctor or pharmacist if you be not sure .
you must use it only if it look like water .
in the rabbit foetal effect ( embryonic death , increase skeletal anomaly , and increase malformation ) be observe in the presence of maternal toxicity .
you may need to read it again .
Παντελεήμονος Τ .Κ .
do not refrigerate .
Enbrel
4 .
- Patients with a history of tendon disease / disorder relate to quinolone treatment .
6.6 Special precaution for disposal
- if you be a girl or a woman of childbearing age , you must have a negative pregnancy test before
base at the EMEA in London , the group support the IT network that connect the national competent authority , European Commission and the EMEA itself .
replace and tighten the bottle cap
oral use
information FOR THE USER
topical administration of imiquimod cream result in no tumour enhancement at any dose , in comparison with the vehicle cream group .
although vaccination may protect you against cervical cancer , it be not a substitute for regular cervical screening .
S Biotechnology
Pure red cell aplasia , a condition where the body stop or reduce the production of red blood cell , have be report .
in patient co-infected with HCV / HIV , limited efficacy and safety data ( N = 25 ) be available in subject with CD4 count le than 200 cell / µl .
clopidogrel significantly reduce the incidence of new ischaemic event ( combined end point of myocardial infarction , ischaemic stroke and vascular death ) when compare to ASA .
LABELLING AND PACKAGE LEAFLET
like all medicine , ADROVANCE can cause side effect , although not everybody get them .
MARKETING AUTHORISATION NUMBER ( S )
the duration of protection be 6 month .
coadministration of antipsychotic medicinal product with pramipexole should be avoid ( see section 4.5 ) .
in a prospective , randomised , double-blind , placebo-controlled trial conduct in 375 anaemic patient with various non-myeloid malignancy receive non-platinum chemotherapy , there be a significant reduction of anaemia-related sequela ( e. g. fatigue , decrease energy , and activity reduction ) , a measure by the following instrument and scale :
Sector for conference service
reduction of zoster pain severity-by-duration in vaccinated individual who develop zoster With regard to the acute pain ( pain between 0-30 day ) there be no statistically significant difference between the vaccine group and the placebo group .
read the package leaflet before use .
- a significant reduction of the absolute risk of any diabetes-related complication in the metformin
interaction with indinavir / ritonavir not study Ritonavir may modify P-glycoprotein mediated fexofenadine efflux when coadministered result in increased concentration of fexofenadine .
B03XA02 . ic ed
in patient with acute ST-segment elevation MI , safety and efficacy of clopidogrel have be evaluate in 2 randomised , placebo-controlled , double-blind study , CLARITY and COMMIT .
please tell your doctor if you have recently receive , or be receive , radiotherapy .
42 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
the patient have receive 400 mg memantine orally .
common ( affect 1 to 10 user in 100 ) :
elderly Nicotinic acid :
Paseo Pintor Rosales , 44 Bajo Izda .
elimination of abacavir be via hepatic metabolism with subsequent excretion of metabolite primarily in the urine .
administration of ambrisentan to female rat from late-pregnancy through lactation cause adverse event on maternal behaviour , reduce pup survival and impairment of the reproductive capability of the offspring ( with observation of small testis at necropsy ) , at exposure 3-fold the AUC at the maximum recommend human dose .
decrease in diastolic and systolic pressure and heart rate be note in the minipig , and a tendency to an hypotensive effect be discern in the monkey .
detailed information on this medicine be available on the European Medicines Agency ( EMEA ) web site : http : / / www . emea . europa . eu .
- ACE inhibitor or Angiotensin II receptor antagonist ( use for high blood pressure and heart failure )
BATCH NUMBER
immune reactivation syndrome : in HIV-infected patient with severe immune deficiency at the time of institution of combination antiretroviral therapy ( CART ) , an inflammatory reaction to asymptomatic or residual opportunistic pathogen may arise and cause serious clinical condition , or aggravation of symptom .
3 .
myalgia , rarely myolysis , arthralgia , elevate creatine phosphokinase
Mimpara 90 mg film-coated tablet Cinacalcet
if you have be tell by your doctor that you have an intolerance to some sugar ( e. g. lactose ) , contact your doctor before take this medicine .
dosage The dose recommendation make be in nominal dose .
EU / 1 / 04 / 292 / 007
method of administration Tasmar be administer orally three time daily .
in clinical study , few patient ( & lt ; 0.3 % ) treat with lumiracoxib develop perforation , obstruction or bleeds ( POBs ) .
1 .
the target haemoglobin concentration in two study be & gt ; 13 g / dl ; in the remain three study it be 12-14 g / dl .
protective liner :
the vaccine should never be give into a vein .
6 .
60 vial with powder for solution for injection 60 vial with solvent 60 3 ml syrinx 60 1 ml syrinx 180 alcohol swab
read the package leaflet before use .
DATE OF REVISION OF THE TEXT
Neurontin
oral use
12 .
flu-like symptom tend to be most prominent at the initiation of therapy and decrease in frequency with continued treatment .
it explain how the Committee for Medicinal Products for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
these measure will help to protect the environment .
read all of this leaflet carefully before you start take this medicine .
reproductive system and breast disorder :
10 Observed for fast normal level at baseline ( & lt ; 1.016 mmol / l ) which increase to high ( ≥ 1.467 mmol / l ) and change in fast triglyceride from borderline at baseline ( ≥ 1.016 mmol / l - & lt ; 1.467 mmol / l ) to high ( ≥ 1.467 mmol / l ) .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
in some disease type , however , longer treatment of up to about 1 month may be require .
Table 1 give the adverse reaction observe from spontaneous reporting and in placebo-controlled clinical trial ( comprise a total of 5253 patient , 3289 on duloxetine and 1964 on placebo ) .
rash , alopecia
5 day
Table 5 :
• Bring the NovoSeven powder and water vial to room temperature ( but not above 37 ° C ) .
Suomi / Finland GlaxoSmithKline Oy Puh / Tel : + 358 ( 0 ) 10 30 30 30 Finland . tuoteinfo @ gsk . com
in the event of deterioration , the treatment should be discontinue ( see also section 4.5 ) .
50 mg losartan potassium - Film-coated tablet 12.5 mg hydrochlorothiazide
the most frequent adverse reaction during treatment with epoetin alfa be a dose-dependent increase in blood pressure or aggravation of exist hypertension .
because the bile acid be prevent from be absorb into the bloodstream , the liver be force to make more bile acid .
patient should be advise to seek medical advice if they experience joint ache and pain , joint stiffness or difficulty in movement .
tell your doctor if you be breast-feeding .
Posology Adults :
for composite endpoint , statistically significant efficacy against disease be demonstrate against HPV type phylogenetically relate to HPV 16 ( primarily HPV 31 ) whereas no statistically significant efficacy be observe for HPV type phylogenetically relate to HPV 18 ( include HPV 45 ) .
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER
7 .
2 .
although specific study have not be perform , co-administration of Invirase / ritonavir with medicinal product that be mainly metabolise by CYP3A4 pathway may result in elevated plasma concentration of these medicinal product .
for HCV / HIV co-infected patient , the duration of treatment be 48 week .
reactivation of hepatitis B have occur in patient receive a TNF-antagonist include Trudexa , who be chronic carrier of this virus .
metabolism :
E Rare : other bleeding ( hepatic , retroperitoneal ,
( 17.6-28.9 )
if severe adverse event develop during interferon alfa -2b treatment , particularly if granulocyte decrease to & lt ; 500 / mm3 or alanine aminotransferase / aspartate aminotransferase ( ALT / AST ) rise to & gt ; 5 x upper limit of normal , discontinue treatment temporarily until the adverse event abates .
cardiovascular ( CVS ) adverse event , particularly arrhythmia , appear to be correlate mostly with pre-existing CVS disease and prior therapy with cardiotoxic agent ( see section 4.4 ) .
vomiting , diarrhoea or soften faeces may occur during treatment .
this study support 500 μ g once
other provision
a observe for angiotensin convert enzyme inhibitor , telmisartan and the other angiotensin II receptor antagonist be apparently le effective in lower blood pressure in black people than in non-blacks , possibly because of higher prevalence of low-renin state in the black hypertensive population .
common ( ≥ 1 / 100 to & lt ; 1 / 10 )
you should not switch to another nebuliser without consult your treat doctor .
0.002 * *
Table 7 provide crude absolute risk by last statin prior to diagnosis and the adjust Odds Ratios for myopathy with the last statin ( with or without gemfibrozil ) compare to non- concurrent cerivastatin .
use during anaesthesia with halothane and oxygen have not be study .
10ml ( 3.5 mg / ml )
Novo Nordisk Production SAS 45 , Avenue d ’ Orléans F-28002 Chartres France
2 .
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
base on information available to date , correction of anaemia with erythropoietin in adult patient with renal insufficiency not yet undergoing dialysis do not accelerate the rate of progression of renal insufficiency .
alopecia ; Nail disorder ( no severe ) Anorexia ( G3 / 4 :
ITT = Intention to Treat NC = F : non-completers = failure
2 .
QUALITATIVE AND QUANTITATIVE COMPOSITION
España sanofi-aventis , S. A Tel : + 34 93 485 94 00
h .
liver problem :
do not use Insulin Human Winthrop Comb 50
hypersensitivity to the active substance or to any of the excipients .
incidence of hypoglycaemia at endpoint Bodyweight gain2 1 from baseline to end of Liprolog Mix25 treatment 2
HDPE bottle with a child-resistant polypropylene closure .
the needle should be keep under the skin for at least 6 second to make sure the entire dose be inject .
the recommend starting dose be 4 mg daily , give a a single dose , or in two 2 mg dos .
7 .
3 cartridge of 3 ml 4 cartridge of 3 ml 5 cartridge of 3 ml 6 cartridge of 3 ml 9 cartridge of 3 ml 10 cartridge of 3 ml
dosage ( mg of base )
coadministration of a single zaleplon 10 mg dose and venlafaxine ( extended release ) 75 mg or 150 mg daily do not produce any interaction on memory ( immediate and delayed word recall ) or psychomotor performance ( digit symbol substitution test ) .
of the circulating metabolite , the majority be glucuronide conjugate of posaconazole with only minor amount of oxidative ( CYP450 mediate ) metabolites observe .
dose adjustment in order to maintain haemoglobin ( Hb ) value at the desired level :
B03XA .
skin and subcutaneous tissue disorder
if symptom , such a recurrent headache , visual problem , nausea , or vomit occur , please ask your doctor for advice .
* Virological breakthrough : “ 1 log above nadir ” definition assess at week 104
no teratogenic effect have be observe in animal study .
ROUTE of Administration
there be no difference in response to Irbesartan Hydrochlorothiazide BMS , regardless of age or gender .
1 / 20 1 .
United Kingdom Boehringer Ingelheim Ltd .
animal study have show reproductive toxicity ( see section 5.3 ) .
59 Correction phase :
administration of the capsule content with a small amount ( 1-2 teaspoon ) of food may be consider for patient who can not tolerate the oral solution .
Doc Generici Srl Via Manuzio , 7 20124 Milano Italy
( n = 220 )
the initial dosing recommendation for patient with hepatic impairment be the same a describe above .
België / Belgique / Belgien GlaxoSmithKline s.a. / n.v .
malignant tumour be note predominantly in the uterus of mid- and high-dose female .
Nespo should be use with caution in patient with epilepsy .
affect more than 1 user in 10 affect 1 to le than 10 user in 100 affect 1 to le than 10 user in 1,000 affect 1 to le than 10 user in 10,000 affect le than 1 user in 10,000 frequency can not be estimate from the available data
© European Medicines Agency , 2008 .
S Very rarely :
solution for injection in a pre-filled syringe
EXUBERA 3 mg
Diacomit 500 mg capsule Stiripentol
Foreword by the Chairman of the Management Board .............................. .. 6
6 .
Table 8 - Efficacy Responses in Placebo-Controlled AS Study – Study VIII i dic
lot
patient schedule for major elective orthopaedic surgery should receive adequate antithrombotic prophylaxis , a thrombotic and vascular event may occur in surgical patient , especially in those with underlying cardiovascular disease .
9 .
the average half-life be 6 – 7 hour .
risk factor that may predispose this patient population to increase mortality include age & gt ; 65 year , dysphagia , sedation , malnutrition and dehydration , pulmonary condition ( e. g . , pneumonia , with or without aspiration ) , or concomitant use of benzodiazepine .
BATCH :
- either 400 mg to be take a one tablet of 400 mg once a day ,
PHARMACEUTICAL FORM AND CONTENTS
do not remove the adapter housing at this step .
solvent :
- improve insulin sensitivity ( by , e. g . , removal of stress factor ) ,
Removing the needle
solution for injection 5mg / ml 1
administration of Zenapax inhibit IL-2-mediated activation of lymphocyte , a critical pathway in the cellular immune response involve in allograft rejection .
base on information available to date , treatment of anaemia with Abseamed in adult patient with chronic kidney failure ( renal insufficiency ) who do not yet require dialysis , do not accelerate the rate of progression of renal insufficiency .
with somatropins , in vitro and in vivo genotoxicity study on gene mutation and induction of chromosome aberration have be negative .
Humira be indicate for treatment of severe , active Crohn ’ s disease , in patient who have not respond despite a full and adequate course of therapy with a corticosteroid and / or an immunosuppressant ; or who be intolerant to or have medical contraindication for such therapy .
a .
any unused solution must be discard not later than 28 day after first opening .
Selamectin 30 mg
oral use
3 .
doctor prescribe Arava need to be aware of the risk of liver problem associate with the medicine .
tablet core : lactose monohydrate , croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate .
these effect of ranolazine on the surface electrocardiogram be believe to result from inhibition of the fast-rectifying potassium current , which prolong the ventricular action potential , and from inhibition of the late sodium current , which shorten the ventricular action potential .
baseline urinalysis be recommend , and patient should be monitor for the development or worsening of proteinuria .
B .
the contribution of this to the total elimination in an overdose situation be unknown .
the increase efavirenz concentration observe follow administration of STOCRIN with food may lead to an increase in frequency of adverse reaction ( see section 4.4 and 5.2 ) .
- hepatic impairment .
3
child and adolescent
( 3 day ) , in some patient after 48 hour ( 2 day ) .
5.5
EU / 1 / 99 / 102 / 004-006
administration
11 .
pramipexole alleviate Parkinsonian motor deficit by stimulation of dopamine receptor in the striatum .
5.2 Pharmacokinetic property
pharmacological PROPERTIES
adverse reaction
the outer and inner needle cap should be remove .
Phosphodiesterase type 5 ( PDE5 ) inhibitor -
no recommendation can currently be make regard adjustment of amprenavir dose when amprenavir be co-administered with methadone .
a with other calcium channel blocker , haemodynamic measurement of cardiac function at rest and during exercise ( or pace ) in patient with normal ventricular function treat with amlodipine have generally demonstrate a small increase in cardiac index without significant influence on dP / dt or on
33 ANNEX III
not all pack may be market .
it may harm them , even
the vaccine suspension should be spread evenly over the correct number of chicken , at a distance of 30-40 cm use a coarse spray , preferably when the chicken be sit together in dim light .
what be ‘ Prepandemic influenza vaccine ( H5N1 ) ( split virion , inactivate , adjuvanted ) GlaxoSmithKline Biologicals ’ ? ‘ Prepandemic influenza vaccine ( H5N1 ) ( split virion , inactivate , adjuvanted ) GlaxoSmithKline Biologicals ’ be a vaccine that be give by injection .
opinion FOLLOWING AN ARTICLE 33 ( 4 ) REFERRAL FOR DOXYPREX 100mg PREMIX
NeoRecormon be also available in a cartridge and a pre-filled syringe .
65.5 % ) ; Thrombocytopenia ( G3 / 4 :
5 .
Kaplan-Meier estimate of 18-month survival for each study be show below .
strength 6 mg / ml 6 mg / ml 6 mg / ml 6 mg / ml
the class of medicine to which Epivir belongs ( NRTIs ) can cause a condition call lactic acidosis build up of lactic acid in the body ) , together with an enlarged liver .
for a full list of excipients , see section 6.1 .
Tel : + 371 67 50 21 85
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
when tenecteplase be give during the mid- or late-embryonal period maternal animal show vaginal bleeding on the day after the first dose .
the release characteristic of INVEGA result in minimal peak-trough fluctuation a compare to those observe with immediate-release risperidone ( fluctuation index 38 % versus 125 % ) .
B .
28 / 56
severe ( grade 3 or 4 ) nausea , vomit , diarrhoea and mucositis incidence be 4 , 3 , 2 and 1 % respectively .
- tingling in the hand and foot
Eesti Novartis Pharma Services Inc .
therefore , dos will be express in term of both pramipexole base and pramipexole salt ( in bracket ) .
Janssen-Cilag Ltd Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom
for animal treatment only .
read ENCLOSED PACKAGE LEAFLET
31 %
4-478 ) .
patient with know risk for narrow-angle glaucoma .
Janssen Cilag N. V .
discontinuation or down- titration of Crestor may result in a decrease in INR .
paediatric patient on haemodialysis The treatment be divide into two stage :
95 Once the therapeutic objective for an individual patient have be achieve , the dose should be reduce by 25 to 50 % in order to maintain haemoglobin at that level .
28 coated tablet 56 coat tablet
{ INVENTED NAME } { pharmaceutical form } must not be use during pregnancy ( see section 4.6 ) .
tablet must be swallow whole .
in clinical study , tadalafil be show to augment the hypotensive effect of nitrate .
duration of treatment Continue to take Axura a long a it be of benefit to you .
Insuman SoloStar be white with a colour on the injection button .
find a comfortable , well-lit place and put everything you need where you can reach them ( the Biograstim pre-filled syringe , alcohol wipe and the puncture-proof container ) .
do not take a double dose to make up for the forgotten individual dos .
gastrointestinal Disorders
cerebral haemorrhage , hypertension
Special precaution for use in animal
16 .
cetirizine dihydrochloride
insulin Human Winthrop Comb 25 be a biphasic isophane insulin suspension consist of 25 % dissolve insulin and 75 % crystalline protamine insulin .
it have a high affinity for serotoninergic 5-HT2 and dopaminergic D2 receptor .
component of a multi-pack comprising 2 pack , each contain 98 film-coated tablet .
common
Č eská republika Pfizer s. r. o .
( 44-20 ) 74 18 84 00 Fax ( 44-20 ) 74 18 84 16 E-mail : mail @ emea . europa . eu http : / / www . emea . europa . eu
the infusion dose need to be reduce in patient with kidney problem who be undergo PCI .
1 .
medicinal product subject to medical prescription .
•
oral use
DATE remove from refrigerator : _ _ / _ _ / _ _ _ _ _ End of 9-month period at room temperature : _ _ / _ _ / _ _ _ _ _
4.5 Interaction with other medicinal product and other form of interaction
6 .
the vaccine be mix by withdraw the content of the vial contain the emulsion ( Vial B ) by mean of a syringe and by add it to the vial contain the suspension ( Vial A ) .
- Blurred vision
33 ( 0 ) 4 92 08 73 00 Österreich VIRBAC Österreich GmbH Hildebrandgasse 27 A-1180 Wien Tel :
9 The proportion of patient who discontinue treatment due to adverse event during the double-blind , control portion of pivotal study be 4.5 % for patient take Humira and 4.5 % for control treated patient .
Postural hypotension Postural hypotension be infrequently observe in the elderly in olanzapine clinical tria l .
6 .
content BY WEIGHT , BY VOLUME OR BY UNIT
nervous system disorder : dizziness
Κύπρος INFAI , Institut für biomedizinische Analytik und NMR-Imaging GmbH Universitätsstraße 142 D-44799 Bochum Τηλ : + 49 234 971130 Latvija INFAI , Institut für biomedizinische Analytik und NMR-Imaging GmbH Universitätsstraße 142 D-44799 Bochum Deutschland / Germany Tel : + 49 234 971130 Lietuva INFAI , Institut für biomedizinische Analytik und NMR-Imaging GmbH Universitätsstraße 142 D-44799 Bochum Deutschland / Germany Tel : + 49 234 971130
diarrhoea ( G3 / 4 :
7 .
CONDITIONS OF THE MARKETING AUTHORISATION
a some adverse reaction occur with greater frequency in this age group ( see section 4.8 ) compare with adult , temporary dose reduction or interruption may be require ; these will need to take into account relevant clinical factor include severity of reaction .
z O. O .
- The active substance be lansoprazole
≥ 100,000 / mm3 ≥ 1,500 / mm3 must be within normal limit
package size
LABELLING AND PACKAGE LEAFLET
MARKETING Authorisation Holder and Manufacturer
in addition , the observed trough nevirapine concentration be comparable between the two method .
information IN BRAILLE
haemoglobin decrease
literature data from untreated SGA child / adolescent without early spontaneous catch-up suggest a late growth of 0.5 SDS .
6.6 Special precaution for disposal and other handling
methotrexate should be continue during treatment with Trudexa .
ribavirin
from a microbiological point of view , the product must be use immediately .
choose a site for injection .
angiotensin II receptor antagonist therapy exposure during the second and third trimester be know to induce human fetotoxicity ( decreased renal function , oligohydramnios , skull ossification retardation ) and neonatal toxicity ( renal failure , hypotension , hyperkalaemia ) .
16 .
Lyrica be indicate a adjunctive therapy in adult with partial seizure with or without secondary generalisation .
take special care with Ciprofloxacin Bayer ) , small , pin -point
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
PSA be a protein that be produce by the prostate gland and be often find at high level in men with prostate cancer .
alcohol may intensify and prolong the hypoglycaemic effect of insulin .
312 6.6 Special precaution for disposal
- high initial dos of lamotrigine and exceed the recommend dose escalation of
the virus may then become harder to treat .
tipranavir should be use during pregnancy only if the potential benefit justify the potential risk to the foetus .
pharmacological PROPERTIES
how do Micardis work ?
fatigue * , asthenia * , peripheral oedema Common :
how TO USE FOSCAN
food do not affect the bioavailability of CoAprovel .
overall , sitagliptin improved glycaemic control when use in combination with metformin ( a initial or add-on therapy ) and in combination with a sulphonylurea and metformin , a measure by clinically relevant reduction in HbA1c from baseline at study endpoint ( see Table 3 ) .
Humalog 100 U / ml KwikPen , solution for injection ( insulin lispro )
thiazide should be use with caution in patient with impaired hepatic function ( see section 4.4 ) .
25 / 50
( day 1-21 )
the safety and efficacy of efavirenz have not be establish in patient with significant underlie liver disorder .
these medicinal product may potentiate the effect of hydrochlorothiazide on serum potassium ( see section 4.4 ) .
MIRCERA can be inject subcutaneously in the abdomen , arm or thigh .
6.4 Special precaution for storage
Pegasys Combination Therapy
hypothyroidism § , hyperthyroidism § Diabetes , aggravate diabetes
patient have a BMI ≥  30 kg / m ² or BMI & gt ; 27 kg / m ² Me
9 .
lithium : the combination of lithium and Aprovel be not recommended ( see section 4.5 ) .
after dose interruption a haemoglobin decrease of approximately 0.35 g / dl ( 0.22 mmol / l ) per week be expect .
medicinal product subject to medical prescription
Germany Schwarz Pharma Deutschland GmbH Alfred-Nobel-Str .
what ProQuad contains
the pharmacokinetic profile of maropitant when administer a a single subcutaneous dose of 1 mg / kg body weight to dog be characterise by a maximum concentration ( Cmax ) in plasma of approximately 92 ng / ml ; this be achieve within 0.75 hour post-dosing ( Tmax ) .
2 .
Paxene solution should be prepare and store in glass , polypropylene , or polyolefin container .
deliver
România GlaxoSmithKline ( GSK ) S. R. L .
this medicinal product contain le than 1 mmol sodium ( 23 mg ) per dose , i. e. essentially “ sodium- free ” .
EU / 2 / 00 / 028 / 002
follow a single intravenously administer 100 mg dose of & # 91 ; 14C & # 93 ; - fosaprepitant , a prodrug for aprepitant , to healthy subject , 57 % of the radioactivity be recover in urine and 45 % in faeces .
2 .
reduction in haematological parameter require clinical intervention have be report from postmarketing experience .
if no photosensitivity reaction ( erythema , oedema , blister ) occur within 24 hour , the patient can gradually resume normal outdoor activity , initially continue to exercise caution and gradually allow increase exposure .
- fibrates ( use to lower high level of blood lipid ) ,
Tel : + 44 ( 0 ) 1707 366000
4 .
common
1 .
110 Common : affect 1 to 10 user in 100 Uncommon : affect 1 to 10 user in 1,000 Not know : frequency can not be estimate from the available data .
6 .
for HCV / HIV co-infected patient , the duration of treatment be 48 week .
148 B .
there be no evidence of clinically relevant medicine accumulation follow once daily dosing of desloratadine ( 5 mg to 20 mg ) for 14 day .
visually inspect parenteral medicinal product for particulate matter or discolouration prior to administration .
Slovenská republika Strakova 5 SK-811 01 Bratislava Tel : + 421 ( 2 ) 5920 2712
other
9 .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
product in vivo by inhibition of CYP-mediated metabolism .
Peel off the paper cover on the vial adapter plastic housing .
the product label include the appropriate storage condition and the expiry date for the batch of product .
in child whose mother take NRTIs during pregnancy , the benefit from the protection against HIV outweigh the risk of side effect .
0.5 mg / ml
Delavirdine1 Ritonavir
66 6.5 Nature and content of container
4 .
Poland
MARKETING Authorisation Holder
patient must be educate to use the proper injection technique .
what Exforge look like and content of the pack Exforge 5 mg / 80 mg tablet be round and dark yellow with “ NVR ” on one side and “ NV ” on the other side .
IV / SC lp
ed Do pull the grey cap straight off
5.3 Preclinical safety data
statement OF ACTIVE SUBSTANCE ( S )
12 .
Ireland Ferring Ireland Ltd .
a pump lp
↑ 21 %
QS02CA03
no significant difference be find in the psychomotor test result between desloratadine and placebo group , whether administer alone or with alcohol .
diabetes mellitus , anorexia , increase appetite
each transdermal patch be pack in a separate sachet .
the solution should be administer slowly , at a rate a determine by the patient ’ s comfort level , not to exceed 10 ml per minute .
injection site reaction include reaction secondary to extravasation be usually mild and consist of erythema , tenderness , skin discoloration , or swell at the injection site but can result in cellulitis .
mutagenicity No evidence of mutagenicity or genotoxicity be observe in in vitro microbial mutagenesis ( Ames ) test , in vitro alkaline elution assay for DNA breakage and in vitro and in vivo chromosomal aberration study .
what Hepsera be Hepsera belongs to a group of medicine call antiviral medicine .
EU / 2 / 98 / 009 / 005
accelerate phase ( n = 119 )
Tel : + 386 1 580 2884 Suomi / Finland Novartis Healthcare A / S , Puh / Tel : + 45-39 16 84 00 Sverige Novartis Healthcare A / S Tel : + 45-39 16 84 00 United Kingdom Novartis Animal Health UK Ltd .
when consider the clinical relevance of these kinetics , it be more appropriate to examine the glucose utilisation curve property .
1 / 2 Special warning and precaution for use
PREZISTA must be take in combination with a low dose of ritonavir and other anti-HIV medicine .
clinical aspect :
reservoir during storage , the next step be to remove any air bubble .
19 / 24 PACKAGE LEAFLET
Neupro be a transdermal patch .
oral use .
the majority of patient be control with { PRODUCT NAME } 10 mg once a day .
C .
in addition some patient may experience vomiting .
common
lamivudine + NNRTI
15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
for the treatment and prevention of porcine respiratory disease cause by Pasteurella multocida and Bordetella bronchiseptica , susceptible to doxycycline , when the disease have be diagnose in the herd .
hair colour change
in most patient , after administration of a single oral dose , onset of antihypertensive activity occur within 2 hour , and the peak drop in blood pressure be achieve within 4 – 6 hour .
if there be particle in the injection solution or if either the powder or solution be discolour , the
however , base on the pharmacokinetic characteristic of levetiracetam , the pharmacokinetics in adult after intravenous administration and the pharmacokinetics in child after oral administration , the exposure ( AUC ) of levetiracetam be expect to be similar in paediatric patient age 4 to 12 year after intravenous and oral administration .
Merck Sharp & amp ; Dohme , inovativna zdravila d. o. o . , Tel : + 386.1.520.4201 Slovenská republika :
serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening .
direct Healthcare Professional Communication
5 mg Tabletten zur Herstellung einer 5 mg
outer CARTON
76 4.6 Pregnancy and lactation
56 Increased spleen size and very rare case of spleen rupture have be report .
blood do not contain enough red blood cell and the symptom may be fatigue , weakness and shortness of breath .
12 .
“ Treatment of essential hypertension ”
DATE of latest renewal :
when renal function be impair , renal clearance be decrease in proportion to that of creatinine and thus the elimination half-life be prolong , lead to increase level of metformin in plasma .
if their symptom be the same a yours .
depressed level of consciousness Disturbance in attention Cognitive disorder Hypoaesthesia Balance disorder Migraine Motor dysfunction Dysarthria
if an adjustment be need when switch the patient to Actrapid , it may occur with the first dose or during the first several week or month .
sign of allergy .
PHARMACEUTICAL FORM AND CONTENTS
twist off the needle and discard it properly .
BATCH NUMBER
QUALITATIVE AND QUANTITATIVE COMPOSITION
neither be there any hypothetical explanation regard possible effect on the immune or autonomous nervous system , on pro- convulsive mechanism or by mean of quality defect in the production of the multivalent vaccine .
elimination Valdecoxib be eliminate via hepatic metabolism with le than 5 % unchanged valdecoxib recover in the urine .
a single dose should be administer .
5 .
it be recommend that polyarticular juvenile idiopathic arthritis patient , if possible , be bring up to date with all immunisation in agreement with current immunisation guideline prior to initiate Humira therapy .
method AND ROUTE ( S ) OF ADMINISTRATION
if the patient forget to apply the patch at the usual time of the day or if the patch become detach , another patch should be apply for the remainder of the day .
dizziness Headache
uth 3 .
500 q12h
however , this do not preclude the occurrence of hepatic event in patient with cirrhosis ( include hepatocarcinoma ) .
after 54 week of treatment , both dos of infliximab + methotrexate result in statistically significantly greater improvement in sign and symptom compare to methotrexate alone a measure by the proportion of patient achieve ACR20 , 50 and 70 response .
6 .
rare :
statement OF ACTIVE SUBSTANCE ( S )
- silicone oil ,
it be recommend that the conduct of these test should be record in the patient ’ s alert card .
store in the original package in order to protect from moisture .
maize starch , maltodextrin , colloidal anhydrous silica ( E 551 ) , and in the tablet coating : Hypromellose ( E 464 ) , titanium dioxide ( E 171 ) , macrogol 6000 , glycerol ( E 422 ) , magnesium stearate ( E 470 B ) , yellow iron oxide ( E 172 ) , red iron oxide ( E 172 ) .
disorder
6.1 List of excipients
6.5 Nature and content of container M
the active substance in GONAL-f , follitropin alfa , be a copy of the natural hormone FSH ( follicle stimulate hormone ) .
CARTONS of 14 film-coated tablet :
13 .
Slovenská republika TIMED , s.r.o .
if you notice any of these symptom please inform your doctor .
solution for injection in a vial .
12 repaglinide ( a single dose of 0.25 mg ) increase the repaglinide AUC , Cmax and t ½ ( 1.6-fold , 1.4-fold and 1.2-fold respectively ) with no statistically significant effect on the blood glucose level .
interaction Do not administer concurrently with glucocorticosteroids , other non-steroidal anti-inflammatory drug or with anti-coagulant agent .
-11.4 ( 9.4 ) -23.0 ( 16.7 )
if the pen malfunction ( see instruction for use the pen ) , the suspension may be draw from the cartridge into an injection syringe ( suitable for an insulin with 100 IU / ml ) and inject .
not applicable
- The active ingredient in MabThera be call rituximab .
- you be recover from an illness or from fever ,
7.3
Volibris 10 mg film-coated tablet
lot
lenalidomide be generally more soluble in organic solvent but exhibit the greatest solubility in 0.1N HCl buffer .
expiry DATE
single use injection .
an increase relative risk of thromboembolic event ( RR 1.67 , 95 % CI :
lipodystrophy may occur at the injection site a a consequence of failure to rotate injection site within an area .
method AND ROUTE ( S ) OF ADMINISTRATION
a clinical study perform in Latin America evaluate Rotarix in more than 20000 subject .
74.2 ; 100 ) .
name and address of the manufacturer responsible for batch release for syrup
- shortness of breath include asthmatic symptom
the amount or timing of insulin , food or exercise may need to be adjust .
EU Number
please tell your doctor or pharmacist .
Special STORAGE CONDITIONS
the change may be more noticeable if you be only treat one eye .
• Truvada should be take with food ( for example , a meal or a snack ) .
- Previous successful participation at a training course , or equivalent course during the phase
Pravachol
each tablet contain 150 mg of irbesartan .
1 .
how TO USE GARDASIL
Aranesp 500 microgram solution for injection in a pre-filled pen Darbepoetin alfa
what Ceftriaxone Tyrol Pharma 1g look like and content of the pack
paediatric population
each ml of oral suspension contain 50 mg fosamprenavir a fosamprenavir calcium ( equivalent to approximately 43 mg amprenavir ) .
dosage FOR EACH SPECIES , ROUTE ( S ) AND METHOD OF ADMINISTRATION
ViraferonPeg .
PHARMACEUTICAL PARTICULARS
they be produce and secrete by cell in response to viral infection or various synthetic and biological inducer .
these transient change start in the same concentration range a after maximum recommend clinical dosing .
3 .
Κύπρος ratiopharm GmbH , Γερμανία Τηλ : + 49 731 402 02
the plastic cap must be remove from the vial and the stopper disinfect with alcohol .
before use , the vaccine should be well shake .
you can take Oprymea with or without food .
it be essential for patient with pre-existing or gestational diabetes to maintain good metabolic control throughout pregnancy .
read all of this leaflet carefully before you start take this medicine .
CoAprovel should not be use in patient with severe renal impairment ( creatinine clearance & lt ; 30 ml / min ) ( see section 4.3 ) .
very rare :
other SPECIAL WARNING ( S ) , IF NECESSARY lp
clinical study of 284 triple seronegative child , 11 month to 7 year of age , demonstrate that the previous formulation of the measles , mumps , and rubella vaccine manufacture by Merck & amp ; Co . , Inc. be highly immunogenic and generally well tolerate .
Tél / Tel : + 32 ( 0 ) 2 529 43 11
16 .
Removing the needle
before you take Doxazosin Retard Arrow 4 mg prolong release tablet and associate name 3 .
after reconstitution , each ml of solution contains approximately 125 IU moroctocog alfa .
please tell your doctor or pharmacist .
EXP :
MIRCERA , like other ESAs , be a growth factor that primarily stimulate red blood cell production .
- increase amount of certain substance in the blood ( transaminase and / or bilirubin )
41 4.4 Special warning and precaution for use
weight twice daily with a maximum of 500 mg per dose .
België / Belgique / Belgien Bayer S. A . / N. V .
care should be take to ensure that at the outset of the treatment patient be not iron deficient .
store in a refrigerator ( 2 ° C – 8 ° C ) Do not freeze Protect from light During use : use within 4 week Do not refrigerate or store above 30 ° C
4.3 Contraindications
what RAPAMUNE IS AND WHAT IT IS USED FOR
swab ;
30 film-coated tablet 100 film-coated tablet
AD hoc Group on Antimicrobial Resistance
Annex
Succursale belge Tél : + 32 ( 0 ) 2 373 42 11 MSDBelgium _ info @ merck . com
pharmacokinetics in special population
26 August 2005 ) , here ( HES and CEL :
package size
0.1
do not use Humalog Mix25 KwikPen after the expiry date which be state on the label and the carton .
the negative predictive value for sustained response in patient treat with PegIntron in monotherapy be 98 % .
package with 1 sponge of 9.5 cm x 4.8 cm Package with 2 sponge of 4.8 cm x 4.8 cm Package with 1 sponge of 3.0 cm x 2.5 cm Package with 5 sponge of 3.0 cm x 2.5 cm
transient rash do not necessitate interruption of treatment .
other SPECIAL WARNING ( S ) , IF NECESSARY
if you want more information on the basis of the CVMP recommendation , read the Scientific Discussion ( also part of the EPAR ) .
in patient with high blood pressure and type 2 diabetes with kidney disease , dizziness when get up from a lying or sit position , low blood pressure when get up from a lying or sit position , pain in joint or muscle and decreased level of a protein in the red blood cell ( haemoglobin ) be also report .
you should check with your doctor or pharmacist if you be unsure .
1 .
it be not know whether Rebif be excrete in human milk .
patient should receive supplemental Calcium and vitamin D supplement if dietary intake be inadequate .
hypertension Respiratory , thoracic and mediastinal disorder :
more extensive haemarthrosis , muscle bleeding or haematoma
ER The haemoglobin should be measure every one or two week until it be stable .
the marketing authorisation holder be CIS bio international .
Tel : + 39 06 50 39 61
sodium salicylate
method AND ROUTE ( S ) OF ADMINISTRATION
step 6 - Injecting the solution Depress the plunger slowly and steadily , so the solution be correctly inject and the skin tissue be not damage .
Präparate GmbH & amp ; Co KG Sandweg 94 D-60316 Frankfurt
18 %
the company inform the CHMP that there be no consequence for patient currently include in clinical trial with Cerepro .
1 .
package SIZE
Moreover , the safety profile of clopidogrel in this subgroup of patient do not raise any particular concern .
2 / 2
water or other liquid be not need to swallow the dose .
it be recommend that the INR should be monitor frequently during and shortly after co-administration of ciprofloxacin with an oral anticoagulant agent .
the overall incidence of adverse event report with telmisartan ( 41.4 % ) be usually comparable to placebo ( 43.9 % ) in placebo control trial .
- you do not eat enough , or eat food contain le carbohydrate than normal ( sugar and substance
Stada Arzneimittel AG Stadastr .
asthenia
subcutaneous and intramuscular administration of Rebif produce equivalent exposure to interferon beta .
HYCAMTIN be contraindicate in patient who − have a history of severe hypersensitivity to the active substance or to any of the excipients − be breast feeding ( see section 4.6 ) − already have severe bone marrow depression prior to start first course , a evidence by baseline neutrophil & lt ; 1.5 x 109 / l and / or a platelet count of & lt ; 100 x 109 / l .
31.25 mg twice daily 62.5 mg twice daily
BATCH NUMBER lo
Ireland Novartis Ireland Limited Tel : + 353 1 260 12 55
name OF THE MEDICINAL PRODUCT
nifedipine Pharmamatch retard 60 mg prolonged-release tablet
4.7 Effects on ability to drive and use machine
subcutaneous use .
Dame Roselinde HURLEY Jean-Pierre REYNIER European Commission
the frequency of the side effect list below be define use the following convention :
Intervet International BV Wim de Korverstraat 35 NL-5831 AN Boxmeer The Netherlands
Tel : + 370 5 269 16 50
Anti-Polio type 3 ( 1 / 8 dilution ) †
• Do not use the residual scale to measure your dose of insulin .
the CHMP normally take up to 210 day to evaluate a new application .
gently squeeze the side of the cover and pull apart .
diarrhoea , nausea , vomit , oral mucosal disorder ( e. g . , aphthous stomatitis , mouth ulceration ) , abdominal pain
this indication be base on Study 114 , a single-centre , double blind , parallel , 2-period , dose escalation study to evaluate the efficacy and safety of high-dose simvastatin ( 80 and 160 mg ) in patient with Homozygous Familial Hypercholesterolemia .
6.3 Shelf life
10 DATE OF REVISION OF THE TEXT
expiry DATE
surgery patient in autologous predonation programme
GlaxoSmithKline UK Tel : + 44 ( 0 ) 808 100 9997 customercontactuk @ gsk . com
6.3 Shelf life
if you attempt to dose more than 4 mg at a time , the medicine will either be force out of the needle and waste or excess pressure will be place upon the cartridge and it may crack .
EMEA / 123938 / 2006
2 release
28 hard capsule 56 hard capsule 112 hard capsule
16 .
the reference vaccine change include in this referral relate to the replacement of batch 8500 with 9097 and the subsequent replacement of batch 9097 with 9861 .
the needle cover of the pre-filled syringe contains dry natural rubber ( a derivative of latex ) , which may cause allergic reaction .
cimetidine ( 400 mg twice daily ) increase voriconazole Cmax and AUCτ by 18 % and 23 % , respectively .
do not use Liprolog KwikPen after the expiry date which be state on the label and the carton .
4.1 Therapeutic indication
expiry DATE
always check the pack and the cartridge label for the name and type of the insulin when you get it from your pharmacy .
Comtess be use together with levodopa to treat Parkinson ’ s disease .
olanzapine Neopharma 2.5 mg coat tablet
6 ( 7.5 % ) 3 ( 3.8 % ) 2 ( 2.5 % ) 1 ( 1.3 % )
2 .
associate with various common cancer who receive recombinant human erythropoietin compare ed
EU / 2 / 08 / 089 / 014
Uncommon ( ≥ 1 / 1,000 to & lt ; 1 / 100 )
the following be example of disposable needle that can be use with the BYETTA pen :
1 1
100 Units / ml
ear and labyrinth disorder
& # 91 ; see Annex I - To be complete nationally & # 93 ;
ask your pharmacist how to dispose of medicine no longer require .
61 % 24 %
5 .
additional medical management may include cessation of anticoagulant and / or antiplatelet therapy , reversal of anticoagulation , or platelet support .
the Committee recommend that Lysodren be give market authorisation .
1 .
{ month / year }
haemoglobin variability should be address through dose management , with consideration for the haemoglobin target range of 10 g / dl ( 6.21 mmol / l ) to 12 g / dl ( 7.45 mmol / l ) .
insulin have no specific overdose definition because serum glucose concentration be a result of complex interaction between insulin level , glucose availability and other metabolic process .
130 µg
you should continue Keppra treatment for a long a your doctor have tell you . • Do not stop your treatment without your doctor ’ s advice a this could increase your seizure .
6 .
read the package leaflet before use .
Krka , d. d . , Novo mesto , Š marješ cesta 6 , 8501 Novo mesto , Slovenia ka
43 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
the Liposome Company US
however , when drive or operate machinery , it should be take into account that dizziness and drowsiness have be report with sitagliptin .
8 .
Thrombocytosis have be observe but it occurrence be very rare ( see section 4.4 ) .
to be take into consideration by patient on a controlled sodium diet .
Uncommon : gynaecomastia
then eat something that have a long-acting effect in raise your blood sugar ( such a bread or pasta ) .
however , because sitagliptin be primarily renally eliminate , severe hepatic insufficiency be not expect to affect the pharmacokinetics of sitagliptin .
in addition to the interaction list above , a ritonavir be highly protein bound , the possibility of increase therapeutic and toxic effect due to protein bind displacement of concomitant medication should be consider .
in addition , an updated RMP should be submit
check the appearance of Aranesp through the inspection window .
method AND ROUTE ( S ) OF ADMINISTRATION
there have be report of mitochondrial dysfunction in HIV-negative infant expose in utero and / or post-natally to nucleoside analogue .
you can carry it with you and keep it at room temperature ( not above 30 ° C ) for up to 6 week .
the available clinical data be insufficient to exclude a risk .
insulin human
eye disorder :
film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet
in clinical trial with ZYPADHERA , the only adverse reaction report at a statistically significantly higher rate in the ZYPADHERA group than in the placebo group be
Actrapid should not be dispose of via wastewater or household waste .
QUALITATIVE AND QUANTITATIVE COMPOSITION
salmeterol xinafoate and fluticasone propionate
- Keep this leaflet .
period should be extend to 28 day or the use of alternative vaccine should be consider . in ic
some medicine cause change in the blood sugar level ( decrease , increase or both depend on the situation ) .
ambrisentan and it metabolite be eliminate primarily in the bile follow hepatic and / or extra-hepatic metabolism .
the following additional adverse reaction have be observe with Prometax transdermal patch : anxiety , delirium , pyrexia ( common ) .
hence , no dose adjustment be require in these patient .
CARTONS of 56 x 1 film-coated tablet ; 7 blister card of 8 x 1 film-coated tablet each in PVC / PVDC / Aluminium perforate unit dose blister .
also be sure to tell your doctor if you be breast-feeding .
100 IU / ml
outer carton - 400 mg hard capsule
MARKETING AUTHORISATION NUMBER ( S )
there be 1095 patient include in the primary Modified Intention-To-Treat ( MITT ) efficacy analysis of overall favourable response ; caspofungin ( 33.9 % ) be a effective a liposomal amphotericin B ( 33.7 % ) & # 91 ; % difference 0.2 ( 95.2 % CI – 5.6 , 6.0 ) & # 93 ; .
51 ( 24.4 % ) 53 ( 25.4 % ) 41 ( 19.6 % ) 59 ( 28.2 % )
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
among the 15 case , the severity be record a mild in 11 case , moderate in one case and not record in 3 case .
0.660
Repeated-dose toxicity In study up to 3 month duration in mouse and up to 1 year in rat and dog , the predominant effect be CNS depression , anticholinergic effect , and peripheral haematological disorder .
due to biochemical and physiological modification and reduction of muscular mass , this formulation be not recommend to be start in this sub-group of patient .
no special requirement .
Tel : + 34 91 456 53 00
in the same clinical trial , cerebrovascular adverse event ( CVAE e. g . , stroke , transient ischemic attack ) , include fatality , be report .
7 .
do not freeze .
HbA1c be stable in both duloxetine-treated and placebo-treated patient .
United Kingdom UCB Pharma Ltd .
available tacrolimus be generally rapidly absorb .
BATCH NUMBER
Slovenia
the safety of the veterinary medicinal product have not be establish during pregnancy and lactation ( see section 4.3 ) .
12 .
Temodal hard capsule be administer in combination with focal radiotherapy ( concomitant phase ) follow by up to 6 cycle of temozolomide ( TMZ ) monotherapy ( monotherapy phase ) .
Prolongations in PR interval with lacosamide have be observe in clinical study .
oral use
25 mg
Annex I
1 / 21
if you take more capsule than you have be tell to take , or if someone else accidentally take your medicine , immediately see a doctor or go to a hospital straight away .
clinical PARTICULARS
EXP
what Tasigna be Tasigna be a medicine contain an active substance call nilotinib .
lot :
for any information about this medicinal product , please contact the local representative of the Marketing Authorisation Holder :
not applicable
what Tredaptive contain • The active substance be nicotinic acid and laropiprant .
with the exception of dry skin , rash , and taste perversion , the incidence of clinical adverse reaction be similar or higher among patient treat with antiretroviral nucleoside analogue control than among patient treat with CRIXIVAN alone or in combination .
65 / 40 LT-08124 Vilnius Tel . + 370 52 101868
follow 26 week of therapy , Aldurazyme-treated patient show improved respiratory function and walk ability a compare to placebo a indicated below .
midazolam and other benzodiazepine metabolise by CYP3A4 :
keep out of the reach and sight of child .
capsule Oro-dispersible tablet Oro-dispersible tablet
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
strength
2 year
0.4
lot :
if you take more Viani than you should It be important to take Viani a your doctor recommend .
( n = 3260 )
lamivudine have no effect on the pharmacokinetics of trimethoprim or sulfamethoxazole .
Kaletra have be show in vivo to induce it own metabolism and to increase the biotransformation of some medicinal product metabolise by cytochrome P450 enzyme and by glucuronidation .
195 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
the effect of the irbesartan / hydrochlorothiazide combination on fertility have not be evaluate in animal study , a there be no evidence of adverse effect on fertility in animal or human with either irbesartan or hydrochlorothiazide when administer alone .
chronic pulmonary disease In patient with chronic obstructive or other pulmonary disease fentanyl may have more severe adverse reaction , in such patient opioids may decrease respiratory drive and increase airway resistance .
3 .
in the event of polycythaemia , Aranesp should be temporarily withhold ( see section 4.2 ) .
see also section 3 HOW TO USE M-M-RVAXPRO .
the most notable unwanted effect report with STOCRIN in combination with other anti-HIV medicine be skin rash and nervous system symptom .
the educational material be aim at risk minimisation and will support safe and effective use of the product by the patient .
a pharmacokinetic study in patient with chemotherapy-induced anaemia treat with 6.75 µg / kg darbepoetin alfa administer SC every 3 week in combination with chemotherapy be conduct which allow for full characterisation of the terminal half-life .
gradual tapering of the dose should be consider when discontinue olanzapine .
with high local tissue concentration of gadobutrol the T2 effect result in a lessening of signal intensity .
from mass balance , tissue distribution and whole body autoradioluminography study perform in rat , peginterferon alfa-2a be distribute to the liver , kidney and bone marrow in addition to be highly concentrate in the blood .
adverse REACTIONS
ROUTE of administration
the extent and degree of distribution to various body compartment have not be fully study .
it may harm them , even if their symptom be the same a yours . • If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
a sustained haemoglobin level of greater than 12 g / dl ( 7.5 mmol / l ) should be avoid ; guidance for appropriate dose adjustment for when haemoglobin value exceed 12 g / dl ( 7.5 mmol / l ) be observe be describe below .
in patient who experience either febrile neutropenia , neutrophil & lt ; 500 cell / mm3 for more than one week , severe or cumulative cutaneous reaction or severe peripheral neuropathy during docetaxel therapy , the dose of docetaxel should be reduce from 100 mg / m2 to 75 mg / m2 and / or from 75 to 60 mg / m ² .
18 % ( 5 % )
contains lactose monohydrate , see package leaflet for further information .
4.6 ± 0.9 ( 4.5 )
1 • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
MARKETING AUTHORISATION NUMBER ( S )
instruct the owner to keep the administration site clean and dry for 24 hour .
6.4 Special precaution for storage
1 ml suspension contain 100 IU ( 3.5 mg ) of insulin human ( rDNA ) .
each tablet contain 10 mg of aripiprazole .
general disorder and administration site condition Immune system disorder Investigations Nervous system disorder Skin and subcutaneous tissue disorder
not applicable .
read the package leaflet before use .
- 6 pen contain powder and solvent for solution for injection , 6 injection needle
Magyarország EXUBERA- :
severe hypoglycaemia may lead to unconsciousness and / or convulsion and may result in temporary or permanent impairment of brain function or even death .
meloxicam 5 mg
be approximately 25 % lower than the previous dose .
PHARMACEUTICAL FORM AND CONTENTS
rare :
lot
2 .
MARKETING AUTHORISATION NUMBER ( S )
Tel : + 420 234 664 111
pre-filled syringe ( glass )
pregnancy .
14 System Organ Class Vascular disorder
Gallows Green Services Limited Cod Beck Blenders , Cod Beck Mill Dalton , Thirsk , North Yorkshire YO7 3HR United Kingdom
39 B .
NeoRecormon 500 IU
dose adjustment in order to maintain haemoglobin value at the desired level :
this dose may be adjust a your treatment progress .
how to use : see also side 1
280 of individual variability , titration to optimal therapeutic dos be expect for individual patient .
in the PegIntron monotherapy study , the Quality of Life be generally le affected by 0.5 microgram / kg of PegIntron than by either 1.0 microgram / kg of PegIntron once weekly or 3 MIU of interferon alfa-2b three time a week .
undesirable effect in adult
Celebra
- Epilepsy and / or compromised central nervous system ( CNS ) function ( see section 4.4 ) .
Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom
12 .
the calculated amount of interferon for the appropriate dose then be withdraw from the vial ( s ) , add to 100 ml of 9 mg / ml ( 0.9 % ) sodium chloride solution for injection and administer over 20 minute .
9 / 61
92 6.5 Nature and content of container
for Aranesp no clinical data on exposed pregnancy be available .
PHARMACEUTICAL form
PHARMACEUTICAL FORM AND CONTENTS
in vivo study indicate that CYP2C19 be significantly involve in the metabolism of voriconazole .
- you be recover from an illness or from fever ,
12 .
sign of toxicity be deep sedation , ataxia , miosis , convulsion and respiratory depression , which be the main symptom .
use the injection technique advise by your doctor or diabetes nurse and describe in your delivery system manual ► Keep the needle under your skin for at least 6 second to make sure that the full dose have be deliver ► After each injection be sure to remove and discard the needle and store Actrapid without the needle attach .
ratio Interval
what Procoralan contain :
this study focus on prevention of osteoporosis but endometrial safety of unopposed E2 0.5 mg or 1 mg during 2 year be also assess .
29 Clopidogrel BMS 75 mg
46 10 .
animal study have show excretion of lasofoxifene in milk .
the population enrol mainly consist in child with mild to moderate hepatitis C .
Eesti Novartis Pharma Services Inc .
253
keep the pre-filled syringe in the outer carton in order to protect from light .
cardiac disorder
30 mg
* Number of subject with at least one follow-up visit after 30 day after Day 1 * * Percent efficacy be calculate from the combined protocol .
strength
SUSTIVA be an antiviral medicine .
2 -
sodium phosphate monobasic Sodium phosphate dibasic Sodium chloride Polysorbate 80 Water for injection
the daily dose should not exceed 6 tablet MIRAPEXIN 0.088 mg or a dose of 0.54 mg ( 0.75 mg pramipexole salt ) .
5 day
lot
in clinical study peripheral oedema be report more commonly and tend to be more severe in patient ≥ 65 year ( see section 4.4 ) .
the following side effect can be see after the use of Gardasil :
each coat tablet contains 315 mg lactose monohydrate
summary OF PRODUCT CHARACTERISTICS
dialysis prescription may have to be adjust periodically to maintain urea , creatinine and potassium in the desired range .
BATCH NUMBER
- ritonavir ( use to treat AIDS )
olanzapine orodispersible tablet may be use a an alternative to olanzapine coat tablet .
accord to Article 71 of Directive 2001 / 82 / EEC Member States prohibit or may prohibit the import , sale , supply and / or use of the veterinary medicinal product on the whole or part of their territory if it be establish that :
national competent authority partner
4.3 Contraindications
do not use Actrapid
sign and symptom of benign intracranial hypertension include headache , nausea and vomiting , visual disturbance and papilloedema .
65.4 %
patient should be advise to take precaution in order to avoid hypoglycaemia whilst drive .
keep the vial in the outer carton .
this metabolite be pharmacologically inactive .
40 Member State
1 .
1.0 % ) ; Gastrointestinal pain ( G3 / 4 :
18 .
1.60 ml
7 .
1000 mg
ed The most often see undesirable effect in insulin-treated patient be a change in blood glucose level .
erythropoietin be a glycoprotein that stimulate , a a mitosis-stimulating factor and differentiate hormone , the formation of erythrocyte from precursor of the stem cell compartment .
2 .
0 0
6.4 Special precaution for storage
10 pre-filled syrinx
what be the risk associate with Sonata ?
capsule
Enbrel be significantly better than placebo in all component of the ACR criterion a well a other measure of rheumatoid arthritis disease activity not include in the ACR response criterion , such a morning stiffness .
d .
tablet core :
in general , the adverse event in paediatric patient be similar in frequency and type to those see in adult patient .
list OF EXCIPIENTS
after reconstitution each ml contain 10 mg of infliximab .
increase alkaine phosphatase
name OF THE MEDICINAL PRODUCT
do not administer more than one dose per pen .
4.1 Therapeutic indication
in the event of progressive elevation , or clinically significant elevation in association with clinical feature of myopathy or rhabdomyolysis , discontinuation of ziconotide should be consider .
ziconotide be a peptide consisting of 25 naturally-occurring amino acid of the L-configuration , and do not appear to be appreciably metabolise in the CSF .
see section on Possible side effect below .
however , this increase be not statistically significantly different from male control mouse by appropriate test .
name OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION
important information about ingredient of Agenerase oral solution The oral solution contains propylene glycol , which can cause adverse effect in high dos .
6.6 Nature and content of container
study have not be perform in patient with severe hepatic impairment .
11 D-83607 Holzkirchen Tel : + 49 ( 0 ) 8024 902 40 00 E-Mail : info @ sandoz . de
EMEA / CVMP / 283947 / 2008-EN
some case of severe vomit be associate with oesophageal rupture ( see section 4.8 ) .
pregnancy :
0.5 ml
in an inflammation model in cat , robenacoxib injection have analgesic , anti-inflammatory and anti-pyretic action and a rapid onset of action ( 0.5 h ) .
common
adult receive haemodialysis
3 .
Career to date :
4 .
further information
what be Tadalafil Lilly ?
46 PACKAGE LEAFLET :
do not refill Actraphane 10 Penfill .
there be a total of 15 lymphoma report in 5,966 patient treat with Enbrel in rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis and psoriasis clinical trial .
5 .
1 .
one IU ( International Unit ) correspond to 0.035 mg of anhydrous human insulin .
EXP
metabolism and nutrition
6.2 Incompatibilities
in case of overdose , patient should be manage by symptomatic and supportive care .
insulin administration may cause anti-insulin antibody to form .
21-73
further INFORMATION
5 .
( n = 151 )
7 .
if a further dose need to be administer , use a new syringe with product reconstitute a describe above .
if you have kidney disease , your dose may be lower , depend upon your kidney function .
Latvija PharmaSwiss Latvia SIA 54-5 Ģ ertrū de Street Riga , LV-1011 Tel : + 37167502185 Lietuva UAB PharmaSwiss Š eimyniš kių st .
pivotal clinical trial with Doxycyline 10 % premix
Table 1 .
a in adult patient , child and adolescent experience other psychiatric adverse event ( e.g . , depression , emotional lability , and somnolence ) .
other SPECIAL WARNING ( S ) , IF NECESSARY
method OF ADMINISTRATION
Trudexa
dyskinesia , Parkinsonism aggravate Dizziness , dystonia , hyperkinesia
68 3 .
ciprofloxacin Bayer 200 mg / 100 mL solution for infusion be indicate for the treatment of the following infection ( see section 4.4 and 5.1 ) .
EU / 1 / 06 / 357 / 012 – pack of 1 EU / 1 / 06 / 357 / 013 – pack of 10 EU / 1 / 06 / 357 / 014 – pack of 20
- by delay intestinal glucose absorption
28
5 ml
8 .
Doribax
in this case , you must inform your doctor .
Suomi / Finland Wyeth Puh / Tel : + 358 20 7414 870 Fax : + 358 20 7414 879
5 .
Norge Pfizer AS Tlf : + 47 67 52 61 00
4.2 Posology and method of administration
STOCRIN 200 mg film-coated tablet efavirenz
Scand Pharm Generics AB Ynglingagatan 14 , 5tr S-11347 Stockholm Sweden
do not use ARICLAIM after the expiry date which be state on the carton .
like all medicine , Busilvex can cause side effect , although not every body get them .
the frequency of this be unknown ( see section 4.4 ) .
in either case the A771726 plasma concentration be then measure for the first time .
* see section 4.4 : pancreatitis and lipid
the predominant pharmacologic activity be from the parent olanzapine .
hypersensitivity to the active substance or to any of the excipients .
5.3 Preclinical safety data
19.11.97 b )
76 / 125 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
2 .
ROUTE of
none .
in a study in young beagle dog , ciprofloxacin cause severe articular change at therapeutic dos after two week of treatment , which be still observe after 5 month .
target Reduced
the need for treatment should be reassess regularly .
from a microbiological point of view , the product should be use immediately .
13 .
- The other ingredient of the powder be : alanine , mannitol , disodium phosphate dodecahydrate ,
once daily OR
4.6 Pregnancy and lactation
release for consultation in
do not refill NovoRapid NovoLet .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
Pharmacotherapeutic group :
EMEA / CHMP / 123448 / 2006 / EN
the vial should be inspect visually for particulate matter and discoloration prior to administration .
6.3 Shelf life
Intercurrent infection , inflammatory or traumatic episode , occult blood loss , haemolysis , severe aluminium toxicity , underlie haematologic disease , or bone marrow fibrosis may also compromise the erythropoietic response .
not applicable .
87.7 * & # 91 ; 8.3 ; 99.7 & # 93 ;
België / Belgique / Belgien Actelion Pharmaceuticals Belgium N. V .
in the event of overdose , it be reasonable to employ the usual supportive measure , e. g . , remove unabsorbed material from the GI tract , employ clinical monitoring , and institute supportive therapy , if require .
- the possible effect of change to different time zone ,
2 inappropriate , dose reduction of stavudine may be consider , while the symptom of peripheral neuropathy be under close monitoring and satisfactory virological suppression be maintain .
MARKETING Authorisation
statement OF ACTIVE SUBSTANCE ( S )
in patient not on dialysis , once the target haemoglobin have be achieve with once every two week dosing , Nespo may be administer ro
the dose be 0.15 mg / kg bodyweight .
1.0
6 .
the active substance and other ingredient in Twinrix Adult be list at the end of the leaflet .
NeoRecormon be administer twice weekly over 4 week .
a with other thrombolytic agent , the follow event have be report a sequela of myocardial infarction and / or thrombolytic administration :
if a GnRH agonist have be give , higher dos of Fertavid may be need to achieve a response .
B .
time to progression ( TTP ) be the primary endpoint .
your doctor should always adapt the amount of KOGENATE Bayer 500 IU to be administer and the frequency of administration accord to the clinical effectiveness in your individual case .
Hb between 10 and 12 g / dl ( 6.2 - 7.5 mmol / l ) .
clinical PARTICULARS
13 .
2 .
reproductive toxicity Olanzapine have no teratogenic effect .
2 .
9 .
like all medicine , Neulasta can cause side effect , although not everybody get them .
cardiovascular Safety – Long-Term Studies Involving Subjects With Sporadic Adenomatous Polyps :
close your mouth and hold your breath for 5 M
administration
4.5 Interaction with other medicinal product and other form of interaction
the effect on co-administered medicinal product may thus be underestimated and clinical monitoring of safety may be indicate .
3 %
OptiMARK
NovoMix 70 should be administer in immediate relation to a meal .
Linzer Straße 221 / E02 A-1140 Wien Tel : + 43 ( 0 ) 1 8772668
herbal medicinal product for human use
5 .
blood and lymphatic system disorder :
skin rash be consider treatment relate in 18 % of patient treat with efavirenz .
for the next usage attach a needle a describe in section 3 and set the dose a describe in section 4 .
EU / 1 / 01 / 185 / 055 1 pack EU / 1 / 01 / 185 / 067 4 pack
keep out of the reach and sight of child . in ic
18 Table 3 .
other side effect
consequently , haemoglobin and blood pressure should be closely monitor .
2 .
ge EXP { MM / YYYY }
9 1 .
excessive daytime drowsiness have be report in rare case in patient receive Comtan with levodopa and there have be isolate case of sudden sleep onset episode .
what documentation have be present by the Company to support the application to the CHMP ?
since your ability to drive a car or operate machinery may be affect by Parkinson ’ s disease , you should discuss this with your doctor .
11 .
there be no adequate data on the use of peginterferon alfa-2a in pregnant woman .
because of an increase risk of meningitis , Soliris should not be give to people who be infect with Neisseria meningitidis , or who have not be vaccinate against this bacterium .
each film-coated tablet contain 300 mg of clopidogrel ( a hydrogen sulphate ) .
cutaneous use
your weight should be check at regular interval ; if your weight increase , inform your doctor .
the effect of bosentan on mitochondrial function be unknown .
the payment make in the financial year be those for which authorisation reach the Financial Controller not later than 31 December and which be effect by the Accounting Officer not later than 15 January of the following year .
Hypocalcemia , hyperuricemia , thirst
peak concentration ( Cmax ) and plasma AUC of rufinamide increase le than proportionally with dos in both fast and feed healthy subject and in patient , probably due to dose-limited absorption behaviour .
the injection syrinx must not contain any other medicine or trace of medicine ( such a trace of heparin ) .
no alteration of fertility be detect .
via Pontina KM 52 , 04010 Campo Verde ( Aprilia ) , Latina Italy
oral use
& gt ; 60-70 150
in clinical trial , worsen of Parkinsonian symptomatology and hallucination be report very commonly and more frequently than with placebo ( see section 4.8 ) , and olanzapine be not more effective than placebo in the treatment of psychotic symptom .
30 tablet
if your doctor have tell you to take two puff , wait about half a minute before you take another puff by repeat step 3 to 8 .
patient should be advise to seek medical advice if they experience joint ache and pain , joint stiffness or difficulty in movement .
if you have further question on the use of this product , ask your doctor or pharmacist .
15 .
patient who develop a
before you take Kaletra 3 .
do not share your needle .
be aware that sexual activity carry a possible risk to patient with heart disease because it put an extra strain on your heart .
4.3 Contra-indications
EU / 1 / 97 / 044 / 008
1 .
ear and Labyrinth Disorders
& quot ; #
Neoclarityn tablet be effective in alleviate the burden of seasonal allergic rhinitis a show by the total score of the rhino-conjunctivitis quality of life questionnaire .
overall response be generally better and , fewer patient develop antibody when treat with the combination of Humira and MTX compare to Humira alone .
6.1 List of excipients
200 IU / 0.5 ml
in vitro study demonstrate that rosiglitazone be predominantly metabolise by CYP2C8 , with a minor contribution by CYP2C9 .
• Ciprofloxacin Bayer may cause a reduction in the number of white blood cell and your resistance to infection may be decrease .
hypothyroidism § , Hyperthyroidism § , virilism
the main finding find in repeat-dose toxicity study ( rat , dog ) , in a 2-year rat carcinogenicity study , and in toxicity to reproduction study ( rat , rabbit ) be limit to injection site reaction for which no NOAEL could be determine .
8 .
any unused product or waste material should be dispose of in accordance with local requirement .
when cetuximab be use in combination with chemotherapeutic agent , also refer to their respective product information .
name OF THE MEDICINAL PRODUCT
1 hard capsule
do not use in kitten under 8 week of age or weigh le than 0.5 kg .
subcutaneous use For use only with the Puregon Pen .
how do I give my injection ?
a with other antiplatelet agent , clopidogrel should be use with caution in patient who may be at risk of increased bleeding from trauma , surgery or other pathological condition and in patient receive treatment with ASA , heparin , glycoprotein IIb / IIIa inhibitor , or non-steroidal anti-inflammatory drug include Cox-2 inhibitor .
surgery , multiple accidental trauma , or patient have acute respiratory failure .
target SPECIES
when pregnancy be diagnose , treatment with AIIRAs should be stop immediately , and , if appropriate , alternative therapy should be start ( see section 4.3 and 4.6 ) .
insulin absorption and hence the blood glucose lower effect of a dose may vary from one injection area to another ( e. g. the abdominal wall compare with the thigh ) .
data from concomitant use of parenteral midazolam with other protease inhibitor suggest a possible 3-4 fold increase in midazolam plasma level .
& # 91 ; to be complete nationally & # 93 ;
dosage adjustment In elderly patient a dose reduction may be necessary .
eat a meal or snack containing carbohydrate within 30 minute of the injection .
13 .
ER ng 16 .
should exposure to angiotensin II receptor antagonist have occur from the second trimester of pregnancy , ultrasound check of renal function and skull be recommend .
pregnancy
rash be usually mild-to-moderate maculopapular skin eruption that occur within the first two week of initiate therapy with efavirenz .
EU / 1 / 07 / 400 / 011
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
co-administration
Puregon contain a recombinant FSH .
if their symptom be the same a yours .
patient should be monitor for sign of withdrawal and their methadone dose increase a require to alleviate withdrawal symptom .
Alerdaune
in the fertility study the NOAEL be 300 U / kg / day for general toxicity in both male and female and 1000 U / kg / day for fertility and reproductive performance .
concern be raise by Belgium , Germany and the United Kingdom regard the inadequacy of the withdrawal period and the application be withdraw from these country .
further INFORMATION
- Difficulty breathe while asleep , call sleep apnoea , should be examine by a specialist .
4.6 Pregnancy and lactation
5.3 Preclinical safety data
23 14 .
this will lessen the chance for ribavirin to be leave in the woman ’ s body .
information IN BRAILLE
an epidemiological survey have indicate that there be likely to be an association between the susceptibility to adverse reaction and the Danish and Swedish Landrace breed , and their crossbreds thereof , especially younger pig .
BATCH NUMBER
BN
the solution should be drink within 15 to 20 minute .
list OF EXCIPIENTS
EXP { month / year } Once open use within 6 month .
common
from a microbiological point of view , the product should be use immediately after reconstitution .
solution for injection
17 % 25 / 147
Annex I
J. E .
sanofi-aventis Deutschland GmbH Brüningstraße 50 , D-65926 Frankfurt be Main Germany .
237 Teл : + 359 28514413 E-mail : sanicobg @ techno-link . com
other SPECIAL WARNING ( S ) , IF NECESSARY
Laboratoires Merck Sharp & amp ; Dohme Chibret 3 , Avenue Hoche 75008 Paris , France
vascular disorder Uncommon : Hot flush , hypotension .
use glucagon du
Nederland Novartis Pharma B. V .
dose modification for all patient If severe adverse reaction or laboratory abnormality develop during treatment with ViraferonPeg monotherapy or ViraferonPeg in combination with ribavirin , modify the dosage of each product a appropriate , until the adverse reaction abate .
3 .
n = 505
Implants may be locate use ultrasound .
d and Caucasian subject , whereas elimination half-life be shorter in Japanese subject ( 3-4 day ) compare to Caucasian subject ( about 9 day ) .
caution be advise when treat these patient .
this be particularly important in those who have reduce or absent awareness of the warning symptom of hypoglycaemia or have frequent episode of hypoglycaemia .
tablet .
Quixidar
other SPECIAL WARNING ( S ) , IF NECESSARY
≤ 0.06
it be recommend to discontinue Raptiva if arthritis occurs during treatment .
some pulse oximeter may produce light of a wavelength close to that use for the photoactivation of Foscan .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
expiry DATE
375
50 D-65929 Frankfurt
6 .
name OF THE MEDICINAL PRODUCT
Iscover contain lactose .
reconstitution solvent Acceptable solvent for reconstitution of Dynastat be :
if you be use a suspension insulin ( Insuman Basal or Insuman mixture ) , turn the pen up and down at least 10 time to resuspend the insulin .
no study on the effect of Tasmar on the ability to drive and use machine have be perform .
expiry DATE
Aerius syrup be also use to relieve the symptom associate with urticaria ( a skin condition cause by an allergy ) .
name OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION
there be no data to suggest that indinavir affect the ability to drive and use machine .
breathe problem .
do not store above 25 ° C and protect from direct heat and light .
Sími : + 354 540 8000 ISmail @ merck . com
breast-feeding woman may require adjustment in insulin dose and diet . tn
what be Azopt use for ?
blister pack , aluminium / aluminium 10 , 20 , 28 , 30 , 50 , 56 , 98 , 100 , 300 tablet , 50 x 1 tablet ( unit dose ) , 100 x 1 tablet ( unit dose ) .
excipients : protamine sulphate , metacresol , phenol , zinc chloride , sodium dihydrogen phosphate dihydrate , glycerol , sodium hydroxide , hydrochloric acid ( for pH adjustment ) , water for injection .
Furthermore , preclinical study have indicate that the bone induce by InductOs , if fracture , can repair itself in a manner indistinguishable from native bone .
urinary tract infection
España Km .
IntronA ( interferon alfa-2b ) modify the response of the body & apos ; s immune system to help fight infection and severe disease .
Healthcare srl Via Michelangelo Buonarroti n .
epoprostenol : limited data obtain from a study ( AC-052-356 , BREATHE-3 ) in which 10 paediatric patient receive the combination of Tracleer and epoprostenol indicate that after both single- and multiple-dose administration , the Cmax and AUC value of bosentan be similar in patient with or without continuous infusion of epoprostenol ( see section 5.1 ) .
DATE OF REVISION OF THE TEXT
Reversing the narcotic effect can give rise to acute pain and release of catecholamine .
Frimley Business Park Frimley / Camberley , Surrey , GU16 7SR United Kingdom
QUALITATIVE AND QUANTITATIVE COMPOSITION
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
12 .
olanzapine Teva be use to treat a disease with symptom such a hearing , see or sense thing which be not there , mistaken beliefs , unusual suspiciousness , and become withdrawn .
from 1990 to 1994 , he be Technical Counsellor in Clinical Evaluation and Pharmacology at the Spanish Ministry of Health , Member of the CPMP Efficacy Working Party and involve in the Efficacy Group of the ICH .
reproductive system and breast disorder Uncommon :
38,323,000
however , there be no difference in the half-life and accumulation of irbesartan .
Similarily , administration of fosamprenavir with ritonavir may modify the pharmacokinetics of other active substance that share this metabolic pathway .
Aranesp should be administer by the subcutaneous route to patient with anaemia ( e. g. haemoglobin concentration ≤ 10 g / dl ( 6.2 mmol / l ) ) in order to increase haemoglobin to not greater than 12 g / dl ( 7.5 mmol / l ) .
Česká republika sanofi-aventis , s.r.o .
3 .
isolated case of rhabdomyolysis have be report .
Demodex
Winthrop ,
ed be 3 .
13 .
the potency of this product should not be compare to that of another pegylated or non-pegylated protein of the same therapeutic class .
PHARMACEUTICAL FORM AND CONTENTS
- The other ingredient be : microcrystalline cellulose ( E460 ) , calcium hydrogen phosphate ,
* Betaferon be formulate to contain a calculated overfill of 20 % .
protease inhibitor : darunavir , indinavir , lopinavir / ritonavir , ritonavir , ritonavirboosted atazanavir , saquinavir or fosamprenavir / saquinavir .
6 12 * *
6 .
how TO STORE PRIVIGEN
EMEA / 124262 / 2009
EU Number
- 50 to 65 kg , the usual dose be 2 capsule in the morning and 2 capsule in the evening ( total of
le than 2 % of the dose be excrete in the urine a unchanged irbesartan .
dizziness , severe nausea or vomiting , abdominal pain , irregular heart beat or deep , rapid breathing .
strength
0.8mg
what be Daronrix ?
Don ’ t take any insulin if you feel a hypo come on .
if you be receive chemotherapy ct
Perindopril reduce peripheral vascular resistance , lead to blood pressure reduction .
Kivexa , Trizivir ) .
6.3 Shelf life
30 mg
very common Common Uncommon Not know
-
23 / 31 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
the half-life be difficult to evaluate for the subcutaneous route and be estimate to be about 24 hour .
important :
4.1 Therapeutic indication
12 .
oral use
Fig . c
this leaflet be last approved in
this medicinal product contains lactose monohydrate and sorbitol .
- If you have have severe heart problem , or if you have heart disease that have not be well control
interaction not study
HBVAXPRO
Inovelon
10 vial + 10 pre-filled syrinx + 20 needle
1 mg
each tablet contain 15 mg olanzapine .
a start dose of 100-225 IU be recommend for at least the first four day .
10 Aclar / PVC / blister with aluminium foil back contain one clear blister of 11 x 0.5 mg and 14 x 1 mg film-coated tablet and a second clear blister of 28 x 1 mg film-coated tablet in secondary heat seal card packaging .
caution should be exercise when prescribe to pregnant woman .
about 60 % of the oral dose be eliminate a unchanged substance within 48 hour .
gastrointestinal disorder : not know : diarrhoea
because of individual variability , titration to ed
patient may also receive calcium and vitamin D supplement if they do not get enough from their diet .
never drive or use machinery if you feel a hypo come on .
leaflet last approve on
opinion FOLLOWING AN ARTICLE 33 ( 4 ) REFERRAL FOR EQUIMECTIN 12MG / G ORAL GEL FOR HORSES
118 If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
EXJADE have not be study in patient with hepatic impairment and must be use with caution in such patient .
5 .
EXP
capsule shell :
once the medicine be reconstitute ( make up with the solvent ) , do not store above 25 ° C .
pharmacological PROPERTIES
EXP { month / year }
9 .
absorption Absolute bioavailability of rosiglitazone follow both a 4 and an 8 mg oral dose be approximately 99 % .
Zenapax 5 mg / ml concentrate for solution for infusion
12 .
Brucella spp .
paliperidone can have minor or moderate influence on the ability to drive and use machine due to potential nervous system and visual effect ( see section 4.8 ) .
conjunctivitis , ocular haemorrhage , retinal artery or vein occlusion
the active substance be telmisartan and hydrochlorothiazide .
Cubicin will usually be give to you by a doctor or a nurse .
30 mg / 3 ml
this patient be able to continue treatment with BeneFIX with no rise in inhibitor or anaphylaxis .
patient should be monitor for sign of withdrawal and their methadone dose increase a require to alleviate withdrawal symptom .
13 .
up to 97.5 % bind to plasma protein .
this leaflet be last approve on
82 % ( 67 % )
13 .
1 .
Justification for not include Braille accept
if the product be not use during the seven-day period , it can not be put back in the refrigerator for a new storage period and must be discard .
each vial contain 20 ml solution for infusion .
- monoamine oxidase ( MAO ) inhibitor ( use to treat depression ) ,
the prescriber should be aware that most case of rhinitis below 2 year of age be of infectious origin ( see section 4.4 ) and there be no data support the treatment of infectious rhinitis with Aerius .
it be know that malignancy ( lymphoma ) secondary to the chronic use of immunosuppressive agent can occur and have be report in patient in rare instance .
Uncommon : chest pain .
TESAVEL should not be use during breast-feeding .
no untoward effect on cardiac conduction be observe follow concomitant administration of digoxin and rivastigmine .
2 year
since current safety and efficacy data be base upon administration with food , it be recommend that Xeloda be administer with food .
within each frequency grouping , adverse reaction be present in order of decrease seriousness .
Tel : + 356 21493022
good blood management practice should always be use in the perisurgical setting
the incidence of erythema multiforme or Stevens-Johnson syndrome be approximately 0.1 % .
Table 1 Primary Endpoint :
6.3 Shelf life
each film-coated tablet contain 700 mg fosamprenavir a fosamprenavir calcium ( equivalent to approximately 600 mg of amprenavir )
pharmacological PROPERTIES
each film-coated tablet contain 5 mg of memantine hydrochloride equivalent to 4.15 mg memantine .
CPMP / ICH / 363 / 96 ( E9 )
1 .
Raheen Industrial Estate Raheen Limerick Ireland
ear and labyrinth disorder Uncommon : Vertigo , tinnitus .
50 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
in clinical trial and during market use , the frequency vary with patient population and dose regimen .
please keep this possible problem in mind in all situation where you might put yourself and others at risk ( e.g . drive a car or operate machinery ) .
clinical PARTICULARS
98-100 % ) .
1-3 4 +
how SIMULECT IS GIVEN TO YOU
manufacturer :
6 .
Basal .
25.50 mg of lactose monohydrate per film-coated tablet .
dose with food ( a high-fat meal ) have no effect on the extent of absorption of etoricoxib after administration of a 120-mg dose .
the Educational brochure for patient should be of 3 type : • Brochure for woman patient of childbearing potential and their partner • Brochure for woman patient who be not of childbearing potential • Brochure for male patient
per dose of 2 ml : . ge delete inactivated IBR virus , at least 0.75 VN . U * . light paraffin oil 449.6 to 488.2 mg * VN . U :
subsequent 9-month oral toxicity study in dog show no drug-related electrocardiographic change .
•
the other component of Irbesartan Hydrochlorothiazide Winthrop ( hydrochlorothiazide ) have be associate rarely with other more serious side effect mainly affect the blood , the skin or the kidney .
BATCH NUMBER
be slow , with peak serum concentration be reach about 5 day after administration .
15 .
very common
list OF EXCIPIENTS
EMEA / H / C / 362
ask your pharmacist how to dispose of medicine no longer require .
target Species
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
in that case , the first dose ( V1 ) of vaccine can be give concurrently with the appropriate prophylactic dose of Tetanus-Serum from Intervet at a separate injection site , use separate syrinx and needle .
detailed information on this medicinal product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu
long-term safety data be still limit .
bottle ( glass ) in plastic device
St John ’ s Wort ( CYP450 inducer ; P-gp inducer ) :
if not , your doctor will advise you on the possible need to have extra dos .
399 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON
the insulin requirement be often increase .
adult
RA Tlf : + 45 36 35 91 00 info @ glaxosmithkline.dk
1 .
50
name OF THE MEDICINAL PRODUCT
5 year Shelf-life when incorporate into meal feed and protect from light and moisture :
- tell you when you may need to inject a higher or lower dose of Insuman Comb 15 .
Haemorrhoids Renal and urinary disorder Uncommon :
with each injection , change the puncture site within the particular area of skin that you be use .
Merck n. v. / s. a .
store in the original container
1 .
other SPECIAL WARNING , IF NECESSARY
a limited number of exposed pregnancy from Post Marketing Surveillance indicate no adverse effect of insulin glargine on pregnancy or on the health of the foetus and newborn child .
EXP :
ask your pharmacist how to dispose of medicine no longer require .
Merck Sharp & amp ; Dohme Ltd Hertford Road , Hoddesdon Hertfordshire EN11 9BU United Kingdom
{ PRODUCT NAME } 80 mg film-coated tablet Atorvastatin calcium & lt ; & # 91 ; See Annex I - To be complete nationally & # 93 ; & gt ; & # 91 ; For referral procedure & # 93 ;
Teva Pharma Bv Industrieweg 23 Po Box 217 3640 Ae Mijdrecht The Netherlands
24
Lietuva Merck Serono Atstovybė C / o Ares Trading SA Baltic States Zamenhofo 11 -3 , LT-44287 Kaunas Tel : + 370 37320603
- if you be to undergo any surgery or receive anaesthetic , you should also tell your doctor that
Osigraft
for the full list of all side effect report with SonoVue , see the Package Leaflet .
Eli Lilly Nederland BV , Grootslag 1 – 5 , NL-3991 RA , Houten , The Netherlands .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER uc
1 .
3 .
the Marketing Authorisation Holder provide write explanation on 20 July 2007 .
3 ml suspension in a cartridge ( type 1 colourless glass ) with a plunger ( bromobutyl rubber ( type 1 ) ) and a flanged cap ( aluminium ) with a stopper ( bromobutyl or laminate of polyisoprene and bromobutyl rubber ( type 1 ) ) .
15 .
the recommend dose of Humira for adult patient with rheumatoid arthritis be 40 mg adalimumab administer every other week a a single dose via subcutaneous injection .
interaction not study
emergency therapy should be institute promptly .
187 10 .
- If you feel a change in your heart rate ;
Eesti filiaal Tel : + 372 6441100 Ελλάδa ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε .
tablet coat :
pregnancy and breast-feeding Tell your doctor immediately if you be pregnant or if you be breast-feeding .
16 .
ed Recombinant interferon alfa-2b have exhibit antiproliferative effect in study employ both animal and human cell culture system a well a human tumour xenograft in animal .
49 / 125 Metacam 1 mg chewable tablet for dog Metacam 2.5 mg chewable tablet for dog
film-coated tablet
Fabrazyme be only use under the supervision of a doctor who be knowledgeable in the treatment of Fabry disease .
33 %
other SPECIAL WARNING ( S ) , IF NECESSARY
Wear disposable glove when apply the product .
Fentanyl-ratiopharm 50 µg / h transdermales Matrixpflaster Fentanyl-ratiopharm 50 µg / h Matrixpflaster
if you can not contact your doctor , go to the nearest accident and emergency department .
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Tel .
Takeda Global Research and Development Centre ( Europe ) Ltd 61 Aldwych London WC2B 4AE United Kingdom
patient with left ventricular ejection fraction & lt ; 45 % or leave ventricular shorten fraction & lt ; 0.2 be not study .
cardiac failure Experience with vildagliptin therapy in patient with congestive heart failure of New York Heart Association ( NYHA ) functional class I-II be limit and therefore vildagliptin should be use cautiously in these patient .
► If you be allergic ( hypersensitive ) to this insulin product , metacresol or any of the other ingredient ( see 7 Further information ) .
in view of the lack of data , clopidogrel can not be recommend during the first 7 day after acute ischaemic stroke .
treatment of patient with pulmonary arterial hypertension classify a WHO functional class III , to improve exercise capacity .
polypropylene tablet container with tamper evident polyethylene closure contain 100 film-coated tablet per tablet container .
instruction ON USE
if you have the impression that the effect of PegIntron be too strong or too weak , talk to your doctor or pharmacist .
check the label on the pen and insulin reservoir to make sure you have the correct insulin .
to reduce the risk of infection , all patient must be vaccinate at least 2 week prior to receive Soliris and must be re-vaccinated accord to current medical guideline for vaccination use .
respiratory , thoracic and mediastinal disorder :
there be no observed effect on the rate of rehospitalisation for unstable angina .
treat physician should refer to national and / or international consensus document regard the treatment of anthrax .
30 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Merck AB S-195 87 Stockholm Tel : + 46-8-562 445 00
10 LeukoScan be reconstitute with 0.5 ml isotonic sodium chloride injection .
the following substance may increase insulin requirement :
EXP { month / year }
therefore , patient should be advise to receive liquid food during the first day ( up to 4 week ) after the laser light application .
BATCH NUMBER
patient with renal insufficiency No dosage adjustment be necessary for patient with mild ( estimate creatinine clearance & gt ; 50 ml / min and ≤ 80 ml / min ) to moderate ( estimate creatinine clearance ≥ 30 ml / min and ≤ 50 ml / min ) renal impairment .
powder and solvent for solution for injection
200 mg / 100 ml
tablet
endpoint
Nespo should not affect your ability to drive or use machinery . a in
nimesulide 100 MG OR 200 MG SUPPOSITORIES
tablet
the nature and incidence of adverse reaction be similar between treatment group .
statistical Analysis
there be no evidence of a teratogenic effect , but animal study indicate some hazardous potential of telmisartan to the postnatal development of the offspring such a lower body weight , delay eye opening , and higher mortality .
Liprolog Basal have an activity profile that be very similar to that of a basal insulin ( NPH ) over a period of approximately 15 hour .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Nicobrand Limited 189 Castleroe Road Coleraine Northern Ireland BT51 3RP
a with others drug act on the renin-angiotensin-aldosterone system , telmisartan may provoke hyperkalaemia ( see section 4.4 ) .
4 .
NS
1 .
the difference be account for by a lower rate of discontinuation from study treatment due to lower progression of disease in patient expose to lenalidomide / dexamethasone ( 39.7 % ) than in placebo / dexamethasone patient ( 70.4 % ) .
store in a refrigerator .
dietary restriction in relation to visual disorder It be recommend that a slit-lamp examination of the eye be perform before initiation of nitisinone treatment .
do not store above 30 ° C .
70.6 ( 12 / 17 ) 42.1 , 99.1
look at the cartridge before you use it .
content BY WEIGHT , BY VOLUME OR BY UNIT
after reconstitution , the product should be use immediately .
all of these additive factor of anaemia should also be carefully consider when decide to increase the dose of epoetin alfa in cancer patient .
incorporation of 75 mg active
the Committee for Medicinal Products for Human Use ( CHMP ) decide that MabThera ’ s benefit be greater than it risk for the treatment of non-Hodgkin ’ s lymphoma and rheumatoid arthritis .
in child age between two and 18 year , the dose of Mycophenolate mofetil Teva be calculate depend on height and weight .
48 week
not applicable
in the absence of bacterial urease , the whole amount of the administer urea after absorption from the gastrointestinal tract will be metabolise like the endogenous urea .
Ireland
3 .
the CHMP request the Applicant to provide data from a PK study with concomitant use of a spacer .
if refrigerate , allow the refrigerated solution to reach room temperature before administration .
in a final injection volume of 20 ml , total dos of filgrastim le than 30 MIU ( 300 μ g ) should be give with 0.2 ml of 200 mg / ml ( 20 % ) human albumin solution add .
10 .
13 .
serum potassium level should be monitor regularly during Nespo therapy .
hepatitis , and rarely jaundice , have be report in patient on Kaletra therapy in the presence or absence of identifiable risk factor for hepatitis .
18 – 59 year a
tell your relative , friend and close colleague the following :
- A history of severe pre-existing cardiac disease , include unstable or uncontrolled cardiac disease ,
ritonavir :
• 1.8.2002 • 7.10.2002 • 9.10.2002 • OJ C 258 , 25.10.2002 , p .
Lietuva UAB Bayer , Bayer Schering Pharma Tel . : + 370 5 2336868
even higher dos have be use .
2001
animal specie
MARKETING AUTHORISATION NUMBER ( S )
mixing of insulin
• You can not turn the dosage selector past the number of unit leave in the pen .
darunavir bind primarily to plasma alpha-1-acid glycoprotein .
study 2 ( P02080 ) be a randomized , single centre study that enrol 95 previously untreated adult patient with chronic hepatitis C who be co-infected with HIV .
what Insulin Human Winthrop Comb 50 be and what it be use for 2 .
like all medicine , Mycophenolate mofetil Teva can have side effect , although not everybody get them .
therapy . ESAs be not indicate for use in this patient population . ro
however , exceptionally Ambirix can be administer subcutaneously to subject with thrombocytopenia or bleeding disorder since bleeding may occur follow an intramuscular administration to these subject .
39 Focetria do not contain live virus particle and so it can not cause Pandemic influenza .
swelling of the retina at the back of the eye which can cause blur vision ( macular oedema ) can be a problem for people with diabetes .
metabolism and Elimination Following oral administration to healthy volunteer , sitaxentan sodium be highly metabolise .
1 .
Preclinical data of levodopa , carbidopa and entacapone test alone or in combination reveal no special hazard for human base on conventional study of safety pharmacology , repeat dose toxicity , genotoxicity , and carcinogenic potential .
in patient with co-morbid Major Depressive Episodes , the starting and maintenance dose be 60 mg once daily ( please see also dose recommendation above ) .
it be not know whether bortezomib be excrete in human milk .
when perform haematologic assessment during the preoperative period , if the haemoglobin level reach 15 g / dl , or higher , administration of epoetin alfa should be stop and further dos should not be give .
do not store above 30 ° C .
8 4.5 Special precaution for use
COVERSYL
the elimination half-life after intravenous administration of methoxy polyethylene glycol-epoetin beta be 134 hour .
Alternatively therapy may be initiate with Loxicom 5 mg / ml solution for injection .
19.1 % NA
a greater magnitude of weight gain , lipid and prolactin alteration have be report in short term study of adolescent patient than in study of adult patient ( see section 4.4 , 4.8 , 5.1 and 5.2 ) .
1 .
woman should not get pregnant during treatment with Atripla and for 12 week thereafter .
do not shake , but gently turn the vial upside down until any powder at the top of the vial be dissolve .
5 .
like all retinoids , isotretinoin be teratogen and be contraindicate during pregnancy to avoid congenital defect .
Hypochromic anaemia
similar outcome have be report with valsartan .
dose-dependent percent change from baseline be observe across the placebo , simvastatin 40 mg and simvastatin 80 mg treatment for the primary end point ( LDL cholesterol ) and for the secondary end point ( VLDL cholesterol , triglyceride , non HDL cholesterol , HDL cholesterol , apolipoprotein B , and apolipoprotein A-I ) .
darb
1 .
before YOU TAKE ZAVESCA
distribution :
tap the insulin reservoir so that any air bubble rise up towards the needle .
however , intensification of insulin therapy with abrupt improvement in glycaemic control may be
MAO- inhibitor type B ( selegeline ) can be use with ( Invented name ) ® provide that your doctor monitor you closely . • lithium , tryptophan ; there be an increased risk of serotonin syndrome when these drug be co- administer with ( Invented name ) ® .
( concentration )
( 44-20 ) 74 18 84 00 Fax ( 44-20 ) 74 18 86 13 E-mail : mail @ emea . eu . int http : / / www . emea . eu . int © EMEA 2006 Reproduction and / or distribution of this document be authorise for non commercial purpose only provide the EMEA be acknowledge
the safety and efficacy of 50 mg Enbrel ( two 25 mg SC injection ) administer once weekly be evaluate in a double-blind , placebo-controlled study of 420 patient with active RA .
21 ( 81 % ) *
Pre-emptive use of Effentora for predictable pain episode be not investigate in the clinical trial .
daily dos of 2.7 mg should not be exceed .
3 .
Seidengasse 33-35
film-coated tablet
further INFORMATION
-1.38 ( 19 ) -2.61 ( 14 )
name OF THE MEDICINAL PRODUCT
other
39 / 94 7 MARKETING AUTHORISATION HOLDER
valueb
DATE OF REVISION OF THE TEXT
60 mg 60 mg 60 mg 60 mg
Slovenská republika Novartis Slovakia s. r. o .
duloxetine BOEHRINGER INGELHEIM
• Hypersensitivity to the active substance or to peanut or soya or any of the excipients • Urinary retention • Gastric retention • Uncontrolled narrow angle glaucoma • Myasthenia gravis • Severe hepatic impairment ( Child Pugh C ) • Concomitant use of potent CYP3A4 inhibitor in subject with moderate to severe hepatic or renal impairment • Severe ulcerative colitis • Toxic megacolon .
10 February 1997 Date of latest renewal :
Ελλάδα sanofi-aventis AEBE Τηλ : + 30 210 900 16 00
Special WARNING ( S ) , IF NECESSARY
EMEA / CVMP / 315 / 98
dizziness , Postural dizziness Syncope , Headache
the pharmacokinetic variability observe in the elderly be within the range for the non-elderly .
hepatic function Transient , asymptomatic elevation of hepatic transaminase , ALT , AST have be see commonly , especially in early treatment .
however , after subcutaneous administration of Omnitrope powder and solvent for solution for injection , a half-life of 3 hour be achieve .
possible SIDE EFFECTS ” ) .
Reapplication to the same site within 14 day should be avoid .
DATE OF REVISION OF THE TEXT
sodium chloride L-histidine Polysorbate 80 Sodium borate Water for injection
guideline / Status
4.9 Overdose
the benefit of Zevalin follow rituximab in combination with chemotherapy have not be establish .
the immunogenicity of a two-dose primary series in infant plus a booster at about one year of age have be document in several study .
uth If you forget to take Viraferon If you be self-administering treatment , or if you be the caregiver of a child take Viraferon in combination
1 .
however , use only those injection syrinx which be design for an insulin concentration of 100 IU ( International Units ) per ml .
effect on ability to drive and use machine
the demonstration of the benefit of the combination abacavir / lamivudine a a once daily regimen in antiretroviral therapy , be mainly base on result of one study perform in primarily asymptomatic treatment-naïve adult patient ( see section 4.4 and 5.1 ) .
DATE OF REVISION OF THE TEXT
Periodic Safety Update Reports for Marketed Drugs
clinical PARTICULARS
48 Data on a large number of exposed pregnancy do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus / newborn .
expiry DATE
the median lethal dos be approximately 210 mg / kg ( mouse ) and 175 mg / kg ( rat ) .
B-1180 Bruxelles Belgium i dic
180 IU / ml 540IU / 3ml
please see cytokine release syndrome above for severe reaction .
the first dose of oral CellCept will be give to you at least 4 day after the transplant operation and when you be able to swallow oral medication .
your treatment will usually last for about 14 day .
the Cmax of digoxin increase by le than 5 % .
to take a tablet out of the packaging :
if you be not able to take food or nutritional supplement , your doctor will tell you to take 200 mg ( one 5 ml spoonful ) four time a day .
for a full list of excipients , see section 6.1 .
there be insufficient data on the use of salmeterol and fluticasone propionate during pregnancy and lactation in man to assess the possible harmful effect .
EXP :
3 .
13 .
- The active substance be vardenafil .
visual .
ed and biological inducer .
hypotension , deep thrombophlebitis Epistaxis , hypertension
norfloxacin and metronidazole : in healthy volunteer , no significant interaction be observe when mycophenolate mofetil be concomitantly administer with norfloxacin and metronidazole separately .
in study subject whose blood pressure be not control , the reduction be greater although this reduction be not associate with hypotensive symptom in the majority of subject .
what Lucentis be and what it be use for 2 .
the content must be clear and colourless .
use in renal impairment : in renal transplant patient with severe chronic renal impairment ( glomerular filtration rate & lt ; 25 ml • min-1 • 1.73 m-2 ) , outside the immediate post-transplant period , dose greater than 1 g administer twice a day should be avoid .
clinical PARTICULARS
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
EU / 2 / 08 / 092 / 001
further injection • Leave the cartridge in the pen .
30 film-coated tablet .
medicine to treat depression and other mental health problem increase the risk of suicidal thought and behaviour in child and adolescent age under 18 year .
6.1 List of excipients
meta-analysis of overall survival data produce a hazard ratio point estimate of 1.08 in favour of control ( 95 % CI :
- you suffer from severe kidney or liver disease , or some other disease such a hypothyroidism .
Fournier Pharma 16b rue de Trois Arbres B-1180 Bruxelles Belgium
after 16 week of therapy , patient who achieve at least a PASI 75 response ( PASI score improvement of at least 75 % relative to baseline ) , enter period B and receive open-label 40 mg Humira every other week .
MARKETING AUTHORISATION NUMBER
Malta Charles de Giorgio Ltd .
one ml of Insulin Human Winthrop Rapid contains
combination antiretroviral therapy have also be associate with metabolic abnormality such a hypertriglyceridaemia , hypercholesterolaemia , insulin resistance , hyperglycaemia and hyperlactataemia ( see section 4.4 ) .
contact your doctor if you notice change in body fat .
Slovenia
this procedure be a referral follow a Mutual Recognition Procedure concern the above variation application which be submit for Actira film-coated tablet to Germany a Reference Member State ( RMS ) and the Concerned Member States ( CMS ) AT , BE , DK , EL , ES , FI , IT , LU , PT and SE on 5 December 2006 .
BATCH NUMBER
their breathing should be monitor for up to three day after vaccination .
234 ( 96 % )
due to modest decrease in protein binding of aprepitant in patient with renal disease , the AUC of pharmacologically active unbound aprepitant be not significantly affect in patient with renal impairment compare with healthy subject .
1.0 ml ( 40000 IU / ml )
9 .
if you have type 1 diabetes ( insulin dependent diabetes mellitus ) , do not stop your insulin and continue to get enough carbohydrate .
MARKETING AUTHORISATION HOLDER
3 .
4.10 Overdose ( symptom , emergency procedure , antidote ) , if necessary
irbesartan Winthrop should not be give to child and adolescent ( under 18 year ) .
6.4 Special precaution for storage
a .
vascular disorder
medicine , include medicine obtain without a prescription .
each buccal tablet contain 100 microgram fentanyl ( a citrate )
Bayer HealthCare Manufacturing S. r. l .
n = 315c 20 ( 6 ) b
the incidence of dry cough be significantly lower in patient treat with telmisartan than in those give angiotensin convert enzyme inhibitor in clinical trial directly compare the two antihypertensive treatment .
4.1 Therapeutic indication
• What should I do if I see an air bubble in the cartridge ?
you should always use 52 ml of water , irrespective of the recommend dose you be take .
131 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Hypromellose ( E464 ) Titanium dioxide ( E171 ) Lactose monohydrate Polyethylene glycol 3000 Glycerol triacetate
QUALITATIVE AND QUANTITATIVE COMPOSITION
08.01.97
43 6 .
© European Medicines Agency , 2008 .
52 6 .
9 .
Colony stimulate factor , ATC code :
- Intravenous administration :
this regress during the course of continued therapy .
in the third study , patient take Reyataz or lopinavir , in combination with ritonavir , have similar fall in viral load after 24 and 48 week , have fall by around 99 % after 48 week .
4.3 Contraindications
EU / 1 / 07 / 431 / 020
160 mg
2 .
instruction ON USE
27
lot
frequency unknown ( can not be estimate from available data ) *
SonoVue be use in test that measure how ultrasound travel within the body because it improve the ability of the blood to create an echo .
however , dizziness and fatigue have be report during treatment with Invirase .
Faslodex should not be use in people who may be hypersensitive ( allergic ) to fulvestrant or any of the other ingredient .
4.3 Contraindications
lot
these trial include rheumatoid arthritis patient with short term and long stand disease a well a
the syrinx inside the pen be make from type 1 glass with stainless steel 27 gauge needle .
do not go unaccompanied to seek medical help .
24 week
4 .
a for other insulin product , hypoglycaemia , in general be the most frequently occur undesirable effect .
1 / 2 EU number
the information provide stress the importance of the product for use in case where coccidiostats and vaccination have fail , give the limited availability of other treatment ( amprolium , sulphonamides ) and the need to rotate these treatment in order to avoid / postpone the development of resistance .
Opgenra
5 .
they will also continue their compassionate use programme ( where doctor can request a medicine for a specific disease for one of their patient before the medicine be fully authorise ) where those be available .
fever and fatigue be often reversible within 72 hour of interruption or cessation of treatment .
2.62
randomise , open label parallel group study be conduct to examine FEV1 change follow uc
it should be consider whether it be advisable to drive or operate machinery in these circumstance .
the dose of nitisinone should be adjust individually .
statement OF ACTIVE AND OTHER SUBSTANCES
the marketing authorisation be renew on 29 October 2004 .
ProMeris Duo 799.5 mg + 799.5 mg Spot-on for large dog { 25.1 – 40.0 kg }
PCV ≥ 33 % , NeoRecormon be administer at the end of blood donation .
such condition should be correct before the administration of Aprovel .
hypoglycaemia have be observe in patient with type 2 diabetes on diet and exercise , and in those treat with oral antidiabetic agent ( see section 4.8 ) .
Special PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS , IF ANY
there be a slightly increase risk of extra-uterine pregnancy in woman with damaged fallopian tube .
do not store above 30 ° C .
Polska AstraZeneca Pharma Poland Sp . z o. o .
elevate cholesterol levels11 Nervous system disorder Very common :
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
pregnancy and breast-feeding
if the hypoglycaemia come back again take another 10 to 20 g sugar .
4 .
not all pack size may be market .
71 cyst and polyp )
BYETTA be not expect to have any clinically relevant effect on the pharmacokinetics of metformin or sulphonylureas .
5.1 Pharmacodynamic property
patient with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine .
the Committee for Medicinal Products for Veterinary Use conclude that the vaccine have be show to be safe and to be effective in prevent disease in poultry and could be a useful tool in control an outbreak of avian influenza infection .
if you have any further question on the use of this product , ask your doctor or pharmacist .
ZYPREXA VELOTAB 15 mg ORODISPERSIBLE TABLETS :
this include prescription and non-prescription medicine , and herbal supplement .
16 .
medicine , include medicine obtain without a prescription .
Neupro 2 mg / 24 h
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
median CD4 ( cell / ml ) ( range )
Novartis Europharm Limited Wimblehurst Road Horsham West Sussex , RH12 5AB United Kingdom
Azomyr be indicate for the relief of symptom associate with :
if both plasma concentration be below 0.02 mg / l no teratogenic risk be to be expect .
inject air into the vial by push the plunger until you feel a clear resistance .
© EMEA 2006
6
woman who use lumiracoxib should not breastfeed .
in vitro study indicate that irbesartan be primarily oxidise by the cytochrome P450 enzyme CYP2C9 ; isoenzyme CYP3A4 have negligible effect .
possible interaction with other medicinal product know to have high affinity for plasma protein should be consider ( e. g . , NSAIDs , oral anticoagulant , or oral antidiabetic ) .
co-administration of cimetidine , nifedipine , oestrogen , or simvastatin with repaglinide , all CYP3A4 substrate , do not significantly alter the pharmacokinetic parameter of repaglinide .
IONSYS should be apply to intact , non-irritated and non-irradiated skin on the chest or upper outer arm .
this be give by injection under the skin ( subcutaneously ) .
4.1 Therapeutic indication
Merz Pharmaceuticals GmbH Eckenheimer Landstr .
dosage FOR EACH SPECIES , ROUTE ( S ) AND METHOD OF ADMINISTRATION
4.9 Overdose
dosage increase of Kaletra from 400 / 100 mg ( 5 ml ) twice daily to 533 / 133 mg ( ~ 6.5 ml ) twice daily should be consider when co-administered with efavirenz .
peripheral sensory neuropathy ( G3 / 4 :
MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
5.1 Pharmacodynamic property
2.4 ml .
the advisability of drive should be consider in these circumstance .
skin and subcutaneous tissue disorder Very common :
upon regain consciousness , administration of oral carbohydrate be recommend for the patient in order to prevent relapse .
13 .
400 / 100 b.i.d . # Sertraline
the indication for treatment with NeoRecormon of nephrosclerotic patient not yet undergoing dialysis should be define individually , a a possible acceleration of progression of renal failure can not be rule out with certainty .
expiry DATE
— — 1 1 4 4 12 18
5 day
7 .
Sanof i Pharma Bristol-Myers Squibb SNC F
10 , 20
pharmacological PROPERTIES
the degree and duration of aPTT normalisation observe after administration of KOGENATE Bayer be similar to that achieve with plasma-derived factor VIII .
what Aerius oral lyophilisate look like and content of the pack
this combination be indicate in first-time user .
daily dose ( mg )
- If you have miss a dose of Insuman Comb 15 or if you have not inject enough insulin , your
Suvaxyn Aujeszky 783 + O / W , solvent for injection .
however , the analysis of data from more than 12,000 patient treat during phase I , II and III do not reveal any clinically relevant interaction with medicinal product commonly use in patient with AMI and concomitantly use with Metalyse .
MIRCERA 200 µg / 0.3 ml injection methoxy polyethylene glycol-epoetin beta SC / IV
9 ANNEX II
with a slightly higher affinity for ETA receptor ( Ki = 4.1 – 43 nM ) than for ETB receptor B
50 50 80 100
dizziness
of 2833 patient , of which four be double-blind placebo-controlled study and one be an open- label study .
for one animal the result at 30 day be not report .
what ( Invented name ) ® be and what it be use for 2 .
in addition , an updated RMP should be submit • When new information be receive that may impact on the current Safety Specification , Pharmacovigilance Plan or risk minimisation activity . • Within 60 day of an important ( pharmacovigilance or risk minimisation ) milestone be reach . • At the request of the EMEA .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
5.2 Inspections The Sector for inspection coordinate the work of inspector and expert group in support of the evaluation of medicinal product and general inspection activity .
drug know to induce electrolyte imbalance may also precipitate QT prolongation and thus interact with terfenadine .
in patient with severely impaired renal function ( creatinine clearance & lt ; 30 ml / min ) the elimination half-life may be prolong by a factor of 2 .
Weaning from inhale nitric oxide should be perform with caution .
take ONSENAL with food and drink You can take Onsenal with or without food .
16 .
syrinx , 24 injection needle and 12 cleanse swab .
dose modification for all patient If severe adverse reaction or laboratory abnormality develop during treatment with PegIntron monotherapy or PegIntron in combination with ribavirin , modify the dosage of each product a appropriate , until the adverse reaction abate .
107 9 .
serum creatinine at Day - X Serum creatinine at Day - Y
take notice of the respective informing text of ribavirin contain medicinal product .
this syndrome be characterise by large ovarian cyst .
6.1 List of excipients
Genzyme Europe B. V .
1 .
aluminium hydroxide-magnesium hydroxide-simethicone antacid / Efavirenz ( 30 ml single dose / 400 mg single dose ) Famotidine / Efavirenz ( 40 mg single dose / 400 mg single dose ) ANTIANXIETY AGENTS
for a full list of excipients , see section 6.1 .
and the liver , and improve pyruvate utilisation .
keep the bottle tightly close .
Special STORAGE CONDITIONS
further INFORMATION
in a study ( RUTH ) of postmenopausal woman with documented coronary heart disease or at increase risk for coronary event , an additional adverse reaction of cholelithiasis occur in 3.3 % of patient treat with raloxifene and 2.6 % of patient treat with placebo .
- The other ingredient be : sodium chloride , disodium phosphate dodecahydrate , potassium
2 .
through Week 240 in nucleoside-naive study , genotypic evidence of ETVr substitution at rtT184 , rtS202 , or rtM250 be identify in 3 patient treat with entecavir , 2 of whom experience virologic breakthrough ( see table ) .
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
lactation ( see section 4.6 ) .
Slovenija Medis , d.o.o .
pregnancy and lactation .
BATCH { number }
prophylaxis of transplant rejection – child & lt ; Invented name & gt ; have be use with or without antibody induction in paediatric heart transplantation .
therefore aliskiren be not expect to affect the systemic exposure of substance that inhibit , induce or be metabolise by these enzyme .
Deutschland TAD Pharma GmbH Tel : + 49 ( 0 ) 4721 6060
2 .
a booster dose of Infanrix Hexa or a similar vaccine must be give at least six month after the last dose of the initial course .
threaten ( grade 3-4 ) or consider medically relevant Skin and subcutaneous tissue disorder
what MicardisPlus contains
10 30
overall SUMMARY OF THE SCIENTIFIC EVALUATION OF CIPROFLOXACIN KABI AND ASSOCIATED NAMES ( see Annex I )
very common ≥ 10 % ; Common be normally define a ≥ 1 % and & lt ; 10 % .
pioglitazone be devoid of genotoxic potential in a comprehensive battery of in vivo and in vitro genotoxicity assay .
what be ZYPREXA VELOTAB use for ?
Triatec Plus 2.5 mg / 12.5 mg δισκία , Triatec Plus 5 mg / 25 mg δισκία
80
haemodialysis to avoid the puncture of peripheral vein . ed
solution for injection ( injection ) in a pre-filled syringe .
2 .
list OF EXCIPIENTS
unopened vial Store in a refrigerator ( 2 ° C - 8 ° C ) .
suspension for injection
- allergic rhinitis ( see section 5.1 )
renal impairment and kidney transplantation : when Irbesartan BMS be use in patient with impaired renal function , a periodic monitoring of potassium and creatinine serum level be recommend .
during treatment with immunosuppressant , include Rapamune , vaccination may be le effective .
EXP :
read and follow the instruction in the product literature supply with the infusion pump . • Be sure to use the correct reservoir and catheter for your pump . • Change the infusion set every 48 hour .
Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
Renagel
ear and labyrinth disorder
mechanism of action Tenecteplase be a recombinant fibrin-specific plasminogen activator that be derive from native t-PA by modification at three site of the protein structure .
indication
6.5 Nature and content of container
this medicinal product do not require any special storage condition .
insulin human
rarely ( ≥ 1 / 10.000 to ≤ 1 / 1.000 ) , epoetin beta treatment-related skin reaction such a rash , pruritus , urticaria or injection site reaction may occur .
EU / 2 / 05 / 054 / 003 12 pipette EU / 2 / 05 / 054 / 004 20 pipette EU / 2 / 05 / 054 / 005 40 pipette
VISTIDE have be show to cause damage in unborn animal and should not be use during pregnancy unless the potential benefit justify the risk to the foetus .
oral use
2
Intercurrent illness require intensified metabolic monitoring .
- if you have advance liver disease ( e. g. your skin have become yellow ) .
malignancy and lymphoproliferative disorder
13.6 ( 188 / 1,385 ) 11.2 , 15.9
other
co-administration of Viraferon with ribavirin increase the efficacy of Viraferon by at least two fold for the treatment of chronic heptatitis C in naïve patient .
peak serum concentration be report to occur 45 to 60 minute follow a single dose in fasted patient .
- If any of the side effect get serious , or if you notice any side effect not list in this leaflet ,
Cystometric study perform with darifenacin in patient with involuntary bladder contraction show increased bladder capacity , increase volume threshold for unstable contraction and diminished frequency of unstable detrusor contraction .
Shire Human Genetic Therapies AB Åldermansgatan 2 , Box 1117 , 221 04 Lund Sweden
talk about your insulin need with your doctor and diabetes nurse .
in September 1997
Celvapan should under no circumstance be administer intravascularly .
Dispersible tablet
general CLASSIFICATION FOR SUPPLY
Zonisamide be a benzisoxazole derivative .
co-administration of Atripla and St .
pregnancy and breast-feeding You must tell your doctor if you think that you be ( or might become ) pregnant .
nervous system disorder :
3 hour .
15 .
Slovenská republika Strakova 5 SK-811 01 Bratislava Tel : + 421 ( 2 ) 5920 2712
3 year Shelf-life when incorporate into meal feed and protect from light and moisture :
Froth may interfere with the correct measurement of the dose .
general CLASSIFICATION FOR SUPPLY
- AV-block of 3rd degree
patient with existence of or history of severe psychiatric condition :
withdrawal PERIOD
Celvapan can only be market when there be an official WHO / EU declaration of an influenza pandemic , on the condition that the Marketing Authorisation Holder for Celvapan take due account of the officially declare pandemic strain .
for intravenous or subcutaneous use Read the package leaflet before use .
the dose , the frequency of injection and how long it be use for depend on why Epoetin Alfa Hexal be be use , and be adjust accord to the patient ’ s response .
14 / 16 ANNEX III
LABELLING AND PACKAGE LEAFLET
Slovenská republika Roche Slovensko , s. r. o .
keep out of the reach and sight of child
first symptom of ovarian hyperstimulation be pain in the lower abdominal region , possibly in combination with nausea , vomit and weight gain .
1 ml 1 : cell culture infective dose 50 % 2 : egg infective dose 50 % For a full list of excipients , see section 6.1 .
read the package leaflet before use .
Lietuva Merck Serono Atstovybė C / o Ares Trading SA Baltic States Zamenhofo 11-3 , LT-44287 Kaunas Tel : + 370 37320603
3 .
15 .
a comprehensive methodology for determine the cost of the EMEA secretariat be approve by the Management Board in 1999 and the Board will continue to monitor data generate by the model .
1 .
after several parenteral dos treatment can be switch over to the oral form .
these symptom be usually of transitory nature .
serious hypoglycaemia may cause a heart attack or brain damage and may be life -threatening .
it be therefore advised that when duloxetine treatment be no longer require , gradual discontinuation by dose tapering should be carry out ( see section 4.2 and 4.4 ) .
CPMP / 4260 / 03 SCIENTIFIC CONCLUSIONS
SP Europe , Rue de Stalle 73 , B-1180 Bruxelles , Belgium .
oral use
- Treatment of duodenal and stomach ulcer
Kentera
Supplementary iron therapy be recommend for all patient with serum ferritin value below 100 µg / l or whose transferrin saturation be below 20 % .
statement OF ACTIVE SUBSTANCE ( S )
any severity Severe † Any severity
how be Exforge use ?
hepatic impairment ( see 5.2 Pharmacokinetic property ) .
not applicable .
in many case , urine test for ketone be indicate , and often it be necessary to adjust the insulin dose .
14 9 .
efavirenz be a non-competitive inhibitor of HIV-1 reverse transcriptase ( RT ) and do not significantly inhibit HIV-2 RT or cellular DNA polymerase ( α , β , γ or δ ) .
however , response rate in this trial be show to be dependent also on the dose of ribavirin administer in combination with Viraferon Peg or interferon alfa-2b .
reproduction be authorise provide the source be acknowledge .
how to take Rapamune 4 .
colourless , clear to slightly opalescent solution .
treatment cycle : • On day 1-21 : take 25 mg of Revlimid once per day • On day 22-28 : do NOT take Revlimid After complete each cycle , start a new one .
if you have a cough , fever and difficulty breathe please tell your doctor .
clinical study , ZIMULTI 20 mg be take in the morning usually before breakfast . lp
each pen contain multiple dos .
EXP
dialysis patient convert from once weekly to once every other week dose with Aranesp should initially receive a dose equivalent to twice the previous once weekly dose .
for more information , see the Package Leaflet provide with the other medicine . • Norvir can also be use a an antiviral medicine .
the kinetics of the main circulating metabolite be linear ( plasma concentration increase in proportion to dose ) in the dose range of 50 to 150 mg of clopidogrel .
statement OF ACTIVE AND OTHER SUBSTANCES
thus , no dosage adjustment be require for digoxin , warfarin or other drug that be CYP2C9 or CYP3A4 substrates upon coadministration with Trazec .
no dosage adjustment be necessary in patient with renal impairment whose renal creatinine clearance be ≥ 30 ml / min ( see section 4.3 and 4.4 ) .
important information about some of the ingredient of Insuman Comb 15
- Solution for injection - 5 mg / ml
instruction ON USE
weight increase ,
always take Prandin exactly a your doctor have tell you .
the product should be use with the accompany solvent only .
25 / 250
Perindopril tert-butylamine salt
in animal , rivastigmine be excrete into milk .
patient with rare hereditary problem of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine .
7 Filgrastim administration should be discontinue or it dosage should be reduce if the leukocyte count rise to & gt ; 70 x109 / l .
Alternatively therapy may be initiate with Loxicom 5 mg / ml solution for injection .
Uncommon :
drug ’ s ability to go through the skin .
rufinamide be active in a range of animal model of epilepsy .
film-coated tablet
Kaletra do not inhibit CYP2D6 , CYP2C9 , CYP2C19 , CYP2E1 , CYP2B6 or CYP1A2 at clinically relevant concentration ( see section 4.3 ) .
1,200 mg )
Film-coating :
vascular disorder
what be Irbesartan Hydrochlorothiazide Winthrop use for ?
dosage • You should normally inject Humalog Mix50 within 15 minute of a meal .
it be important you tell your doctor if you have symptom of infection ( e.g . fever , malaise , dental problem ) .
the length of treatment depend on where the infection be , how severe it be , and the patient ’ s response to treatment .
if not , repeat the above procedure until content be mixed .
EU / 2 / 01 / 029 / 001 10 dos : powder ( 10 bottle ) + solvent ( 10 bottle )
- Constipation
Focetria suspension for injection in multidose container Pandemic influenza vaccine ( surface antigen , inactivate , adjuvanted )
take other medicine Some medicine may affect the action of Zeffix .
in an embryotoxicity study in the rabbit , a higher incidence of cardiovascular and skeletal malformation be observe at systemic exposure level below the maximun clinical exposure ( AUC ) .
mannitol content be below the threshold of the Excipient guideline & apos ; s annex .
for patient treat with filgrastim dilute to concentration & lt ; 1.5 MU / ml ( 15 μ g / ml ) , human serum albumin ( HSA ) should be add to a final concentration of 2 mg / ml .
pharmacological PROPERTIES
lithium :
1 .
in both comparator-controlled ( not placebo-controlled ) clinical study on patient with heart failure the tolerability of Losartan be superior to that of captopril , measure on the basis of a significantly lower rate of discontinuation of therapy on account of adverse event and a significantly lower frequency of cough .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
EU / 0 / 00 / 000 / 000 EU / 0 / 00 / 000 / 000 EU / 0 / 00 / 000 / 000
- 12 vial of powder for solution for injection , 12 ampoule of solvent for parenteral use ,
take one tablet once a week .
interaction with other form of hormonal contraception have not be investigate .
Temodal may cause permanent infertility .
store in the original package .
voriconazole increase tacrolimus ( 0.1 mg / kg single dose ) Cmax and AUCt ( area under the plasma concentration time curve to the last quantifiable measurement ) by 117 % and 221 % , respectively .
7 Westferry Circus , Canary Wharf , London , E14 4HB , UK Tel .
therefore , Bondronat should not be use during pregnancy .
dyspepsia , dysgeusia
discard unused portion .
3 .
CONDITIONS OF THE MARKETING AUTHORISATION
1 .
1 .
30 .
ination :
a variety of neoplasm , include mammary carcinoma , keratocanthoma of the skin and basal cell adenoma be observe in the 6-cycle rat study while no tumour or pre-neoplastic change be evident in dog study .
PHARMACEUTICAL FORM
at week 16 , 47 placebo patient with & lt ; 10 % improvement from baseline in both swollen and tender joint count be switch to infliximab induction ( early escape ) .
each film-coated tablet contain 150 mg of maraviroc .
15 .
12 .
BATCH NUMBER
the review find that limited epidemiological data and spontaneous adverse drug reaction data provide a signal of increase risk of gastrointestinal and skin reaction ( include life-threatening bullous reaction ) for piroxicam relative to other non-selective NSAIDs .
sodium chloride Disodium phosphate dodecahydrate Potassium dihydrogen phosphate Potassium chloride Magnesium chloride hexahydrate Thiomersal Water for injection
the medicine can only be obtain with a prescription .
the infomation on metabolite be incomplete .
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
inhalation use
dosage adjustment in renal impairment :
this include advice and recommendation on general public health issue relate to medicinal product such a transmissible spongiform encephalopathy ( TSE ) or Creutzfeld-Jakobs ’ s Disease ( CJD ) , or viral safety on plasma derivative .
total plasma clearance ( Cltot ) be high ( approximately 1,000 ml / min ) compare with hepatic blood flow ( about 1,500 ml / min ) .
follow oral administration , the plasma concentration of unchanged lacosamide increase rapidly and reach Cmax about 0.5 to 4 hour post-dose .
name OF THE MEDICINAL PRODUCT
EU / 1 / 07 / 396 / 003
Oro-dispersible tablet
the European Commission grant a marketing authorisation valid throughout the European Union , for Orgalutran to N. V .
swallow your prescribed dose of Remeron without chew , with some water or juice .
Similarly , the significant advantage for Enbrel monotherapy compare with methotrexate monotherapy be also observe after 24 month .
skin and subcutaneous tissue disorder
SP Europe , 73 , rue de Stalle , B-1180 Bruxelles , Belgium
- in muscle , by modestly increase insulin sensitivity , improve peripheral glucose uptake and
MIRAPEXIN 0.088 mg tablet pramipexole
look out for the sign of allergy in 5 Possible side effect If you feel a hypo come on ( a hypo be short for a hypoglycaemic reaction and be symptom of low blood sugar ) .
do not chew the tablet or allow it to dissolve in your mouth .
rare : very rare :
treatment of essential hypertension .
what MICARDISPLUS IS AND WHAT IT IS USED FOR
animal reproduction study have not be conduct with factor IX .
9.9 ( 44 / 446 )
white , opaque capsule mark “ NTBC 10mg ” on one side of the capsule .
gender and the concomitant use of intravenous epoprostenol have no significant effect on the pharmacokinetics of bosentan .
4.4 Special warning and precaution for use
aripiprazole be excrete in the milk of treated rat during lactation .
if the patient experience any break in the skin , which may be associate with swell or drainage of fluid from the injection site , the patient should be advise to consult with his / her physician before continue injection with Extavia .
therefore , the bolus dose and infusion rate must be reduce in case of know or suspect renal insufficiency ( creatinine clearance below 60 ml / min or creatinine value above 15 mg / l & # 91 ; 133 μ mol / l & # 93 ; ) .
30
in the absence of detailed information on the pre-existing history of individual acute and tardive extrapyramidal movement disorder , it can not be conclude at present that olanzapine produce le tardive dyskinesia and / or other tardive extrapyramidal syndrome .
7
6.6 Special precaution for disposal
119 I
show the direction to pull or be push in and the pen be
BATCH NUMBER
pregnancy There be no data on the use of duloxetine in pregnant woman .
10 ml type I glass vial with rubber stopper ( bromobutyl ) and flip-off aluminium cap .
your doctor will therefore be monitor the effectiveness of your treatment .
PHARMACEUTICAL FORM
subcutaneous use
10 pre-filled syrinx without needle
6 .
CLASSIFICATION of expect frequency :
genotype 2 / 3 / 4 ( n = 26 ) * Number ( % ) of patient
the predefined blood pressure goal be ≤ 135 / 85 mmHg .
6.5 Nature and content of container
common : insomnia .
an increase relative risk of thromboembolic event ( RR 1.67 , 95 % CI :
expiry DATE
powder and solvent for solution for injection
there be no clinical experience of vildagliptin and metformin in triple combination with other antidiabetic agent .
dental and periodontal disorder , which may lead to loss of teeth , have be report in patient receive Peg Intron and ribavirin combination therapy .
BeneFIX be give by a slow infusion into a vein ( usually up to 4 ml per minute ) .
medicinal product subject to medical prescription .
the drop should be pour in a spoon or dilute in water , and take orally .
figure 1 Percent of Patients Receiving Highly Emetogenic Chemotherapy Who Remain Emesis Free Over Time – Cycle 1
clinical 3
patient with existence of or history of severe psychiatric condition :
MARKETING AUTHORISATION NUMBER ( S )
carry glucose tablet , sweet , biscuit or fruit juice with you , just in case .
8.5 mg / ml orbifloxacin , 0.9 mg / ml mometasone furoate ( a monohydrate ) and 0.9 mg / ml posaconazole .
România Ş o .
for therapeutic dos of irbesartan in human , the hyperplasia / hypertrophy of the renal juxtaglomerular cell do not appear to have any relevance .
immune system disorder
- if you be pregnant ;
withdrawal PERIOD
do not use Cervarix after the expiry date which be state on the carton .
your needle may be clog .
PHARMACEUTICAL Form
in the four placebo-controlled study the hazard ratio for overall survival range between 1.25 and 2.47 in favour of control .
oral use
human insulin be produce by recombinant DNA technology in Escherichia coli .
do not freeze .
th Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
how to take ADARTREL 4 .
in pediatric patient suffer from renal impairment , the dose will have to be adjust on an individual basis take into account the renal clearance of the patient , his age and his body weight .
8 .
EU / 1 / 08 / 463 / 003
like all medicine , Epivir can cause side effect , although not everybody get them .
the maximum dose should not exceed 1600 IU / kg body weight per week for intravenous or 1200 IU / kg per week for subcutaneous administration .
if available , 90 % confidence interval ( CI ) be show in parenthesis .
the initial half-life be in the order of minute and the terminal half-life be several hour , with the possible presence of a deep compartment .
if any of the side effect get serious , or if you notice any sided effect not list in this leaflet , please tell your doctor or pharmacist .
4 .
2 .
Protaphane Penfill 100 IU / ml suspension for injection in a cartridge Insulin human ( rDNA )
facial palsy , neuropathy , mononeuropathy
person with known hypersensitivity to quinolones should avoid contact with the product .
6 .
ho subject with type 1 diabetes ( see section 4.2 ) .
España Wyeth Farma S. A .
Special STORAGE CONDITIONS
paediatric population
maintenance Study AUS01
patient should be advise not to take a second dose within a single night .
hepatic insufficiency :
limited experience be available in patient with severe renal impairment or haemodialysis .
do not freeze .
to diminish the toxicity and counteract the action of folic acid antagonist such a methotrexate in cytotoxic therapy and overdose in adult and child .
cyclosporine Sirolimus Tacrolimus
pack size of 1 .
week 24
2 .
2 .
expiry DATE
common
in a prospective , randomised , double-blind , placebo-controlled trial conduct in 375 anaemic patient with various non-myeloid malignancy receive non-platinum chemotherapy , there be a significant reduction of anaemia-related sequela ( e. g. fatigue , decrease energy , and activity reduction ) , a measure by the following instrument and scale :
- sulfonamide antibiotic .
PHARMACEUTICAL FORM AND CONTENTS
47 % 41 % 48 %
oral use .
• Hypersensitivity to the active substance or to any of the excipients • Hypoglycaemia .
15 .
a number of cleavage ( hydrolysis ) sit on the human insulin molecule have be propose ; none of the metabolite form follow the cleavage be active .
2 .
5.9 ( 36 )
blood and the lymphatic system disorder U
Krka , d. d . , Novo mesto , Š marješ cesta 6 , 8501 Novo mesto , Slovenia ka
there be neither clinical experience nor evidence from study in animal that use of Puregon during pregnancy might lead to congenital abnormality .
there be further increase in the risk of gastrointestinal adverse effect ( gastrointestinal ulceration or other gastrointestinal complication ) when celecoxib be take concomitantly with acetylsalicylic acid ( even at low dos ) .
base on the review of the initial documentation , the CHMP prepare a list of question at day 120 , which be send to the company .
upon abrupt cessation of treatment with telmisartan , blood pressure gradually return to pre-treatment value over a period of several day without evidence of rebound hypertension .
82 % 79 %
the lp
turn the bottle back upright with the oral syringe still in place .
GSK d. o. o . , Ljubljana , Knezov stradon 90 , 1000 Ljubljana , Slovenia
if it occur , appropriate dose adjustment should be make a provided .
Rheumocam contain the active substance meloxicam in a strength of 1.5 mg / ml .
Azomyr oral solution relief symptom associate with allergic rhinitis ( inflammation of the nasal passage cause by an allergy , for example , hay fever or allergy to dust mite ) . these symptom include sneeze , runny or itchy nose , itchy palate , and itchy , red or watery eye .
in the open-label study there be no difference in overall survival between patient treat with recombinant human erythropoietin and control .
in both placebo-controlled , double-blind study , patient already receive ITP medical therapy at a constant dosing schedule be allow to continue receive these medical treatment throughout the study ( corticosteroid , danazol and / or azathioprine ) .
do not drive or use machinery if you be affect .
child and adolescent
administer volume ( nominal tube size- ml )
- carton box with 5 x 15 ml ( 0.5 ml step ) pre-filled syrinx ( Ibaflin 3 % Oral Gel )
FOLDING BOX FOR UNIT PACK
9 %
- what you should do in emergency situation when you feel unwell or become ill .
among these , two case of platelet & lt ; 50 x 109 / l be report and attribute to the leukapheresis procedure .
blood and the lymphatic system disorder
if you stop take Stalevo
the immunogenicity of Silgard be assess in 8,915 ( Silgard n = 4,666 ; placebo n = 4,249 ) woman 18 to 26 year of age and 3,400 female ( Silgard n = 1,471 ; placebo n = 583 ) and male ( Silgard n = 1,071 ; placebo n = 275 ) adolescent 9 to 17 year of age .
Arcoxia
this difference be not statistically significant .
this should be consider for a continuous infusion administration .
neutrophil produce in response to filgrastim show normal or enhanced function a demonstrate by test of chemotactic and phagocytic function .
supraventricular tachycardia , extrasystole
visually confirm that the needle be fully engage into the needle protection device .
a test set contain the following part :
VIRACEPT , in combination with other antiviral medicine , be more effective than the comparator medicine in both main study .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
at Week 52 , 42.9 % of patient who receive Humira / methotrexate combination therapy achieve clinical remission ( DAS28 & lt ; 2.6 ) compare to 20.6 % of patient receive methotrexate monotherapy and 23.4 % of patient receive Humira monotherapy .
BATCH
4 .
{ MM / YYYY }
6.1 List of excipients
6 .
caution should be exercise in patient with hypotension , a there be a risk of further reduction in blood pressure .
Feldene Dispersal
Ελλάδα Merck A. E .
renal and urinary disorder
it be available a 2-g sachet contain yellow granule , which be make up into an oral suspension .
clinical trial result All clinical trial recruit patient with chronic hepatitis B who have active viral replication measure by HBV DNA , elevate level of ALT and a liver biopsy consistent with chronic hepatitis .
• •
when use the individual correction formula , none of the value be out of the limit .
the shelf-life of the reconstituted suspension be 2 month .
5.1 Pharmacodynamic property
- your child have diarrhoea or be vomit .
DEXDOMITOR 0.5 mg / ml solution for injection
method AND ROUTE ( S ) OF ADMINISTRATION
4.3 Contraindications
the ability to donate blood depend predominantly on the patient & apos ; s blood volume and baseline PCV .
how TO USE Vaniqa
telmisartan be largely bind to plasma protein ( & gt ; 99.5 % ) , mainly albumin and alpha-1 acid glycoprotein .
driving and use machine You may feel dizzy and this can affect your ability to concentrate .
pharmacological PROPERTIES
method AND ROUTE ( S ) OF ADMINISTRATION
2000 / mm3
EU / 1 / 06 / 367 / 004-6
6
7 .
Forty-seven percent ( 47.2 % ) of patient on the combination achieve trough SeDBP & lt ; 90 mmHg compare to 33.2 % of patient on irbesartan ( p = 0.0005 ) .
not applicable .
Lipobay
EXP
2.1 4.8
18 Commonly susceptible specie
keep the container tightly close in order to protect from light and moisture
the reconstituted solution should be administer immediately .
the NeoRecormon pre-filled syringe be ready for use .
“ Children 2 to 12 year { Tradename } be indicated a adjunctive therapy in the treatment of epilepsy , for partial seizure and generalised seizure include tonic-clonic seizure and the seizure associate with Lennox-Gastaut Syndrome ” .
if severe OHSS occurs , gonadotrophin treatment should be stop if still ongoing , the patient hospitalise and specific therapy for OHSS start .
read all of this leaflet carefully before you start take this medicine .
suspension for injection 1 x 3 ml 5 x 3 ml 10 x 3 ml
in preclinical study , olanzapine exhibit a range of receptor affinity ( Ki ; & lt ; 100 nM ) for serotonin 5 HT2A / 2C , 5 HT3 , 5 HT6 ; dopamine D1 , D2 , D3 , D4 , D5 ; cholinergic muscarinic receptor m1-m5 ; α adrenergic ; and histamine H1 receptor .
information IN BRAILLE
oral use
100 U / ml
expiry DATE
Malta Associated Drug Company Ltd Tel : + 356 ( 0 ) 227 780 00
in patient undergo ART procedures the risk of multiple pregnancy be relate mainly to the number of embryo replace , their quality and the patient age .
not all pack size may be market .
BRISTOL-MYERS Squibb S. r. l .
summary OF PRODUCT CHARACTERISTICS
Diagram F
no data be available on patient with severe hepatic impairment treat by Rasilez HCT .
cervical cancer Cervical cancer also have be find more often in woman take combined hormonal contraceptive .
Malta V. J. Salomone Pharma Limited 79 , Simpson Street , Marsa HMR 14 , Malta .
common :
Κύπρος MEDA Pharmaceuticals AE Ευρυτανίας 3 GR-15231 Χαλάνδρι -Αττική Ελλάδα Τηλ : + 30 210 6 77 5690
if you notice your skin pitting or thickening at the injection site , tell your doctor or diabetes nurse because these reaction can become more severe , or they may change the absorption of your insulin if you inject in such a site .
AIIRAs therapy exposure during the second and third trimester be know to induce human foetotoxicity ( decreased renal function , oligohydramnios , skull ossification retardation ) and neonatal toxicity ( renal failure , hypotension , hyperkalaemia ) ( see also section 5.3 ) .
you must throw away the bottle four week after you first open it , even if there be still some drop leave .
dose adjustment for neutropenia and thrombocytopenia
19 PACKAGE LEAFLET ProMeris Spot-on for cat
2 mg ) .
therapy complete prior to the institution of growth hormone therapy .
rotigotine may pass into your breast milk and affect your baby and be also likely to reduce the amount of milk you produce .
in alkylating-failure patient , docetaxel be compare to doxorubicin ( 75 mg / m ² every 3 week ) .
Tlf : + 47 22 88 18 00
vision blur Conjunctivitis , vision abnormal , lacrimal gland disorder , eye
tacrolimus be start a continuous intravenous infusion at a dose of 0.05 mg / kg / day and oral tacrolimus be administer at a dose of 0.1 to 0.3 mg / kg / day with subsequent dose adjustment to target trough level of 12 to 15 ng / ml .
10 .
C02CA04
205 • Don ’ t put your hand over the push-button when you set the dose .
3 year .
12 .
12 1 .
5 .
your doctor will normally advise you to stop take Dafiro a soon a you know you be pregnant .
the WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN ”
52 10 .
6.4 Special precaution for storage
ER • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ng Medicinal product subject to restrict medical prescription ( See Annex I :
UCB Pharma SA Allée de la Recherche 60 B-1070 Bruxelles Belgium
4.5 Interaction with other medicinal product and other form of interaction
STELARA be use to treat moderate to severe plaque psoriasis in patient who can not use or do not respond to other medicine and phototherapy .
© EMEA 2008
before stop use of rotigotine completely see section 4.2 .
use other medicine
these type of cancer affect the cell of the lining of the mouth or the throat , or of organ such a the larynx ( voice box ) .
cholesterol level should be periodically monitor .
the instruction for use the pen must be follow carefully .
•
patient experience xerostomia be advise to drink water to moisten the buccal cavity prior to administration of Effentora .
these measure will help to protect the environment .
in patient with haemophilia Type A and B , there have be report of increase bleeding while take protease inhibitor .
3 .
↔ ↑ 75 %
post-marketing commitment , whether or not link to market authorisation grant under exceptional circumstance , also show a grow trend in 2001 .
if you suffer from these effect you must not drive or put yourself in a situation where sleepiness or fall asleep may put you at risk of serious injury or death ( for example use machinery ) until these episode have be resolve .
75 kg patient be initiate at 1 µg / kg of romiplostim .
a few patient have have an allergic reaction to TYSABRI .
do not freeze .
slowly press the plunger to push bubble out of the syringe and into the vial .
- you be take or have stop take certain other medicine ( see section 2 , & quot ; Using other
Regranex be a clear colourless to straw-coloured gel , which contain 0.01 % of the active substance becaplermin .
Cardboard box contain one aluminium-aluminium blister pack , each contain four tablet per pack .
1 .
a per the CHMP Guideline on Risk Management Systems for medicinal product for human use , the updated RMP should be submit at the same time a the next Periodic Safety Update Report ( PSUR ) .
absorption
detailed information on this medicinal product be available on the website of the European Medicines Agency ( EMEA ) http : / / www . emea . europa . eu .
skin and subcutaneous tissue disorder :
the degree to which hydrochlorothiazide be remove by haemodialysis have not be establish .
all patient and parent / caregiver should be advise that if the patient develop sign and symptom suggestive of blood dyscrasia or infection ( e. g. persistent fever , sore throat , bruising , bleeding , paleness ) whilst on Enbrel , they should seek immediate medical advice .
medicinal product affect potassium : the potassium-depleting effect of hydrochlorothiazide be attenuate by the potassium-sparing effect of irbesartan .
dose
Aranesp 40 µg injection Darbepoetin alfa SC
Implant Subcutaneous use
21 10 .
CPMP work party chemical substance leave the EMEA in 1998 to become director of the Spanish Medicines Agency and be succeed by Dr Patrick Le Courtois .
distribution
ampoule TEXT Puregon 50 IU powder
5 .
4 .
injection site pain
nausea or vomiting )
lot :
disorder
European PUBLIC ASSESSMENT REPORT ( EPAR )
Hearing thing that be not real ) , confusion or suicide
in addition , rare case of liver failure / renal failure or fatal hepatitis have be report .
tn uc od Pr al i cin
the dose button should be easy to pull out without too much force be need ( figure 4 ) .
bag PP / polyamide / PE )
in major surgery , the dose should be continue at 2 - 4 hour interval for 6 - 7 day .
•
F4 Baseline Viral Load
the production of erythropoietin primarily occur in and be regulate by the M
the group also work on the revision of the current CVMP injection site guideline a well a a new guideline on user safety .
since the use of factor IX complex concentrate have historically be associate with the development of thromboembolic complication , the risk be higher in low purity preparation , the use of factor IX-containing product may be potentially hazardous in patient with sign of fibrinolysis and in patient with disseminated intravascular coagulation ( DIC ) .
1 .
the following substance may reduce the patient ’ s insulin requirement :
general CLASSIFICATION FOR SUPPLY
use in hepatic impairment :
clinical trial data
6 .
epoetin beta be identical in it amino acid and carbohydrate composition to erythropoietin that have be isolate from the urine of anaemic patient .
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
no study on the effect on the ability to drive and use machine have be perform .
23 Long-term exposure ( at least 48 week ) The proportion of patient who have adverse , clinically significant change in weight gain , glucose , total / LDL / HDL cholesterol or triglyceride increase over time .
take Irbesartan Hydrochlorothiazide BMS with food and drink Irbesartan Hydrochlorothiazide BMS can be take with or without food .
your doctor will decide if ZOSTAVAX should be give .
place the needle cover back on the work surface .
57-72 73-89 90-106 & gt ; 106
RISPERDAL Consta
in randomise , placebo-controlled clinical trial , filgrastim do not increase the incidence of undesirable effect associate with cytotoxic chemotherapy .
in a mass balance study use radiolabelled material , 78 % of the administer dose be recover from the urine base on total radioactivity , whilst urinary recovery of unchanged daptomycin be approximately 50 % of the dose .
6.5 Nature and content of container
Insuman Rapid be administer subcutaneously .
20 µg
Special WARNING ( S ) , IF NECESSARY
Teva Santé SA Rue Bellocier 89107 Sens France
before YOU USE GARDASIL
read all of this leaflet carefully before you start take this medicine . • Keep this leaflet .
indication ( S )
- the first warning symptom which help you to recognise hypoglycaemia be reduce or absent .
Efexor XR
in patient with diabetes mellitus optimise metabolic control effectively delay the onset and slow the progression of diabetic late complication .
typically , such reaction have be observe within the first few week or month of initiation of CART .
PHARMACEUTICAL PARTICULARS
use other medicine
6 .
you may need to read it again .
transient , asymptomatic elevation of hepatic transaminase ( ALT , AST ) , especially in early treatment ( see section 4.4 )
the most frequent adverse reaction during treatment with epoetin alfa be a dose-dependent increase in blood pressure or aggravation of exist hypertension .
no statistical comparison to placebo be make at week 24 in study 2 and 4 because the original placebo group begin receive Enbrel 25 mg BIW or 50 mg once weekly from week 13 to week 24. b .
2 minute .
7
efavirenz have not be study in controlled study in patient with advanced HIV disease , namely with CD4 count & lt ; 50 cell / mm3 , or in PI or NNRTI experience patient .
mixing or diluting may change the action of Lantus .
Rapilysin contain the active substance reteplase .
paediatric patient :
• 192 day • 127 day
Humira 40 mg solution for injection Adalimumab
this leaflet be a general guide .
if there be evidence of worsen liver disease in such patient , interruption or discontinuation of treatment must be consider .
what Tevagrastim IS AND WHAT IT IS USED FOR
suspension for injection
mannitol Sodium phosphate monobasic , monohydrate Sodium phosphate dibasic , heptahydrate .
Никола Вапцаров № 55 1407 София Τ eл : + 359 8985 99700
two juvenile idiopathic arthritis patient develop varicella infection and sign and symptom of aseptic meningitis , which resolve without sequela .
EXP
4.8 1.7
keep out of the reach and sight of child .
the use of epoetin alfa in patient schedule for major elective orthopaedic surgery and not participate in an autologous blood predonation programme be contraindicate in patient with severe coronary , peripheral arterial , carotid or cerebral vascular disease , include patient with recent myocardial infarction or cerebral vascular accident .
4.7 Effects on ability to drive and use machine
usually you will need to take Remeron until your symptom of depression have disappear for 4 to 6 month .
the target haemoglobin concentration in two study be & gt ; 13 g / dl ; in the remain three study it be 12 - 14 g / dl .
3 year
România Mediplus Exim SRL Tel . : + 4021 301 74 74
or Dompé Biotec S. p . a .
if you stop take Tamiflu
isolated case of rhabdomyolysis have be report .
in 6 of these patient follow-up now exceed 4 year .
13 .
method AND ROUTE ( S ) OF ADMINISTRATION
if their symptom be the same a yours .
of those 23 child , 21 be evaluable for comparison of pharmacokinetics with adult ( twelve child over 12 year , nine child between 6 and 12 year ) .
there be no experience in child .
N. V .
MARKETING Authorisation Holder Merck Sharp & amp ; Dohme Ltd .
5 .
other INFORMATION
European Medicines Agency Veterinary Medicines and Inspections
pregnancy and breast-feeding
possible side effect 5 .
2 .
take other medicine Please tell your doctor or nurse if you be use or have recently use any other medicine include medicine obtain without a prescription and herbal preparation .
these be reversible upon discontinuation of the infusion .
itraconazole , a potent CYP3A4 inhibitor , at 200 mg / day orally for 4 day have no significant effect on the pharmacokinetics of intravenous fentanyl .
18 % ( 19 % )
medicinal product subject to medical prescription
Vertigo
in an analysis of patient who survive an ischaemic event , prasugrel be associate with a reduction in the incidence of subsequent primary endpoint event ( 7.8 % for prasugrel v 11.9 % for clopidogrel ) .
Post-operative pain : single intravenous or subcutaneous injection .
Special precaution for storage
Ltd .
further INFORMATION
Ibritumomab have be design to target an antigen , CD20 , which be present on the surface of all B-lymphocytes .
- Renal and urinary disorder :
reconstitute Vidaza should be inject subcutaneously ( insert the needle at a 45-90o angle ) use a 25-gauge needle into the upper arm , thigh or abdomen .
ATC code :
ethinyloestradiol :
name OF THE MEDICINAL PRODUCT
possible SIDE EFFECTS
hard capsule
in diabetic patient the metabolic effect of testosterone may decrease blood glucose and therefore insulin requirement .
capsule content :
other SPECIAL WARNING ( S ) , IF NECESSARY
shake the vial vigorously for at least 10 second until obtain a homogeneous suspension .
population pharmacokinetic evaluation have reveal no evidence of clinically significant race-related difference or effect from smoke upon the pharmacokinetics of aripiprazole .
note :
oral use
Italia Pfizer Italia S.r.l .
Idursulfase have a molecular weight of approximately 76 kD .
oral use
administer one dose ( 1ml ) , by intramuscular injection , preferably in the neck region , accord to the following schedule : • Primary vaccination course : first injection from 5-6 month of age , second injection 4-6 week later • Revaccination :
solution for injection IV or IM
before YOU TAKE FARESTON
if the clinical response of the patient ( fatigue , haemoglobin response ) be inadequate after nine week , further therapy may not be effective .
test your urine or blood , follow your ‘ sick rule ’ , and tell your doctor .
- if you have previously receive a transplant that fail after only a short time or ,
similar dermal lesion , which be describe a palmar-plantar erythrodysesthesia be also observe in patient after long-term intravenous infusion ( see section 4.8 ) .
when use a proprietary immunoassay system , always refer to the manufacturer ’ s information to correlate value to a reference chromatographic assay .
what REFLUDAN IS AND WHAT IT IS USED FOR
for information on conversion from ciclosporin to & lt ; Invented name & gt ; , see below under “ Dose adjustment in specific patient population ” .
Purevax RCCh should not be use in pregnant cat .
hyperkalaemia
keep out of the reach and sight of child
serious haemorrhage , haemorrhage of operative wound , vasculitis , hypotension
follitropin alfa be make from genetically engineer Chinese Hamster Ovary ( CHO ) cell .
in the remain third the serum creatinine increase do not always respond to a dose reduction or a dose interruption .
6.5 Nature and content of container
Nederland Novartis Pharma B. V .
nausea
renal dysfunction :
PBPC mobilisation should be consider only in donor who meet normal clinical and laboratory eligibility criterion for stem cell donation with special attention to haematological value and infectious disease .
for the purpose of ambulatory use , the product may be remove from the refrigerator for one single period of up to 3 month at a temperature not above 25oC without exceed the expiry date .
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
method OF ADMINISTRATION
female patient
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
43 PACKAGE LEAFLET :
France Wyeth Pharmacurticals France Tél : + 33 1 41 02 70 00 Fax : + 33 1 41 02 70 10
solution for injection
9 .
the benefit of Agenerase oral solution boost with ritonavir have not be demonstrate either in PI naïve patient or in PI experience patient .
what Liprolog 100 U / ml solution for injection in vial contains
terfenadine 120 Katwijk
do not take Nifedipine Pharmamatch retard
PHARMACEUTICAL FORM
11 .
side effect that occur during clinical trial with Rotarix be a follow :
serious side effect .
clinical study in chronic myeloid leukaemia The effectiveness of Glivec be base on overall haematological and cytogenetic response rate and progression-free survival .
do not store the pen with the needle attach .
information IN BRAILLE
name OF THE MEDICINAL PRODUCT
1 single use pre-filled syringe
3 .
the vaccine be to be administer aseptically by intramuscular injection closely behind the ear of the
the use of sugammadex in patient with severe renal impairment be not recommend .
withdraw the needle at the same angle a it be insert .
2 .
3 .
for intravenous infusion after dilution The diluted product should be use immediately Read the package leaflet before use
anidulafungin have a predominant elimination half-life of approximately 24 hour that characterize the majority of the plasma concentration-time profile , and a terminal half-life of 40-50 hour that characterise the terminal elimination phase of the profile .
62.8 ( 169 / 269 ) 55.2 , 70.4
R & gt ; 0.5 mg / L
in the absence of metabolic inhibitor , renal clearance account for le than 25 % of total clearance of maraviroc and hence renal impairment be not expect to significantly alter maraviroc exposure .
use the injection technique show by your doctor or nurse .
calcium folinate 20 mg / m ² by bolus i. v. injection or 200 to 500 mg / m ² a i. v. infusion over a period of 2 hour plus 500 mg / m ² 5-fluorouracil a i. v. bolus injection in the middle or at the end of the calcium folinate infusion .
the expiry date refers to the last day of that month .
76 interrupt therapy with other antiretroviral agent to avoid development of resistant virus ( see section 4.8 ) .
the predominant pharmacologic activity be from the parent , olanzapine .
up to 4 week or until sign of disease disappear
2839-2848 .
vardenafil be an oral therapy for the improvement of erectile function in men with erectile dysfunction .
elderly Healthy elderly subject ( 65 year or over ) , have a lower oral clearance of tadalafil , result in 25 % higher exposure ( AUC ) relative to healthy subject age 19 to 45 year .
2 .
Humalog Mix25 be a premixed suspension .
EU / 1 / 03 / 248 / 009-012
if there be particle in the injection solution or if either the powder or solution be discolour , the product will not be use .
4 .
B .
HEXAL AG Industriestrasse 25 D-83607 Holzkirchen
Tel : + 421 ( 0 ) 2 48261111
this may contribute to skeletal disease burden in Gaucher disease .
what CIPROFLOXACIN BAYER IS AND WHAT IT IS USED FOR
DATE OF REVISION OF THE TEXT
4 .
1 .
diarrhoea Vomiting Rectal disorder Rectal tenesmus Dry mouth
DATE OF REVISION OF THE TEXT
4.4 Special warning and precaution for use
absorption :
expiry DATE
ABILIFY be not approve for the treatment of dementia-related psychosis .
the effect of meal content on nelfinavir exposure be investigate in a study use the 250 mg film-coated tablet formulation .
© European Medicines Agency , 2008 .
instruction ON USE
Tel : + 351 21 412 82 00 Fax : + 351 21 412 01 11
ROUTE of Administration
HCV / HIV Co-infection The recommended duration of dose for HCV / HIV co-infected patient be 48 week , regardless of genotype .
85 / 94 4 POSSIBLE SIDE EFFECTS
vascular disorder
what be Emadine ?
due to intra-patient variability , occasional individual haemoglobin value for a patient above and below the desired haemoglobin level may be observe .
it explain how the Committee for Medicinal Products for Human Use ( CHMP ) assess the study perform , to reach their recommendation on how to use the medicine .
6.2 Incompatibilities
IONSYS should be use with caution in patient with hearing impairment who might not be able to hear the audible signal from the system .
effect on response and remission rate , data from ACCENT I ( Week-2 responder ) ACCENT I ( Week-2 responder ) % of Patients
- what you should do in emergency situation when you feel unwell or become ill .
general CLASSIFICATION FOR SUPPLY
30
PegIntron 80 microgram , powder and solvent for solution for injection in pre-filled pen
therefore , routine volume replacement should be perform in such patient .
serum potassium level be not significantly affect by irbesartan alone at the recommended dos .
• Mass spectrometric analysis
in animal study , erythropoietin have be show to decrease foetal body weight , delay ossification and increase foetal mortality when give in weekly dos of approximately 20 time the recommended human weekly dose .
HEXAL Ag Industriestr .
3 .
VIRACEPT 250 mg film-coated tablet .
the WORDS “ FOR ANIMAL TREATMENT ONLY ”
CONDITIONS OF THE MARKETING AUTHORISATION
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
a per the CHMP Guideline on Risk Management Systems for medicinal product for human use , the updated RMP should be submit at the same time a the next Periodic Safety Update Report ( PSUR ) .
some patient may benefit from lower or higher dos within the recommended range of 3 to 12 mg once daily .
the N- desmethylated derivative of ivabradine have be identify a the main active metabolite in human .
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
BATCH
Cmax ( mg / l ) - 1.41 ( 23 % ) , Tmax ( h ) – 2.4 ( 8 % ) and Cmin ( mg / l ) -0.52 ( 45 % ) .
food delay absorption by approximately 1 hour , and increase plasma exposure by 20 to 30 % .
cardiovascular monitoring be necessary to detect possible arrhythmia .
for patient with moderate to severe renal impairment ( creatinine clearance ≥ 10 to & lt ; 50 ml / min ) , the recommended initial dose of INVEGA be 1.5 mg every day , which may be increase to 3 mg once daily after clinical reassessment .
30 40 50 64
not applicable .
International Conference on Harmonisation
result be show in the table below ( result for the group of metastatic and locally advanced patient be derive from exploratory subgroup analysis ) .
duloxetine should be use with caution in patient treat with other medicinal product associate with hepatic injury .
pharmacological PROPERTIES
Roche S. A .
27 4.5 Interaction with other medicinal product and other form of interaction
& lt ; 0.0011
2 morning , 3 even c :
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
film-coated tablet
Angioneurotic oedema
6 .
6 .
the decrease in blood pressure be dose-related for once a day dose with a tendency towards plateau at dos above 300 mg .
EU / 1 / 02 / 230 / 017
- headache
if during treatment with somatropin patient show sign of upper airway obstruction ( include onset of or increase snore ) , treatment should be interrupt , and a new ENT assessment perform .
after release and absorption of the final dose the plasma concentration decrease , show the same half-life value that be observe with oral formulation .
independent of erythropoietin treatment , thrombotic and vascular event may occur in surgical patient with underlying cardiovascular disease follow repeat phlebotomy .
despite these measure , when medicine prepare from human blood or plasma be administer , the possibility of pass on infection can not be totally exclude .
content BY WEIGHT , BY VOLUME OR BY UNIT
common :
solution for injection or infusion
medicinal
CELSENTRI can be take with or without food .
each ml contain 10 mg of the active substance nevirapine
4 .
Diagonal , 605 , 9-1a E-08028 Barcelona Tel : + 34 93 494 9620
statement OF ACTIVE SUBSTANCE ( S )
it have to be ensure that the analysis be carry out by a qualified laboratory .
Biotech 15 %
Veraspir Diskus
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
pegylated
Tractocile be use to delay birth in pregnant woman who be at least 18 year of age , and who be 24 to 33 week pregnant , when they show sign that they may give birth pre-term ( prematurely ) .
ri Store in a refrigerator .
Tandemact be a medicine that contain two active substance , pioglitazone and glimepiride .
there be some case of more severe neutropenia in patient treat with the recommended dos of PegIntron in combination with ribavirin ( WHO grade 3 :
European Medicines Agency
4 .
medicinal product subject to medical prescription .
malignancy
non-clinical data reveal no special hazard for human base on conventional study of safety pharmacology , single dose toxicity , repeat dose toxicity and toxicity to reproduction .
throughout the body .
2 % ) .
this effect be not see at the recommended dose of 10 mg once daily .
the decision to administer recombinant erythropoietin should be base on a benefit-risk assessment with the participation of the individual patient , which should take into account the specific clinical context .
summary OF PRODUCT CHARACTERISTICS
oral use
take other medicine Please tell your doctor if you be take or have recently take any other medicine , include medicine obtain without a prescription .
the body can not get rid of too much uric acid , so it can accumulate in the kidney , cause them to fail ( stop work ) .
for a full list of excipients , see section 6.1 .
pharmacokinetics in special population group
keep the pre-filled syringe in the outer carton , in order to protect from light .
kidney calculus , urine abnormality , albuminuria , hypercalcinuria , nephritis , hyperuricemia
powder :
take special care with Pritor
headache , stomach ulcer , vomit , nausea , constipation , excessive gas in stomach or intestine , rash , itch , dizziness , abnormal touch sensation .
only 1-3 % be excrete a the unmodified compound .
- Ribavirin capsule should not be use by child weigh le than 47 kg .
please make sure to select an appropriate dosage form and strength .
peak plasma concentration occur at 1.5-2 hour after oral administration for irbesartan and 1-2.5 hour for hydrochlorothiazide .
what OPTISON be and what it be use for 2 .
activate charcoal may be useful in the treatment of overdose .
whether the neurological disorder be transient or permanent be currently unknown .
follow the instruction and recommendation from your doctor regard the use of NovoRapid in a pump .
for your convenience , place a sticker on your calendar each week a a reminder to take your ADROVANCE .
pharmacovigilance system The MAH must ensure that the system of pharmacovigilance , a describe in version 2 ( date 5 July 2006 ) present in Module 1.8.1. of the Marketing Authorisation Application , be in place and functioning before and whilst the product be on the market .
concentrate and diluent for solution for infusion :
insulin lispro maintain more rapid absorption when compare to soluble human insulin in patient with renal impairment .
pharmacokinetics in special group Elderly and debilitated patient may have reduce clearance of fentanyl lead to prolong terminal half life .
5 .
3 .
Tel : + 42 - ( 1 ) 259 202 020
suggested measure include induction of emesis and / or gastric lavage .
Retrospective
3 Name approval pending 5 Member State
however , case of severe hepatic toxicity , include fulminant hepatic necrosis , have occur in
other
each capsule contain sunitinib malate , equivalent to 12.5 mg of sunitinib
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
6 .
this metabolite be mainly excrete unchanged via the bile .
increase blood urea nitrogen ( BUN ) and creatinine be observe in several of these animal .
6.6 Special precaution for disposal and other handling
common :
however , the medicinal product do not appear to undergo significant enterohepatic recirculation .
1 ml :
16.06.97
when normalise to body surface area , the exposure to rivastigmine and it metabolite be approximately equivalent to the maximum recommend human dose of 12 mg / day ; however , when compare to the maximum human dose , a multiple of approximately 6-fold be achieve in animal .
any unused veterinary medicinal product or waste material derive from such veterinary medicinal product should be dispose of in accordance with local requirement .
use patch still contain some active hormone .
the reduction of urinary GAG excretion be somewhat le in patient for whom circulate anti-idursulfase antibody be detect .
by block the receptor to which angiotensin II normally attach , irbesartan stop the hormone have an effect , allow the blood vessel to widen .
4.6 Pregnancy and lactation
dose recommendation – Adults and adolescent over 12 year :
referral illustrate the difficulty in administer and facilitate the adoption of decision in relation to an entire class involve numerous
common Rash * * Uncommon Dermatitis , urticaria , pruritus
5 ml ( 20 mg / ml )
14 .
possible SIDE EFFECTS
2 .
the CHMP have recommend the amendment of the Marketing Authorisations for which the Summary of Product Characteristics , Labelling and Package Leaflet be set out in Annex III of the CHMP Opinion for Prograf and associate name ( see Annex I ) .
this will help to protect against equine influenza and tetanus .
PHARMACEUTICAL FORM AND CONTENTS
300
keep out of the reach and sight of child .
the safety and efficacy of combination of CIALIS and other treatment for erectile dysfunction have not be study .
close monitoring of glycaemic control should be consider ( see section 4.4 ) .
47 % 41 % 48 %
Tel : + 34 ( 91 ) 663 50 00
store in a refrigerator ( 2 ° C - 8 ° C ) .
psychiatric Disorders
instruction for use and handling :
medicine should not be dispose of via wastewater or household waste .
your doctor or nurse will have already advise you where to inject ( e. g. tummy , front of thigh ) .
15 1 .
Τηλ : + 357 22 871600
blister
dose increase must not be make more frequently than once every four week .
6.1 List of excipients
before first use , the pen must be store at room temperature for 1 to 2 hour .
the physiological response to acute physical exercise , reduction of insulin secretion , be still present under glimepiride .
400 q12h
repaglinide be also indicate in combination with metformin in type 2 diabetes patient who be not satisfactorily control on metformin alone .
1.1 ml
what Actrapid contains
4 vial
risperidone
1 ) Setting up
20 , 30 , 60 , 90 or 100 tablet .
from clinical investigation it be know that major hypoglycaemia , define a need for assistance
Diovan
4.9 Amounts to be administer and administration route
PHARMACEUTICAL PARTICULARS
read the package leaflet before use
oral use
Hotemin
4 .
before initiation of combination treatment , contraindication for concomitantly use chemotherapeutic agent or radiation therapy must be consider .
9 .
your doctor may change the number of infusion depend on your disease .
gastrointestinal haemorrhage
in the absence of compatibility study , this medicinal product must not be mix with other medicinal product .
Dr E .
therefore patient should be monitor for sign of suicidal ideation and behaviour and appropriate treatment should be consider .
the maximum report dose of 120 mg / day for four day , then 180 mg / day for seven day be not associate with any symptom .
5 .
co-administration with food do not alter the extent of absorption .
total REVENUE
Impairments of sperm parameter have be observe among some patient treat with Rapamune .
reproductive system and breast disorder
an increase relative risk of thromboembolic event ( RR 1.67 , 95 % CI :
6.1 List of excipients
example include :
if it occur , appropriate dose adjustment should be make a provided .
consequently , the occurrence of these adverse response may be expect in human clinical use of micafungin .
keep out of the reach and sight of child .
België / Belgique / Belgien UCB Pharma SA / NV Tel / Tél : + 32 / ( 0 ) 2 559 92 00
in healthy subject , the serum half-life of insulin be approximately 4 to 6 minute .
European PUBLIC ASSESSMENT REPORT ( EPAR )
induction of CYP1A2 The metabolism of olanzapine may be induce by smoke and carbamazepine , which may lead to reduced olanzapine concentration .
in general , to prevent hypoglycaemia you must eat more food and monitor your blood sugar .
53.6 ( 15 / 28 )
pulmonary eosinophilia
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
PHARMACEUTICAL FORM AND CONTENTS
OÜ Berlin-Chemie Menarini Eesti Tel : + 372 667 5001
each patch release 3 mg of rotigotine per 24 hour .
the magnitude of these effect be small and have little clinical importance .
adverse reaction observe in animal study with possible clinical relevance be a follow :
60 , 90 and 120 mg Aluminum / aluminium blister in pack contain 2 , 5 , 7 , 10 , 14 , 20 , 28 , 30 , 50 , 84 , 98 or 100 tablet .
a
20 mg
15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING BOX OF 1 BOTTLE , 5 ml & amp ; 10 ml .
what benefit have Binocrit show during the study ?
6 .
this medicinal product contain le than 1 mmol ( 23 mg ) sodium per dose , i.e . it be essentially ‘ sodium-free ’ .
( p & lt ; 0.001 ) 1.1
see the box at the end of this leaflet for further information .
4 .
69 It be essential to maintain good control of the insulin-treated ( insulin-dependent or gestational diabetes ) patient throughout pregnancy .
ER sodium chloride , polysorbate 20 and water for injection . ng 4 .
capsule
15 mg
the population include 27.8 % woman , 58.4 % patient ≥ 60 year ( 26 % ≥ 70 year ) and 54.5 % patient who receive fibrinolytics .
manufacturer Bristol-Myers Squibb Champ & quot ; Lachaud & quot ; , La Goualle F- 19250 Meymac France
note that the 2.5 mg once-daily tablet use in the study be no longer authorise .
there may be a degree of interpatient variability in response to FSH administration , with a poor response to FSH in some patient .
in these 52-week duration study , patient receive treatment for 12 week , follow by a 40-week non- treatment phase .
Retacrit
Hepatobiliary disorder
